OG_ID,loading,group_id,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_02472,0.492204779056719,OG_02472,FUN_009674-T1,Peve_00009258,Pocillopora_meandrina_HIv1___RNAseq.g24570.t1,three_way,65.10866666666666,FUN_009674-T1,Q7ZW47,,,,,34.7,625.0,1.4e-71,272.3,sp|Q7ZW47|STAU2_DANRE Double-stranded RNA-binding protein Staufen homolog 2 OS=Danio rerio OX=7955 GN=stau2 PE=2 SV=2,,,,,,
OG_04464,0.4844936711503125,OG_04464,FUN_019346-T1,Peve_00032914,Pocillopora_meandrina_HIv1___RNAseq.g20864.t1,three_way,58.6805,FUN_019346-T1,Q80XP9,WNK3_MOUSE,,Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3),Mus musculus (Mouse),68.5,378.0,6e-143,510.8,sp|Q80XP9|WNK3_MOUSE Serine/threonine-protein kinase WNK3 OS=Mus musculus OX=10090 GN=Wnk3 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005912; GO:0005923; GO:0006884; GO:0007231; GO:0010765; GO:0010800; GO:0035633; GO:0043066; GO:0044325; GO:0050801; GO:0051928; GO:0070294; GO:0071474; GO:0072659; GO:0090188; GO:0090279; GO:0106310; GO:0140693; GO:0140694; GO:0141109; GO:1903077; GO:1903078; GO:1904062; GO:2000651,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; maintenance of blood-brain barrier [GO:0035633]; membraneless organelle assembly [GO:0140694]; monoatomic ion homeostasis [GO:0050801]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; osmosensory signaling pathway [GO:0007231]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of calcium ion import [GO:0090279]; regulation of monoatomic cation transmembrane transport [GO:1904062]; renal sodium ion absorption [GO:0070294],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transmembrane transporter binding [GO:0044325]; transporter activator activity [GO:0141109],GO:0003014; GO:0003824; GO:0016740; GO:0060090; GO:0072659; GO:0098772; GO:0140096,"renal system process; catalytic activity; transferase activity; molecular adaptor activity; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03779,0.4664345850937053,OG_03779,FUN_015109-T1,Peve_00024001,Pocillopora_meandrina_HIv1___RNAseq.g21738.t1,three_way,67.93483333333333,FUN_015109-T1,Q9QXZ0,MACF1_MOUSE,,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 (Actin cross-linking family 7)",Mus musculus (Mouse),25.3,2944.0,1.6e-256,890.6,"sp|Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 OS=Mus musculus OX=10090 GN=Macf1 PE=1 SV=2",GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005938; GO:0006620; GO:0007163; GO:0008017; GO:0008104; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893; GO:0150011,cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011],GO:0003824; GO:0005794; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0042060; GO:0043226; GO:0048870; GO:0072659,catalytic activity; Golgi apparatus; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; wound healing; organelle; cell motility; protein localization to plasma membrane
OG_07641,0.4571540058690896,OG_07641,FUN_034420-T1,Peve_00021291,Pocillopora_meandrina_HIv1___RNAseq.g28575.t1,three_way,76.00066666666666,FUN_034420-T1,Q32LP4,S4A10_BOVIN,,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),Bos taurus (Bovine),48.4,1093.0,1.6000000000000002e-273,944.1,sp|Q32LP4|S4A10_BOVIN Sodium-driven chloride bicarbonate exchanger OS=Bos taurus OX=9913 GN=SLC4A10 PE=2 SV=1,GO:0005452; GO:0005886; GO:0007601; GO:0008509; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0030425; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0051453; GO:0055085; GO:0098794; GO:0098982,bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; transmembrane transport [GO:0055085]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202],monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_09597,0.4569890665248489,OG_09597,FUN_041744-T1,Peve_00000340,Pocillopora_meandrina_HIv1___RNAseq.g15789.t1,three_way,72.12516666666667,,,,,,,,,,,,,,,,,
OG_03674,0.4513699121575653,OG_03674,FUN_014925-T1,Peve_00006270,Pocillopora_meandrina_HIv1___RNAseq.g21082.t1,three_way,77.86116666666666,FUN_014925-T1,Q9I9E0,,,,,43.7,581.0,9.9e-52,206.5,sp|Q9I9E0|TAOK3_CHICK Serine/threonine-protein kinase TAO3 OS=Gallus gallus OX=9031 GN=TAOK3 PE=2 SV=2,,,,,,
OG_09988,0.4495104373970358,OG_09988,FUN_043182-T1,Peve_00043027,Pocillopora_meandrina_HIv1___RNAseq.g6806.t1,three_way,59.36083333333333,FUN_043182-T1,Q9Z136,,,,,38.8,361.0,3.4e-62,241.9,sp|Q9Z136|TSC1_RAT Hamartin OS=Rattus norvegicus OX=10116 GN=Tsc1 PE=1 SV=1,,,,,,
OG_02930,0.4492696069195749,OG_02930,FUN_012029-T1,Peve_00044958,Pocillopora_meandrina_HIv1___RNAseq.g24045.t1,three_way,82.663,FUN_012029-T1,P11533,,,,,29.7,3968.0,0.0,1575.5,sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1,,,,,,
OG_07716,0.4423038586325293,OG_07716,FUN_034870-T1,Peve_00005769,Pocillopora_meandrina_HIv1___RNAseq.g27159.t1,three_way,54.551,FUN_034870-T1,Q91Y77,,,,,29.8,423.0,2.3e-49,198.7,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_07233,0.4422475933380078,OG_07233,FUN_032906-T1,Peve_00014529,Pocillopora_meandrina_HIv1___RNAseq.g24991.t1,three_way,83.96633333333334,FUN_032906-T1,Q14671,,,,,46.1,1272.0,9e-53,210.7,sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3,,,,,,
OG_09808,0.4372272451105322,OG_09808,FUN_042630-T1,Peve_00033746,Pocillopora_meandrina_HIv1___RNAseq.g11507.t1,three_way,66.90383333333334,FUN_042630-T1,Q8TEK3,DOT1L_HUMAN,,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)",Homo sapiens (Human),42.8,636.0,2.0999999999999998e-129,465.7,"sp|Q8TEK3|DOT1L_HUMAN Histone-lysine N-methyltransferase, H3 lysine-79 specific OS=Homo sapiens OX=9606 GN=DOT1L PE=1 SV=3",GO:0000077; GO:0000781; GO:0003676; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0010467; GO:0031151; GO:0031509; GO:0032200; GO:0032259; GO:0032991; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:0140938; GO:0140956; GO:2000677,DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; subtelomeric heterochromatin formation [GO:0031509]; telomere organization [GO:0032200],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K79 methyltransferase activity [GO:0031151]; histone H3K79 trimethyltransferase activity [GO:0140956]; histone methyltransferase activity [GO:0042054]; nucleic acid binding [GO:0003676]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0032200; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; telomere organization; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_05785,0.4361991736140399,OG_05785,FUN_025760-T1,Peve_00041463,Pocillopora_meandrina_HIv1___RNAseq.g10421.t1,three_way,74.163,FUN_025760-T1,Q566I1,,,,,31.3,518.0,1.4e-47,193.0,sp|Q566I1|IN80D_XENLA INO80 complex subunit D OS=Xenopus laevis OX=8355 GN=ino80d PE=2 SV=1,,,,,,
OG_08878,0.4319784363492051,OG_08878,FUN_038277-T1,Peve_00041700,Pocillopora_meandrina_HIv1___TS.g8098.t1,three_way,74.06316666666667,FUN_038277-T1,Q0V8S9,,,,,34.8,135.0,1.4e-13,84.7,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_04880,0.4309557581255104,OG_04880,FUN_022914-T1,Peve_00001826,Pocillopora_meandrina_HIv1___RNAseq.g3710.t1,three_way,80.40933333333334,FUN_022914-T1,Q63028,ADDA_RAT,,Alpha-adducin (Erythrocyte adducin subunit alpha),Rattus norvegicus (Rat),47.2,375.0,3.7e-87,323.9,sp|Q63028|ADDA_RAT Alpha-adducin OS=Rattus norvegicus OX=10116 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0005200; GO:0005516; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006811; GO:0006884; GO:0007010; GO:0008290; GO:0014069; GO:0016020; GO:0020027; GO:0030218; GO:0030425; GO:0030507; GO:0030837; GO:0035264; GO:0042608; GO:0042803; GO:0043197; GO:0045202; GO:0045766; GO:0045807; GO:0046982; GO:0046983; GO:0048471; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0061629; GO:0071277; GO:0071300; GO:1903142; GO:1903393,actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; cytoskeleton organization [GO:0007010]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; monoatomic ion transport [GO:0006811]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; T cell receptor binding [GO:0042608],GO:0005198; GO:0005634; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; nucleus; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_04165,0.4280824244111734,OG_04165,FUN_016646-T1,Peve_00042745,Pocillopora_meandrina_HIv1___RNAseq.g199.t1,three_way,51.387166666666666,FUN_016646-T1,P30173,,,,,42.1,378.0,2.2e-80,302.4,sp|P30173|ACT13_SOLTU Actin-101 OS=Solanum tuberosum OX=4113 GN=AC101 PE=3 SV=1,,,,,,
OG_02309,0.4274159729107415,OG_02309,FUN_008889-T1,Peve_00020945,Pocillopora_meandrina_HIv1___RNAseq.g4003.t1,three_way,51.47683333333334,FUN_008889-T1,D3Z8E6,CAMP1_RAT,,Calmodulin-regulated spectrin-associated protein 1,Rattus norvegicus (Rat),43.7,142.0,7.000000000000001e-32,142.1,sp|D3Z8E6|CAMP1_RAT Calmodulin-regulated spectrin-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Camsap1 PE=1 SV=2,GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0036449; GO:0051011,cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule minus-end [GO:0036449],calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507],GO:0007010; GO:0008092,cytoskeleton organization; cytoskeletal protein binding
OG_08049,0.42521759433954,OG_08049,FUN_035737-T1,Peve_00044088,Pocillopora_meandrina_HIv1___RNAseq.g11864.t1,three_way,77.52216666666666,FUN_035737-T1,Q8BYH8,CHD9_MOUSE,,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.-) (ATP-dependent helicase CHD9) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),Mus musculus (Mouse),43.2,2161.0,0.0,1496.1,sp|Q8BYH8|CHD9_MOUSE Chromodomain-helicase-DNA-binding protein 9 OS=Mus musculus OX=10090 GN=Chd9 PE=1 SV=2,GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005829; GO:0006325; GO:0016887,chromatin organization [GO:0006325],cytosol [GO:0005829]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0140657,DNA binding; catalytic activity; nucleoplasm; cytosol; chromatin organization; hydrolase activity; isomerase activity; ATP-dependent activity
OG_09806,0.4217823549212687,OG_09806,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_07718,0.421433782394141,OG_07718,FUN_034873-T1,Peve_00005762,Pocillopora_meandrina_HIv1___RNAseq.g27162.t1,three_way,90.15966666666668,FUN_034873-T1,A1L3F5,,,,,44.8,724.0,1.6e-163,577.8,sp|A1L3F5|CMIP_XENLA C-Maf-inducing protein OS=Xenopus laevis OX=8355 GN=cmip PE=2 SV=2,,,,,,
OG_01630,0.4196907535620283,OG_01630,FUN_006744-T1,Peve_00039581,Pocillopora_meandrina_HIv1___RNAseq.g20530.t1,three_way,63.90916666666666,FUN_006744-T1,Q8BNA6,FAT3_MOUSE,,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Mus musculus (Mouse),33.8,4122.0,0.0,2094.3,sp|Q8BNA6|FAT3_MOUSE Protocadherin Fat 3 OS=Mus musculus OX=10090 GN=Fat3 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:1904936; GO:2000171,cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842],dendrite [GO:0030425]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0048856; GO:0048870,plasma membrane; cell adhesion; anatomical structure development; cell motility
OG_02112,0.4162402118968828,OG_02112,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_04454,0.414369016591737,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,41.9,508.0,1.3e-103,382.9,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04454,0.414369016591737,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,32.7,107.0,8.6e-10,71.2,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_03482,0.4142946936623456,OG_03482,FUN_014584-T1,Peve_00001487,Pocillopora_meandrina_HIv1___RNAseq.g22720.t1,three_way,49.659333333333336,FUN_014584-T1,Q1L5Z9,LONF2_HUMAN,,LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192),Homo sapiens (Human),31.0,625.0,2.6999999999999993e-68,261.5,sp|Q1L5Z9|LONF2_HUMAN LON peptidase N-terminal domain and RING finger protein 2 OS=Homo sapiens OX=9606 GN=LONRF2 PE=1 SV=3,GO:0005737; GO:0006515; GO:0008270; GO:0021522; GO:0031175; GO:0043021; GO:0043524; GO:0050905; GO:0051402; GO:0051787; GO:0061630; GO:0061744,motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; spinal cord motor neuron differentiation [GO:0021522],cytoplasm [GO:0005737],misfolded protein binding [GO:0051787]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0012501; GO:0016740; GO:0030154; GO:0050877; GO:0140096,"catalytic activity; programmed cell death; transferase activity; cell differentiation; nervous system process; catalytic activity, acting on a protein"
OG_04359,0.4132650799752208,OG_04359,FUN_018010-T1,Peve_00000404,Pocillopora_meandrina_HIv1___RNAseq.g25255.t4,three_way,81.14033333333334,FUN_018010-T1,A2CG49,,,,,35.3,3036.0,0.0,1707.6,sp|A2CG49|KALRN_MOUSE Kalirin OS=Mus musculus OX=10090 GN=Kalrn PE=1 SV=1,,,,,,
OG_06004,0.4116776295449174,OG_06004,FUN_026494-T1,Peve_00004180,Pocillopora_meandrina_HIv1___RNAseq.g4199.t1,three_way,63.488,FUN_026494-T1,Q71M21,,,,,28.2,1343.0,2.3000000000000001e-88,329.7,sp|Q71M21|RH21B_XENLA Rho GTPase-activating protein 21-B OS=Xenopus laevis OX=8355 GN=arhgap21-b PE=2 SV=1,,,,,,
OG_04759,0.4079313803160345,OG_04759,FUN_022649-T1,Peve_00019793,Pocillopora_meandrina_HIv1___RNAseq.g4450.t2,three_way,87.07466666666667,FUN_022649-T1,Q6ZWH5,NEK10_HUMAN,,Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10),Homo sapiens (Human),45.7,1046.0,4.3e-211,736.5,sp|Q6ZWH5|NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens OX=9606 GN=NEK10 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911,mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372],extracellular region [GO:0005576]; protein kinase complex [GO:1902911],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003016; GO:0003824; GO:0005576; GO:0007018; GO:0016740; GO:0140096,"respiratory system process; catalytic activity; extracellular region; microtubule-based movement; transferase activity; catalytic activity, acting on a protein"
OG_05958,0.4067733564741577,OG_05958,FUN_026305-T1,Peve_00025709,Pocillopora_meandrina_HIv1___RNAseq.g3058.t1,three_way,89.43866666666666,FUN_026305-T1,P21613,,,,,58.8,972.0,2.4e-239,830.5,sp|P21613|KINH_DORPE Kinesin heavy chain OS=Doryteuthis pealeii OX=1051067 PE=1 SV=1,,,,,,
OG_01522,0.4067223334945673,OG_01522,FUN_006276-T1,Peve_00031100,Pocillopora_meandrina_HIv1___RNAseq.g20369.t1,three_way,84.9125,FUN_006276-T1,Q8K5C0,GRHL2_MOUSE,,Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3),Mus musculus (Mouse),32.7,620.0,2.6999999999999998e-70,268.1,sp|Q8K5C0|GRHL2_MOUSE Grainyhead-like protein 2 homolog OS=Mus musculus OX=10090 GN=Grhl2 PE=2 SV=1,GO:0001161; GO:0001228; GO:0001701; GO:0001843; GO:0003208; GO:0003382; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005911; GO:0006355; GO:0006357; GO:0007155; GO:0007420; GO:0008544; GO:0010468; GO:0016020; GO:0021915; GO:0030216; GO:0030323; GO:0031490; GO:0034329; GO:0035264; GO:0042733; GO:0042802; GO:0043010; GO:0043565; GO:0045893; GO:0045944; GO:0048568; GO:0048701; GO:0060324; GO:0060463; GO:0060487; GO:0060672; GO:0061713; GO:0070830; GO:0090132; GO:0140297,anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory tube development [GO:0030323],cell-cell junction [GO:0005911]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007155; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell adhesion; cell differentiation; cell junction organization; organelle; anatomical structure development; transcription regulator activity
OG_04351,0.4065272074682835,OG_04351,FUN_017990-T1,Peve_00037470,Pocillopora_meandrina_HIv1___RNAseq.g25285.t1,three_way,80.066,FUN_017990-T1,Q16665,,,,,40.2,388.0,3.2e-77,291.2,sp|Q16665|HIF1A_HUMAN Hypoxia-inducible factor 1-alpha OS=Homo sapiens OX=9606 GN=HIF1A PE=1 SV=1,,,,,,
OG_06372,0.4065087792628508,OG_06372,FUN_028977-T1,Peve_00014804,Pocillopora_meandrina_HIv1___RNAseq.g25607.t1,three_way,64.57616666666667,FUN_028977-T1,Q3UG20,KMT2E_MOUSE,,Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog),Mus musculus (Mouse),30.4,460.0,1e-47,194.1,sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2,GO:0000791; GO:0002446; GO:0003713; GO:0005737; GO:0005813; GO:0008270; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0035064; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:1900087,epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; retinoic acid receptor signaling pathway [GO:0048384],centrosome [GO:0005813]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005815; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"immune system process; catalytic activity; microtubule organizing center; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_04983,0.4055759057561268,OG_04983,FUN_023110-T1,Peve_00000494,Pocillopora_meandrina_HIv1___RNAseq.g1701.t2,three_way,63.913,FUN_023110-T1,Q8IUR6,,,,,61.0,59.0,2e-11,71.6,sp|Q8IUR6|CRERF_HUMAN CREB3 regulatory factor OS=Homo sapiens OX=9606 GN=CREBRF PE=1 SV=2,,,,,,
OG_06571,0.4035254374910201,OG_06571,FUN_029484-T1,Peve_00017245,Pocillopora_meandrina_HIv1___RNAseq.g17128.t1,three_way,64.353,FUN_029484-T1,Q8NEA6,GLIS3_HUMAN,,Zinc finger protein GLIS3 (GLI-similar 3) (Zinc finger protein 515),Homo sapiens (Human),64.3,70.0,4.8e-23,110.9,sp|Q8NEA6|GLIS3_HUMAN Zinc finger protein GLIS3 OS=Homo sapiens OX=9606 GN=GLIS3 PE=1 SV=5,GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008270; GO:0045944,negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_01314,0.4022073277094747,OG_01314,FUN_005177-T1,Peve_00022720,Pocillopora_meandrina_HIv1___RNAseq.g7584.t1,three_way,78.689,FUN_005177-T1,Q7Z401,MYCPP_HUMAN,,C-myc promoter-binding protein (DENN domain-containing protein 4A),Homo sapiens (Human),34.8,1885.0,8.6e-282,971.8,sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2,GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483,regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_00388,0.4010764280946303,OG_00388,FUN_001241-T1,Peve_00022814,Pocillopora_meandrina_HIv1___TS.g4819.t1,three_way,90.189,FUN_001241-T1,Q5BJ41,CNOT6_XENLA,,CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase),Xenopus laevis (African clawed frog),59.0,558.0,8e-140,498.8,sp|Q5BJ41|CNOT6_XENLA CCR4-NOT transcription complex subunit 6 OS=Xenopus laevis OX=8355 GN=cnot6 PE=1 SV=1,GO:0000175; GO:0000289; GO:0003713; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0035279; GO:0046872; GO:0070966,"miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]",CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; RNA exonuclease activity [GO:0004532]; transcription coactivator activity [GO:0003713],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0031047; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_06109,0.4001772499796116,OG_06109,FUN_027814-T1,Peve_00036499,Pocillopora_meandrina_HIv1___RNAseq.g13890.t1,three_way,84.264,FUN_027814-T1,O00571,DDX3X_HUMAN,,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)",Homo sapiens (Human),71.5,425.0,1.6999999999999996e-177,623.6,sp|O00571|DDX3X_HUMAN ATP-dependent RNA helicase DDX3X OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=3,GO:0002753; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010628; GO:0010629; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031252; GO:0031333; GO:0031369; GO:0032481; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035591; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043186; GO:0043273; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0070131; GO:0071243; GO:0071470; GO:0071651; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243,cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytosolic ribosome assembly [GO:0042256]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055],cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; signaling adaptor activity [GO:0035591]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0060090; GO:0098542; GO:0098772; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; GTPase activity; extracellular region; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; molecular adaptor activity; defense response to other organism; molecular function regulator activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_00402,0.399294218004506,OG_00402,FUN_001289-T1,Peve_00037015,Pocillopora_meandrina_HIv1___TS.g4708.t1a,three_way,81.49916666666667,FUN_001289-T1,Q9ULJ6,,,,,45.5,1166.0,3.5e-155,550.8,sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3,,,,,,
OG_09596,0.3992828760125964,OG_09596,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_01324,0.3981517400686992,OG_01324,FUN_005194-T1,Peve_00001277,Pocillopora_meandrina_HIv1___RNAseq.g15136.t1,three_way,66.81283333333333,,,,,,,,,,,,,,,,,
OG_05881,0.3978523639967909,OG_05881,FUN_026034-T1,Peve_00022184,Pocillopora_meandrina_HIv1___RNAseq.g10547.t1,three_way,87.94766666666666,FUN_026034-T1,P29074,PTN4_HUMAN,,Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1),Homo sapiens (Human),43.1,929.0,2e-217,757.3,sp|P29074|PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens OX=9606 GN=PTPN4 PE=1 SV=1,GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0035254,protein dephosphorylation [GO:0006470],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00154,0.3968988073488017,OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),47.8,912.0,6.499999999999998e-229,796.2,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_00154,0.3968988073488017,OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),37.4,286.0,1.3e-27,127.5,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_02454,0.3968366628771556,OG_02454,FUN_009532-T1,Peve_00009560,Pocillopora_meandrina_HIv1___RNAseq.g24493.t1,three_way,88.02533333333334,FUN_009532-T1,Q148N0,,,,,64.9,976.0,0.0,1304.7,sp|Q148N0|ODO1_BOVIN 2-oxoglutarate dehydrogenase complex component E1 OS=Bos taurus OX=9913 GN=OGDH PE=1 SV=1,,,,,,
OG_04746,0.3964203558175507,OG_04746,FUN_022627-T1,Peve_00012280,Pocillopora_meandrina_HIv1___RNAseq.g4385.t1,three_way,74.43166666666667,FUN_022627-T1,Q13485,SMAD4_HUMAN,,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),Homo sapiens (Human),52.7,220.0,2.4e-51,205.7,sp|Q13485|SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens OX=9606 GN=SMAD4 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001837; GO:0003148; GO:0003161; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0006357; GO:0006366; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007411; GO:0008283; GO:0008285; GO:0009653; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048665; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0097191; GO:1901203; GO:1902895; GO:1905305,activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412],activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_06181,0.395806804934849,OG_06181,FUN_028088-T1,Peve_00031660,Pocillopora_meandrina_HIv1___TS.g11574.t1,three_way,88.21483333333333,FUN_028088-T1,P18907,,,,,76.6,988.0,0.0,1502.3,sp|P18907|AT1A1_HORSE Sodium/potassium-transporting ATPase subunit alpha-1 OS=Equus caballus OX=9796 GN=ATP1A1 PE=3 SV=1,,,,,,
OG_00213,0.3937926601376929,OG_00213,FUN_000932-T1,Peve_00009724,Pocillopora_meandrina_HIv1___RNAseq.g29460.t1,three_way,85.761,FUN_000932-T1,P00516,,,,,65.8,619.0,1.3e-240,833.9,sp|P00516|KGP1_BOVIN cGMP-dependent protein kinase 1 OS=Bos taurus OX=9913 GN=PRKG1 PE=1 SV=2,,,,,,
OG_01532,0.3937163719305493,OG_01532,FUN_006331-T1,Peve_00012580,Pocillopora_meandrina_HIv1___RNAseq.g20347.t1,three_way,69.86616666666667,FUN_006331-T1,Q92545,TM131_HUMAN,,Transmembrane protein 131 (Protein RW1),Homo sapiens (Human),41.2,1098.0,1.3000000000000002e-218,762.3,sp|Q92545|TM131_HUMAN Transmembrane protein 131 OS=Homo sapiens OX=9606 GN=TMEM131 PE=1 SV=3,GO:0005518; GO:0016020; GO:0032964,collagen biosynthetic process [GO:0032964],membrane [GO:0016020],collagen binding [GO:0005518],,
OG_06592,0.3921043004306556,OG_06592,FUN_029640-T1,Peve_00037895,Pocillopora_meandrina_HIv1___RNAseq.g17204.t1,three_way,61.37616666666666,FUN_029640-T1,A2ARV4,LRP2_MOUSE,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Mus musculus (Mouse),38.1,428.0,4.3e-50,201.4,sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1,GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0016020; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0034311; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045177; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1904888,aorta development [GO:0035904]; cell population proliferation [GO:0008283]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006629; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085,endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; lipid metabolic process; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_09605,0.3911615065533916,OG_09605,FUN_041759-T1,Peve_00041567,Pocillopora_meandrina_HIv1___RNAseq.g15102.t1,three_way,88.23033333333333,FUN_041759-T1,Q7XMK8,,,,,72.9,402.0,1.1e-173,610.9,sp|Q7XMK8|RH6_ORYSJ DEAD-box ATP-dependent RNA helicase 6 OS=Oryza sativa subsp. japonica OX=39947 GN=Os04g0533000 PE=2 SV=1,,,,,,
OG_08594,0.3908659244803555,OG_08594,FUN_037709-T1,Peve_00027437,Pocillopora_meandrina_HIv1___RNAseq.g1402.t1,three_way,58.09033333333333,FUN_037709-T1,E7F1U2,DNMBP_DANRE,,Dynamin-binding protein (Scaffold protein Tuba),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,728.0,7.8e-103,377.5,sp|E7F1U2|DNMBP_DANRE Dynamin-binding protein OS=Danio rerio OX=7955 GN=dnmbp PE=2 SV=1,GO:0001822; GO:0005085; GO:0005737; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793,cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005794; GO:0005856; GO:0043226; GO:0044782; GO:0048856; GO:0098772,Golgi apparatus; cytoskeleton; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_09811,0.3899186835722406,OG_09811,FUN_042633-T1,Peve_00030033,Pocillopora_meandrina_HIv1___RNAseq.19516_t,three_way,82.042,FUN_042633-T1,P08651,NFIC_HUMAN,,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),Homo sapiens (Human),48.2,390.0,3.2e-79,297.7,sp|P08651|NFIC_HUMAN Nuclear factor 1 C-type OS=Homo sapiens OX=9606 GN=NFIC PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006357; GO:0006366; GO:0042475; GO:0045944; GO:1990837,DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA replication; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_06281,0.3895532754815927,OG_06281,FUN_028450-T1,Peve_00002378,Pocillopora_meandrina_HIv1___RNAseq.g16191.t1,three_way,41.13883333333333,FUN_028450-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),28.0,168.0,1.3e-08,62.8,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_04542,0.3892453073886436,OG_04542,FUN_022103-T1,Peve_00009716,Pocillopora_meandrina_HIv1___RNAseq.g4105.t1,three_way,85.40766666666667,FUN_022103-T1,A6H779,FBXL2_BOVIN,,F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2),Bos taurus (Bovine),69.6,102.0,2.1e-37,158.3,sp|A6H779|FBXL2_BOVIN F-box/LRR-repeat protein 2 OS=Bos taurus OX=9913 GN=FBXL2 PE=2 SV=1,GO:0005516; GO:0006513; GO:0010506; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036312; GO:0044830; GO:0050727; GO:0051896; GO:1900226; GO:1990756,modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005],calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_01906,0.3890509254722917,OG_01906,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),61.6,620.0,3.3e-199,697.6,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01906,0.3890509254722917,OG_01906,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),40.4,146.0,3.1999999999999997e-29,132.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_03957,0.3878163213993525,OG_03957,FUN_016102-T1,Peve_00010769,Pocillopora_meandrina_HIv1___RNAseq.g21592.t1,three_way,72.49366666666667,FUN_016102-T1,Q62985,SH2B1_RAT,,SH2B adapter protein 1 (FceRI gamma-chain-interacting protein SH2-B) (SH2 domain-containing protein 1B) (SH2-B PH domain-containing signaling mediator 1),Rattus norvegicus (Rat),39.9,358.0,1.1e-52,209.5,sp|Q62985|SH2B1_RAT SH2B adapter protein 1 OS=Rattus norvegicus OX=10116 GN=Sh2b1 PE=1 SV=1,GO:0005068; GO:0005634; GO:0005737; GO:0005886; GO:0030032; GO:0035556; GO:0045840; GO:0048870; GO:0060391; GO:2000278,cell motility [GO:0048870]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of DNA biosynthetic process [GO:2000278],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0005634; GO:0005886; GO:0043226; GO:0048870; GO:0060090,nucleus; plasma membrane; organelle; cell motility; molecular adaptor activity
OG_09247,0.3875120983111484,OG_09247,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08842,0.3872477739759213,OG_08842,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_05287,0.3870962661625374,OG_05287,FUN_023950-T1,Peve_00017994,Pocillopora_meandrina_HIv1___RNAseq.g18524.t1a,three_way,76.55283333333334,FUN_023950-T1,Q92793,CBP_HUMAN,,CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein lactyltransferas CREBBP) (EC 2.3.1.-) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-),Homo sapiens (Human),41.9,2186.0,0.0,1193.7,sp|Q92793|CBP_HUMAN CREB-binding protein OS=Homo sapiens OX=9606 GN=CREBBP PE=1 SV=3,GO:0000122; GO:0000123; GO:0000785; GO:0001223; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006473; GO:0007165; GO:0007249; GO:0008270; GO:0008589; GO:0016407; GO:0016479; GO:0016604; GO:0018076; GO:0030511; GO:0031490; GO:0031648; GO:0031669; GO:0034644; GO:0042592; GO:0042733; GO:0043426; GO:0043993; GO:0044017; GO:0045893; GO:0045944; GO:0048156; GO:0048511; GO:0061629; GO:0061733; GO:0065003; GO:0120300; GO:0140297; GO:1900034; GO:1900182; GO:1905168,canonical NF-kappaB signal transduction [GO:0007249]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of DNA-templated transcription [GO:0006355]; regulation of smoothened signaling pathway [GO:0008589]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0008092; GO:0016740; GO:0043226; GO:0051604; GO:0060090; GO:0065003; GO:0140096; GO:0140110,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; organelle; protein maturation; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein; transcription regulator activity"
OG_04032,0.386793509652522,OG_04032,FUN_016340-T1,Peve_00044576,Pocillopora_meandrina_HIv1___RNAseq.g9730.t1,three_way,73.72266666666667,FUN_016340-T1,Q6P7A2,UBE4A_RAT,,Ubiquitin conjugation factor E4 A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 A),Rattus norvegicus (Rat),39.6,1095.0,2.2e-194,681.0,sp|Q6P7A2|UBE4A_RAT Ubiquitin conjugation factor E4 A OS=Rattus norvegicus OX=10116 GN=Ube4a PE=2 SV=1,GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0034450; GO:0036503; GO:0061630,ERAD pathway [GO:0036503]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_06961,0.3867347322463446,OG_06961,FUN_032091-T1,Peve_00012819,Pocillopora_meandrina_HIv1___RNAseq.g5277.t1,three_way,71.29066666666667,FUN_032091-T1,Q00IB7,,,,,40.9,952.0,1.5e-190,668.7,sp|Q00IB7|PKHH1_DANRE Pleckstrin homology domain-containing family H member 1 OS=Danio rerio OX=7955 GN=plekhh1 PE=2 SV=1,,,,,,
OG_10051,0.3866147070883992,OG_10051,FUN_043325-T1,Peve_00043035,Pocillopora_meandrina_HIv1___RNAseq.g8952.t1,three_way,72.11733333333333,FUN_043325-T1,Q2HWF0,FBP1L_RAT,,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),Rattus norvegicus (Rat),31.6,604.0,1.9000000000000002e-74,281.6,sp|Q2HWF0|FBP1L_RAT Formin-binding protein 1-like OS=Rattus norvegicus OX=10116 GN=Fnbp1l PE=1 SV=2,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0007399; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0030154; GO:0031410; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320,autophagy [GO:0006914]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; nervous system development [GO:0007399]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886],GTPase binding [GO:0051020]; lipid binding [GO:0008289],GO:0005829; GO:0005856; GO:0005886; GO:0006914; GO:0008289; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0061024,cytosol; cytoskeleton; plasma membrane; autophagy; lipid binding; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; membrane organization
OG_01584,0.3860886649658558,OG_01584,FUN_006621-T1,Peve_00040867,Pocillopora_meandrina_HIv1___RNAseq.g20504.t1,three_way,51.0425,FUN_006621-T1,Q8WWI1,LMO7_HUMAN,,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),Homo sapiens (Human),43.5,131.0,4.7e-23,112.8,sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005635; GO:0005739; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nuclear envelope; mitochondrion; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02516,0.3858568813970299,OG_02516,FUN_010575-T1,Peve_00032734,Pocillopora_meandrina_HIv1___RNAseq.g21523.t1,three_way,73.19066666666667,FUN_010575-T1,Q9C091,GRB1L_HUMAN,,GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein),Homo sapiens (Human),33.4,1940.0,6.8e-250,866.3,sp|Q9C091|GRB1L_HUMAN GREB1-like protein OS=Homo sapiens OX=9606 GN=GREB1L PE=1 SV=2,GO:0001656; GO:0001658; GO:0001822; GO:0002009; GO:0003151; GO:0003231; GO:0016020; GO:0030539; GO:0035050; GO:0042254; GO:0048384; GO:0055007; GO:0060065; GO:0061205; GO:0072177,branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; embryonic heart tube development [GO:0035050]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; morphogenesis of an epithelium [GO:0002009]; outflow tract morphogenesis [GO:0003151]; paramesonephric duct development [GO:0061205]; retinoic acid receptor signaling pathway [GO:0048384]; ribosome biogenesis [GO:0042254]; uterus development [GO:0060065],membrane [GO:0016020],,GO:0022414; GO:0030154; GO:0042254; GO:0048856,reproductive process; cell differentiation; ribosome biogenesis; anatomical structure development
OG_07674,0.385783789593092,OG_07674,FUN_034781-T1,Peve_00029730,Pocillopora_meandrina_HIv1___RNAseq.g12276.t1,three_way,58.02466666666667,FUN_034781-T1,Q6DIJ4,UBP10_XENTR,,Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),43.1,485.0,6.800000000000001e-100,366.7,sp|Q6DIJ4|UBP10_XENTR Ubiquitin carboxyl-terminal hydrolase 10 OS=Xenopus tropicalis OX=8364 GN=usp10 PE=2 SV=1,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344,"autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; rescue of stalled ribosome [GO:0072344]",cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005634; GO:0005768; GO:0006281; GO:0006914; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; DNA repair; autophagy; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_02562,0.3855382157089561,OG_02562,FUN_010661-T1,Peve_00031438,Pocillopora_meandrina_HIv1___RNAseq.g21311.t1,three_way,73.56683333333334,FUN_010661-T1,O43491,E41L2_HUMAN,,Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G),Homo sapiens (Human),49.4,336.0,2.6e-87,325.1,sp|O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1,GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778,actomyosin structure organization [GO:0031032]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778],cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091],actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198],GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,structural molecule activity; nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_02683,0.3854627870322012,OG_02683,FUN_010941-T1,Peve_00005967,Pocillopora_meandrina_HIv1___RNAseq.g21806.t1,three_way,91.54933333333334,FUN_010941-T1,E2QWQ2,NLK_CANLF,,Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase),Canis lupus familiaris (Dog) (Canis familiaris),72.8,390.0,1.6000000000000002e-164,580.5,sp|E2QWQ2|NLK_CANLF Serine/threonine-protein kinase NLK OS=Canis lupus familiaris OX=9615 GN=NLK PE=3 SV=1,GO:0000287; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0007179; GO:0016055; GO:0030178; GO:0031625; GO:0035556; GO:0042169; GO:0050821; GO:0071470; GO:0106310; GO:0140297; GO:1904262; GO:1904894,cellular response to osmotic stress [GO:0071470]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH2 domain binding [GO:0042169]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01954,0.3843782905038624,OG_01954,FUN_008020-T1,Peve_00031302,Pocillopora_meandrina_HIv1___RNAseq.g30341.t1,three_way,85.20216666666667,FUN_008020-T1,P27448,MARK3_HUMAN,,MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78),Homo sapiens (Human),52.2,826.0,3.2000000000000005e-201,703.4,sp|P27448|MARK3_HUMAN MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens OX=9606 GN=MARK3 PE=1 SV=5,GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0048156; GO:0050321; GO:0070062; GO:0106310; GO:1900181,intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005829; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09598,0.3837539447875412,OG_09598,FUN_041745-T1,Peve_00000338,Pocillopora_meandrina_HIv1___RNAseq.g15790.t1,three_way,56.4945,,,,,,,,,,,,,,,,,
OG_01447,0.3836116844051033,OG_01447,FUN_005896-T1,Peve_00035817,Pocillopora_meandrina_HIv1___RNAseq.3177_t,three_way,67.3925,FUN_005896-T1,Q8K2Y0,,,,,39.0,141.0,1.2e-15,86.3,sp|Q8K2Y0|OBI1_MOUSE ORC ubiquitin ligase 1 OS=Mus musculus OX=10090 GN=Obi1 PE=1 SV=2,,,,,,
OG_03209,0.383203719550061,OG_03209,FUN_012701-T1,Peve_00016835,Pocillopora_meandrina_HIv1___RNAseq.g12828.t1,three_way,66.00966666666667,,,,,,,,,,,,,,,,,
OG_09830,0.3831663921207868,OG_09830,FUN_042807-T1,Peve_00003076,Pocillopora_meandrina_HIv1___RNAseq.g7424.t1,three_way,78.86633333333333,FUN_042807-T1,P41240,CSK_HUMAN,,Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL),Homo sapiens (Human),56.1,442.0,8.4e-143,508.4,sp|P41240|CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens OX=9606 GN=CSK PE=1 SV=1,GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0034236; GO:0034332; GO:0035556; GO:0042802; GO:0042997; GO:0045779; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0050860; GO:0050868; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375; GO:1990782,adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; cellular response to peptide hormone stimulus [GO:0071375]; intracellular signal transduction [GO:0035556]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; oligodendrocyte differentiation [GO:0048709]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0140096,"immune system process; catalytic activity; cytosol; plasma membrane; transferase activity; cell differentiation; cell junction organization; organelle; catalytic activity, acting on a protein"
OG_02940,0.3826093823608974,OG_02940,FUN_012049-T1,Peve_00004088,Pocillopora_meandrina_HIv1___RNAseq.g23650.t3,three_way,68.88266666666667,FUN_012049-T1,E7EZG2,MY9AA_DANRE,,Unconventional myosin-IXAa (Myosin IXAa),Danio rerio (Zebrafish) (Brachydanio rerio),33.3,2215.0,4.1e-257,890.2,sp|E7EZG2|MY9AA_DANRE Unconventional myosin-IXAa OS=Danio rerio OX=7955 GN=myo9aa PE=3 SV=1,GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0007626; GO:0008270; GO:0016020; GO:0016459; GO:0035556; GO:0036269; GO:0044295; GO:0045198; GO:0045202; GO:0048675; GO:0051015; GO:0061564; GO:0098529,"axon development [GO:0061564]; axon extension [GO:0048675]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; swimming behavior [GO:0036269]",actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; membrane [GO:0016020]; myosin complex [GO:0016459]; synapse [GO:0045202],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270],GO:0003774; GO:0003824; GO:0007163; GO:0008092; GO:0016853; GO:0030154; GO:0034330; GO:0098772; GO:0140657,cytoskeletal motor activity; catalytic activity; establishment or maintenance of cell polarity; cytoskeletal protein binding; isomerase activity; cell differentiation; cell junction organization; molecular function regulator activity; ATP-dependent activity
OG_00055,0.3825183989266394,OG_00055,FUN_000330-T1,Peve_00033547,Pocillopora_meandrina_HIv1___RNAseq.g29083.t1,three_way,89.4465,FUN_000330-T1,A0A3G2LGI8,,,,,54.5,2571.0,0.0,2154.8,sp|A0A3G2LGI8|TLN_OSCPE Talin OS=Oscarella pearsei OX=1940113 GN=TLN PE=1 SV=1,,,,,,
OG_01740,0.3820836861983352,OG_01740,FUN_007062-T1,Peve_00025326,Pocillopora_meandrina_HIv1___RNAseq.g20109.t1,three_way,70.79983333333334,FUN_007062-T1,Q8IX03,KIBRA_HUMAN,,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),Homo sapiens (Human),29.0,1136.0,8.3e-51,204.1,sp|Q8IX03|KIBRA_HUMAN Protein KIBRA OS=Homo sapiens OX=9606 GN=WWC1 PE=1 SV=1,GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0035329; GO:0035330; GO:0035331; GO:0035591; GO:0043410; GO:0046621; GO:0048471; GO:0060090,cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587],kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005829; GO:0006355; GO:0007163; GO:0043226; GO:0048870; GO:0060090; GO:0140110,nucleus; cytosol; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_00386,0.3814553894024755,OG_00386,FUN_001238-T1,Peve_00002842,Pocillopora_meandrina_HIv1___RNAseq.g2515.t2,three_way,45.375,FUN_001238-T1,Q8IVU1,,,,,32.5,517.0,1.1e-67,260.4,sp|Q8IVU1|IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 OS=Homo sapiens OX=9606 GN=IGDCC3 PE=1 SV=2,,,,,,
OG_07039,0.3808047337140385,OG_07039,FUN_032235-T1,Peve_00043486,Pocillopora_meandrina_HIv1___RNAseq.g24841.t1,three_way,59.83833333333334,,,,,,,,,,,,,,,,,
OG_01290,0.3806353176264245,OG_01290,FUN_005113-T1,Peve_00007463,Pocillopora_meandrina_HIv1___RNAseq.g8268.t1,three_way,72.56616666666666,FUN_005113-T1,O15945,ARNT_DROME,,Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango),Drosophila melanogaster (Fruit fly),57.4,378.0,5.4e-115,416.8,sp|O15945|ARNT_DROME Aryl hydrocarbon receptor nuclear translocator homolog OS=Drosophila melanogaster OX=7227 GN=tgo PE=1 SV=3,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0034751; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575,appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_10221,0.3803220715878879,OG_10221,FUN_043835-T1,Peve_00041794,Pocillopora_meandrina_HIv1___TS.g12323.t1,three_way,54.1065,,,,,,,,,,,,,,,,,
OG_06719,0.3802133885397039,OG_06719,FUN_031470-T1,Peve_00026552,Pocillopora_meandrina_HIv1___RNAseq.g5082.t1,three_way,68.5885,FUN_031470-T1,Q9JLC8,,,,,30.2,4722.0,0.0,1872.1,sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2,,,,,,
OG_03562,0.3795394087555299,OG_03562,FUN_014710-T1,Peve_00004185,Pocillopora_meandrina_HIv1___TS.g27294.t1,three_way,91.096,FUN_014710-T1,Q5SPC5,OTOF_DANRE,,Otoferlin (Fer-1-like protein 2),Danio rerio (Zebrafish) (Brachydanio rerio),49.8,2026.0,0.0,1855.5,sp|Q5SPC5|OTOF_DANRE Otoferlin OS=Danio rerio OX=7955 GN=otof PE=3 SV=1,GO:0000139; GO:0001964; GO:0005509; GO:0005789; GO:0007009; GO:0007605; GO:0010996; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0036465; GO:0042995; GO:0048787; GO:0050885,neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle recycling [GO:0036465],basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672],AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509],GO:0016192; GO:0050877; GO:0061024; GO:0065003,vesicle-mediated transport; nervous system process; membrane organization; protein-containing complex assembly
OG_07404,0.3789675524185736,OG_07404,FUN_033855-T1,Peve_00039888,Pocillopora_meandrina_HIv1___RNAseq.g28422.t1,three_way,68.755,FUN_033855-T1,O75581,LRP6_HUMAN,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Homo sapiens (Human),46.7,1685.0,2.9e-254,880.6,sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2,GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909,canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851],coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005576; GO:0005783; GO:0005886; GO:0006355; GO:0007155; GO:0016192; GO:0023052; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0060089; GO:0072659; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; cell adhesion; vesicle-mediated transport; signaling; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; molecular transducer activity; protein localization to plasma membrane; molecular function regulator activity
OG_00414,0.3789084255023304,OG_00414,FUN_001316-T1,Peve_00036964,Pocillopora_meandrina_HIv1___RNAseq.g2261.t1,three_way,53.97383333333333,FUN_001316-T1,Q8IVL1,,,,,36.1,388.0,7.2e-66,255.0,sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3,,,,,,
OG_08131,0.3786809979465113,OG_08131,FUN_035891-T1,Peve_00029395,Pocillopora_meandrina_HIv1___RNAseq.g12008.t1,three_way,81.82483333333333,FUN_035891-T1,Q9WUU6,,,,,68.0,325.0,9.9e-122,438.3,sp|Q9WUU6|HNF4G_MOUSE Hepatocyte nuclear factor 4-gamma OS=Mus musculus OX=10090 GN=Hnf4g PE=2 SV=2,,,,,,
OG_02611,0.3786275477102628,OG_02611,FUN_010745-T1,Peve_00038409,Pocillopora_meandrina_HIv1___TS.g25690.t1,three_way,79.04633333333334,FUN_010745-T1,O75153,,,,,47.6,1302.0,0.0,1138.6,sp|O75153|CLU_HUMAN Clustered mitochondria protein homolog OS=Homo sapiens OX=9606 GN=CLUH PE=1 SV=2,,,,,,
OG_08411,0.3783403630338287,OG_08411,FUN_037062-T1,Peve_00018396,Pocillopora_meandrina_HIv1___RNAseq.g26779.t1,three_way,65.08266666666667,FUN_037062-T1,O95628,CNOT4_HUMAN,,CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4),Homo sapiens (Human),48.8,441.0,2.6e-103,377.9,sp|O95628|CNOT4_HUMAN CCR4-NOT transcription complex subunit 4 OS=Homo sapiens OX=9606 GN=CNOT4 PE=1 SV=3,GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0030014; GO:0045652; GO:0051865,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634],RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; cytosol; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04711,0.3772205601056336,OG_04711,FUN_022518-T1,Peve_00030465,Pocillopora_meandrina_HIv1___TS.g21661.t1,three_way,66.89816666666665,FUN_022518-T1,Q99996,AKAP9_HUMAN,,A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao),Homo sapiens (Human),36.4,291.0,1.9e-34,152.1,sp|Q99996|AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens OX=9606 GN=AKAP9 PE=1 SV=4,GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007268; GO:0008076; GO:0015459; GO:0031116; GO:0031503; GO:0034237; GO:0034705; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0098909; GO:0098978; GO:0099104; GO:0099147; GO:1903358,cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165],centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076],DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325],GO:0003677; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0023052; GO:0043226; GO:0060090; GO:0098772,DNA binding; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; signaling; organelle; molecular adaptor activity; molecular function regulator activity
OG_09037,0.3762291822335303,OG_09037,FUN_038638-T1,Peve_00013491,Pocillopora_meandrina_HIv1___RNAseq.g26490.t2,three_way,56.39266666666666,FUN_038638-T1,Q8WXD9,,,,,42.0,143.0,2e-27,126.7,sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1,,,,,,
OG_04478,0.3761085731706505,OG_04478,FUN_021108-T1,Peve_00008861,Pocillopora_meandrina_HIv1___RNAseq.g4371.t1,three_way,84.41233333333334,FUN_021108-T1,Q15119,PDK2_HUMAN,,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)",Homo sapiens (Human),50.9,385.0,7.8e-108,392.1,"sp|Q15119|PDK2_HUMAN [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial OS=Homo sapiens OX=9606 GN=PDK2 PE=1 SV=2",GO:0004672; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006006; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0045254; GO:0050848; GO:0072332,cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of ketone metabolic process [GO:0010565]; regulation of pH [GO:0006885],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254],ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0005975; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; mitochondrion; cytosol; carbohydrate metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08721,0.3757935411278424,OG_08721,FUN_037974-T1,Peve_00013894,Pocillopora_meandrina_HIv1___RNAseq.g26183.t1,three_way,56.88933333333333,FUN_037974-T1,Q3UHR0,,,,,27.2,746.0,2.1e-45,187.6,sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2,,,,,,
OG_00843,0.3749725848472732,OG_00843,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_02786,0.3736892344510068,OG_02786,FUN_011741-T1,Peve_00015648,Pocillopora_meandrina_HIv1___RNAseq.g23891.t1,three_way,43.050666666666665,,,,,,,,,,,,,,,,,
OG_09269,0.3733781335799643,OG_09269,FUN_040075-T1,Peve_00021003,Pocillopora_meandrina_HIv1___RNAseq.g7690.t1,three_way,38.61383333333333,,,,,,,,,,,,,,,,,
OG_08022,0.3731525189347747,OG_08022,FUN_035677-T1,Peve_00002799,Pocillopora_meandrina_HIv1___RNAseq.g28144.t1,three_way,61.552,FUN_035677-T1,Q96I34,PP16A_HUMAN,,Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3),Homo sapiens (Human),37.7,371.0,1.2e-26,123.2,sp|Q96I34|PP16A_HUMAN Protein phosphatase 1 regulatory subunit 16A OS=Homo sapiens OX=9606 GN=PPP1R16A PE=1 SV=1,GO:0004857; GO:0005737; GO:0005886; GO:0017020,,cytoplasm [GO:0005737]; plasma membrane [GO:0005886],enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020],GO:0005886; GO:0098772,plasma membrane; molecular function regulator activity
OG_05647,0.3729347014483661,OG_05647,FUN_025365-T1,Peve_00040518,Pocillopora_meandrina_HIv1___RNAseq.g13333.t1,three_way,68.1275,FUN_025365-T1,Q62504,MINT_MOUSE,,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),Mus musculus (Mouse),40.8,610.0,6.4e-84,314.3,sp|Q62504|MINT_MOUSE Msx2-interacting protein OS=Mus musculus OX=10090 GN=Spen PE=1 SV=2,GO:0003697; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0007219; GO:0045892; GO:0045893; GO:0060816,negative regulation of DNA-templated transcription [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; random inactivation of X chromosome [GO:0060816],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; RNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_05647,0.3729347014483661,OG_05647,FUN_025365-T1,Peve_00040518,Pocillopora_meandrina_HIv1___RNAseq.g13333.t1,three_way,68.1275,FUN_025365-T1,Q62504,MINT_MOUSE,,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),Mus musculus (Mouse),61.2,188.0,5.7e-56,221.5,sp|Q62504|MINT_MOUSE Msx2-interacting protein OS=Mus musculus OX=10090 GN=Spen PE=1 SV=2,GO:0003697; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0007219; GO:0045892; GO:0045893; GO:0060816,negative regulation of DNA-templated transcription [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; random inactivation of X chromosome [GO:0060816],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; RNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_08165,0.372906807984794,OG_08165,FUN_035962-T1,Peve_00006624,Pocillopora_meandrina_HIv1___RNAseq.g12329.t1,three_way,87.42883333333333,FUN_035962-T1,Q9GYZ0,,,,,39.5,1065.0,2e-180,634.8,sp|Q9GYZ0|KIF15_STRPU Kinesin-like protein KIF15 OS=Strongylocentrotus purpuratus OX=7668 GN=KIF15 PE=1 SV=1,,,,,,
OG_07947,0.3721998248465927,OG_07947,FUN_035468-T1,Peve_00012132,Pocillopora_meandrina_HIv1___TS.g14397.t1,three_way,83.6845,FUN_035468-T1,Q8BH04,PCKGM_MOUSE,,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)",Mus musculus (Mouse),65.5,611.0,6.100000000000001e-248,858.2,"sp|Q8BH04|PCKGM_MOUSE Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Mus musculus OX=10090 GN=Pck2 PE=1 SV=1",GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0006090; GO:0006094; GO:0006107; GO:0030145; GO:0032024; GO:0032496; GO:0071333; GO:0071356; GO:0071548,cellular response to glucose stimulus [GO:0071333]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; pyruvate metabolic process [GO:0006090]; response to dexamethasone [GO:0071548]; response to lipopolysaccharide [GO:0032496],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613],GO:0003824; GO:0005739; GO:0005975; GO:0016829; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lyase activity; organelle
OG_01161,0.3721861819729339,OG_01161,FUN_004780-T1,Peve_00037744,Pocillopora_meandrina_HIv1___RNAseq.g6689.t1,three_way,84.39833333333334,FUN_004780-T1,Q6P3J5,EF2_DANRE,,Elongation factor 2b (EF-2) (EC 3.6.5.-),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,858.0,0.0,1342.8,sp|Q6P3J5|EF2_DANRE Elongation factor 2b OS=Danio rerio OX=7955 GN=eef2b PE=1 SV=1,GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0006414; GO:0043009; GO:0043022; GO:0071466; GO:1990904,cellular response to xenobiotic stimulus [GO:0071466]; chordate embryonic development [GO:0043009]; translational elongation [GO:0006414],cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development
OG_09513,0.3717481866099438,OG_09513,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,27.8,752.0,2.7e-39,166.4,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_09513,0.3717481866099438,OG_09513,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,36.9,187.0,1.8e-19,100.5,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_00618,0.3715587139877923,OG_00618,FUN_001784-T1,Peve_00011611,Pocillopora_meandrina_HIv1___RNAseq.g2640.t1a,three_way,76.89133333333334,FUN_001784-T1,Q91ZR4,NEK8_MOUSE,,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8),Mus musculus (Mouse),40.8,650.0,1.2e-118,429.9,sp|Q91ZR4|NEK8_MOUSE Serine/threonine-protein kinase Nek8 OS=Mus musculus OX=10090 GN=Nek8 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005929; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310,animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330],centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005815; GO:0005929; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cilium; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01466,0.3714911224276757,OG_01466,FUN_006002-T1,Peve_00036060,Pocillopora_meandrina_HIv1___RNAseq.g19927.t1,three_way,76.86133333333333,FUN_006002-T1,A0A1U8QWA2,ATR12_EMENI,,Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)],Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans),38.2,1317.0,3.3e-237,823.5,sp|A0A1U8QWA2|ATR12_EMENI Glycine betaine reductase ATRR OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=ATRR PE=1 SV=1,GO:0009058; GO:0016491; GO:0031177,biosynthetic process [GO:0009058],,oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_07938,0.3711046531396927,OG_07938,FUN_035444-T1,Peve_00002174,Pocillopora_meandrina_HIv1___RNAseq.g27111.t1,three_way,85.51933333333334,FUN_035444-T1,Q8BZZ3,WWP1_MOUSE,,NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase WWP1) (WW domain-containing protein 1),Mus musculus (Mouse),57.0,910.0,8.499999999999999e-234,811.6,sp|Q8BZZ3|WWP1_MOUSE NEDD4-like E3 ubiquitin-protein ligase WWP1 OS=Mus musculus OX=10090 GN=Wwp1 PE=1 SV=2,GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0016567; GO:0030217; GO:0030324; GO:0043161; GO:0045892; GO:0061630; GO:0070161,lung development [GO:0030324]; negative regulation of DNA-templated transcription [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217],anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01452,0.3710685944627567,OG_01452,FUN_005908-T1,Peve_00038389,Pocillopora_meandrina_HIv1___RNAseq.g19573.t1,three_way,84.7165,FUN_005908-T1,P23634,AT2B4_HUMAN,,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),Homo sapiens (Human),59.0,1089.0,0.0,1226.8,sp|P23634|AT2B4_HUMAN Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens OX=9606 GN=ATP2B4 PE=1 SV=2,GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005739; GO:0005886; GO:0005901; GO:0005929; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0034220; GO:0036064; GO:0036126; GO:0036487; GO:0038060; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0071878; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0150104; GO:1900082; GO:1901660; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145,calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832],basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080],GO:0003012; GO:0003013; GO:0003824; GO:0005215; GO:0005739; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0007018; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0098772; GO:0140657,muscle system process; circulatory system process; catalytic activity; transporter activity; mitochondrion; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; microtubule-based movement; hydrolase activity; reproductive process; organelle; anatomical structure development; cell motility; transmembrane transport; molecular function regulator activity; ATP-dependent activity
OG_04968,0.3705853748574955,OG_04968,FUN_023073-T1,Peve_00014063,Pocillopora_meandrina_HIv1___RNAseq.g1646.t2,three_way,77.28333333333333,FUN_023073-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),42.4,2171.0,0.0,1587.8,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_02571,0.3705068983615905,OG_02571,FUN_010674-T1,Peve_00044786,Pocillopora_meandrina_HIv1___RNAseq.g21350.t1,three_way,81.68766666666667,FUN_010674-T1,O75116,ROCK2_HUMAN,,"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)",Homo sapiens (Human),50.3,445.0,8.199999999999999e-109,396.7,sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=4,GO:0000281; GO:0001837; GO:0001934; GO:0002020; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007266; GO:0008270; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0036464; GO:0042752; GO:0043410; GO:0044788; GO:0045019; GO:0045616; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061133; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; mitotic cytokinesis [GO:0000281]; modulation by host of viral process [GO:0044788]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; zinc ion binding [GO:0008270],GO:0000910; GO:0003012; GO:0003013; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0030154; GO:0043226; GO:0072659; GO:0098772; GO:0140096,"cytokinesis; muscle system process; circulatory system process; RNA binding; catalytic activity; structural molecule activity; nucleus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; cell differentiation; organelle; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01698,0.3704902574755585,OG_01698,FUN_006941-T1,Peve_00042016,Pocillopora_meandrina_HIv1___RNAseq.g20150.t1,three_way,80.58666666666667,FUN_006941-T1,Q32N90,,,,,36.0,566.0,4.4000000000000003e-100,367.9,sp|Q32N90|MBTD1_XENLA MBT domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=mbtd1 PE=2 SV=1,,,,,,
OG_00952,0.3703031242631331,OG_00952,FUN_004312-T1,Peve_00033934,Pocillopora_meandrina_HIv1___RNAseq.g16986.t1,three_way,70.072,FUN_004312-T1,Q98864,,,,,42.5,1133.0,1.3999999999999999e-244,847.8,sp|Q98864|PTC1_DANRE Protein patched homolog 1 OS=Danio rerio OX=7955 GN=ptch1 PE=2 SV=1,,,,,,
OG_09888,0.3701425186038873,OG_09888,FUN_042963-T1,Peve_00039045,Pocillopora_meandrina_HIv1___RNAseq.4783_t,three_way,65.88283333333334,FUN_042963-T1,Q4VGL6,RC3H1_MOUSE,,Roquin-1 (Roquin) (EC 2.3.2.27) (Protein Sanroque) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1),Mus musculus (Mouse),60.2,523.0,1.3e-165,585.5,sp|Q4VGL6|RC3H1_MOUSE Roquin-1 OS=Mus musculus OX=10090 GN=Rc3h1 PE=1 SV=1,GO:0000184; GO:0000209; GO:0000288; GO:0000932; GO:0000956; GO:0001782; GO:0002634; GO:0002635; GO:0003725; GO:0003729; GO:0003730; GO:0004842; GO:0005737; GO:0008270; GO:0010468; GO:0010494; GO:0010608; GO:0030889; GO:0033962; GO:0035198; GO:0035613; GO:0042098; GO:0043029; GO:0043488; GO:0045623; GO:0046007; GO:0048535; GO:0048536; GO:0050852; GO:0050856; GO:0061014; GO:0061158; GO:0061470; GO:0071347; GO:1900151; GO:1901224; GO:1905762; GO:2000320; GO:2000628,"3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; P-body assembly [GO:0033962]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900151]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932],CCR4-NOT complex binding [GO:1905762]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0016071; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; RNA binding; catalytic activity; mRNA metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08929,0.3696406416515309,OG_08929,FUN_038387-T1,Peve_00000060,Pocillopora_meandrina_HIv1___RNAseq.g28287.t1,three_way,63.87316666666666,FUN_038387-T1,P55202,,,,,36.6,940.0,3e-137,491.1,sp|P55202|ANPRB_ANGJA Atrial natriuretic peptide receptor 2 OS=Anguilla japonica OX=7937 GN=npr2 PE=2 SV=1,,,,,,
OG_06005,0.3693802080205117,OG_06005,FUN_026501-T1,Peve_00004184,Pocillopora_meandrina_HIv1___TS.g21607.t1,three_way,44.153333333333336,FUN_026501-T1,Q9VTT0,SEM5C_DROME,,Semaphorin 5c,Drosophila melanogaster (Fruit fly),27.1,630.0,1.7e-51,206.1,sp|Q9VTT0|SEM5C_DROME Semaphorin 5c OS=Drosophila melanogaster OX=7227 GN=Sema5c PE=1 SV=3,GO:0001700; GO:0005768; GO:0005886; GO:0007411; GO:0016324; GO:0016328; GO:0030215; GO:0030335; GO:0042048; GO:0045499; GO:0048036; GO:0071526,axon guidance [GO:0007411]; central complex development [GO:0048036]; embryonic development via the syncytial blastoderm [GO:0001700]; olfactory behavior [GO:0042048]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526],apical plasma membrane [GO:0016324]; endosome [GO:0005768]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215],GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0048018; GO:0048856; GO:0098772,endosome; plasma membrane; cytoplasmic vesicle; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_07177,0.3692267249116776,OG_07177,FUN_032628-T1,Peve_00033703,Pocillopora_meandrina_HIv1___RNAseq.g29789.t1,three_way,82.41583333333334,FUN_032628-T1,Q9EQW7,KI13A_MOUSE,,Kinesin-like protein KIF13A,Mus musculus (Mouse),47.9,1454.0,0.0,1170.6,sp|Q9EQW7|KI13A_MOUSE Kinesin-like protein KIF13A OS=Mus musculus OX=10090 GN=Kif13a PE=1 SV=1,GO:0000139; GO:0003777; GO:0005524; GO:0005813; GO:0005874; GO:0006886; GO:0008017; GO:0008333; GO:0010008; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383,cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459],centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0006886; GO:0007018; GO:0008092; GO:0016192; GO:0016853; GO:0072659; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; intracellular protein transport; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; protein localization to plasma membrane; ATP-dependent activity
OG_08042,0.3687274442203204,OG_08042,FUN_035719-T1,Peve_00044099,Pocillopora_meandrina_HIv1___RNAseq.g11850.t2,three_way,78.6335,FUN_035719-T1,Q3US41,,,,,38.6,681.0,3.3e-122,440.7,sp|Q3US41|ESRP1_MOUSE Epithelial splicing regulatory protein 1 OS=Mus musculus OX=10090 GN=Esrp1 PE=1 SV=2,,,,,,
OG_06101,0.3683469217864872,OG_06101,FUN_027779-T1,Peve_00034984,Pocillopora_meandrina_HIv1___RNAseq.g12667.t1,three_way,61.244166666666665,FUN_027779-T1,Q7Z408,CSMD2_HUMAN,,CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2),Homo sapiens (Human),23.2,921.0,4.8e-24,116.7,sp|Q7Z408|CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CSMD2 PE=1 SV=2,GO:0097107; GO:0098839; GO:0098978; GO:0099562,maintenance of postsynaptic density structure [GO:0099562]; postsynaptic density assembly [GO:0097107],glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839],,GO:0034330,cell junction organization
OG_02248,0.3681789009554566,OG_02248,FUN_008665-T1,Peve_00044711,Pocillopora_meandrina_HIv1___RNAseq.g64.t1,three_way,73.61466666666666,FUN_008665-T1,Q6RHR9,,,,,33.7,1372.0,3.9e-185,650.6,"sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1",,,,,,
OG_08599,0.3681061608365633,OG_08599,FUN_037741-T1,Peve_00037358,Pocillopora_meandrina_HIv1___RNAseq.g1334.t1,three_way,67.00733333333334,,,,,,,,,,,,,,,,,
OG_00913,0.3681035113498013,OG_00913,FUN_004247-T1,Peve_00019440,Pocillopora_meandrina_HIv1___RNAseq.g11529.t1,three_way,67.11033333333333,FUN_004247-T1,P41233,,,,,40.9,2521.0,0.0,1671.4,sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4,,,,,,
OG_05672,0.3675775888417235,OG_05672,FUN_025466-T1,Peve_00043837,Pocillopora_meandrina_HIv1___RNAseq.g13240.t1,three_way,86.86633333333333,FUN_025466-T1,Q8VDJ3,,,,,52.2,1291.0,0.0,1320.8,sp|Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus OX=10090 GN=Hdlbp PE=1 SV=1,,,,,,
OG_04199,0.3675201087016005,OG_04199,FUN_016732-T1,Peve_00014684,Pocillopora_meandrina_HIv1___RNAseq.g234.t1,three_way,56.1385,,,,,,,,,,,,,,,,,
OG_02006,0.3673603732444823,OG_02006,FUN_008121-T1,Peve_00022347,Pocillopora_meandrina_HIv1___RNAseq.g17884.t1,three_way,60.455666666666666,FUN_008121-T1,Q5TCY1,TTBK1_HUMAN,,Tau-tubulin kinase 1 (EC 2.7.11.1) (Brain-derived tau kinase),Homo sapiens (Human),65.9,308.0,9.2e-116,419.9,sp|Q5TCY1|TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens OX=9606 GN=TTBK1 PE=1 SV=2,GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005875; GO:0007165; GO:0007611; GO:0010628; GO:0010629; GO:0018105; GO:0018107; GO:0018108; GO:0021762; GO:0032273; GO:0043025; GO:0048156; GO:0048471; GO:0050321; GO:0061890; GO:0106310; GO:1903980,learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_02517,0.3672579573896889,OG_02517,FUN_010576-T1,Peve_00032735,Pocillopora_meandrina_HIv1___RNAseq.g21522.t1,three_way,61.242666666666665,,,,,,,,,,,,,,,,,
OG_01123,0.3667762199675818,OG_01123,FUN_004691-T1,Peve_00019711,Pocillopora_meandrina_HIv1___TS.g20478.t1,three_way,79.91966666666667,FUN_004691-T1,Q9Y2I6,NINL_HUMAN,,Ninein-like protein,Homo sapiens (Human),30.6,517.0,7.2999999999999975e-47,191.8,sp|Q9Y2I6|NINL_HUMAN Ninein-like protein OS=Homo sapiens OX=9606 GN=NINL PE=1 SV=2,GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0034454,microtubule anchoring at centrosome [GO:0034454],centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874],calcium ion binding [GO:0005509],GO:0005815; GO:0005829; GO:0007010,microtubule organizing center; cytosol; cytoskeleton organization
OG_04966,0.366742420006674,OG_04966,FUN_023066-T1,Peve_00024667,Pocillopora_meandrina_HIv1___RNAseq.g3884.t2,three_way,87.49933333333333,FUN_023066-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),46.5,2103.0,0.0,1895.2,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_08830,0.3667342132956645,OG_08830,FUN_038167-T1,Peve_00025790,Pocillopora_meandrina_HIv1___RNAseq.g1070.t1,three_way,91.073,FUN_038167-T1,P23098,,,,,73.8,4465.0,0.0,6623.9,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_00100,0.3660047864739284,OG_00100,FUN_000483-T1,Peve_00038235,Pocillopora_meandrina_HIv1___RNAseq.g2342.t1,three_way,68.861,FUN_000483-T1,Q8CFV2,,,,,27.0,559.0,5.399999999999999e-31,137.5,sp|Q8CFV2|F149A_MOUSE Protein FAM149A OS=Mus musculus OX=10090 GN=Fam149a PE=2 SV=1,,,,,,
OG_00540,0.3655959339088491,OG_00540,FUN_001562-T1,Peve_00013899,Pocillopora_meandrina_HIv1___RNAseq.g2018.t1,three_way,83.21833333333333,FUN_001562-T1,Q8IWZ3,,,,,58.1,812.0,4.4e-82,308.9,sp|Q8IWZ3|ANKH1_HUMAN Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKHD1 PE=1 SV=1,,,,,,
OG_00196,0.3652983211110028,OG_00196,FUN_000908-T1,Peve_00010044,Pocillopora_meandrina_HIv1___RNAseq.g29495.t1,three_way,77.85966666666667,FUN_000908-T1,Q8QG61,,,,,64.7,499.0,3.3e-210,732.6,sp|Q8QG61|CRY1_CHICK Cryptochrome-1 OS=Gallus gallus OX=9031 GN=CRY1 PE=2 SV=1,,,,,,
OG_09609,0.3645974321842598,OG_09609,FUN_041767-T1,Peve_00041572,Pocillopora_meandrina_HIv1___RNAseq.g15244.t1,three_way,57.924,FUN_041767-T1,Q6WRH9,,,,,29.6,406.0,5.6000000000000005e-28,128.6,sp|Q6WRH9|IGS10_RAT Immunoglobulin superfamily member 10 OS=Rattus norvegicus OX=10116 GN=Igsf10 PE=1 SV=1,,,,,,
OG_04026,0.3644227728628341,OG_04026,FUN_016333-T1,Peve_00044546,Pocillopora_meandrina_HIv1___TS.g23374.t1,three_way,71.42983333333333,FUN_016333-T1,P35869,AHR_HUMAN,,Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76),Homo sapiens (Human),40.4,381.0,7.4e-62,240.4,sp|P35869|AHR_HUMAN Aryl hydrocarbon receptor OS=Homo sapiens OX=9606 GN=AHR PE=1 SV=2,GO:0000785; GO:0000976; GO:0000981; GO:0000987; GO:0001094; GO:0001223; GO:0001568; GO:0002819; GO:0002841; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006805; GO:0006915; GO:0009410; GO:0009636; GO:0010468; GO:0017025; GO:0030888; GO:0032922; GO:0032991; GO:0034751; GO:0034752; GO:0034753; GO:0042803; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837,"apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]",aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic aryl hydrocarbon receptor complex [GO:0034752]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_09455,0.3644215953413914,OG_09455,FUN_041463-T1,Peve_00013687,Pocillopora_meandrina_HIv1___RNAseq.g15689.t1,three_way,54.7395,FUN_041463-T1,Q95209,SORL_RABIT,,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),Oryctolagus cuniculus (Rabbit),36.6,2110.0,7.4e-199,697.2,sp|Q95209|SORL_RABIT Sortilin-related receptor OS=Oryctolagus cuniculus OX=9986 GN=SORL1 PE=1 SV=1,GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0045053; GO:0046628; GO:0055038; GO:1904179; GO:1990845,adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658],,GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226,extracellular space; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09963,0.3641839624221888,OG_09963,FUN_043144-T1,Peve_00034957,Pocillopora_meandrina_HIv1___RNAseq.g6886.t1,three_way,84.25150000000001,FUN_043144-T1,Q26481,,,,,73.1,279.0,2e-116,420.2,sp|Q26481|RL5_STYCL Large ribosomal subunit protein uL18 OS=Styela clava OX=7725 GN=RPL5 PE=3 SV=3,,,,,,
OG_00060,0.3641086925377986,OG_00060,FUN_000352-T1,Peve_00033531,Pocillopora_meandrina_HIv1___RNAseq.g29116.t1,three_way,77.85483333333333,FUN_000352-T1,P18395,,,,,46.0,817.0,5.600000000000001e-180,632.9,sp|P18395|CSDE1_RAT Cold shock domain-containing protein E1 OS=Rattus norvegicus OX=10116 GN=Csde1 PE=2 SV=1,,,,,,
OG_08305,0.3636289396260869,OG_08305,FUN_036260-T1,Peve_00012320,Pocillopora_meandrina_HIv1___RNAseq.g27582.t1,three_way,82.303,FUN_036260-T1,Q8WXH2,JPH3_HUMAN,,Junctophilin-3 (JP-3) (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein),Homo sapiens (Human),66.7,57.0,9.9e-20,99.4,sp|Q8WXH2|JPH3_HUMAN Junctophilin-3 OS=Homo sapiens OX=9606 GN=JPH3 PE=1 SV=2,GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0010880; GO:0010882; GO:0014701; GO:0016020; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060402,calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic plasticity [GO:0048167],endoplasmic reticulum membrane [GO:0005789]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886],,GO:0005886; GO:0050877; GO:0055085,plasma membrane; nervous system process; transmembrane transport
OG_02338,0.3636052217335769,OG_02338,FUN_008934-T1,Peve_00036402,Pocillopora_meandrina_HIv1___RNAseq.g14257.t1,three_way,76.08966666666667,FUN_008934-T1,A5D7I4,EXT1_BOVIN,,Exostosin-1 (EC 2.4.1.225) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase),Bos taurus (Bovine),50.3,749.0,7.999999999999999e-217,755.0,sp|A5D7I4|EXT1_BOVIN Exostosin-1 OS=Bos taurus OX=9913 GN=EXT1 PE=2 SV=1,GO:0000139; GO:0000271; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0007033; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0010803; GO:0014033; GO:0015012; GO:0015020; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030199; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1902494; GO:1904888; GO:1990823,"antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; glycosaminoglycan biosynthetic process [GO:0006024]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal-level water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; polysaccharide biosynthetic process [GO:0000271]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]",catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; synapse [GO:0045202],acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003013; GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006790; GO:0006954; GO:0007155; GO:0009101; GO:0016740; GO:0023052; GO:0030154; GO:0030163; GO:0030198; GO:0034330; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0065003; GO:1901135,immune system process; circulatory system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; sulfur compound metabolic process; inflammatory response; cell adhesion; glycoprotein biosynthetic process; transferase activity; signaling; cell differentiation; protein catabolic process; extracellular matrix organization; cell junction organization; wound healing; organelle; anatomical structure development; cell motility; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_07584,0.3634357391924857,OG_07584,FUN_034278-T1,Peve_00012564,Pocillopora_meandrina_HIv1___RNAseq.g28525.t1,three_way,80.85883333333334,FUN_034278-T1,Q0VCK5,AP2A2_BOVIN,,AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit),Bos taurus (Bovine),67.1,952.0,0.0,1247.6,sp|Q0VCK5|AP2A2_BOVIN AP-2 complex subunit alpha-2 OS=Bos taurus OX=9913 GN=AP2A2 PE=1 SV=1,GO:0006886; GO:0008289; GO:0019901; GO:0030122; GO:0035615; GO:0048268; GO:0048488; GO:0072583; GO:0097718; GO:0098793,clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488],AP-2 adaptor complex [GO:0030122]; presynapse [GO:0098793],clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901],GO:0006886; GO:0008289; GO:0016192; GO:0060090; GO:0065003,intracellular protein transport; lipid binding; vesicle-mediated transport; molecular adaptor activity; protein-containing complex assembly
OG_04146,0.363199292628042,OG_04146,FUN_016608-T1,Peve_00010249,Pocillopora_meandrina_HIv1___RNAseq.g9623.t1b,three_way,79.465,FUN_016608-T1,P58465,,,,,63.3,270.0,1.5e-89,330.9,sp|P58465|CTDSL_MOUSE CTD small phosphatase-like protein OS=Mus musculus OX=10090 GN=Ctdspl PE=2 SV=3,,,,,,
OG_00092,0.3630603641478729,OG_00092,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),34.1,695.0,4.9e-100,368.2,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00092,0.3630603641478729,OG_00092,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),47.9,71.0,4.6e-13,79.3,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_10063,0.3630242754281949,OG_10063,FUN_043363-T1,Peve_00016658,Pocillopora_meandrina_HIv1___RNAseq.g8970.t1,three_way,82.36583333333333,FUN_043363-T1,Q8C4Y3,NELFB_MOUSE,,Negative elongation factor B (NELF-B) (Cofactor of BRCA1),Mus musculus (Mouse),45.5,587.0,1.2e-135,485.0,sp|Q8C4Y3|NELFB_MOUSE Negative elongation factor B OS=Mus musculus OX=10090 GN=Nelfb PE=1 SV=2,GO:0003723; GO:0005741; GO:0005829; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:2000737,cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; stem cell differentiation [GO:0048863],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; NELF complex [GO:0032021],RNA binding [GO:0003723],GO:0003723; GO:0005829; GO:0006355; GO:0030154,RNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation
OG_01905,0.3624032096365689,OG_01905,FUN_007919-T1,Peve_00040675,Pocillopora_meandrina_HIv1___RNAseq.g30121.t1,three_way,90.73183333333331,FUN_007919-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),63.3,608.0,1.6e-207,724.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_05026,0.3615485612388387,OG_05026,FUN_023189-T1,Peve_00009992,Pocillopora_meandrina_HIv1___TS.g25367.t1,three_way,58.125,FUN_023189-T1,O43490,,,,,27.2,751.0,1.8e-53,212.6,sp|O43490|PROM1_HUMAN Prominin-1 OS=Homo sapiens OX=9606 GN=PROM1 PE=1 SV=1,,,,,,
OG_03914,0.3615139961162864,OG_03914,FUN_015998-T1,Peve_00023991,Pocillopora_meandrina_HIv1___RNAseq.g21377.t2,three_way,83.981,FUN_015998-T1,Q00944,,,,,41.0,1143.0,8.4e-229,795.4,sp|Q00944|FAK1_CHICK Focal adhesion kinase 1 OS=Gallus gallus OX=9031 GN=PTK2 PE=1 SV=2,,,,,,
OG_07579,0.3614007125539273,OG_07579,FUN_034260-T1,Peve_00009311,Pocillopora_meandrina_HIv1___RNAseq.g26620.t1,three_way,74.869,FUN_034260-T1,Q9H2X6,HIPK2_HUMAN,,Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1),Homo sapiens (Human),49.5,662.0,4.4e-159,563.9,sp|Q9H2X6|HIPK2_HUMAN Homeodomain-interacting protein kinase 2 OS=Homo sapiens OX=9606 GN=HIPK2 PE=1 SV=2,GO:0000122; GO:0001654; GO:0003016; GO:0003713; GO:0003714; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007179; GO:0007224; GO:0007628; GO:0008283; GO:0008284; GO:0009952; GO:0010467; GO:0010494; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0030182; GO:0030218; GO:0030330; GO:0030511; GO:0030514; GO:0030578; GO:0030878; GO:0040029; GO:0042771; GO:0043524; GO:0045766; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051402; GO:0051726; GO:0060059; GO:0060235; GO:0060395; GO:0060425; GO:0061072; GO:0061629; GO:0071456; GO:0090575; GO:0097193; GO:0106310; GO:1901796; GO:2000059,"adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cell population proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; gene expression [GO:0010467]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; lung morphogenesis [GO:0060425]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of JNK cascade [GO:0046330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; respiratory system process [GO:0003016]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790],GO:0003016; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140096; GO:0140110,"respiratory system process; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; programmed cell death; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_03500,0.3613919454146898,OG_03500,FUN_014610-T1,Peve_00027567,Pocillopora_meandrina_HIv1___TS.g27529.t1,three_way,75.49566666666666,FUN_014610-T1,P27465,,,,,48.5,361.0,3.7e-97,356.7,"sp|P27465|PISD_CRIGR Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Cricetulus griseus OX=10029 GN=Pisd PE=1 SV=2",,,,,,
OG_04046,0.3611930209502555,OG_04046,FUN_016360-T1,Peve_00004338,Pocillopora_meandrina_HIv1___RNAseq.g9672.t1,three_way,64.9715,FUN_016360-T1,Q9Y6R0,NUMBL_HUMAN,,Numb-like protein (Numb-related protein) (Numb-R),Homo sapiens (Human),58.1,160.0,1e-46,189.5,sp|Q9Y6R0|NUMBL_HUMAN Numb-like protein OS=Homo sapiens OX=9606 GN=NUMBL PE=1 SV=1,GO:0005737; GO:0007399; GO:0007409; GO:0019221; GO:0019538; GO:0021670; GO:0021849; GO:0034332; GO:0050769; GO:0050775; GO:0098978; GO:0150052,adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cytokine-mediated signaling pathway [GO:0019221]; lateral ventricle development [GO:0021670]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neurogenesis [GO:0050769]; protein metabolic process [GO:0019538]; regulation of postsynapse assembly [GO:0150052],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978],,GO:0034330; GO:0048856,cell junction organization; anatomical structure development
OG_08324,0.3610041528200399,OG_08324,FUN_036753-T1,Peve_00001060,Pocillopora_meandrina_HIv1___RNAseq.g12113.t1,three_way,78.39483333333332,FUN_036753-T1,Q2V2M9,FHOD3_HUMAN,,FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2),Homo sapiens (Human),42.2,1460.0,2.6000000000000004e-214,747.7,sp|Q2V2M9|FHOD3_HUMAN FH1/FH2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FHOD3 PE=1 SV=2,GO:0005737; GO:0005856; GO:0030018; GO:0030866; GO:0045214; GO:0051015; GO:0055003,cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; sarcomere organization [GO:0045214],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018],actin filament binding [GO:0051015],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_02596,0.3609420286510097,OG_02596,FUN_010717-T1,Peve_00022590,Pocillopora_meandrina_HIv1___RNAseq.g20954.t1,three_way,77.32616666666667,FUN_010717-T1,Q9V9J3,SRC42_DROME,,Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41),Drosophila melanogaster (Fruit fly),57.2,530.0,1.7e-168,594.0,sp|Q9V9J3|SRC42_DROME Tyrosine-protein kinase Src42A OS=Drosophila melanogaster OX=7227 GN=Src42A PE=1 SV=1,GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136; GO:0106016,"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005829; GO:0005886; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; cytosol; plasma membrane; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_01038,0.3601758936846586,OG_01038,FUN_004473-T1,Peve_00007172,Pocillopora_meandrina_HIv1___RNAseq.g4948.t1,three_way,45.68216666666667,FUN_004473-T1,P98081,DAB_DROME,,Protein disabled,Drosophila melanogaster (Fruit fly),41.4,157.0,2.5e-28,129.4,sp|P98081|DAB_DROME Protein disabled OS=Drosophila melanogaster OX=7227 GN=Dab PE=1 SV=2,GO:0005118; GO:0005829; GO:0006898; GO:0007349; GO:0007391; GO:0008045; GO:0016319; GO:0017124; GO:0030424; GO:0035591; GO:0042051; GO:0045874; GO:0048488; GO:0072583; GO:0098793,cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; positive regulation of sevenless signaling pathway [GO:0045874]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488],axon [GO:0030424]; cytosol [GO:0005829]; presynapse [GO:0098793],sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591],GO:0005829; GO:0016192; GO:0048856; GO:0060090,cytosol; vesicle-mediated transport; anatomical structure development; molecular adaptor activity
OG_04381,0.3597379778012931,OG_04381,FUN_018086-T1,Peve_00021774,Pocillopora_meandrina_HIv1___RNAseq.g25348.t1,three_way,67.76233333333333,FUN_018086-T1,A0JM23,,,,,37.7,1131.0,2.1e-142,508.4,sp|A0JM23|NPHP3_XENTR Nephrocystin-3 OS=Xenopus tropicalis OX=8364 GN=nphp3 PE=2 SV=2,,,,,,
OG_06366,0.3593113989135701,OG_06366,FUN_028970-T1,Peve_00006113,Pocillopora_meandrina_HIv1___RNAseq.g25636.t1,three_way,82.70400000000001,FUN_028970-T1,P13195,HEM1_RAT,,"5-aminolevulinate synthase, non-specific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)",Rattus norvegicus (Rat),52.0,611.0,1.8e-169,597.4,"sp|P13195|HEM1_RAT 5-aminolevulinate synthase, non-specific, mitochondrial OS=Rattus norvegicus OX=10116 GN=Alas1 PE=2 SV=2",GO:0001666; GO:0003870; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0009410; GO:0009635; GO:0010045; GO:0030170; GO:0031667; GO:0032025; GO:0032869; GO:0034698; GO:0042541; GO:0042802; GO:0045471; GO:0048034; GO:0048821; GO:0051591; GO:0070541; GO:1903412,cellular response to insulin stimulus [GO:0032869]; erythrocyte development [GO:0048821]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to bile acid [GO:1903412]; response to cAMP [GO:0051591]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to nickel cation [GO:0010045]; response to nutrient levels [GO:0031667]; response to platinum ion [GO:0070541]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleoplasm; mitochondrion; cytosol; transferase activity; organelle; anatomical structure development
OG_03839,0.3592290507910801,OG_03839,FUN_015298-T1,Peve_00004801,Pocillopora_meandrina_HIv1___RNAseq.g22106.t1,three_way,63.3705,FUN_015298-T1,Q8QFX1,,,,,28.4,1242.0,2.3999999999999997e-83,313.2,sp|Q8QFX1|RIMB2_CHICK RIMS-binding protein 2 OS=Gallus gallus OX=9031 GN=RIMBP2 PE=1 SV=1,,,,,,
OG_04627,0.3591778066115362,OG_04627,FUN_022340-T1,Peve_00028608,Pocillopora_meandrina_HIv1___RNAseq.g4654.t1,three_way,62.08733333333333,FUN_022340-T1,Q63258,ITA7_RAT,,Integrin alpha-7 (H36-alpha7) [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form],Rattus norvegicus (Rat),27.7,1149.0,3.1e-87,325.1,sp|Q63258|ITA7_RAT Integrin alpha-7 OS=Rattus norvegicus OX=10116 GN=Itga7 PE=1 SV=2,GO:0005178; GO:0005737; GO:0005927; GO:0007155; GO:0007229; GO:0007519; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016477; GO:0031594; GO:0033627; GO:0034113; GO:0034677; GO:0035987; GO:0042383; GO:0043236; GO:0044877; GO:0046872; GO:0048514; GO:0050839; GO:0050900; GO:0098609,blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519],cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integrin alpha7-beta1 complex [GO:0034677]; integrin complex [GO:0008305]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383],cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0002376; GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0048870,immune system process; plasma membrane; cell adhesion; cell differentiation; anatomical structure development; cell motility
OG_09140,0.3589838583103161,OG_09140,FUN_039779-T1,Peve_00017588,Pocillopora_meandrina_HIv1___RNAseq.g7461.t1,three_way,84.48583333333333,FUN_039779-T1,O95263,,,,,46.7,904.0,5.4e-218,759.2,"sp|O95263|PDE8B_HUMAN High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B OS=Homo sapiens OX=9606 GN=PDE8B PE=1 SV=2",,,,,,
OG_04097,0.3587493584070601,OG_04097,FUN_016439-T1,Peve_00013822,Pocillopora_meandrina_HIv1___RNAseq.g9838.t1,three_way,64.92133333333334,FUN_016439-T1,O54928,SOCS5_MOUSE,,Suppressor of cytokine signaling 5 (SOCS-5) (Cytokine-inducible SH2-containing protein 5),Mus musculus (Mouse),47.5,219.0,2.9e-47,191.0,sp|O54928|SOCS5_MOUSE Suppressor of cytokine signaling 5 OS=Mus musculus OX=10090 GN=Socs5 PE=1 SV=2,GO:0005154; GO:0005737; GO:0007173; GO:0007175; GO:0007259; GO:0009968; GO:0016567; GO:0019210; GO:0019221; GO:0030971; GO:0032436; GO:0032715; GO:0035556; GO:0045627; GO:0045629; GO:0050728; GO:0071404; GO:0071638; GO:0097699; GO:1904988,cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; negative regulation of endothelial cell activation [GO:1904988]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of signal transduction [GO:0009968]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; protein ubiquitination [GO:0016567]; vascular endothelial cell response to fluid shear stress [GO:0097699],cytoplasm [GO:0005737],epidermal growth factor receptor binding [GO:0005154]; kinase inhibitor activity [GO:0019210]; receptor tyrosine kinase binding [GO:0030971],GO:0098772,molecular function regulator activity
OG_05397,0.3587096264070163,OG_05397,FUN_024224-T1,Peve_00031887,Pocillopora_meandrina_HIv1___TS.g28304.t1,three_way,65.771,FUN_024224-T1,O60343,TBCD4_HUMAN,,TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160),Homo sapiens (Human),33.6,1274.0,8.199999999999999e-148,526.6,sp|O60343|TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens OX=9606 GN=TBC1D4 PE=1 SV=2,GO:0005096; GO:0005794; GO:0005829; GO:0016192; GO:0031339; GO:0031982; GO:0032869,cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],GTPase activator activity [GO:0005096],GO:0005794; GO:0005829; GO:0016192; GO:0043226; GO:0098772,Golgi apparatus; cytosol; vesicle-mediated transport; organelle; molecular function regulator activity
OG_09881,0.3586774109271878,OG_09881,FUN_042949-T1,Peve_00019972,Pocillopora_meandrina_HIv1___TS.g886.t1,three_way,68.23983333333334,FUN_042949-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),34.1,560.0,6.8e-78,293.1,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_05333,0.3586535614499183,OG_05333,FUN_024043-T1,Peve_00020342,Pocillopora_meandrina_HIv1___RNAseq.g19269.t1,three_way,88.07966666666667,FUN_024043-T1,Q5T0T0,MARH8_HUMAN,,E3 ubiquitin-protein ligase MARCHF8 (EC 2.3.2.27) (Cellular modulator of immune recognition) (c-MIR) (Membrane-associated RING finger protein 8) (Membrane-associated RING-CH protein VIII) (MARCH-VIII) (RING finger protein 178) (RING-type E3 ubiquitin transferase MARCHF8),Homo sapiens (Human),59.5,237.0,4.300000000000001e-74,279.3,sp|Q5T0T0|MARH8_HUMAN E3 ubiquitin-protein ligase MARCHF8 OS=Homo sapiens OX=9606 GN=MARCHF8 PE=1 SV=1,GO:0000139; GO:0000209; GO:0002250; GO:0002495; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005789; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0042287; GO:0061630,adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764],MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"immune system process; catalytic activity; lysosome; endosome; vacuole; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_00489,0.3581946309694319,OG_00489,FUN_001455-T1,Peve_00018433,Pocillopora_meandrina_HIv1___RNAseq.g1953.t1,three_way,74.87066666666666,FUN_001455-T1,O94844,RHBT1_HUMAN,,Rho-related BTB domain-containing protein 1,Homo sapiens (Human),39.0,693.0,1.1999999999999999e-113,412.1,sp|O94844|RHBT1_HUMAN Rho-related BTB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RHOBTB1 PE=1 SV=2,GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0010008; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995,actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264],cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; hydrolase activity; cytoplasmic vesicle; organelle
OG_03990,0.3579786855348565,OG_03990,FUN_016158-T1,Peve_00022563,Pocillopora_meandrina_HIv1___RNAseq.g21233.t1,three_way,67.15366666666667,FUN_016158-T1,G3UYX5,,,,,31.1,775.0,2.5e-103,379.4,sp|G3UYX5|RGS22_MOUSE Regulator of G-protein signaling 22 OS=Mus musculus OX=10090 GN=Rgs22 PE=1 SV=1,,,,,,
OG_06743,0.3576313257627485,OG_06743,FUN_031549-T1,Peve_00022771,Pocillopora_meandrina_HIv1___RNAseq.g5142.t1,three_way,79.50266666666667,FUN_031549-T1,Q5F480,ITPK1_CHICK,,"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)",Gallus gallus (Chicken),42.8,320.0,4.6e-77,289.7,sp|Q5F480|ITPK1_CHICK Inositol-tetrakisphosphate 1-kinase OS=Gallus gallus OX=9031 GN=ITPK1 PE=2 SV=1,GO:0000287; GO:0000825; GO:0005524; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052835; GO:0070266,inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266],,"ATP binding [GO:0005524]; inositol-1,3,4,5-tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol-3,4,5,6-tetrakisphosphate 1-kinase activity [GO:0047325]; inositol-3,4,6-trisphosphate 1-kinase activity [GO:0052835]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]",GO:0003824; GO:0012501; GO:0016740; GO:0016853,catalytic activity; programmed cell death; transferase activity; isomerase activity
OG_06119,0.3574411712754532,OG_06119,FUN_027850-T1,Peve_00024333,Pocillopora_meandrina_HIv1___TS.g11653.t1,three_way,77.86916666666667,,,,,,,,,,,,,,,,,
OG_00314,0.3558083100671518,OG_00314,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_03938,0.3554392809363446,OG_03938,FUN_016055-T1,Peve_00011789,Pocillopora_meandrina_HIv1___RNAseq.g21631.t1,three_way,71.45683333333334,FUN_016055-T1,Q8IYT8,ULK2_HUMAN,,Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2),Homo sapiens (Human),34.9,1096.0,7e-132,473.4,sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens OX=9606 GN=ULK2 PE=1 SV=3,GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0006914; GO:0007165; GO:0007411; GO:0008104; GO:0010506; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0046777; GO:0048668; GO:0048671; GO:0048675; GO:0061709; GO:0106310; GO:0160038,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; axon guidance [GO:0007411]; collateral sprouting [GO:0048668]; mitophagy [GO:0000423]; negative regulation of collateral sprouting [GO:0048671]; piecemeal microautophagy of the nucleus [GO:0034727]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]; somatic sensory system development [GO:0160038],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02795,0.3550431418837257,OG_02795,FUN_011758-T1,Peve_00037784,Pocillopora_meandrina_HIv1___RNAseq.g23896.t1,three_way,91.42466666666668,FUN_011758-T1,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),63.4,4613.0,0.0,5645.5,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_08328,0.3550221499837102,OG_08328,FUN_036764-T1,Peve_00006972,Pocillopora_meandrina_HIv1___RNAseq.g10638.t1,three_way,53.79416666666667,,,,,,,,,,,,,,,,,
OG_05874,0.3548539536904316,OG_05874,FUN_026023-T1,Peve_00026728,Pocillopora_meandrina_HIv1___RNAseq.g10495.t1,three_way,61.43916666666667,FUN_026023-T1,Q91717,,,,,31.0,277.0,2.3e-26,123.6,sp|Q91717|CO2A1_XENLA Collagen alpha-1(II) chain OS=Xenopus laevis OX=8355 GN=col2a1 PE=2 SV=2,,,,,,
OG_05207,0.3547906974713503,OG_05207,FUN_023591-T1,Peve_00023917,Pocillopora_meandrina_HIv1___RNAseq.g3310.t1,three_way,53.26583333333333,FUN_023591-T1,A7Z035,EPN4_BOVIN,,Clathrin interactor 1 (Epsin-4),Bos taurus (Bovine),38.2,626.0,8.3e-77,289.7,sp|A7Z035|EPN4_BOVIN Clathrin interactor 1 OS=Bos taurus OX=9913 GN=CLINT1 PE=2 SV=1,GO:0005543; GO:0005654; GO:0005768; GO:0005798; GO:0005802; GO:0005886; GO:0006897; GO:0030125; GO:0030276; GO:0048471,endocytosis [GO:0006897],clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; Golgi-associated vesicle [GO:0005798]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],clathrin binding [GO:0030276]; phospholipid binding [GO:0005543],GO:0005654; GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; endosome; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_00053,0.3547500694642435,OG_00053,FUN_000323-T1,Peve_00012596,Pocillopora_meandrina_HIv1___RNAseq.g29002.t2,three_way,82.90066666666667,FUN_000323-T1,Q9QYF3,MYO5A_RAT,,"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle)",Rattus norvegicus (Rat),51.1,1879.0,0.0,1338.6,sp|Q9QYF3|MYO5A_RAT Unconventional myosin-Va OS=Rattus norvegicus OX=10116 GN=Myo5a PE=1 SV=1,GO:0000146; GO:0000149; GO:0001726; GO:0001750; GO:0003774; GO:0003779; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005777; GO:0005783; GO:0005790; GO:0005794; GO:0005829; GO:0005882; GO:0005884; GO:0006582; GO:0006887; GO:0006892; GO:0007015; GO:0007268; GO:0007601; GO:0008021; GO:0015629; GO:0016020; GO:0016192; GO:0016236; GO:0016459; GO:0016461; GO:0016887; GO:0017075; GO:0017157; GO:0019901; GO:0030048; GO:0030050; GO:0030073; GO:0030141; GO:0030318; GO:0030424; GO:0030425; GO:0031267; GO:0031982; GO:0031987; GO:0032252; GO:0032400; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0033602; GO:0042417; GO:0042438; GO:0042470; GO:0042476; GO:0042552; GO:0042641; GO:0042642; GO:0042759; GO:0042802; GO:0043008; GO:0043025; GO:0043473; GO:0044877; GO:0048066; GO:0048306; GO:0048820; GO:0050808; GO:0050885; GO:0051015; GO:0051643; GO:0051967; GO:0055037; GO:0065003; GO:0072659; GO:0097718; GO:0098685; GO:0098794; GO:0098871; GO:0098978; GO:0099089; GO:0099566; GO:0099640; GO:0150103; GO:1900078; GO:1903078; GO:1904754; GO:1990904,"actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; axo-dendritic protein transport [GO:0099640]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; developmental pigmentation [GO:0048066]; dopamine metabolic process [GO:0042417]; endoplasmic reticulum localization [GO:0051643]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; macroautophagy [GO:0016236]; melanin biosynthetic process [GO:0042438]; melanin metabolic process [GO:0006582]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; myelination [GO:0042552]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuromuscular process controlling balance [GO:0050885]; odontogenesis [GO:0042476]; pigmentation [GO:0043473]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; reactive gliosis [GO:0150103]; regulation of exocytosis [GO:0017157]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin, myosin complex part [GO:0042642]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; postsynaptic actin cytoskeleton [GO:0098871]; recycling endosome [GO:0055037]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]",actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075],GO:0003774; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0023052; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0050877; GO:0065003; GO:0072659; GO:0140657,cytoskeletal motor activity; catalytic activity; lysosome; endosome; vacuole; peroxisome; endoplasmic reticulum; Golgi apparatus; cytosol; cytoskeleton; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; signaling; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; nervous system process; protein-containing complex assembly; protein localization to plasma membrane; ATP-dependent activity
OG_08928,0.3547471741636961,OG_08928,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_07594,0.3544896600364002,OG_07594,FUN_034300-T1,Peve_00013958,Pocillopora_meandrina_HIv1___RNAseq.g28501.t1,three_way,80.99333333333334,FUN_034300-T1,Q86WG5,MTMRD_HUMAN,,Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2),Homo sapiens (Human),39.3,2002.0,0.0,1303.1,sp|Q86WG5|MTMRD_HUMAN Myotubularin-related protein 13 OS=Homo sapiens OX=9606 GN=SBF2 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005774; GO:0005829; GO:0006914; GO:0010008; GO:0016020; GO:0019208; GO:0019902; GO:0030424; GO:0035091; GO:0042552; GO:0042802; GO:0048471,autophagy [GO:0006914]; myelination [GO:0042552],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774],guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0006914; GO:0008289; GO:0098772,cytosol; autophagy; lipid binding; molecular function regulator activity
OG_04593,0.35310913122237,OG_04593,FUN_022271-T1,Peve_00007683,Pocillopora_meandrina_HIv1___RNAseq.g4712.t1,three_way,56.11566666666666,FUN_022271-T1,Q5F479,,,,,25.6,679.0,7.7e-41,171.4,sp|Q5F479|S11IP_CHICK Serine/threonine-protein kinase 11-interacting protein OS=Gallus gallus OX=9031 GN=STK11IP PE=2 SV=1,,,,,,
OG_09256,0.3526878434064594,OG_09256,FUN_040058-T1,Peve_00018499,Pocillopora_meandrina_HIv1___RNAseq.g7727.t1b,three_way,76.5945,FUN_040058-T1,Q8CFI0,NED4L_MOUSE,,E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (EC 2.3.2.36) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2),Mus musculus (Mouse),47.7,973.0,1.6e-243,844.0,sp|Q8CFI0|NED4L_MOUSE E3 ubiquitin-protein ligase NEDD4-like OS=Mus musculus OX=10090 GN=Nedd4l PE=1 SV=2,GO:0002028; GO:0003085; GO:0005771; GO:0005794; GO:0006511; GO:0006814; GO:0009651; GO:0010765; GO:0010766; GO:0016567; GO:0019871; GO:0030154; GO:0031647; GO:0051649; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252; GO:1902305; GO:2000810,cell differentiation [GO:0030154]; establishment of localization in cell [GO:0051649]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of sodium ion transport [GO:0010765]; protein ubiquitination [GO:0016567]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transport [GO:0002028]; regulation protein catabolic process at postsynapse [GO:0140252]; response to salt stress [GO:0009651]; sodium ion transport [GO:0006814]; ubiquitin-dependent protein catabolic process [GO:0006511],glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; postsynapse [GO:0098794],sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005768; GO:0005794; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endosome; Golgi apparatus; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00703,0.3526114144573851,OG_00703,FUN_002453-T1,Peve_00023668,Pocillopora_meandrina_HIv1___RNAseq.g14891.t1,three_way,78.35433333333334,,,,,,,,,,,,,,,,,
OG_05724,0.352548854118353,OG_05724,FUN_025643-T1,Peve_00002527,Pocillopora_meandrina_HIv1___TS.g15983.t1,three_way,64.00683333333333,FUN_025643-T1,Q04637,IF4G1_HUMAN,,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),Homo sapiens (Human),39.4,1020.0,1.2e-159,566.2,sp|Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=4,GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0016020; GO:0016281; GO:0030182; GO:0030307; GO:0031369; GO:0031669; GO:0035278; GO:0036493; GO:0045666; GO:0051247; GO:0060090; GO:0080135; GO:0097009; GO:1900087; GO:1904377; GO:1905537; GO:1905606; GO:1905612,behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840],"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]",GO:0003723; GO:0005634; GO:0005829; GO:0005840; GO:0030154; GO:0031047; GO:0043226; GO:0060090,RNA binding; nucleus; cytosol; ribosome; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity
OG_00078,0.352540340983901,OG_00078,FUN_000403-T1,Peve_00033519,Pocillopora_meandrina_HIv1___RNAseq.g2544.t1,three_way,79.21583333333334,FUN_000403-T1,A0A0G2K2P5,ZO1_RAT,,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),Rattus norvegicus (Rat),28.2,1783.0,6.4e-140,500.7,sp|A0A0G2K2P5|ZO1_RAT Tight junction protein ZO-1 OS=Rattus norvegicus OX=10116 GN=Tjp1 PE=1 SV=1,GO:0001825; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005921; GO:0005923; GO:0007605; GO:0008013; GO:0008284; GO:0009410; GO:0009986; GO:0014704; GO:0016020; GO:0016301; GO:0016323; GO:0016324; GO:0016327; GO:0019904; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0031410; GO:0032496; GO:0032991; GO:0034334; GO:0036305; GO:0043066; GO:0043116; GO:0043296; GO:0044325; GO:0045177; GO:0045216; GO:0045471; GO:0046581; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0070830; GO:0071000; GO:0071253; GO:0071277; GO:0071333; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; bicellular tight junction assembly [GO:0070830]; blastocyst formation [GO:0001825]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; intercalated disc [GO:0014704]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; connexin binding [GO:0071253]; kinase activity [GO:0016301]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0003824; GO:0005634; GO:0005886; GO:0007010; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,circulatory system process; catalytic activity; nucleus; plasma membrane; cytoskeleton organization; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_03291,0.3524030900577702,OG_03291,FUN_013350-T1,Peve_00041996,Pocillopora_meandrina_HIv1___TS.g2168.t1a,three_way,66.735,FUN_013350-T1,Q8CBF3,EPHB1_MOUSE,,Ephrin type-B receptor 1 (EC 2.7.10.1),Mus musculus (Mouse),38.3,975.0,3.2e-176,620.5,sp|Q8CBF3|EPHB1_MOUSE Ephrin type-B receptor 1 OS=Mus musculus OX=10090 GN=Ephb1 PE=1 SV=1,GO:0001525; GO:0001771; GO:0005005; GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007411; GO:0008046; GO:0014719; GO:0016020; GO:0021545; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070372; GO:0098978; GO:1902723; GO:1902725,angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; cranial nerve development [GO:0021545]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein-containing complex binding [GO:0044877]; transmembrane-ephrin receptor activity [GO:0005005],GO:0003824; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007163; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endoplasmic reticulum; cytosol; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; transferase activity; cell differentiation; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_00827,0.3523632870112524,OG_00827,FUN_004056-T1,Peve_00007130,Pocillopora_meandrina_HIv1___TS.g18499.t1,three_way,72.9045,FUN_004056-T1,Q6P0Q8,MAST2_HUMAN,,Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1),Homo sapiens (Human),43.5,1429.0,1.8999999999999995e-236,821.2,sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2,GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310,cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_01874,0.3522506492852338,OG_01874,FUN_007846-T1,Peve_00014226,Pocillopora_meandrina_HIv1___RNAseq.g20393.t1,three_way,68.34366666666666,FUN_007846-T1,Q9TTR8,,,,,36.1,382.0,1.5e-58,228.4,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_08716,0.3520730516583433,OG_08716,FUN_037968-T1,Peve_00012657,Pocillopora_meandrina_HIv1___RNAseq.g26237.t1,three_way,76.11933333333333,FUN_037968-T1,Q16658,FSCN1_HUMAN,,Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55),Homo sapiens (Human),40.2,488.0,2.5e-97,357.5,sp|Q16658|FSCN1_HUMAN Fascin OS=Homo sapiens OX=9606 GN=FSCN1 PE=1 SV=3,GO:0001725; GO:0001726; GO:0002102; GO:0003723; GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0005902; GO:0005911; GO:0005938; GO:0007043; GO:0007163; GO:0010592; GO:0015629; GO:0016477; GO:0030027; GO:0030035; GO:0030036; GO:0030046; GO:0030175; GO:0030426; GO:0030674; GO:0031253; GO:0032534; GO:0032956; GO:0035089; GO:0044393; GO:0045296; GO:0048870; GO:0051015; GO:0051017; GO:0051491; GO:0070062; GO:0071803; GO:0090091,actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-cell junction assembly [GO:0007043]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725],actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723],GO:0003723; GO:0005829; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0034330; GO:0043226; GO:0048870; GO:0060090,RNA binding; cytosol; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_04244,0.3520254889057377,OG_04244,FUN_017766-T1,Peve_00035953,Pocillopora_meandrina_HIv1___RNAseq.g462.t1,three_way,86.78283333333333,FUN_017766-T1,P19517,,,,,56.8,405.0,1.8e-114,414.5,sp|P19517|CACB1_RABIT Voltage-dependent L-type calcium channel subunit beta-1 OS=Oryctolagus cuniculus OX=9986 GN=CACNB1 PE=1 SV=1,,,,,,
OG_08994,0.3519155973137254,OG_08994,FUN_038524-T1,Peve_00041750,Pocillopora_meandrina_HIv1___RNAseq.g28186.t1,three_way,79.337,FUN_038524-T1,Q8BKX6,SMG1_MOUSE,,Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1),Mus musculus (Mouse),37.7,3713.0,0.0,2274.6,sp|Q8BKX6|SMG1_MOUSE Serine/threonine-protein kinase SMG1 OS=Mus musculus OX=10090 GN=Smg1 PE=1 SV=3,GO:0000184; GO:0004674; GO:0005524; GO:0005654; GO:0006281; GO:0032204; GO:0033391; GO:0042162; GO:0046854; GO:0046872; GO:0106310,"DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of telomere maintenance [GO:0032204]",chromatoid body [GO:0033391]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0005654; GO:0006281; GO:0006629; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleoplasm; DNA repair; lipid metabolic process; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01942,0.3514814659187592,OG_01942,FUN_007995-T1,Peve_00018055,Pocillopora_meandrina_HIv1___RNAseq.g18162.t1,three_way,60.7,FUN_007995-T1,Q13308,,,,,32.5,1058.0,5.8e-147,523.5,sp|Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens OX=9606 GN=PTK7 PE=1 SV=2,,,,,,
OG_08228,0.3512013147765387,OG_08228,FUN_036100-T1,Peve_00032196,Pocillopora_meandrina_HIv1___RNAseq.g27435.t1,three_way,77.412,FUN_036100-T1,Q0P8I7,GMHD_CAMJE,,GDP-D-glycero-alpha-D-manno-heptose dehydrogenase (EC 1.1.98.-),Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168),41.3,310.0,2.6e-64,247.3,sp|Q0P8I7|GMHD_CAMJE GDP-D-glycero-alpha-D-manno-heptose dehydrogenase OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) OX=192222 GN=Cj1427c PE=1 SV=1,GO:0003978; GO:0016491; GO:0019003; GO:0042802; GO:0045227; GO:0051289; GO:0070404,capsule polysaccharide biosynthetic process [GO:0045227]; protein homotetramerization [GO:0051289],,GDP binding [GO:0019003]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; oxidoreductase activity [GO:0016491]; UDP-glucose 4-epimerase activity [GO:0003978],GO:0003824; GO:0005975; GO:0016491; GO:0016853; GO:0065003,catalytic activity; carbohydrate metabolic process; oxidoreductase activity; isomerase activity; protein-containing complex assembly
OG_02318,0.3508977375662473,OG_02318,FUN_008909-T1,Peve_00017911,Pocillopora_meandrina_HIv1___RNAseq.g3974.t1,three_way,62.283166666666666,FUN_008909-T1,Q9EQZ7,,,,,32.2,1005.0,1.6e-93,346.7,sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1,,,,,,
OG_09835,0.350582230183963,OG_09835,FUN_042814-T1,Peve_00021878,Pocillopora_meandrina_HIv1___RNAseq.g7429.t1,three_way,82.54266666666666,FUN_042814-T1,E9Q634,MYO1E_MOUSE,,Unconventional myosin-Ie (Unconventional myosin 1E),Mus musculus (Mouse),66.0,1113.0,0.0,1439.5,sp|E9Q634|MYO1E_MOUSE Unconventional myosin-Ie OS=Mus musculus OX=10090 GN=Myo1e PE=1 SV=1,GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005903; GO:0005912; GO:0006897; GO:0016459; GO:0016887; GO:0030097; GO:0032836; GO:0035091; GO:0035166; GO:0045334; GO:0048008; GO:0051015; GO:0072015,endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570],adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091],GO:0003014; GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856,renal system process; cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development
OG_01404,0.350393869818515,OG_01404,FUN_005470-T1,Peve_00002032,Pocillopora_meandrina_HIv1___RNAseq.g6626.t1,three_way,74.86033333333333,FUN_005470-T1,Q07817,B2CL1_HUMAN,,Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X),Homo sapiens (Human),38.9,126.0,2.2e-19,97.1,sp|Q07817|B2CL1_HUMAN Bcl-2-like protein 1 OS=Homo sapiens OX=9606 GN=BCL2L1 PE=1 SV=1,GO:0001541; GO:0001701; GO:0001836; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005813; GO:0005829; GO:0006897; GO:0007281; GO:0007283; GO:0008584; GO:0008630; GO:0008637; GO:0009566; GO:0010507; GO:0015267; GO:0019901; GO:0030672; GO:0031965; GO:0032465; GO:0032946; GO:0034097; GO:0035234; GO:0040008; GO:0042802; GO:0043065; GO:0043066; GO:0043524; GO:0044565; GO:0046898; GO:0046902; GO:0050673; GO:0051093; GO:0051402; GO:0051434; GO:0051607; GO:0051881; GO:0071230; GO:0071312; GO:0071480; GO:0071839; GO:0090201; GO:0097048; GO:0097136; GO:0097192; GO:0097284; GO:1900118; GO:1901029; GO:1902042; GO:1902230; GO:1902236; GO:1903077; GO:2000242; GO:2000669; GO:2000811; GO:2001240; GO:2001243,apoptotic mitochondrial changes [GO:0008637]; apoptotic process in bone marrow cell [GO:0071839]; cellular response to alkaloid [GO:0071312]; cellular response to amino acid stimulus [GO:0071230]; cellular response to gamma radiation [GO:0071480]; defense response to virus [GO:0051607]; dendritic cell apoptotic process [GO:0097048]; dendritic cell proliferation [GO:0044565]; ectopic germ cell programmed cell death [GO:0035234]; endocytosis [GO:0006897]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fertilization [GO:0009566]; germ cell development [GO:0007281]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of developmental process [GO:0051093]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of reproductive process [GO:2000242]; neuron apoptotic process [GO:0051402]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mononuclear cell proliferation [GO:0032946]; regulation of cytokinesis [GO:0032465]; regulation of growth [GO:0040008]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to cycloheximide [GO:0046898]; response to cytokine [GO:0034097]; spermatogenesis [GO:0007283],Bcl-2 family protein complex [GO:0097136]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; synaptic vesicle membrane [GO:0030672],BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901],GO:0005215; GO:0005739; GO:0005783; GO:0005815; GO:0005829; GO:0007005; GO:0012501; GO:0016192; GO:0022414; GO:0043226; GO:0048856; GO:0061024,transporter activity; mitochondrion; endoplasmic reticulum; microtubule organizing center; cytosol; mitochondrion organization; programmed cell death; vesicle-mediated transport; reproductive process; organelle; anatomical structure development; membrane organization
OG_09702,0.3499200054025509,OG_09702,FUN_041933-T1,Peve_00023581,Pocillopora_meandrina_HIv1___RNAseq.g15700.t1,three_way,61.377,FUN_041933-T1,P52594,AGFG1_HUMAN,,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),Homo sapiens (Human),57.9,183.0,3.4e-54,214.9,sp|P52594|AGFG1_HUMAN Arf-GAP domain and FG repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=AGFG1 PE=1 SV=2,GO:0001675; GO:0003677; GO:0003723; GO:0005096; GO:0005643; GO:0005737; GO:0005829; GO:0006406; GO:0007289; GO:0008270; GO:0031410; GO:0042995; GO:0043025; GO:0043231; GO:0045109,acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; mRNA export from nucleus [GO:0006406]; spermatid nucleus differentiation [GO:0007289],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nuclear pore [GO:0005643],DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005829; GO:0006913; GO:0007010; GO:0022414; GO:0031410; GO:0043226; GO:0098772,DNA binding; RNA binding; cytosol; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_03309,0.3497089005020969,OG_03309,FUN_013385-T1,Peve_00015992,Pocillopora_meandrina_HIv1___RNAseq.g22980.t2,three_way,65.83083333333333,FUN_013385-T1,Q24180,DEAF1_DROME,,Deformed epidermal autoregulatory factor 1 (Protein DEAF-1),Drosophila melanogaster (Fruit fly),45.2,84.0,2.6e-16,87.8,sp|Q24180|DEAF1_DROME Deformed epidermal autoregulatory factor 1 OS=Drosophila melanogaster OX=7227 GN=Deaf1 PE=1 SV=1,GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776,embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]; polytene chromosome [GO:0005700],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005694; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; chromosome; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_01060,0.3496023819129172,OG_01060,FUN_004515-T1,Peve_00044063,Pocillopora_meandrina_HIv1___RNAseq.g11318.t1,three_way,65.01150000000001,FUN_004515-T1,Q9Z1P7,,,,,39.5,253.0,1.3e-45,186.8,sp|Q9Z1P7|KANK3_MOUSE KN motif and ankyrin repeat domain-containing protein 3 OS=Mus musculus OX=10090 GN=Kank3 PE=1 SV=1,,,,,,
OG_05003,0.3492216067754001,OG_05003,FUN_023139-T1,Peve_00042477,Pocillopora_meandrina_HIv1___RNAseq.g1749.t1,three_way,49.72316666666666,FUN_023139-T1,P70399,TP53B_MOUSE,,TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),Mus musculus (Mouse),27.4,559.0,4.7999999999999996e-43,179.1,sp|P70399|TP53B_MOUSE TP53-binding protein 1 OS=Mus musculus OX=10090 GN=Tp53bp1 PE=1 SV=3,GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0005634; GO:0005657; GO:0005737; GO:0006281; GO:0006303; GO:0006355; GO:0006974; GO:0016604; GO:0035064; GO:0035861; GO:0042162; GO:0043565; GO:0045830; GO:0045944; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:0097680; GO:0140005; GO:0140941; GO:1990166; GO:1990391; GO:2000042,cellular response to X-ray [GO:0071481]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; protein localization to site of double-strand break [GO:1990166]; regulation of DNA-templated transcription [GO:0006355],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",damaged DNA binding [GO:0003684]; histone H4K20me methyltransferase activity [GO:0140941]; histone H4K20me2 reader activity [GO:0140005]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; ubiquitin-modified histone reader activity [GO:0061649],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0065003; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; DNA repair; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein; transcription regulator activity"
OG_02668,0.3492062738888191,OG_02668,FUN_010887-T1,Peve_00035839,Pocillopora_meandrina_HIv1___RNAseq.g21002.t1,three_way,87.91066666666666,FUN_010887-T1,Q32LP2,RADI_BOVIN,,Radixin,Bos taurus (Bovine),67.4,307.0,5e-129,463.0,sp|Q32LP2|RADI_BOVIN Radixin OS=Bos taurus OX=9913 GN=RDX PE=2 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005912; GO:0008360; GO:0030175; GO:0032154; GO:0045177; GO:0050839; GO:0051693; GO:0120044; GO:1902115; GO:1902966; GO:2000643,actin filament capping [GO:0051693]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; stereocilium base [GO:0120044],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839],GO:0005856; GO:0005886; GO:0008092; GO:0043226,cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_07730,0.3490980507224878,OG_07730,FUN_034891-T1,Peve_00037339,Pocillopora_meandrina_HIv1___TS.g15151.t2,three_way,94.67133333333334,FUN_034891-T1,Q13951,,,,,57.1,170.0,1.1e-48,194.5,sp|Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2,,,,,,
OG_03771,0.3490975430463486,OG_03771,FUN_015100-T1,Peve_00027023,Pocillopora_meandrina_HIv1___RNAseq.g22141.t1,three_way,83.81099999999999,FUN_015100-T1,Q5U3N5,,,,,51.7,238.0,6.2e-63,242.3,sp|Q5U3N5|PPTC7_DANRE Protein phosphatase PTC7 homolog OS=Danio rerio OX=7955 GN=pptc7 PE=2 SV=1,,,,,,
OG_06273,0.3487919262834959,OG_06273,FUN_028309-T1,Peve_00037726,Pocillopora_meandrina_HIv1___RNAseq.g16424.t1,three_way,73.845,FUN_028309-T1,O15550,KDM6A_HUMAN,,Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A),Homo sapiens (Human),40.4,1012.0,2.5e-115,418.3,sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2,GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558,chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468],histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016491; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; oxidoreductase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04261,0.34826851303319,OG_04261,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,54.0,767.0,3.7e-223,777.3,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_04261,0.34826851303319,OG_04261,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,38.5,78.0,0.002,47.4,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_09964,0.3478787275655204,OG_09964,FUN_043145-T1,Peve_00044698,Pocillopora_meandrina_HIv1___RNAseq.g6860.t1,three_way,79.27533333333334,,,,,,,,,,,,,,,,,
OG_06653,0.3476630488887712,OG_06653,FUN_030678-T1,Peve_00028161,Pocillopora_meandrina_HIv1___RNAseq.g6203.t1,three_way,43.779,,,,,,,,,,,,,,,,,
OG_00679,0.3473708057324747,OG_00679,FUN_002102-T1,Peve_00004294,Pocillopora_meandrina_HIv1___RNAseq.g1737.t1,three_way,59.12716666666666,FUN_002102-T1,P18461,,,,,37.9,833.0,3.8e-141,503.8,sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus OX=9031 GN=FGFR2 PE=2 SV=1,,,,,,
OG_04436,0.3472726591914774,OG_04436,FUN_018806-T1,Peve_00035781,Pocillopora_meandrina_HIv1___TS.g23409.t1,three_way,74.02616666666667,FUN_018806-T1,P97411,,,,,37.4,604.0,6.7e-85,316.6,sp|P97411|ICA69_MOUSE Islet cell autoantigen 1 OS=Mus musculus OX=10090 GN=Ica1 PE=1 SV=3,,,,,,
OG_09588,0.3472333596315835,OG_09588,FUN_041730-T1,Peve_00006454,Pocillopora_meandrina_HIv1___TS.g10510.t1,three_way,71.7615,FUN_041730-T1,Q6DFR2,CBLB_XENTR,,E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),62.5,491.0,5.1e-171,603.2,sp|Q6DFR2|CBLB_XENTR E3 ubiquitin-protein ligase CBL-B OS=Xenopus tropicalis OX=8364 GN=cblb PE=2 SV=1,GO:0001784; GO:0004842; GO:0005509; GO:0005737; GO:0007166; GO:0008270; GO:0016567; GO:2000583,cell surface receptor signaling pathway [GO:0007166]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583],cytoplasm [GO:0005737],calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_03546,0.347167884462851,OG_03546,FUN_014673-T1,Peve_00013033,Pocillopora_meandrina_HIv1___RNAseq.g22680.t1,three_way,77.56683333333334,FUN_014673-T1,Q96AY4,TTC28_HUMAN,,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),Homo sapiens (Human),44.3,828.0,5.7e-171,604.4,sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4,GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301,cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922],kinase binding [GO:0019900],GO:0005815,microtubule organizing center
OG_05486,0.3471428959928562,OG_05486,FUN_024483-T1,Peve_00010585,Pocillopora_meandrina_HIv1___RNAseq.g19068.t1,three_way,49.94483333333333,FUN_024483-T1,Q9UHB7,,,,,27.0,248.0,1.4e-13,80.5,sp|Q9UHB7|AFF4_HUMAN AF4/FMR2 family member 4 OS=Homo sapiens OX=9606 GN=AFF4 PE=1 SV=1,,,,,,
OG_03673,0.3471343547458483,OG_03673,FUN_014924-T1,Peve_00006268,Pocillopora_meandrina_HIv1___RNAseq.g21081.t1,three_way,64.52166666666666,FUN_014924-T1,Q6PAJ1,BCR_MOUSE,,Breakpoint cluster region protein (EC 2.7.11.1),Mus musculus (Mouse),38.2,798.0,1.9999999999999997e-142,508.8,sp|Q6PAJ1|BCR_MOUSE Breakpoint cluster region protein OS=Mus musculus OX=10090 GN=Bcr PE=1 SV=3,GO:0002692; GO:0003014; GO:0004674; GO:0005085; GO:0005096; GO:0005524; GO:0005829; GO:0005886; GO:0006909; GO:0007264; GO:0007420; GO:0014069; GO:0016477; GO:0030036; GO:0030216; GO:0030424; GO:0032496; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043312; GO:0043314; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051649; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0106310; GO:1905517; GO:1905522; GO:2000378,actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cell migration [GO:0016477]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; establishment of localization in cell [GO:0051649]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; macrophage migration [GO:1905517]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; phagocytosis [GO:0006909]; positive regulation of phagocytosis [GO:0050766]; regulation of cell cycle [GO:0051726]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; response to lipopolysaccharide [GO:0032496]; small GTPase-mediated signal transduction [GO:0007264],axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685],ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003013; GO:0003014; GO:0003824; GO:0005829; GO:0005886; GO:0006886; GO:0007010; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0098772; GO:0140096,"immune system process; circulatory system process; renal system process; catalytic activity; cytosol; plasma membrane; intracellular protein transport; cytoskeleton organization; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09657,0.3467853922971833,OG_09657,FUN_041862-T1,Peve_00030448,Pocillopora_meandrina_HIv1___RNAseq.g15123.t1,three_way,78.17916666666666,FUN_041862-T1,A0A8C0TYJ0,DLG1_CANLF,,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97),Canis lupus familiaris (Dog) (Canis familiaris),54.7,959.0,1.8e-266,920.2,sp|A0A8C0TYJ0|DLG1_CANLF Disks large homolog 1 OS=Canis lupus familiaris OX=9615 GN=DLG1 PE=3 SV=1,GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0005604; GO:0005634; GO:0005789; GO:0005794; GO:0005874; GO:0005923; GO:0007268; GO:0008284; GO:0008360; GO:0009898; GO:0010669; GO:0014069; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019900; GO:0019902; GO:0030041; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031579; GO:0031594; GO:0031641; GO:0033268; GO:0035748; GO:0042098; GO:0042130; GO:0042383; GO:0042982; GO:0043219; GO:0043268; GO:0043491; GO:0043622; GO:0044325; GO:0045121; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0098609; GO:0098911; GO:0098915; GO:0098919; GO:0098978; GO:0099645; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903764; GO:2000134,actin filament polymerization [GO:0030041]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; epithelial structure maintenance [GO:0010669]; establishment of centrosome localization [GO:0051660]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell projection membrane [GO:0031253]; cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060],kinase binding [GO:0019900]; L27 domain binding [GO:0097016]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; potassium channel regulator activity [GO:0015459]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0003012; GO:0005198; GO:0005634; GO:0005794; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0022414; GO:0023052; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0060090; GO:0061024; GO:0065003; GO:0072659; GO:0098772,immune system process; muscle system process; structural molecule activity; nucleus; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; reproductive process; signaling; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; molecular adaptor activity; membrane organization; protein-containing complex assembly; protein localization to plasma membrane; molecular function regulator activity
OG_09510,0.3467336892544994,OG_09510,FUN_041562-T1,Peve_00033130,Pocillopora_meandrina_HIv1___RNAseq.g16036.t1,three_way,88.02866666666667,FUN_041562-T1,Q93008,USP9X_HUMAN,,"Ubiquitin carboxyl-terminal hydrolase 9X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)",Homo sapiens (Human),61.0,2508.0,0.0,2993.4,sp|Q93008|USP9X_HUMAN Ubiquitin carboxyl-terminal hydrolase 9X OS=Homo sapiens OX=9606 GN=USP9X PE=1 SV=4,GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006307; GO:0007059; GO:0007179; GO:0007292; GO:0008104; GO:0008234; GO:0016020; GO:0016477; GO:0016562; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0031647; GO:0032092; GO:0032435; GO:0035520; GO:0042752; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0060271; GO:0061578; GO:0061824; GO:0070410; GO:0070536; GO:0071947; GO:0101005; GO:0140313; GO:0180017; GO:1904515; GO:1990000; GO:1990380,"amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; DNA alkylation repair [GO:0006307]; female gamete generation [GO:0007292]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]",centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634],co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; K11-linked deubiquitinase activity [GO:0180017]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; molecular sequestering activity [GO:0140313],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0006281; GO:0006355; GO:0007059; GO:0016787; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140096; GO:0140313,"catalytic activity; nucleus; microtubule organizing center; cytosol; cilium; DNA repair; regulation of DNA-templated transcription; chromosome segregation; hydrolase activity; reproductive process; organelle; cilium organization; cell motility; catalytic activity, acting on a protein; molecular sequestering activity"
OG_04089,0.3466282867084445,OG_04089,FUN_016428-T1,Peve_00004356,Pocillopora_meandrina_HIv1___RNAseq.g9809.t1,three_way,74.45816666666666,FUN_016428-T1,Q15147,,,,,38.6,1257.0,9.2e-231,802.4,"sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3",,,,,,
OG_03805,0.3466075221150695,OG_03805,FUN_015192-T1,Peve_00013032,Pocillopora_meandrina_HIv1___RNAseq.g22303.t1,three_way,69.30916666666666,FUN_015192-T1,Q8WY54,PPM1E_HUMAN,,Protein phosphatase 1E (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase N) (CaMKP-N) (CaMKP-nucleus) (CaMKN) (Partner of PIX 1) (Partner of PIX-alpha) (Partner of PIXA),Homo sapiens (Human),52.3,367.0,7.700000000000001e-98,359.0,sp|Q8WY54|PPM1E_HUMAN Protein phosphatase 1E OS=Homo sapiens OX=9606 GN=PPM1E PE=1 SV=3,GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006469; GO:0007165; GO:0032991; GO:0035970; GO:0046872; GO:0051496; GO:0071222; GO:0071466,cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_06197,0.3462858658391348,OG_06197,FUN_028122-T1,Peve_00004261,Pocillopora_meandrina_HIv1___RNAseq.g15557.t2,three_way,43.58133333333333,FUN_028122-T1,P36335,,,,,26.3,598.0,1.3e-35,152.9,sp|P36335|NCA12_XENLA Neural cell adhesion molecule 1-B OS=Xenopus laevis OX=8355 GN=ncam1-b PE=2 SV=1,,,,,,
OG_04932,0.3462317861844218,OG_04932,FUN_023000-T1,Peve_00024659,Pocillopora_meandrina_HIv1___RNAseq.g3813.t1,three_way,53.00183333333333,FUN_023000-T1,Q90Z00,FGR1A_DANRE,,Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A),Danio rerio (Zebrafish) (Brachydanio rerio),37.9,804.0,7.2e-136,486.5,sp|Q90Z00|FGR1A_DANRE Fibroblast growth factor receptor 1-A OS=Danio rerio OX=7955 GN=fgfr1a PE=1 SV=2,GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043410; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699,anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_09621,0.3461405612269439,OG_09621,FUN_041784-T1,Peve_00025206,Pocillopora_meandrina_HIv1___RNAseq.g15487.t1,three_way,95.13633333333333,FUN_041784-T1,P16912,KAPC3_DROME,,cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2),Drosophila melanogaster (Fruit fly),66.2,314.0,8.1e-132,471.5,sp|P16912|KAPC3_DROME cAMP-dependent protein kinase catalytic subunit 3 OS=Drosophila melanogaster OX=7227 GN=Pka-C3 PE=2 SV=2,GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0007155; GO:0007165; GO:0007476; GO:0106310,cell adhesion [GO:0007155]; imaginal disc-derived wing morphogenesis [GO:0007476]; signal transduction [GO:0007165],cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829],ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005829; GO:0007155; GO:0016740; GO:0140096,"catalytic activity; cytosol; cell adhesion; transferase activity; catalytic activity, acting on a protein"
OG_03764,0.3457930327036903,OG_03764,FUN_015089-T1,Peve_00010705,Pocillopora_meandrina_HIv1___RNAseq.g21187.t1,three_way,72.56533333333334,FUN_015089-T1,Q71F56,MD13L_HUMAN,,Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like),Homo sapiens (Human),29.0,2382.0,7.899999999999999e-204,713.4,sp|Q71F56|MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like OS=Homo sapiens OX=9606 GN=MED13L PE=1 SV=1,GO:0003713; GO:0005654; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592]; nucleoplasm [GO:0005654],transcription coactivator activity [GO:0003713],GO:0005654; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_02829,0.345519368835135,OG_02829,FUN_011844-T1,Peve_00034372,Pocillopora_meandrina_HIv1___RNAseq.g23374.t1,three_way,76.01283333333333,FUN_011844-T1,Q8VHI6,WASF3_MOUSE,,Actin-binding protein WASF3 (Protein WAVE-3) (Wiskott-Aldrich syndrome protein family member 3) (WASP family protein member 3),Mus musculus (Mouse),40.6,502.0,1.2e-40,169.1,sp|Q8VHI6|WASF3_MOUSE Actin-binding protein WASF3 OS=Mus musculus OX=10090 GN=Wasf3 PE=1 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0031643; GO:0097386; GO:0098794; GO:0098885; GO:0098978,actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; regulation of cell shape [GO:0008360],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794],actin binding [GO:0003779],GO:0005856; GO:0007010; GO:0008092; GO:0034330; GO:0043226; GO:0048856,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; cell junction organization; organelle; anatomical structure development
OG_06284,0.3454810942795118,OG_06284,FUN_028470-T1,Peve_00036788,Pocillopora_meandrina_HIv1___RNAseq.g16126.t1,three_way,85.66233333333334,FUN_028470-T1,Q17LW0,,,,,59.3,1107.0,1.4e-292,1007.3,sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1,,,,,,
OG_02407,0.3454549902795202,OG_02407,FUN_009056-T1,Peve_00032033,Pocillopora_meandrina_HIv1___RNAseq.g14479.t1,three_way,51.15833333333333,,,,,,,,,,,,,,,,,
OG_02074,0.3453731449423131,OG_02074,FUN_008290-T1,Peve_00018505,Pocillopora_meandrina_HIv1___RNAseq.g18018.t1,three_way,70.76516666666666,FUN_008290-T1,Q5PRF9,SMAG2_HUMAN,,Protein Smaug homolog 2 (Smaug 2) (hSmaug2) (Sterile alpha motif domain-containing protein 4B) (SAM domain-containing protein 4B),Homo sapiens (Human),32.0,719.0,1.7e-72,275.4,sp|Q5PRF9|SMAG2_HUMAN Protein Smaug homolog 2 OS=Homo sapiens OX=9606 GN=SAMD4B PE=1 SV=1,GO:0000289; GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005829; GO:0030371,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289],cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0045182,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; translation regulator activity
OG_09216,0.3450176458503057,OG_09216,FUN_039935-T1,Peve_00036234,Pocillopora_meandrina_HIv1___RNAseq.g7328.t1,three_way,60.9255,FUN_039935-T1,Q3TLH4,,,,,29.5,451.0,5.8e-24,116.3,sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3,,,,,,
OG_06110,0.3449246583770259,OG_06110,FUN_027815-T1,Peve_00036487,Pocillopora_meandrina_HIv1___RNAseq.g13889.t2,three_way,90.976,FUN_027815-T1,Q23356,MIG15_CAEEL,,Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15),Caenorhabditis elegans,44.9,1094.0,1.7e-240,833.9,sp|Q23356|MIG15_CAEEL Serine/threonine-protein kinase mig-15 OS=Caenorhabditis elegans OX=6239 GN=mig-15 PE=2 SV=3,GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0022414; GO:0030334; GO:0032228; GO:0033563; GO:0043408; GO:0048812; GO:0106310,"body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of MAPK cascade [GO:0043408]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproductive process [GO:0022414]",cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_08415,0.3448372917823589,OG_08415,FUN_037071-T1,Peve_00004736,Pocillopora_meandrina_HIv1___RNAseq.g26783.t1,three_way,86.73233333333333,FUN_037071-T1,Q99973,TEP1_HUMAN,,Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog),Homo sapiens (Human),26.9,577.0,1.6999999999999998e-43,179.9,sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2,GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904,telomere maintenance via recombination [GO:0000722],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0006310; GO:0016740; GO:0032200; GO:0140097,"RNA binding; catalytic activity; DNA recombination; transferase activity; telomere organization; catalytic activity, acting on DNA"
OG_06189,0.3444347747780051,OG_06189,FUN_028104-T1,Peve_00004896,Pocillopora_meandrina_HIv1___RNAseq.g15572.t1,three_way,86.157,FUN_028104-T1,Q6XBT4,,,,,36.7,343.0,4.1e-42,173.7,sp|Q6XBT4|USF1_BOVIN Upstream stimulatory factor 1 OS=Bos taurus OX=9913 GN=USF1 PE=2 SV=1,,,,,,
OG_10062,0.3440786881712379,OG_10062,FUN_043362-T1,Peve_00016657,Pocillopora_meandrina_HIv1___RNAseq.g8969.t1,three_way,65.42666666666666,FUN_043362-T1,Q8STF6,DYC1_CAEEL,,Dystrophin-like protein 1 (Dyb-1-binding and CAPON-related protein),Caenorhabditis elegans,41.2,228.0,8.5e-40,166.4,sp|Q8STF6|DYC1_CAEEL Dystrophin-like protein 1 OS=Caenorhabditis elegans OX=6239 GN=dyc-1 PE=1 SV=1,GO:0007626; GO:0008307; GO:0016010; GO:0030235; GO:0030424; GO:0040017; GO:0045214; GO:0046662; GO:0046716; GO:0050998; GO:0055120,locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of locomotion [GO:0040017]; regulation of egg-laying behavior [GO:0046662]; sarcomere organization [GO:0045214],axon [GO:0030424]; dystrophin-associated glycoprotein complex [GO:0016010]; striated muscle dense body [GO:0055120],nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; structural constituent of muscle [GO:0008307],GO:0005198; GO:0007010; GO:0098772,structural molecule activity; cytoskeleton organization; molecular function regulator activity
OG_00295,0.3437070550154886,OG_00295,FUN_001086-T1,Peve_00003185,Pocillopora_meandrina_HIv1___RNAseq.g29387.t1,three_way,66.87883333333333,FUN_001086-T1,Q6DRG7,MYPT1_DANRE,,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),Danio rerio (Zebrafish) (Brachydanio rerio),65.8,225.0,9.999999999999999e-33,143.7,sp|Q6DRG7|MYPT1_DANRE Protein phosphatase 1 regulatory subunit 12A OS=Danio rerio OX=7955 GN=ppp1r12a PE=2 SV=2,GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0017020; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0030510; GO:0031017; GO:0031672; GO:0046982; GO:0048812; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357,actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; neuron projection morphogenesis [GO:0048812]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165],A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018],14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0048856; GO:0098772,anatomical structure development; molecular function regulator activity
OG_00295,0.3437070550154886,OG_00295,FUN_001086-T1,Peve_00003185,Pocillopora_meandrina_HIv1___RNAseq.g29387.t1,three_way,66.87883333333333,FUN_001086-T1,Q6DRG7,MYPT1_DANRE,,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),Danio rerio (Zebrafish) (Brachydanio rerio),81.6,38.0,1.9e-07,59.7,sp|Q6DRG7|MYPT1_DANRE Protein phosphatase 1 regulatory subunit 12A OS=Danio rerio OX=7955 GN=ppp1r12a PE=2 SV=2,GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0017020; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0030510; GO:0031017; GO:0031672; GO:0046982; GO:0048812; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357,actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; neuron projection morphogenesis [GO:0048812]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165],A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018],14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0048856; GO:0098772,anatomical structure development; molecular function regulator activity
OG_01171,0.3436035485963597,OG_01171,FUN_004795-T1,Peve_00010263,Pocillopora_meandrina_HIv1___RNAseq.g8536.t1,three_way,53.3395,FUN_004795-T1,Q56A10,ZN608_MOUSE,,Zinc finger protein 608,Mus musculus (Mouse),41.6,219.0,6.9e-29,132.1,sp|Q56A10|ZN608_MOUSE Zinc finger protein 608 OS=Mus musculus OX=10090 GN=Znf608 PE=1 SV=1,GO:0000122; GO:0008270; GO:0033085,negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription by RNA polymerase II [GO:0000122],,zinc ion binding [GO:0008270],GO:0006355,regulation of DNA-templated transcription
OG_05484,0.343239163062326,OG_05484,FUN_024481-T1,Peve_00016898,Pocillopora_meandrina_HIv1___RNAseq.g19066.t2,three_way,65.00099999999999,FUN_024481-T1,Q92870,APBB2_HUMAN,,Amyloid beta precursor protein binding family B member 2 (Amyloid-beta (A4) precursor protein-binding family B member 2) (Protein Fe65-like 1),Homo sapiens (Human),36.6,331.0,3.8e-55,218.8,sp|Q92870|APBB2_HUMAN Amyloid beta precursor protein binding family B member 2 OS=Homo sapiens OX=9606 GN=APBB2 PE=1 SV=3,GO:0000122; GO:0001540; GO:0001764; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0006355; GO:0006939; GO:0007411; GO:0016020; GO:0030027; GO:0030198; GO:0030426; GO:0035556; GO:0036438; GO:0043065; GO:0043066; GO:0045202; GO:0045944; GO:0050808; GO:0060090; GO:1901988,axon guidance [GO:0007411]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; maintenance of lens transparency [GO:0036438]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle phase transition [GO:1901988]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; smooth muscle contraction [GO:0006939]; synapse organization [GO:0050808],cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202],amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090],GO:0003012; GO:0005634; GO:0005768; GO:0005783; GO:0005794; GO:0006355; GO:0030198; GO:0031410; GO:0034330; GO:0043226; GO:0048870; GO:0060090,muscle system process; nucleus; endosome; endoplasmic reticulum; Golgi apparatus; regulation of DNA-templated transcription; extracellular matrix organization; cytoplasmic vesicle; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_05733,0.3432115829682367,OG_05733,FUN_025659-T1,Peve_00042174,Pocillopora_meandrina_HIv1___RNAseq.g23073.t1,three_way,72.82333333333334,,,,,,,,,,,,,,,,,
OG_03066,0.3431556350418861,OG_03066,FUN_012333-T1,Peve_00028481,Pocillopora_meandrina_HIv1___RNAseq.g23758.t1,three_way,69.9595,FUN_012333-T1,O43524,,,,,35.0,546.0,2e-50,201.8,sp|O43524|FOXO3_HUMAN Forkhead box protein O3 OS=Homo sapiens OX=9606 GN=FOXO3 PE=1 SV=1,,,,,,
OG_07838,0.3431476408396001,OG_07838,FUN_035169-T1,Peve_00036181,Pocillopora_meandrina_HIv1___RNAseq.g27918.t1,three_way,87.309,FUN_035169-T1,Q9JK84,,,,,54.5,299.0,5.5000000000000004e-80,299.3,sp|Q9JK84|PAR6G_MOUSE Partitioning defective 6 homolog gamma OS=Mus musculus OX=10090 GN=Pard6g PE=2 SV=1,,,,,,
OG_03021,0.342961034329968,OG_03021,FUN_012241-T1,Peve_00018303,Pocillopora_meandrina_HIv1___RNAseq.g23522.t2,three_way,67.49,FUN_012241-T1,O14497,ARI1A_HUMAN,,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",Homo sapiens (Human),36.1,711.0,1.3e-109,400.2,sp|O14497|ARI1A_HUMAN AT-rich interactive domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ARID1A PE=1 SV=3,GO:0000785; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0016922; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815],bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_09463,0.3428031160959339,OG_09463,FUN_041486-T1,Peve_00004078,Pocillopora_meandrina_HIv1___RNAseq.g15672.t2,three_way,56.60683333333333,FUN_041486-T1,D3ZZL9,,,,,35.3,388.0,1.7e-30,137.9,sp|D3ZZL9|GCC2_RAT GRIP and coiled-coil domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Gcc2 PE=1 SV=1,,,,,,
OG_02762,0.3428012596373866,OG_02762,FUN_011699-T1,Peve_00018060,Pocillopora_meandrina_HIv1___RNAseq.g23827.t1,three_way,86.615,FUN_011699-T1,P47836,,,,,73.9,241.0,3.3e-106,386.0,sp|P47836|RS4_CHICK Small ribosomal subunit protein eS4 OS=Gallus gallus OX=9031 GN=RPS4 PE=1 SV=2,,,,,,
OG_04370,0.3427749354595057,OG_04370,FUN_018029-T1,Peve_00017615,Pocillopora_meandrina_HIv1___RNAseq.g25340.t1,three_way,59.88433333333333,FUN_018029-T1,Q9ULJ8,,,,,25.1,1213.0,1.4999999999999999e-40,170.2,sp|Q9ULJ8|NEB1_HUMAN Neurabin-1 OS=Homo sapiens OX=9606 GN=PPP1R9A PE=1 SV=2,,,,,,
OG_05286,0.3427193183773816,OG_05286,FUN_023949-T1,Peve_00016150,Pocillopora_meandrina_HIv1___RNAseq.2014_t,three_way,80.2065,FUN_023949-T1,P51830,,,,,39.3,1189.0,3.8999999999999997e-205,716.8,sp|P51830|ADCY9_MOUSE Adenylate cyclase type 9 OS=Mus musculus OX=10090 GN=Adcy9 PE=1 SV=1,,,,,,
OG_05177,0.3425026912668891,OG_05177,FUN_023507-T1,Peve_00005822,Pocillopora_meandrina_HIv1___RNAseq.g568.t1,three_way,58.58383333333333,,,,,,,,,,,,,,,,,
OG_06500,0.342294362608157,OG_06500,FUN_029291-T1,Peve_00036559,Pocillopora_meandrina_HIv1___RNAseq.g11686.t1,three_way,61.11266666666666,FUN_029291-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),44.3,300.0,2.0999999999999997e-68,263.1,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_02158,0.3422558311111067,OG_02158,FUN_008490-T1,Peve_00028832,Pocillopora_meandrina_HIv1___RNAseq.g30381.t1,three_way,71.13933333333334,FUN_008490-T1,Q6A070,TGRM1_MOUSE,,TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B),Mus musculus (Mouse),27.4,2074.0,5.2e-149,531.2,sp|Q6A070|TGRM1_MOUSE TOG array regulator of axonemal microtubules protein 1 OS=Mus musculus OX=10090 GN=Togaram1 PE=1 SV=3,GO:0005737; GO:0005929; GO:0031116; GO:0035082; GO:0036064; GO:1905515,axoneme assembly [GO:0035082]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005815; GO:0005929; GO:0007010; GO:0043226; GO:0044782,microtubule organizing center; cilium; cytoskeleton organization; organelle; cilium organization
OG_06717,0.3422075349043869,OG_06717,FUN_031467-T1,Peve_00026558,Pocillopora_meandrina_HIv1___RNAseq.g5084.t2,three_way,78.09566666666667,FUN_031467-T1,Q5RDQ2,PALS1_PONAB,,Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),46.4,576.0,2.3e-140,501.5,sp|Q5RDQ2|PALS1_PONAB Protein PALS1 OS=Pongo abelii OX=9601 GN=PALS1 PE=2 SV=1,GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0017015; GO:0021954; GO:0021987; GO:0030424; GO:0043204,central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204],ATP binding [GO:0005524],GO:0005794; GO:0043226; GO:0048856,Golgi apparatus; organelle; anatomical structure development
OG_05326,0.3421809834725215,OG_05326,FUN_024018-T1,Peve_00023795,Pocillopora_meandrina_HIv1___RNAseq.g19283.t1,three_way,81.60583333333334,FUN_024018-T1,Q96T37,RBM15_HUMAN,,RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),Homo sapiens (Human),35.3,835.0,2.1e-99,365.2,sp|Q96T37|RBM15_HUMAN RNA-binding protein 15 OS=Homo sapiens OX=9606 GN=RBM15 PE=1 SV=2,GO:0000381; GO:0001510; GO:0001569; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0007221; GO:0009048; GO:0016607; GO:0031965; GO:0036396; GO:0038163; GO:0045638; GO:0045652; GO:0048536; GO:0060412; GO:0060674,"branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412]",nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0048856,RNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development
OG_04724,0.3418506787741817,OG_04724,FUN_022589-T1,Peve_00020263,Pocillopora_meandrina_HIv1___RNAseq.g4431.t1,three_way,80.9065,FUN_022589-T1,O70172,,,,,50.9,450.0,7.000000000000003e-110,399.1,sp|O70172|PI42A_MOUSE Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha OS=Mus musculus OX=10090 GN=Pip4k2a PE=1 SV=1,,,,,,
OG_04758,0.3416576576167117,OG_04758,FUN_022647-T1,Peve_00036577,Pocillopora_meandrina_HIv1___RNAseq.g4454.t1,three_way,72.587,FUN_022647-T1,Q15434,,,,,61.2,232.0,9.8e-69,262.7,"sp|Q15434|RBMS2_HUMAN RNA-binding motif, single-stranded-interacting protein 2 OS=Homo sapiens OX=9606 GN=RBMS2 PE=1 SV=1",,,,,,
OG_08334,0.3414333780208352,OG_08334,FUN_036829-T1,Peve_00006952,Pocillopora_meandrina_HIv1___TS.g13147.t1,three_way,73.91533333333334,FUN_036829-T1,Q9NYI0,PSD3_HUMAN,,PH and SEC7 domain-containing protein 3 (Epididymis tissue protein Li 20mP) (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Hepatocellular carcinoma-associated antigen 67) (Pleckstrin homology and SEC7 domain-containing protein 3),Homo sapiens (Human),44.6,417.0,3.3999999999999997e-91,337.8,sp|Q9NYI0|PSD3_HUMAN PH and SEC7 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=PSD3 PE=1 SV=2,GO:0005085; GO:0014069; GO:0032012; GO:0032587,regulation of ARF protein signal transduction [GO:0032012],postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0043226; GO:0098772,organelle; molecular function regulator activity
OG_02721,0.3412542222389748,OG_02721,FUN_011049-T1,Peve_00013424,Pocillopora_meandrina_HIv1___TS.g26228.t1,three_way,60.9865,,,,,,,,,,,,,,,,,
OG_09075,0.3412155184712177,OG_09075,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_06124,0.3411898190539434,OG_06124,FUN_027902-T1,Peve_00020105,Pocillopora_meandrina_HIv1___RNAseq.g13882.t1,three_way,48.062,,,,,,,,,,,,,,,,,
OG_00721,0.3405245308174615,OG_00721,FUN_002661-T1,Peve_00043790,Pocillopora_meandrina_HIv1___RNAseq.g14882.t1a,three_way,78.43133333333333,FUN_002661-T1,Q00709,,,,,40.5,116.0,4.1e-20,99.8,sp|Q00709|BCL2_CHICK Apoptosis regulator Bcl-2 OS=Gallus gallus OX=9031 GN=BCL2 PE=2 SV=1,,,,,,
OG_03491,0.3403159814004641,OG_03491,FUN_014598-T1,Peve_00010088,Pocillopora_meandrina_HIv1___RNAseq.g22739.t1,three_way,60.3855,FUN_014598-T1,Q8VIP2,,,,,36.9,279.0,3.8e-32,142.1,sp|Q8VIP2|MLXPL_RAT Carbohydrate-responsive element-binding protein OS=Rattus norvegicus OX=10116 GN=Mlxipl PE=1 SV=1,,,,,,
OG_05074,0.3401776191173885,OG_05074,FUN_023300-T1,Peve_00041309,Pocillopora_meandrina_HIv1___RNAseq.g17778.t1,three_way,86.52966666666667,FUN_023300-T1,Q3ZCF5,,,,,75.7,276.0,3.2e-128,459.5,"sp|Q3ZCF5|OAT_BOVIN Ornithine aminotransferase, mitochondrial OS=Bos taurus OX=9913 GN=OAT PE=2 SV=1",,,,,,
OG_05974,0.3397716225145418,OG_05974,FUN_026394-T1,Peve_00032420,Pocillopora_meandrina_HIv1___RNAseq.g2941.t1,three_way,86.70166666666667,FUN_026394-T1,Q01583,DGK1_DROME,,Diacylglycerol kinase 1 (DAG kinase 1) (DGK 1) (Diglyceride kinase 1) (EC 2.7.1.107),Drosophila melanogaster (Fruit fly),39.6,450.0,3.8e-71,270.4,sp|Q01583|DGK1_DROME Diacylglycerol kinase 1 OS=Drosophila melanogaster OX=7227 GN=Dgk PE=2 SV=5,GO:0004143; GO:0005509; GO:0005524; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0035556; GO:0046339,diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0006629; GO:0016740,catalytic activity; plasma membrane; lipid metabolic process; transferase activity
OG_08960,0.3397700449479374,OG_08960,FUN_038438-T1,Peve_00029444,Pocillopora_meandrina_HIv1___RNAseq.g885.t1,three_way,75.46883333333334,FUN_038438-T1,O43670,ZN207_HUMAN,,BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (hBuGZ) (Zinc finger protein 207),Homo sapiens (Human),86.7,90.0,2.7e-43,177.9,sp|O43670|ZN207_HUMAN BUB3-interacting and GLEBS motif-containing protein ZNF207 OS=Homo sapiens OX=9606 GN=ZNF207 PE=1 SV=1,GO:0000070; GO:0000776; GO:0001578; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008201; GO:0008270; GO:0008608; GO:0046785; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047,attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983],cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047],DNA binding [GO:0003677]; heparin binding [GO:0008201]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0007010; GO:0007059; GO:0008092; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; nucleolus; cytoskeleton organization; chromosome segregation; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_07738,0.3396243324752081,OG_07738,FUN_034917-T1,Peve_00039135,Pocillopora_meandrina_HIv1___RNAseq.g12141.t1,three_way,71.13166666666666,,,,,,,,,,,,,,,,,
OG_00708,0.3395701259645969,OG_00708,FUN_002469-T1,Peve_00034012,Pocillopora_meandrina_HIv1___TS.g4051.t1,three_way,74.81733333333334,FUN_002469-T1,Q7TMY8,HUWE1_MOUSE,,"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (E3Histone) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",Mus musculus (Mouse),41.0,4757.0,0.0,2664.4,sp|Q7TMY8|HUWE1_MOUSE E3 ubiquitin-protein ligase HUWE1 OS=Mus musculus OX=10090 GN=Huwe1 PE=1 SV=5,GO:0000209; GO:0003677; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0006284; GO:0006513; GO:0030154; GO:0031398; GO:0032922; GO:0035359; GO:0043123; GO:0043161; GO:0061630; GO:0070936; GO:0140852; GO:0141198,base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; transferase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02394,0.3395282918719116,OG_02394,FUN_009022-T1,Peve_00044352,Pocillopora_meandrina_HIv1___RNAseq.g3941.t1,three_way,75.0855,FUN_009022-T1,Q1AAU6,ASAP1_RAT,,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)",Rattus norvegicus (Rat),38.6,1193.0,7.400000000000001e-201,702.6,"sp|Q1AAU6|ASAP1_RAT Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Asap1 PE=1 SV=2",GO:0000139; GO:0001786; GO:0002102; GO:0005096; GO:0005546; GO:0005547; GO:0008270; GO:0032588; GO:0043197; GO:0060271; GO:0061000; GO:0061512; GO:0098978; GO:0099175; GO:1903527,cilium assembly [GO:0060271]; negative regulation of dendritic spine development [GO:0061000]; positive regulation of membrane tubulation [GO:1903527]; protein localization to cilium [GO:0061512]; regulation of postsynapse organization [GO:0099175],dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; podosome [GO:0002102]; trans-Golgi network membrane [GO:0032588],"GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; zinc ion binding [GO:0008270]",GO:0008289; GO:0043226; GO:0044782; GO:0098772,lipid binding; organelle; cilium organization; molecular function regulator activity
OG_08433,0.3394022437701163,OG_08433,FUN_037167-T1,Peve_00003254,Pocillopora_meandrina_HIv1___RNAseq.g11080.t1,three_way,59.40383333333333,,,,,,,,,,,,,,,,,
OG_06242,0.3393422522911136,OG_06242,FUN_028232-T1,Peve_00018561,Pocillopora_meandrina_HIv1___RNAseq.g15526.t1,three_way,81.03166666666667,FUN_028232-T1,Q96KN3,,,,,45.9,407.0,1.1e-76,289.3,sp|Q96KN3|PKNX2_HUMAN Homeobox protein PKNOX2 OS=Homo sapiens OX=9606 GN=PKNOX2 PE=1 SV=2,,,,,,
OG_09093,0.3392732459429091,OG_09093,FUN_038891-T1,Peve_00028706,Pocillopora_meandrina_HIv1___RNAseq.g28660.t1,three_way,59.693333333333335,FUN_038891-T1,Q8CBY3,,,,,44.1,488.0,6.699999999999999e-90,333.6,sp|Q8CBY3|LENG8_MOUSE Leukocyte receptor cluster member 8 homolog OS=Mus musculus OX=10090 GN=Leng8 PE=1 SV=1,,,,,,
OG_01378,0.3391818256263629,OG_01378,FUN_005335-T1,Peve_00035219,Pocillopora_meandrina_HIv1___RNAseq.g8197.t1,three_way,80.54866666666666,FUN_005335-T1,Q9Z1N9,,,,,49.1,1628.0,0.0,1434.9,sp|Q9Z1N9|UN13B_MOUSE Protein unc-13 homolog B OS=Mus musculus OX=10090 GN=Unc13b PE=1 SV=2,,,,,,
OG_09839,0.3389356539056875,OG_09839,FUN_042820-T1,Peve_00019572,Pocillopora_meandrina_HIv1___RNAseq.g7438.t1,three_way,89.72666666666667,FUN_042820-T1,P40424,PBX1_HUMAN,,Pre-B-cell leukemia transcription factor 1 (Homeobox protein PBX1) (Homeobox protein PRL),Homo sapiens (Human),69.0,407.0,9.8e-132,471.9,sp|P40424|PBX1_HUMAN Pre-B-cell leukemia transcription factor 1 OS=Homo sapiens OX=9606 GN=PBX1 PE=1 SV=1,GO:0000086; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001222; GO:0001228; GO:0001654; GO:0001655; GO:0001658; GO:0001779; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006694; GO:0007420; GO:0007548; GO:0009887; GO:0009952; GO:0009954; GO:0010971; GO:0030278; GO:0030325; GO:0030326; GO:0035162; GO:0043433; GO:0045665; GO:0045944; GO:0048536; GO:0048538; GO:0048568; GO:0048666; GO:0048706; GO:0072089; GO:0090575; GO:0140297; GO:1990837; GO:2000648,adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic hemopoiesis [GO:0035162]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; G2/M transition of mitotic cell cycle [GO:0000086]; natural killer cell differentiation [GO:0001779]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of ossification [GO:0030278]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; steroid biosynthetic process [GO:0006694]; thymus development [GO:0048538]; urogenital system development [GO:0001655],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]",GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0006629; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; lipid metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02595,0.338923607558548,OG_02595,FUN_010716-T1,Peve_00022598,Pocillopora_meandrina_HIv1___RNAseq.g20955.t1,three_way,82.276,FUN_010716-T1,P17713,,,,,64.1,512.0,3.7e-192,672.5,sp|P17713|STK_HYDVU Tyrosine-protein kinase STK OS=Hydra vulgaris OX=6087 GN=STK PE=2 SV=1,,,,,,
OG_08852,0.3387241377793515,OG_08852,FUN_038217-T1,Peve_00038841,Pocillopora_meandrina_HIv1___RNAseq.g901.t2,three_way,66.15016666666666,FUN_038217-T1,Q9UKN7,,,,,32.5,2688.0,0.0,1096.6,sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2,,,,,,
OG_02620,0.3383464456266032,OG_02620,FUN_010763-T1,Peve_00008038,Pocillopora_meandrina_HIv1___RNAseq.g20924.t1,three_way,83.1185,FUN_010763-T1,O46382,,,,,58.7,1985.0,0.0,2090.5,sp|O46382|BIG1_BOVIN Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Bos taurus OX=9913 GN=ARFGEF1 PE=1 SV=1,,,,,,
OG_07669,0.3382706518010128,OG_07669,FUN_034724-T1,Peve_00033264,Pocillopora_meandrina_HIv1___RNAseq.g28719.t1,three_way,89.57333333333334,FUN_034724-T1,P39023,RL3_HUMAN,,Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (HIV-1 TAR RNA-binding protein B) (TARBP-B),Homo sapiens (Human),72.8,397.0,2.4e-170,599.7,sp|P39023|RL3_HUMAN Large ribosomal subunit protein uL3 OS=Homo sapiens OX=9606 GN=RPL3 PE=1 SV=2,GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0022625; GO:0022626; GO:0032991; GO:0070062; GO:0071353,cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198; GO:0005634; GO:0005730; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; RNA binding; structural molecule activity; nucleus; nucleolus; cytosol; ribosome; organelle
OG_04816,0.3382242607256948,OG_04816,FUN_022797-T1,Peve_00024723,Pocillopora_meandrina_HIv1___TS.g9662.t2,three_way,93.94933333333334,FUN_022797-T1,P36876,,,,,76.0,441.0,2.8e-204,712.6,sp|P36876|2ABA_RAT Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform OS=Rattus norvegicus OX=10116 GN=Ppp2r2a PE=2 SV=1,,,,,,
OG_09217,0.3379778818074785,OG_09217,FUN_039937-T1,Peve_00007733,Pocillopora_meandrina_HIv1___RNAseq.g15743.t1,three_way,79.05833333333334,FUN_039937-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,451.0,1.1e-66,255.8,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_08513,0.337696671638489,OG_08513,FUN_037439-T1,Peve_00014239,Pocillopora_meandrina_HIv1___RNAseq.g10962.t1,three_way,78.76766666666666,FUN_037439-T1,P97393,RHG05_MOUSE,,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),Mus musculus (Mouse),30.1,1790.0,6.2e-194,680.2,sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3,GO:0002053; GO:0005096; GO:0005783; GO:0005829; GO:0005886; GO:0007165; GO:0008361; GO:0010631; GO:0010634; GO:0016477; GO:0030879; GO:0042169,cell migration [GO:0016477]; epithelial cell migration [GO:0010631]; mammary gland development [GO:0030879]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of cell size [GO:0008361]; signal transduction [GO:0007165],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; SH2 domain binding [GO:0042169],GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0048856; GO:0048870; GO:0098772,endoplasmic reticulum; cytosol; plasma membrane; organelle; anatomical structure development; cell motility; molecular function regulator activity
OG_05951,0.3371285636313303,OG_05951,FUN_026211-T1,Peve_00044665,Pocillopora_meandrina_HIv1___RNAseq.g3049.t1,three_way,49.01616666666666,FUN_026211-T1,A2AX52,CO6A4_MOUSE,,Collagen alpha-4(VI) chain,Mus musculus (Mouse),24.8,1256.0,9.1e-63,246.1,sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2,GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991],collagen binding [GO:0005518],GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_01100,0.337063375398003,OG_01100,FUN_004601-T1,Peve_00020781,Pocillopora_meandrina_HIv1___RNAseq.g6777.t1,three_way,49.251333333333335,,,,,,,,,,,,,,,,,
OG_08639,0.336767287257416,OG_08639,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05455,0.3366982487328503,OG_05455,FUN_024413-T1,Peve_00029254,Pocillopora_meandrina_HIv1___TS.g28094.t1,three_way,72.38216666666666,FUN_024413-T1,Q08874,MITF_MOUSE,,Microphthalmia-associated transcription factor,Mus musculus (Mouse),41.5,366.0,1.1e-46,189.1,sp|Q08874|MITF_MOUSE Microphthalmia-associated transcription factor OS=Mus musculus OX=10090 GN=Mitf PE=1 SV=4,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0006357; GO:0010468; GO:0010628; GO:0016055; GO:0030154; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0043066; GO:0043473; GO:0043565; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:1902362; GO:2000144,bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; melanocyte apoptotic process [GO:1902362]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; pigmentation [GO:0043473]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_02674,0.336444667429836,OG_02674,FUN_010919-T1,Peve_00044947,Pocillopora_meandrina_HIv1___RNAseq.g20988.t2,three_way,84.51416666666667,FUN_010919-T1,Q91437,PYR1_SQUAC,,Multifunctional protein CAD (Carbamoyl phosphate synthetase 2-aspartate transcarbamylase-dihydroorotase) [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Glutamine amidotransferase (GATase) (GLNase) (EC 3.5.1.2); Ammonium-dependent carbamoyl phosphate synthase (CPS) (CPSase) (EC 6.3.4.16); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)],Squalus acanthias (Spiny dogfish),66.0,2277.0,0.0,2989.9,sp|Q91437|PYR1_SQUAC Multifunctional protein CAD OS=Squalus acanthias OX=7797 GN=CAD PE=2 SV=1,GO:0004070; GO:0004087; GO:0004088; GO:0004151; GO:0004359; GO:0005524; GO:0005634; GO:0005951; GO:0006207; GO:0006526; GO:0006541; GO:0008270; GO:0016597; GO:0044205,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]; L-arginine biosynthetic process [GO:0006526],carbamoyl-phosphate synthase complex [GO:0005951]; nucleus [GO:0005634],amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutaminase activity [GO:0004359]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006520; GO:0016740; GO:0016787; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; amino acid metabolic process; transferase activity; hydrolase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02627,0.336063035829056,OG_02627,FUN_010779-T1,Peve_00004487,Pocillopora_meandrina_HIv1___TS.g25955.t1,three_way,91.82266666666666,FUN_010779-T1,Q9D1P2,KAT8_MOUSE,,"Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1) (Males-absent on the first protein homolog) (mMof) (Protein acetyltransferase KAT8) (EC 2.3.1.-) (Protein propionyltransferase KAT8) (EC 2.3.1.-)",Mus musculus (Mouse),76.1,397.0,6.4e-180,631.7,sp|Q9D1P2|KAT8_MOUSE Histone acetyltransferase KAT8 OS=Mus musculus OX=10090 GN=Kat8 PE=1 SV=1,GO:0000123; GO:0000776; GO:0003713; GO:0005634; GO:0005694; GO:0005739; GO:0008270; GO:0009048; GO:0010506; GO:0010719; GO:0016363; GO:0016407; GO:0019899; GO:0022008; GO:0030099; GO:0032480; GO:0035166; GO:0043995; GO:0043996; GO:0044545; GO:0045815; GO:0045892; GO:0045893; GO:0046972; GO:0048477; GO:0050684; GO:0060261; GO:0061629; GO:0061733; GO:0061920; GO:0071339; GO:0072487; GO:1902726; GO:1903108; GO:1990841,dosage compensation by inactivation of X chromosome [GO:0009048]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of type I interferon production [GO:0032480]; neurogenesis [GO:0022008]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; regulation of autophagy [GO:0010506]; regulation of mitochondrial transcription [GO:1903108]; regulation of mRNA processing [GO:0050684]; transcription initiation-coupled chromatin remodeling [GO:0045815],chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; promoter-specific chromatin binding [GO:1990841]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005694; GO:0005739; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; chromosome; mitochondrion; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_01595,0.3360044599785213,OG_01595,FUN_006637-T1,Peve_00024050,Pocillopora_meandrina_HIv1___RNAseq.g20237.t1,three_way,73.5665,FUN_006637-T1,Q9P2Q2,FRM4A_HUMAN,,FERM domain-containing protein 4A,Homo sapiens (Human),44.8,504.0,7.7000000000000005e-118,426.4,sp|Q9P2Q2|FRM4A_HUMAN FERM domain-containing protein 4A OS=Homo sapiens OX=9606 GN=FRMD4A PE=1 SV=3,GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162,establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],protein-macromolecule adaptor activity [GO:0030674],GO:0005856; GO:0007163; GO:0043226; GO:0060090,cytoskeleton; establishment or maintenance of cell polarity; organelle; molecular adaptor activity
OG_01608,0.335790951320951,OG_01608,FUN_006652-T1,Peve_00029039,Pocillopora_meandrina_HIv1___RNAseq.g19955.t1,three_way,64.58433333333333,FUN_006652-T1,Q6V0I7,FAT4_HUMAN,,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Homo sapiens (Human),32.4,1666.0,2.3000000000000004e-224,781.6,sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0043226; GO:0048856,plasma membrane; cell adhesion; cell differentiation; organelle; anatomical structure development
OG_03629,0.3356397265348336,OG_03629,FUN_014846-T1,Peve_00038813,Pocillopora_meandrina_HIv1___RNAseq.g22386.t2,three_way,83.38516666666666,FUN_014846-T1,P97526,NF1_RAT,,Neurofibromin (Neurofibromatosis-related protein NF-1),Rattus norvegicus (Rat),46.1,2783.0,0.0,2161.0,sp|P97526|NF1_RAT Neurofibromin OS=Rattus norvegicus OX=10116 GN=Nf1 PE=1 SV=1,GO:0000165; GO:0001525; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001935; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0002686; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0006606; GO:0006915; GO:0007154; GO:0007265; GO:0007269; GO:0007405; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008283; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010626; GO:0010976; GO:0014009; GO:0014010; GO:0014037; GO:0014044; GO:0016477; GO:0016525; GO:0016601; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030316; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0033024; GO:0033027; GO:0033028; GO:0033034; GO:0034605; GO:0035021; GO:0036135; GO:0042060; GO:0042127; GO:0042308; GO:0043065; GO:0043408; GO:0043409; GO:0043473; GO:0043491; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045765; GO:0046580; GO:0046929; GO:0048144; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048708; GO:0048709; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0051402; GO:0060253; GO:0060291; GO:0061534; GO:0061535; GO:0070372; GO:0070662; GO:0070667; GO:0071549; GO:0071887; GO:0072089; GO:0097192; GO:0097529; GO:0098597; GO:0098793; GO:0098926; GO:0098978; GO:0099159; GO:0099175; GO:1900148; GO:1900271; GO:1904707; GO:1904738; GO:1904753; GO:1990090; GO:1990874; GO:2000108; GO:2000647; GO:2001241,"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; endothelial cell proliferation [GO:0001935]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fibroblast proliferation [GO:0048144]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glial cell proliferation [GO:0014009]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; mast cell apoptotic process [GO:0033024]; mast cell proliferation [GO:0070662]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid cell apoptotic process [GO:0033028]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; neuroblast proliferation [GO:0007405]; neuron apoptotic process [GO:0051402]; neurotransmitter secretion [GO:0007269]; observational learning [GO:0098597]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte apoptotic process [GO:2000108]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynaptic signal transduction [GO:0098926]; protein import into nucleus [GO:0006606]; Rac protein signal transduction [GO:0016601]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; Schwann cell migration [GO:0036135]; Schwann cell proliferation [GO:0014010]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; stem cell proliferation [GO:0072089]; sympathetic nervous system development [GO:0048485]; vascular associated smooth muscle cell migration [GO:1904738]; vascular associated smooth muscle cell proliferation [GO:1990874]; visual learning [GO:0008542]; wound healing [GO:0042060]",axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991],GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545],GO:0002376; GO:0005634; GO:0005730; GO:0005886; GO:0006886; GO:0006913; GO:0007010; GO:0008092; GO:0008289; GO:0012501; GO:0030154; GO:0030198; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0098772,immune system process; nucleus; nucleolus; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; cytoskeletal protein binding; lipid binding; programmed cell death; cell differentiation; extracellular matrix organization; wound healing; organelle; anatomical structure development; cell motility; nervous system process; molecular function regulator activity
OG_03321,0.3356152706389519,OG_03321,FUN_013400-T1,Peve_00028081,Pocillopora_meandrina_HIv1___RNAseq.g22939.t1,three_way,70.60533333333333,FUN_013400-T1,B5DE31,YBOX1_DANRE,,Y-box-binding protein 1 (YB-1) (ZfY1) (Y-box transcription factor),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,107.0,1e-40,168.7,sp|B5DE31|YBOX1_DANRE Y-box-binding protein 1 OS=Danio rerio OX=7955 GN=ybx1 PE=1 SV=1,GO:0000932; GO:0001556; GO:0003676; GO:0003723; GO:0005634; GO:0006397; GO:0007343; GO:0008190; GO:0008327; GO:0008380; GO:0008544; GO:0010468; GO:0017148; GO:0035198; GO:0043009; GO:0045947; GO:0048025; GO:0048255; GO:0048598; GO:0050658; GO:0050686; GO:0051031; GO:0051236; GO:0062153; GO:0070062; GO:1990428; GO:2000773,"chordate embryonic development [GO:0043009]; egg activation [GO:0007343]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; establishment of RNA localization [GO:0051236]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of mRNA processing [GO:0050686]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; oocyte maturation [GO:0001556]; regulation of gene expression [GO:0010468]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]",extracellular exosome [GO:0070062]; nucleus [GO:0005634]; P-body [GO:0000932],C5-methylcytidine-containing RNA reader activity [GO:0062153]; eukaryotic initiation factor 4E binding [GO:0008190]; methyl-CpG binding [GO:0008327]; miRNA binding [GO:0035198]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0060090,DNA binding; RNA binding; nucleus; mRNA metabolic process; reproductive process; organelle; anatomical structure development; molecular adaptor activity
OG_05737,0.3355244183836701,OG_05737,FUN_025663-T1,Peve_00042168,Pocillopora_meandrina_HIv1___RNAseq.g23062.t1,three_way,73.4105,FUN_025663-T1,Q9UPW0,FOXJ3_HUMAN,,Forkhead box protein J3,Homo sapiens (Human),43.9,321.0,8.1e-57,223.0,sp|Q9UPW0|FOXJ3_HUMAN Forkhead box protein J3 OS=Homo sapiens OX=9606 GN=FOXJ3 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007141; GO:0007283; GO:0030154; GO:0043565; GO:0045944; GO:1990837,cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0140013; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; meiotic nuclear division; transcription regulator activity
OG_01166,0.3354857533898711,OG_01166,FUN_004786-T1,Peve_00037743,Pocillopora_meandrina_HIv1___RNAseq.g8520.t1,three_way,93.30766666666666,FUN_004786-T1,Q8C4X2,,,,,80.6,330.0,1.9e-155,550.1,sp|Q8C4X2|KC1G3_MOUSE Casein kinase I isoform gamma-3 OS=Mus musculus OX=10090 GN=Csnk1g3 PE=1 SV=2,,,,,,
OG_06103,0.3352885841243966,OG_06103,FUN_027804-T1,Peve_00036486,Pocillopora_meandrina_HIv1___RNAseq.g13899.t1,three_way,84.46000000000001,FUN_027804-T1,Q9U9L2,,,,,82.8,250.0,9.3e-123,441.0,sp|Q9U9L2|RL8_ANOGA Large ribosomal subunit protein uL2 OS=Anopheles gambiae OX=7165 GN=RpL8 PE=2 SV=2,,,,,,
OG_04560,0.3352001662210665,OG_04560,FUN_022199-T1,Peve_00041449,Pocillopora_meandrina_HIv1___RNAseq.g4798.t1,three_way,67.538,,,,,,,,,,,,,,,,,
OG_08880,0.3351757720293171,OG_08880,FUN_038280-T1,Peve_00041710,Pocillopora_meandrina_HIv1___RNAseq.g28313.t1,three_way,72.69066666666667,FUN_038280-T1,Q3TEL6,RN157_MOUSE,,E3 ubiquitin ligase Rnf157 (EC 2.3.2.27) (RING finger protein 157) (RING-type E3 ubiquitin transferase Rnf157),Mus musculus (Mouse),47.4,380.0,1e-91,339.0,sp|Q3TEL6|RN157_MOUSE E3 ubiquitin ligase Rnf157 OS=Mus musculus OX=10090 GN=Rnf157 PE=1 SV=2,GO:0005737; GO:0008270; GO:0016567; GO:0043066; GO:0044297; GO:0061630; GO:1903861,negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite extension [GO:1903861]; protein ubiquitination [GO:0016567],cell body [GO:0044297]; cytoplasm [GO:0005737],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09116,0.3348941230731165,OG_09116,FUN_039091-T1,Peve_00028752,Pocillopora_meandrina_HIv1___RNAseq.g28707.t1,three_way,75.19333333333334,FUN_039091-T1,A0A571BF63,ANKF1_MOUSE,,Ankyrin-repeat and fibronectin type III domain-containing 1,Mus musculus (Mouse),35.6,824.0,9.6e-135,483.0,sp|A0A571BF63|ANKF1_MOUSE Ankyrin-repeat and fibronectin type III domain-containing 1 OS=Mus musculus OX=10090 GN=Ankfn1 PE=1 SV=1,GO:0001662; GO:0045475; GO:0050957,behavioral fear response [GO:0001662]; equilibrioception [GO:0050957]; locomotor rhythm [GO:0045475],,,GO:0050877,nervous system process
OG_07474,0.3348055210759534,OG_07474,FUN_033989-T1,Peve_00004922,Pocillopora_meandrina_HIv1___RNAseq.g26102.t1,three_way,69.42083333333333,FUN_033989-T1,E9Q2Z1,CECR2_MOUSE,,Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2 homolog),Mus musculus (Mouse),46.8,571.0,1.8e-84,316.2,sp|E9Q2Z1|CECR2_MOUSE Chromatin remodeling regulator CECR2 OS=Mus musculus OX=10090 GN=Cecr2 PE=1 SV=1,GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006338; GO:0007338; GO:0021915; GO:0031010; GO:0060122; GO:0090102; GO:0090537; GO:0097194; GO:0140658,chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; single fertilization [GO:0007338],CERF complex [GO:0090537]; euchromatin [GO:0000791]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634],ATP-dependent chromatin remodeler activity [GO:0140658],GO:0003824; GO:0005634; GO:0006325; GO:0022414; GO:0043226; GO:0048856; GO:0140097; GO:0140657,"catalytic activity; nucleus; chromatin organization; reproductive process; organelle; anatomical structure development; catalytic activity, acting on DNA; ATP-dependent activity"
OG_04723,0.3347062661604997,OG_04723,FUN_022586-T1,Peve_00020593,Pocillopora_meandrina_HIv1___RNAseq.g4434.t2,three_way,67.00133333333333,FUN_022586-T1,Q9BE31,,,,,29.9,632.0,8e-77,289.7,sp|Q9BE31|RHG12_MACFA Rho GTPase-activating protein 12 OS=Macaca fascicularis OX=9541 GN=ARHGAP12 PE=2 SV=1,,,,,,
OG_02305,0.3346926656964192,OG_02305,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,42.3,137.0,2.1e-31,140.2,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_02305,0.3346926656964192,OG_02305,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,46.9,128.0,2.5e-29,133.3,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_09908,0.334100396203662,OG_09908,FUN_043005-T1,Peve_00017775,Pocillopora_meandrina_HIv1___RNAseq.g7029.t1,three_way,70.90416666666667,FUN_043005-T1,Q90416,RXRGA_DANRE,,Retinoic acid receptor RXR-gamma-A (Nuclear receptor subfamily 2 group B member 3-A) (Retinoic acid receptor RXR-alpha) (Retinoid X receptor alpha) (Retinoid X receptor gamma-A),Danio rerio (Zebrafish) (Brachydanio rerio),36.4,365.0,1.1999999999999999e-61,239.2,sp|Q90416|RXRGA_DANRE Retinoic acid receptor RXR-gamma-A OS=Danio rerio OX=7955 GN=rxrga PE=2 SV=2,GO:0003700; GO:0003707; GO:0004879; GO:0007399; GO:0008270; GO:0030154; GO:0044323; GO:0045893; GO:0045944; GO:0048384; GO:0090575,cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384],RNA polymerase II transcription regulator complex [GO:0090575],DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; retinoic acid-responsive element binding [GO:0044323]; zinc ion binding [GO:0008270],GO:0003677; GO:0006355; GO:0030154; GO:0048856; GO:0060089; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_02564,0.3335408833803553,OG_02564,FUN_010663-T1,Peve_00031442,Pocillopora_meandrina_HIv1___RNAseq.g21359.t1,three_way,44.581500000000005,FUN_010663-T1,Q99MV1,TDRD1_MOUSE,,Tudor domain-containing protein 1,Mus musculus (Mouse),28.6,814.0,2.1e-72,277.7,sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2,GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0005829; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,cytosol; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_05645,0.3333800914775714,OG_05645,FUN_025363-T1,Peve_00040516,Pocillopora_meandrina_HIv1___RNAseq.g13346.t1,three_way,65.52933333333334,FUN_025363-T1,Q9ER65,CSTN2_MOUSE,,Calsyntenin-2,Mus musculus (Mouse),27.8,856.0,4.6e-77,291.2,sp|Q9ER65|CSTN2_MOUSE Calsyntenin-2 OS=Mus musculus OX=10090 GN=Clstn2 PE=1 SV=2,GO:0000139; GO:0005509; GO:0005789; GO:0007156; GO:0008306; GO:0009986; GO:0014069; GO:0030425; GO:0045211; GO:0050806; GO:0051965; GO:0098839; GO:0098978; GO:1904862,associative learning [GO:0008306]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inhibitory synapse assembly [GO:1904862]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806],cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211],calcium ion binding [GO:0005509],GO:0007155; GO:0034330; GO:0043226; GO:0050877,cell adhesion; cell junction organization; organelle; nervous system process
OG_07435,0.3333716571085346,OG_07435,FUN_033924-T1,Peve_00022623,Pocillopora_meandrina_HIv1___RNAseq.g26586.t2,three_way,66.44966666666667,FUN_033924-T1,Q14444,CAPR1_HUMAN,,Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105),Homo sapiens (Human),38.3,180.0,4.2e-27,123.2,sp|Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens OX=9606 GN=CAPRIN1 PE=1 SV=2,GO:0000932; GO:0003723; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0007416; GO:0008298; GO:0010494; GO:0016020; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0035591; GO:0043232; GO:0045202; GO:0048699; GO:0050775; GO:0061003; GO:0062029; GO:0106288; GO:0140677; GO:0140693; GO:0140694,generation of neurons [GO:0048699]; intracellular mRNA localization [GO:0008298]; membraneless organelle assembly [GO:0140694]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of stress granule assembly [GO:0062029]; regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106288]; synapse assembly [GO:0007416],cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membraneless organelle [GO:0043232]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; synapse [GO:0045202],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling adaptor activity [GO:0035591],GO:0003723; GO:0005829; GO:0030154; GO:0034330; GO:0043226; GO:0060090; GO:0098772,RNA binding; cytosol; cell differentiation; cell junction organization; organelle; molecular adaptor activity; molecular function regulator activity
OG_05222,0.3333627814880728,OG_05222,FUN_023634-T1,Peve_00027833,Pocillopora_meandrina_HIv1___RNAseq.g17811.t1,three_way,78.49183333333333,FUN_023634-T1,Q98TX3,,,,,45.7,438.0,1.4e-94,348.2,sp|Q98TX3|PDCD4_CHICK Programmed cell death protein 4 OS=Gallus gallus OX=9031 GN=PDCD4 PE=2 SV=1,,,,,,
OG_01504,0.3332222220114647,OG_01504,FUN_006236-T1,Peve_00011453,Pocillopora_meandrina_HIv1___RNAseq.g20448.t1,three_way,65.54733333333333,,,,,,,,,,,,,,,,,
OG_03987,0.3331929722305275,OG_03987,FUN_016152-T1,Peve_00022569,Pocillopora_meandrina_HIv1___RNAseq.g21229.t1,three_way,62.593833333333336,FUN_016152-T1,Q3U487,HECD3_MOUSE,,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),Mus musculus (Mouse),47.1,425.0,5.6e-104,380.9,sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2,GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],perinuclear region of cytoplasm [GO:0048471],syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_08800,0.3330689131548499,OG_08800,FUN_038103-T1,Peve_00025353,Pocillopora_meandrina_HIv1___RNAseq.g837.t1,three_way,71.89616666666667,FUN_038103-T1,Q4R7U0,,,,,32.1,701.0,1.2e-85,319.3,sp|Q4R7U0|TMC7_MACFA Transmembrane channel-like protein 7 OS=Macaca fascicularis OX=9541 GN=TMC7 PE=2 SV=1,,,,,,
OG_03736,0.3329955562101582,OG_03736,FUN_015036-T1,Peve_00024712,Pocillopora_meandrina_HIv1___RNAseq.g21165.t1,three_way,78.18966666666667,FUN_015036-T1,Q9BZ72,PITM2_HUMAN,,"Membrane-associated phosphatidylinositol transfer protein 2 (Phosphatidylinositol transfer protein, membrane-associated 2) (PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3) (NIR-3)",Homo sapiens (Human),42.6,1386.0,1.2e-287,991.1,sp|Q9BZ72|PITM2_HUMAN Membrane-associated phosphatidylinositol transfer protein 2 OS=Homo sapiens OX=9606 GN=PITPNM2 PE=1 SV=1,GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008525; GO:0008526; GO:0012505; GO:0016020; GO:0030971; GO:0031210; GO:0035091,phosphatidylinositol biosynthetic process [GO:0006661],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020],calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971],GO:0005215; GO:0005829; GO:0006629; GO:0008289,transporter activity; cytosol; lipid metabolic process; lipid binding
OG_04959,0.3328901373910553,OG_04959,FUN_023050-T1,Peve_00008516,Pocillopora_meandrina_HIv1___RNAseq.g3873.t1,three_way,85.382,FUN_023050-T1,Q7M760,ZRAN1_MOUSE,,Ubiquitin thioesterase Zranb1 (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1),Mus musculus (Mouse),46.4,724.0,1.2e-185,651.4,sp|Q7M760|ZRAN1_MOUSE Ubiquitin thioesterase Zranb1 OS=Mus musculus OX=10090 GN=Zranb1 PE=2 SV=1,GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007010; GO:0008270; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0035523; GO:0070530; GO:0070536; GO:0071947; GO:1990168,cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0007010; GO:0016787; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton organization; hydrolase activity; organelle; cell motility; catalytic activity, acting on a protein"
OG_05460,0.3328633477934962,OG_05460,FUN_024439-T1,Peve_00004162,Pocillopora_meandrina_HIv1___RNAseq.g18714.t1,three_way,80.35366666666667,FUN_024439-T1,Q9Z206,ARHG8_MOUSE,,Neuroepithelial cell-transforming gene 1 protein (Rho guanine nucleotide exchange factor 8),Mus musculus (Mouse),45.5,444.0,1.8000000000000002e-104,381.3,sp|Q9Z206|ARHG8_MOUSE Neuroepithelial cell-transforming gene 1 protein OS=Mus musculus OX=10090 GN=Net1 PE=1 SV=2,GO:0005085; GO:0005634; GO:0005737; GO:0005886; GO:0031267; GO:0035556; GO:0043065; GO:0043547; GO:0051451; GO:0070301; GO:0071479; GO:1900026,cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005634; GO:0005886; GO:0043226; GO:0048870; GO:0098772,nucleus; plasma membrane; organelle; cell motility; molecular function regulator activity
OG_05413,0.3326865578413772,OG_05413,FUN_024350-T1,Peve_00021948,Pocillopora_meandrina_HIv1___RNAseq.g18672.t1,three_way,54.338166666666666,FUN_024350-T1,Q01804,OTUD4_HUMAN,,OTU domain-containing protein 4 (EC 3.4.19.12) (HIV-1-induced protein HIN-1),Homo sapiens (Human),46.7,285.0,7.4e-66,254.2,sp|Q01804|OTUD4_HUMAN OTU domain-containing protein 4 OS=Homo sapiens OX=9606 GN=OTUD4 PE=1 SV=4,GO:0003723; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006307; GO:0006508; GO:0034122; GO:0035871; GO:0060090; GO:0061578; GO:0070536; GO:0071108; GO:0140374; GO:1903093; GO:2000660,antiviral innate immune response [GO:0140374]; DNA alkylation repair [GO:0006307]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of protein K48-linked deubiquitination [GO:1903093],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; K63-linked deubiquitinase activity [GO:0061578]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0016787; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; RNA binding; catalytic activity; nucleus; cytosol; DNA repair; hydrolase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_03496,0.3326634752498141,OG_03496,FUN_014605-T1,Peve_00001902,Pocillopora_meandrina_HIv1___RNAseq.g22752.t1,three_way,91.59133333333334,FUN_014605-T1,Q14254,FLOT2_HUMAN,,Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1),Homo sapiens (Human),58.5,417.0,1.6999999999999998e-105,384.4,sp|Q14254|FLOT2_HUMAN Flotillin-2 OS=Homo sapiens OX=9606 GN=FLOT2 PE=1 SV=2,GO:0001931; GO:0002020; GO:0002080; GO:0005768; GO:0005886; GO:0005901; GO:0005912; GO:0005925; GO:0007155; GO:0008544; GO:0010629; GO:0016020; GO:0016323; GO:0016600; GO:0030027; GO:0030139; GO:0031410; GO:0031982; GO:0032839; GO:0043123; GO:0043231; GO:0044291; GO:0044860; GO:0045661; GO:0048471; GO:0050821; GO:0070062; GO:0072659; GO:0098937; GO:0098978; GO:0099072; GO:1902992; GO:1903905,anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of establishment of T cell polarity [GO:1903905]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; vesicle [GO:0031982],protease binding [GO:0002020],GO:0005768; GO:0005886; GO:0007018; GO:0007155; GO:0031410; GO:0043226; GO:0048856; GO:0072659,endosome; plasma membrane; microtubule-based movement; cell adhesion; cytoplasmic vesicle; organelle; anatomical structure development; protein localization to plasma membrane
OG_04857,0.3323226535973595,OG_04857,FUN_022871-T1,Peve_00012299,Pocillopora_meandrina_HIv1___RNAseq.g3616.t1,three_way,89.286,FUN_022871-T1,Q90788,NKX25_CHICK,,Homeobox protein Nkx-2.5 (cNKx-2.5) (Homeobox protein NK-2 homolog E),Gallus gallus (Chicken),52.2,159.0,1.2e-33,145.2,sp|Q90788|NKX25_CHICK Homeobox protein Nkx-2.5 OS=Gallus gallus OX=9031 GN=NKX-2.5 PE=2 SV=1,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001947; GO:0003148; GO:0003166; GO:0003168; GO:0003211; GO:0003221; GO:0003222; GO:0003228; GO:0003278; GO:0003285; GO:0003342; GO:0003350; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007512; GO:0010628; GO:0010667; GO:0010765; GO:0010832; GO:0030097; GO:0030154; GO:0030855; GO:0030878; GO:0032991; GO:0032993; GO:0042803; GO:0045666; GO:0045823; GO:0048536; GO:0050673; GO:0050679; GO:0051891; GO:0055005; GO:0055117; GO:0060037; GO:0060038; GO:0060043; GO:0060048; GO:0060261; GO:0060347; GO:0060412; GO:0060413; GO:0060928; GO:0060929; GO:0060971; GO:0061629; GO:0071772; GO:0090090; GO:1903779; GO:1904019; GO:1904036; GO:1990664,adult heart development [GO:0007512]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial cardiac muscle tissue development [GO:0003228]; atrial septum morphogenesis [GO:0060413]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; bundle of His development [GO:0003166]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle contraction [GO:0060048]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; embryonic heart tube left/right pattern formation [GO:0060971]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal system development [GO:0060037]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of heart contraction [GO:0045823]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; proepicardium development [GO:0003342]; pulmonary myocardium development [GO:0003350]; Purkinje myocyte differentiation [GO:0003168]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cardiac muscle contraction [GO:0055117]; regulation of transcription by RNA polymerase II [GO:0006357]; response to BMP [GO:0071772]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; septum secundum development [GO:0003285]; spleen development [GO:0048536]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],cytosol [GO:0005829]; Nkx-2.5 complex [GO:1990664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0007010; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04202,0.3322562412744723,OG_04202,FUN_016744-T1,Peve_00025013,Pocillopora_meandrina_HIv1___RNAseq.g9954.t1,three_way,80.80783333333333,FUN_016744-T1,Q9P2K3,RCOR3_HUMAN,,REST corepressor 3,Homo sapiens (Human),45.4,443.0,7.8e-93,342.8,sp|Q9P2K3|RCOR3_HUMAN REST corepressor 3 OS=Homo sapiens OX=9606 GN=RCOR3 PE=1 SV=2,GO:0000118; GO:0003714; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0045892,negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],transcription corepressor activity [GO:0003714],GO:0005654; GO:0005829; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; cytosol; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_05457,0.3320949774357294,OG_05457,FUN_024418-T1,Peve_00029260,Pocillopora_meandrina_HIv1___RNAseq.g18720.t1,three_way,74.32566666666666,FUN_024418-T1,Q98SN7,,,,,55.1,345.0,5e-110,399.4,sp|Q98SN7|WNT2B_CHICK Protein Wnt-2b OS=Gallus gallus OX=9031 GN=WNT2B PE=1 SV=1,,,,,,
OG_09341,0.3316259056295313,OG_09341,FUN_040306-T1,Peve_00020535,Pocillopora_meandrina_HIv1___RNAseq.g9079.t1,three_way,53.34833333333333,FUN_040306-T1,Q8BH48,UBAP1_MOUSE,,Ubiquitin-associated protein 1 (UBAP-1),Mus musculus (Mouse),28.2,202.0,2.4e-08,62.0,sp|Q8BH48|UBAP1_MOUSE Ubiquitin-associated protein 1 OS=Mus musculus OX=10090 GN=Ubap1 PE=1 SV=1,GO:0000813; GO:0005829; GO:0005886; GO:0015031; GO:0043130; GO:0043162,protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; plasma membrane [GO:0005886],ubiquitin binding [GO:0043130],GO:0005829; GO:0005886,cytosol; plasma membrane
OG_02855,0.3316200433582442,OG_02855,FUN_011893-T1,Peve_00008033,Pocillopora_meandrina_HIv1___TS.g16684.t2,three_way,72.4585,FUN_011893-T1,Q9WVE9,ITSN1_RAT,,Intersectin-1 (EH domain and SH3 domain regulator of endocytosis 1),Rattus norvegicus (Rat),40.1,1088.0,5.1e-58,228.0,sp|Q9WVE9|ITSN1_RAT Intersectin-1 OS=Rattus norvegicus OX=10116 GN=Itsn1 PE=1 SV=2,GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007267; GO:0008104; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0042734; GO:0043025; GO:0043195; GO:0043197; GO:0043524; GO:0044305; GO:0048488; GO:0051402; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098843; GO:0098871; GO:0098978; GO:0099175; GO:0150007; GO:1905274; GO:2001288,cell-cell signaling [GO:0007267]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; small GTPase-mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488],apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone [GO:0098833]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; terminal bouton [GO:0043195],calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064],GO:0005635; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0060090; GO:0098772,nuclear envelope; endosome; cytosol; cytoskeleton; plasma membrane; programmed cell death; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular adaptor activity; molecular function regulator activity
OG_06246,0.3313499447776838,OG_06246,FUN_028241-T1,Peve_00019542,Pocillopora_meandrina_HIv1___RNAseq.g15522.t1,three_way,71.78316666666666,FUN_028241-T1,Q155Q3,DIXC1_HUMAN,,Dixin (Coiled-coil protein DIX1) (Coiled-coil-DIX1) (DIX domain-containing protein 1),Homo sapiens (Human),41.1,725.0,4.900000000000001e-71,270.8,sp|Q155Q3|DIXC1_HUMAN Dixin OS=Homo sapiens OX=9606 GN=DIXDC1 PE=1 SV=2,GO:0001725; GO:0003779; GO:0005829; GO:0005925; GO:0019904; GO:0021799; GO:0021869; GO:0030177; GO:0032956; GO:0043015; GO:0045665; GO:0060070; GO:0070507; GO:0098794; GO:0098885; GO:0098978,canonical Wnt signaling pathway [GO:0060070]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507],cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; stress fiber [GO:0001725],actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; protein domain specific binding [GO:0019904],GO:0005829; GO:0008092; GO:0034330; GO:0048870,cytosol; cytoskeletal protein binding; cell junction organization; cell motility
OG_03729,0.331287530925893,OG_03729,FUN_015022-T1,Peve_00004790,Pocillopora_meandrina_HIv1___TS.g25933.t1,three_way,69.6595,FUN_015022-T1,Q9Z0J4,,,,,46.8,1462.0,0.0,1275.0,sp|Q9Z0J4|NOS1_MOUSE Nitric oxide synthase 1 OS=Mus musculus OX=10090 GN=Nos1 PE=1 SV=1,,,,,,
OG_06301,0.330949848521875,OG_06301,FUN_028506-T1,Peve_00029711,Pocillopora_meandrina_HIv1___RNAseq.g15898.t1,three_way,64.91666666666667,,,,,,,,,,,,,,,,,
OG_06700,0.3309418432756944,OG_06700,FUN_031267-T1,Peve_00036736,Pocillopora_meandrina_HIv1___RNAseq.11406_t,three_way,69.776,FUN_031267-T1,P20072,,,,,40.6,313.0,1.1000000000000001e-60,237.3,sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2,,,,,,
OG_08440,0.3307393957226065,OG_08440,FUN_037199-T1,Peve_00004724,Pocillopora_meandrina_HIv1___RNAseq.g11071.t1,three_way,64.9865,FUN_037199-T1,F1M3L7,EPS8_RAT,,Epidermal growth factor receptor kinase substrate 8,Rattus norvegicus (Rat),31.0,826.0,2.5e-71,272.3,sp|F1M3L7|EPS8_RAT Epidermal growth factor receptor kinase substrate 8 OS=Rattus norvegicus OX=10116 GN=Eps8 PE=1 SV=2,GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030036; GO:0030426; GO:0030832; GO:0031267; GO:0032420; GO:0032421; GO:0032426; GO:0032587; GO:0035023; GO:0036336; GO:0045202; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830,actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],brush border [GO:0005903]; cell cortex [GO:0005938]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202],actin binding [GO:0003779]; small GTPase binding [GO:0031267],GO:0002376; GO:0005886; GO:0007010; GO:0008092; GO:0043226; GO:0048870,immune system process; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle; cell motility
OG_04002,0.3304957262767282,OG_04002,FUN_016297-T1,Peve_00002880,Pocillopora_meandrina_HIv1___RNAseq.g9883.t1,three_way,94.22166666666666,FUN_016297-T1,P35224,,,,,57.2,711.0,3.1e-203,709.9,sp|P35224|CTNB_URECA Catenin beta OS=Urechis caupo OX=6431 PE=2 SV=1,,,,,,
OG_06599,0.3304462338918612,OG_06599,FUN_029673-T1,Peve_00038759,Pocillopora_meandrina_HIv1___RNAseq.g17212.t1,three_way,61.962,FUN_029673-T1,O88572,LRP6_MOUSE,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Mus musculus (Mouse),38.7,310.0,4.200000000000001e-58,228.0,sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1,GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043065; GO:0045121; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0110135; GO:1990963; GO:2000051; GO:2000648,anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],apolipoprotein binding [GO:0034185]; low-density lipoprotein particle receptor activity [GO:0005041]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005768; GO:0005783; GO:0005886; GO:0006355; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0048870; GO:0060089,transporter activity; endosome; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_08173,0.3302776405924938,OG_08173,FUN_035981-T1,Peve_00045083,Pocillopora_meandrina_HIv1___RNAseq.g12342.t1,three_way,87.08966666666667,FUN_035981-T1,Q9QYJ0,,,,,57.3,410.0,3.3e-127,456.4,sp|Q9QYJ0|DNJA2_MOUSE DnaJ homolog subfamily A member 2 OS=Mus musculus OX=10090 GN=Dnaja2 PE=1 SV=1,,,,,,
OG_04946,0.3301597217055667,OG_04946,FUN_023033-T1,Peve_00008499,Pocillopora_meandrina_HIv1___RNAseq.g3855.t2,three_way,61.9305,FUN_023033-T1,O14924,,,,,29.3,1289.0,6.6e-108,394.4,sp|O14924|RGS12_HUMAN Regulator of G-protein signaling 12 OS=Homo sapiens OX=9606 GN=RGS12 PE=1 SV=1,,,,,,
OG_08859,0.3300253458899574,OG_08859,FUN_038245-T1,Peve_00007985,Pocillopora_meandrina_HIv1___TS.g5460.t2,three_way,84.75483333333334,FUN_038245-T1,P24733,,,,,61.2,841.0,5e-306,1052.7,"sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1",,,,,,
OG_08709,0.3298506902206099,OG_08709,FUN_037961-T1,Peve_00009703,Pocillopora_meandrina_HIv1___RNAseq.g26230.t1,three_way,75.68066666666667,FUN_037961-T1,A7RKS5,RSSA_NEMVE,,Small ribosomal subunit protein uS2 (40S ribosomal protein SA),Nematostella vectensis (Starlet sea anemone),75.9,257.0,1e-107,391.3,sp|A7RKS5|RSSA_NEMVE Small ribosomal subunit protein uS2 OS=Nematostella vectensis OX=45351 GN=v1g198553 PE=3 SV=1,GO:0000028; GO:0002181; GO:0003735; GO:0022627,cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028],cytosolic small ribosomal subunit [GO:0022627],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0065003,cytoplasmic translation; structural molecule activity; protein-containing complex assembly
OG_04001,0.3297353869823882,OG_04001,FUN_016296-T1,Peve_00043168,Pocillopora_meandrina_HIv1___RNAseq.g503.t1,three_way,73.475,FUN_016296-T1,Q99758,ABCA3_HUMAN,,Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form],Homo sapiens (Human),35.3,1952.0,2.1e-296,1020.8,sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2,GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140,lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908],alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019],GO:0003824; GO:0005215; GO:0005615; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; extracellular space; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_00644,0.3296538624691463,OG_00644,FUN_001889-T1,Peve_00030492,Pocillopora_meandrina_HIv1___RNAseq.g2578.t2,three_way,70.65033333333334,,,,,,,,,,,,,,,,,
OG_04357,0.3296511550016712,OG_04357,FUN_018007-T1,Peve_00015729,Pocillopora_meandrina_HIv1___RNAseq.g25257.t1,three_way,73.35633333333334,FUN_018007-T1,E7FCP8,NAGS_DANRE,,"N-acetylglutamate synthase, mitochondrial (EC 2.3.1.1) [Cleaved into: N-acetylglutamate synthase, mature form (NAGS-M); N-acetylglutamate synthase, conserved domain form (NAGS-C)]",Danio rerio (Zebrafish) (Brachydanio rerio),41.3,453.0,7.5e-89,329.3,"sp|E7FCP8|NAGS_DANRE N-acetylglutamate synthase, mitochondrial OS=Danio rerio OX=7955 GN=nags PE=1 SV=1",GO:0000050; GO:0004042; GO:0005759; GO:0006526; GO:0006536; GO:0034618,glutamate metabolic process [GO:0006536]; L-arginine biosynthetic process [GO:0006526]; urea cycle [GO:0000050],mitochondrial matrix [GO:0005759],arginine binding [GO:0034618]; L-glutamate N-acetyltransferase activity [GO:0004042],GO:0003824; GO:0006520; GO:0016740; GO:0071941,catalytic activity; amino acid metabolic process; transferase activity; nitrogen cycle metabolic process
OG_07356,0.3295300954600926,OG_07356,FUN_033764-T1,Peve_00009254,Pocillopora_meandrina_HIv1___RNAseq.g28733.t1,three_way,74.24483333333333,FUN_033764-T1,Q8INF0,GCY8E_DROME,,Soluble guanylate cyclase 88E (EC 4.6.1.2),Drosophila melanogaster (Fruit fly),52.7,609.0,2.7e-178,627.1,sp|Q8INF0|GCY8E_DROME Soluble guanylate cyclase 88E OS=Drosophila melanogaster OX=7227 GN=Gyc88E PE=1 SV=4,GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482,cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302],"guanylate cyclase complex, soluble [GO:0008074]",carbon monoxide binding [GO:0070025]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0009975; GO:0016787; GO:0016829; GO:0098772; GO:0140299,catalytic activity; GTPase activity; cyclase activity; hydrolase activity; lyase activity; molecular function regulator activity; molecular sensor activity
OG_02511,0.3295087267705897,OG_02511,FUN_010518-T1,Peve_00003566,Pocillopora_meandrina_HIv1___RNAseq.g12949.t1,three_way,56.06633333333333,FUN_010518-T1,Q5BKC9,NGEF_RAT,,Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor),Rattus norvegicus (Rat),35.8,573.0,2.1e-92,342.4,sp|Q5BKC9|NGEF_RAT Ephexin-1 OS=Rattus norvegicus OX=10116 GN=Ngef PE=1 SV=2,GO:0005085; GO:0005737; GO:0007399; GO:0016020; GO:0030154; GO:0030426; GO:0032956; GO:0043087; GO:0046875; GO:0048013; GO:0061002; GO:0098794; GO:0098978; GO:1905806,cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of synapse pruning [GO:1905806],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; postsynapse [GO:0098794],ephrin receptor binding [GO:0046875]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0030154; GO:0048856; GO:0098772,cell differentiation; anatomical structure development; molecular function regulator activity
OG_08876,0.3293912756905128,OG_08876,FUN_038275-T1,Peve_00041698,Pocillopora_meandrina_HIv1___RNAseq.g28318.t1,three_way,51.19616666666667,,,,,,,,,,,,,,,,,
OG_00741,0.3293814140748905,OG_00741,FUN_002723-T1,Peve_00025040,Pocillopora_meandrina_HIv1___RNAseq.g14943.t1,three_way,95.002,FUN_002723-T1,Q96HN2,SAHH3_HUMAN,,Adenosylhomocysteinase 3 (AdoHcyase 3) (EC 3.13.2.1) (IP(3)Rs binding protein released with IP(3) 2) (IRBIT2) (Long-IRBIT) (S-adenosyl-L-homocysteine hydrolase 3) (S-adenosylhomocysteine hydrolase-like protein 2),Homo sapiens (Human),79.1,470.0,2.7e-219,762.7,sp|Q96HN2|SAHH3_HUMAN Adenosylhomocysteinase 3 OS=Homo sapiens OX=9606 GN=AHCYL2 PE=1 SV=1,GO:0005783; GO:0005829; GO:0006730; GO:0016787; GO:0033353; GO:0043005,one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005],hydrolase activity [GO:0016787],GO:0003824; GO:0005783; GO:0005829; GO:0006790; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; cytosol; sulfur compound metabolic process; hydrolase activity; organelle
OG_02650,0.3293667156388753,OG_02650,FUN_010832-T1,Peve_00017537,Pocillopora_meandrina_HIv1___RNAseq.g20916.t1,three_way,73.97983333333333,FUN_010832-T1,Q13118,KLF10_HUMAN,,Krueppel-like factor 10 (EGR-alpha) (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1),Homo sapiens (Human),62.6,179.0,2.5e-12,74.7,sp|Q13118|KLF10_HUMAN Krueppel-like factor 10 OS=Homo sapiens OX=9606 GN=KLF10 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0007267; GO:0007623; GO:0008270; GO:0008285; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:1990837,bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019],chromatin [GO:0000785]; nucleus [GO:0005634],"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0023052; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; signaling; organelle; anatomical structure development; transcription regulator activity
OG_09486,0.3292659722970497,OG_09486,FUN_041519-T1,Peve_00024151,Pocillopora_meandrina_HIv1___RNAseq.g15592.t1,three_way,58.06766666666667,FUN_041519-T1,P27393,,,,,62.9,224.0,9e-84,314.3,sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1,,,,,,
OG_02132,0.3292222225210091,OG_02132,FUN_008436-T1,Peve_00003898,Pocillopora_meandrina_HIv1___RNAseq.g18055.t1,three_way,83.60333333333334,FUN_008436-T1,Q07889,SOS1_HUMAN,,Son of sevenless homolog 1 (SOS-1),Homo sapiens (Human),56.7,1047.0,0.0,1162.9,sp|Q07889|SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens OX=9606 GN=SOS1 PE=1 SV=1,GO:0001782; GO:0001942; GO:0002931; GO:0003209; GO:0003344; GO:0005085; GO:0005096; GO:0005154; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007165; GO:0007173; GO:0007265; GO:0007296; GO:0007411; GO:0008286; GO:0008543; GO:0014044; GO:0014069; GO:0017124; GO:0019221; GO:0019901; GO:0033081; GO:0035264; GO:0038095; GO:0042110; GO:0042127; GO:0042129; GO:0042552; GO:0043025; GO:0045742; GO:0046982; GO:0048009; GO:0048011; GO:0048514; GO:0050853; GO:0050900; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:0098978; GO:0140693; GO:1904693; GO:1905360; GO:2000973,axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ischemia [GO:0002931]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vitellogenesis [GO:0007296],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular condensate scaffold activity [GO:0140693]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124],GO:0002376; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0098772,immune system process; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; anatomical structure development; cell motility; molecular adaptor activity; molecular function regulator activity
OG_00320,0.3292124649854806,OG_00320,FUN_001139-T1,Peve_00029334,Pocillopora_meandrina_HIv1___RNAseq.g29336.t1,three_way,78.20866666666667,FUN_001139-T1,Q761V0,SC6A5_MOUSE,,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Mus musculus (Mouse),46.3,609.0,5.5e-158,559.3,sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1,GO:0001504; GO:0005886; GO:0015375; GO:0046872; GO:0098690; GO:0098793; GO:0098810,neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504],glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynapse [GO:0098793],glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_02124,0.3291894098497969,OG_02124,FUN_008418-T1,Peve_00009794,Pocillopora_meandrina_HIv1___RNAseq.g18045.t1,three_way,95.60633333333334,FUN_008418-T1,P53488,,,,,89.1,359.0,1.2e-192,673.7,sp|P53488|ARP2_CHICK Actin-related protein 2 OS=Gallus gallus OX=9031 GN=ACTR2 PE=2 SV=1,,,,,,
OG_06314,0.3291810560799343,OG_06314,FUN_028554-T1,Peve_00002501,Pocillopora_meandrina_HIv1___RNAseq.g20706.t2,three_way,70.67833333333333,FUN_028554-T1,A8MWY0,ELAP2_HUMAN,,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (hEIG121L),Homo sapiens (Human),35.5,1029.0,1.2e-176,622.1,sp|A8MWY0|ELAP2_HUMAN Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Homo sapiens OX=9606 GN=ELAPOR2 PE=1 SV=2,GO:0005886; GO:0016020; GO:0030513; GO:0045684; GO:0051961; GO:0070700,negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684],membrane [GO:0016020]; plasma membrane [GO:0005886],BMP receptor binding [GO:0070700],GO:0005886,plasma membrane
OG_09642,0.3289875083485661,OG_09642,FUN_041837-T1,Peve_00009647,Pocillopora_meandrina_HIv1___RNAseq.g15083.t1,three_way,77.079,FUN_041837-T1,Q676U5,A16L1_HUMAN,,Autophagy-related protein 16-1 (APG16-like 1),Homo sapiens (Human),34.9,601.0,7.8e-79,296.2,sp|Q676U5|A16L1_HUMAN Autophagy-related protein 16-1 OS=Homo sapiens OX=9606 GN=ATG16L1 PE=1 SV=2,GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0006501; GO:0010508; GO:0015031; GO:0016236; GO:0016237; GO:0019787; GO:0021766; GO:0022038; GO:0030424; GO:0034045; GO:0034274; GO:0034497; GO:0036020; GO:0039689; GO:0042802; GO:0043495; GO:0051020; GO:0051607; GO:0097225; GO:0098792; GO:0098930; GO:0098978; GO:0120095; GO:0140059; GO:1903860,autophagosome assembly [GO:0000045]; axonal transport [GO:0098930]; C-terminal protein lipidation [GO:0006501]; corpus callosum development [GO:0022038]; defense response to virus [GO:0051607]; dendrite arborization [GO:0140059]; hippocampus development [GO:0021766]; macroautophagy [GO:0016236]; microautophagy [GO:0016237]; negative regulation of dendrite extension [GO:1903860]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095],GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like protein transferase activity [GO:0019787],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0007018; GO:0016740; GO:0043226; GO:0048856; GO:0060090; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; microtubule-based movement; transferase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein"
OG_01611,0.3288023248237829,OG_01611,FUN_006656-T1,Peve_00029042,Pocillopora_meandrina_HIv1___RNAseq.3492_t,three_way,56.7115,FUN_006656-T1,Q9HC56,,,,,32.8,704.0,2.2e-87,325.5,sp|Q9HC56|PCDH9_HUMAN Protocadherin-9 OS=Homo sapiens OX=9606 GN=PCDH9 PE=1 SV=2,,,,,,
OG_06270,0.3284787614446904,OG_06270,FUN_028301-T1,Peve_00000714,Pocillopora_meandrina_HIv1___TS.g10572.t1,three_way,51.42816666666666,FUN_028301-T1,D3ZSP7,TTC3_RAT,,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D),Rattus norvegicus (Rat),27.5,741.0,7.4e-62,241.5,sp|D3ZSP7|TTC3_RAT E3 ubiquitin-protein ligase TTC3 OS=Rattus norvegicus OX=10116 GN=Ttc3 PE=3 SV=3,GO:0004842; GO:0005634; GO:0005773; GO:0005794; GO:0006511; GO:0008270; GO:0030517; GO:0045665; GO:0070936,negative regulation of axon extension [GO:0030517]; negative regulation of neuron differentiation [GO:0045665]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; vacuole [GO:0005773],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005773; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vacuole; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00421,0.3284138012690025,OG_00421,FUN_001328-T1,Peve_00036956,Pocillopora_meandrina_HIv1___RNAseq.g2270.t1b,three_way,79.90283333333333,FUN_001328-T1,Q5F471,,,,,41.4,903.0,8.500000000000001e-174,612.5,sp|Q5F471|PP6R3_CHICK Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Gallus gallus OX=9031 GN=PPP6R3 PE=2 SV=1,,,,,,
OG_01493,0.3283269302327043,OG_01493,FUN_006169-T1,Peve_00021028,Pocillopora_meandrina_HIv1___RNAseq.g20427.t1,three_way,83.96716666666667,FUN_006169-T1,Q80UV9,TAF1_MOUSE,,Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250),Mus musculus (Mouse),45.8,1844.0,0.0,1349.7,sp|Q80UV9|TAF1_MOUSE Transcription initiation factor TFIID subunit 1 OS=Mus musculus OX=10090 GN=Taf1 PE=1 SV=2,GO:0003677; GO:0004402; GO:0004674; GO:0005524; GO:0005634; GO:0005669; GO:0016251; GO:0017025; GO:0042789; GO:0045120; GO:0051123; GO:0060261; GO:0071339; GO:0106310; GO:1990841,mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123],MLL1 complex [GO:0071339]; nucleus [GO:0005634]; pronucleus [GO:0045120]; transcription factor TFIID complex [GO:0005669],ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025],GO:0003677; GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0043226; GO:0065003; GO:0140096; GO:0140223,"DNA binding; catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; general transcription initiation factor activity"
OG_07720,0.3282788106872473,OG_07720,FUN_034875-T1,Peve_00005784,Pocillopora_meandrina_HIv1___RNAseq.g27164.t1b,three_way,85.19866666666667,FUN_034875-T1,Q8QZR1,ATTY_MOUSE,,Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase),Mus musculus (Mouse),53.7,408.0,7.9e-140,498.4,sp|Q8QZR1|ATTY_MOUSE Tyrosine aminotransferase OS=Mus musculus OX=10090 GN=Tat PE=1 SV=1,GO:0004838; GO:0005739; GO:0006103; GO:0006536; GO:0006559; GO:0006572; GO:0006979; GO:0009058; GO:0016597; GO:0030170; GO:0042802; GO:0046689; GO:0071548,2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to dexamethasone [GO:0071548]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572],mitochondrion [GO:0005739],amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine-2-oxoglutarate transaminase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; organelle
OG_07499,0.3281406516908708,OG_07499,FUN_034036-T1,Peve_00019782,Pocillopora_meandrina_HIv1___RNAseq.g26045.t1b,three_way,76.29766666666667,FUN_034036-T1,Q95L46,,,,,39.6,793.0,4.6999999999999995e-143,510.0,sp|Q95L46|IF4G2_BOVIN Eukaryotic translation initiation factor 4 gamma 2 OS=Bos taurus OX=9913 GN=EIF4G2 PE=2 SV=2,,,,,,
OG_00661,0.3281186947996871,OG_00661,FUN_001954-T1,Peve_00024484,Pocillopora_meandrina_HIv1___RNAseq.g29228.t1,three_way,86.64866666666667,FUN_001954-T1,Q6FIF0,ZFAN6_HUMAN,,AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3),Homo sapiens (Human),38.9,208.0,1.9e-29,130.6,sp|Q6FIF0|ZFAN6_HUMAN AN1-type zinc finger protein 6 OS=Homo sapiens OX=9606 GN=ZFAND6 PE=1 SV=2,GO:0003677; GO:0005829; GO:0006625; GO:0006915; GO:0008270; GO:0015031; GO:0031593; GO:0043066; GO:0043122; GO:0071356,apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; protein transport [GO:0015031]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cytosol [GO:0005829],DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270],GO:0003677; GO:0005829; GO:0012501,DNA binding; cytosol; programmed cell death
OG_08661,0.3280098706576506,OG_08661,FUN_037877-T1,Peve_00027466,Pocillopora_meandrina_HIv1___TS.g13174.t1,three_way,47.705333333333336,FUN_037877-T1,P86733,,,,,41.8,110.0,7.4e-27,125.6,sp|P86733|KCP_HALAI BPTI/Kunitz domain-containing protein (Fragment) OS=Haliotis asinina OX=109174 PE=1 SV=1,,,,,,
OG_06523,0.3279603262130711,OG_06523,FUN_029340-T1,Peve_00023362,Pocillopora_meandrina_HIv1___RNAseq.g17300.t2,three_way,70.36116666666666,FUN_029340-T1,Q99KY4,GAK_MOUSE,,Cyclin-G-associated kinase (EC 2.7.11.1) (DnaJ homolog subfamily C member 26),Mus musculus (Mouse),37.7,1476.0,1e-239,832.0,sp|Q99KY4|GAK_MOUSE Cyclin-G-associated kinase OS=Mus musculus OX=10090 GN=Gak PE=1 SV=2,GO:0002064; GO:0004674; GO:0005524; GO:0005794; GO:0005925; GO:0007029; GO:0007030; GO:0009913; GO:0010977; GO:0030136; GO:0030216; GO:0031982; GO:0035622; GO:0046907; GO:0048471; GO:0048853; GO:0048863; GO:0060563; GO:0061351; GO:0061436; GO:0072318; GO:0072583; GO:0106310; GO:1905443; GO:2000179,clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; epidermal cell differentiation [GO:0009913]; epithelial cell development [GO:0002064]; establishment of skin barrier [GO:0061436]; forebrain morphogenesis [GO:0048853]; Golgi organization [GO:0007030]; intracellular transport [GO:0046907]; intrahepatic bile duct development [GO:0035622]; keratinocyte differentiation [GO:0030216]; negative regulation of neuron projection development [GO:0010977]; neural precursor cell proliferation [GO:0061351]; neuroepithelial cell differentiation [GO:0060563]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of clathrin coat assembly [GO:1905443]; stem cell differentiation [GO:0048863],clathrin-coated vesicle [GO:0030136]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005794; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05454,0.3279211563780105,OG_05454,FUN_024412-T1,Peve_00007146,Pocillopora_meandrina_HIv1___RNAseq.g18635.t1,three_way,68.411,FUN_024412-T1,Q6ZQ58,,,,,38.2,878.0,1.9e-105,385.6,sp|Q6ZQ58|LARP1_MOUSE La-related protein 1 OS=Mus musculus OX=10090 GN=Larp1 PE=1 SV=3,,,,,,
OG_05364,0.3279087633327831,OG_05364,FUN_024151-T1,Peve_00036839,Pocillopora_meandrina_HIv1___RNAseq.g19861.t1,three_way,80.388,FUN_024151-T1,Q9I9K7,TBX20_DANRE,,T-box transcription factor TBX20 (T-box protein 20) (H15-related T-box transcription factor hrT),Danio rerio (Zebrafish) (Brachydanio rerio),50.2,408.0,9.599999999999999e-95,348.6,sp|Q9I9K7|TBX20_DANRE T-box transcription factor TBX20 OS=Danio rerio OX=7955 GN=tbx20 PE=2 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001568; GO:0001570; GO:0001708; GO:0001947; GO:0003313; GO:0005634; GO:0006357; GO:0007507; GO:0035050; GO:0035162; GO:0035844; GO:0045892; GO:0045893; GO:0060038; GO:0060043,angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cardiac muscle cell proliferation [GO:0060038]; cell fate specification [GO:0001708]; cloaca development [GO:0035844]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; heart development [GO:0007507]; heart looping [GO:0001947]; heart rudiment development [GO:0003313]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of transcription by RNA polymerase II [GO:0006357]; vasculogenesis [GO:0001570],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02260,0.3277044837466673,OG_02260,FUN_008707-T1,Peve_00034989,Pocillopora_meandrina_HIv1___TS.g9102.t1,three_way,77.2585,FUN_008707-T1,Q99246,,,,,52.7,1458.0,0.0,1323.9,sp|Q99246|CAC1D_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1D OS=Mus musculus OX=10090 GN=Cacna1d PE=1 SV=3,,,,,,
OG_03772,0.3275445631056859,OG_03772,FUN_015101-T1,Peve_00027022,Pocillopora_meandrina_HIv1___RNAseq.g22124.t1,three_way,62.69583333333333,FUN_015101-T1,P47708,RP3A_MOUSE,,Rabphilin-3A (Exophilin-1),Mus musculus (Mouse),37.0,683.0,1.8e-109,398.3,sp|P47708|RP3A_MOUSE Rabphilin-3A OS=Mus musculus OX=10090 GN=Rph3a PE=1 SV=2,GO:0005509; GO:0005544; GO:0005546; GO:0006886; GO:0008270; GO:0008430; GO:0016082; GO:0019898; GO:0030141; GO:0030672; GO:0031267; GO:0032991; GO:0042301; GO:0043005; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0061669; GO:0070679,intracellular protein transport [GO:0006886]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle priming [GO:0016082],dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; selenium binding [GO:0008430]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0006886; GO:0008289; GO:0031410; GO:0043226; GO:0065003,intracellular protein transport; lipid binding; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_07889,0.3272676699561476,OG_07889,FUN_035267-T1,Peve_00032639,Pocillopora_meandrina_HIv1___RNAseq.g27876.t1,three_way,69.10499999999999,FUN_035267-T1,Q4R7K1,MCES_MACFA,,mRNA cap guanine-N(7) methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7))-methyltransferase) (mRNA cap methyltransferase),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),55.7,334.0,8e-103,375.9,sp|Q4R7K1|MCES_MACFA mRNA cap guanine-N(7) methyltransferase OS=Macaca fascicularis OX=9541 GN=RNMT PE=2 SV=1,GO:0003723; GO:0004482; GO:0005634; GO:0006370; GO:0160130,7-methylguanosine mRNA capping [GO:0006370],mRNA cap methyltransferase RNMT:RAMAC complex [GO:0160130]; nucleus [GO:0005634],mRNA 5'-cap (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_04270,0.327086731416454,OG_04270,FUN_017828-T1,Peve_00032669,Pocillopora_meandrina_HIv1___RNAseq.g9643.t1,three_way,84.98966666666666,FUN_017828-T1,P52162,,,,,65.5,139.0,1.8e-38,160.6,sp|P52162|MAX_CHICK Protein max OS=Gallus gallus OX=9031 GN=MAX PE=3 SV=1,,,,,,
OG_00571,0.3269823127683307,OG_00571,FUN_001630-T1,Peve_00009934,Pocillopora_meandrina_HIv1___RNAseq.g2163.t1,three_way,60.408,FUN_001630-T1,Q7KM13,,,,,40.7,167.0,8.1e-17,90.1,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_02331,0.3267680239359376,OG_02331,FUN_008924-T1,Peve_00028630,Pocillopora_meandrina_HIv1___RNAseq.g14267.t1,three_way,80.87533333333333,FUN_008924-T1,O76756,,,,,75.1,209.0,9.500000000000001e-86,317.8,sp|O76756|RS8_APIME Small ribosomal subunit protein eS8 OS=Apis mellifera OX=7460 GN=RpS8 PE=2 SV=2,,,,,,
OG_03369,0.3267310407584574,OG_03369,FUN_013615-T1,Peve_00002656,Pocillopora_meandrina_HIv1___RNAseq.g13534.t1,three_way,66.598,FUN_013615-T1,Q6Y7W8,,,,,35.4,621.0,1.4999999999999999e-40,170.2,sp|Q6Y7W8|GGYF2_MOUSE GRB10-interacting GYF protein 2 OS=Mus musculus OX=10090 GN=Gigyf2 PE=1 SV=2,,,,,,
OG_06410,0.3264950308141718,OG_06410,FUN_029093-T1,Peve_00007821,Pocillopora_meandrina_HIv1___TS.g9197.t1,three_way,87.07566666666666,FUN_029093-T1,Q6GNL7,AL1L1_XENLA,,Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1),Xenopus laevis (African clawed frog),64.4,634.0,9.2e-244,844.3,sp|Q6GNL7|AL1L1_XENLA Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Xenopus laevis OX=8355 GN=aldh1l1 PE=2 SV=1,GO:0004029; GO:0005829; GO:0006730; GO:0006740; GO:0009058; GO:0009258; GO:0016155,10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730],cytosol [GO:0005829],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155],GO:0003824; GO:0005829; GO:0006091; GO:0006575; GO:0016491; GO:0055086,catalytic activity; cytosol; generation of precursor metabolites and energy; modified amino acid metabolic process; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_04916,0.3263185594795529,OG_04916,FUN_022970-T1,Peve_00011906,Pocillopora_meandrina_HIv1___RNAseq.17380_t,three_way,66.845,FUN_022970-T1,Q9QYC0,ADDA_MOUSE,,Alpha-adducin (Erythrocyte adducin subunit alpha),Mus musculus (Mouse),34.7,395.0,3.5e-58,227.6,sp|Q9QYC0|ADDA_MOUSE Alpha-adducin OS=Mus musculus OX=10090 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0003779; GO:0005200; GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006884; GO:0016020; GO:0016604; GO:0020027; GO:0030218; GO:0035264; GO:0045202; GO:0048873; GO:0071277; GO:1903142; GO:1903393,cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; synapse [GO:0045202],actin binding [GO:0003779]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005856; GO:0005886; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_01728,0.3263021354321734,OG_01728,FUN_007020-T1,Peve_00037180,Pocillopora_meandrina_HIv1___RNAseq.g20542.t1,three_way,63.67233333333333,FUN_007020-T1,Q6ZZY0,,,,,46.9,497.0,1.3e-139,499.6,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_01750,0.3261361350900692,OG_01750,FUN_007084-T1,Peve_00019890,Pocillopora_meandrina_HIv1___RNAseq.g20077.t2,three_way,43.15733333333333,FUN_007084-T1,Q99PF6,,,,,38.2,173.0,8.5e-17,90.9,sp|Q99PF6|GAB1_MESAU GRB2-associated-binding protein 1 OS=Mesocricetus auratus OX=10036 GN=GAB1 PE=2 SV=1,,,,,,
OG_03716,0.3260280022899008,OG_03716,FUN_014991-T1,Peve_00032857,Pocillopora_meandrina_HIv1___RNAseq.g21154.t2,three_way,83.89333333333333,FUN_014991-T1,Q9BUZ4,TRAF4_HUMAN,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),Homo sapiens (Human),30.0,621.0,3.3e-94,347.4,sp|Q9BUZ4|TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism
OG_00252,0.3257584848635904,OG_00252,FUN_001016-T1,Peve_00041043,Pocillopora_meandrina_HIv1___RNAseq.g29160.t1,three_way,48.55133333333333,FUN_001016-T1,Q0IHU9,,,,,42.9,203.0,7.6e-44,180.6,sp|Q0IHU9|PRUN2_XENTR Protein prune homolog 2 OS=Xenopus tropicalis OX=8364 GN=Prune2 PE=2 SV=1,,,,,,
OG_08105,0.3257455954024209,OG_08105,FUN_035852-T1,Peve_00032510,Pocillopora_meandrina_HIv1___RNAseq.g11950.t1,three_way,70.93616666666667,FUN_035852-T1,Q63185,E2AK1_RAT,,Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (Hemin-sensitive initiation factor 2-alpha kinase),Rattus norvegicus (Rat),33.4,626.0,4.1e-72,274.2,sp|Q63185|E2AK1_RAT Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Rattus norvegicus OX=10116 GN=Eif2ak1 PE=1 SV=2,GO:0002526; GO:0004672; GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0006446; GO:0006909; GO:0008285; GO:0017148; GO:0020037; GO:0030225; GO:0042803; GO:0046501; GO:0046777; GO:0046984; GO:0046986; GO:0051649; GO:0060586; GO:0070585; GO:0106310; GO:0140467; GO:0140468; GO:1901526; GO:1990641,acute inflammatory response [GO:0002526]; establishment of localization in cell [GO:0051649]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; macrophage differentiation [GO:0030225]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translation [GO:0017148]; phagocytosis [GO:0006909]; positive regulation of mitophagy [GO:1901526]; protein autophosphorylation [GO:0046777]; protein localization to mitochondrion [GO:0070585]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of hemoglobin biosynthetic process [GO:0046984]; regulation of translation [GO:0006417]; regulation of translational initiation [GO:0006446]; response to iron ion starvation [GO:1990641],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005829; GO:0006954; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; inflammatory response; vesicle-mediated transport; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_03948,0.3257294094998238,OG_03948,FUN_016087-T1,Peve_00010774,Pocillopora_meandrina_HIv1___RNAseq.g21606.t1,three_way,69.82266666666666,FUN_016087-T1,Q92667,AKAP1_HUMAN,,"A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84)",Homo sapiens (Human),36.7,316.0,8.2e-45,183.0,"sp|Q92667|AKAP1_HUMAN A-kinase anchor protein 1, mitochondrial OS=Homo sapiens OX=9606 GN=AKAP1 PE=1 SV=1",GO:0003723; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0016020; GO:0034237; GO:0140374,antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005739; GO:0005829; GO:0012501; GO:0043226; GO:0098542,immune system process; RNA binding; mitochondrion; cytosol; programmed cell death; organelle; defense response to other organism
OG_08395,0.3255672744231134,OG_08395,FUN_037007-T1,Peve_00032339,Pocillopora_meandrina_HIv1___RNAseq.g26697.t1,three_way,81.91016666666667,,,,,,,,,,,,,,,,,
OG_09015,0.3255360072422082,OG_09015,FUN_038577-T1,Peve_00012107,Pocillopora_meandrina_HIv1___RNAseq.g1011.t1,three_way,67.471,FUN_038577-T1,Q0QWG9,GRD2I_MOUSE,,"Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)",Mus musculus (Mouse),28.8,420.0,9.800000000000001e-34,147.1,sp|Q0QWG9|GRD2I_MOUSE Delphilin OS=Mus musculus OX=10090 GN=Grid2ip PE=1 SV=1,GO:0007216; GO:0030036; GO:0043197; GO:0045202; GO:0045211; GO:0060292; GO:0098688; GO:0098978; GO:0099072; GO:0099092; GO:0099566; GO:0150048,actin cytoskeleton organization [GO:0030036]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],"cerebellar granule cell to Purkinje cell synapse [GO:0150048]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]",,GO:0007010; GO:0043226,cytoskeleton organization; organelle
OG_08826,0.325455178850534,OG_08826,FUN_038163-T1,Peve_00025803,Pocillopora_meandrina_HIv1___RNAseq.g1066.t1,three_way,90.66833333333334,FUN_038163-T1,Q6Q0C0,TRAF7_HUMAN,,E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7),Homo sapiens (Human),53.5,486.0,1.1000000000000005e-111,405.6,sp|Q6Q0C0|TRAF7_HUMAN E3 ubiquitin-protein ligase TRAF7 OS=Homo sapiens OX=9606 GN=TRAF7 PE=1 SV=1,GO:0000151; GO:0004842; GO:0005634; GO:0005886; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0035519; GO:0043231; GO:0043410; GO:0043525; GO:0061630; GO:0070372; GO:2000060; GO:2001235,apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372],cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005886; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_06001,0.3253954415462264,OG_06001,FUN_026490-T1,Peve_00002095,Pocillopora_meandrina_HIv1___RNAseq.g4192.t1,three_way,88.14433333333334,FUN_026490-T1,O57683,,,,,77.7,1266.0,0.0,1677.9,sp|O57683|SF3B1_XENLA Splicing factor 3B subunit 1 OS=Xenopus laevis OX=8355 GN=sf3b1 PE=2 SV=1,,,,,,
OG_09117,0.3253185909625709,OG_09117,FUN_039101-T1,Peve_00028755,Pocillopora_meandrina_HIv1___RNAseq.g28705.t1,three_way,90.875,FUN_039101-T1,P27600,GNA12_MOUSE,,Guanine nucleotide-binding protein subunit alpha-12 (G alpha-12) (G-protein subunit alpha-12),Mus musculus (Mouse),67.3,349.0,4.800000000000001e-130,465.7,sp|P27600|GNA12_MOUSE Guanine nucleotide-binding protein subunit alpha-12 OS=Mus musculus OX=10090 GN=Gna12 PE=1 SV=3,GO:0001701; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005834; GO:0007186; GO:0007266; GO:0008217; GO:0008360; GO:0009410; GO:0010762; GO:0016328; GO:0030154; GO:0031526; GO:0031683; GO:0031752; GO:0032006; GO:0032434; GO:0035556; GO:0042733; GO:0043005; GO:0043025; GO:0046872; GO:0051721; GO:0072542; GO:0160221; GO:1904706; GO:1904753,cell differentiation [GO:0030154]; embryonic digit morphogenesis [GO:0042733]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221],brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025],D5 dopamine receptor binding [GO:0031752]; G protein activity [GO:0003925]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase activator activity [GO:0072542],GO:0003824; GO:0003924; GO:0016787; GO:0030154; GO:0048856; GO:0098772,catalytic activity; GTPase activity; hydrolase activity; cell differentiation; anatomical structure development; molecular function regulator activity
OG_03143,0.3252734858591298,OG_03143,FUN_012528-T1,Peve_00013908,Pocillopora_meandrina_HIv1___RNAseq.g23974.t1,three_way,64.574,FUN_012528-T1,Q14149,MORC3_HUMAN,,MORC family CW-type zinc finger protein 3 (Nuclear matrix protein 2) (Zinc finger CW-type coiled-coil domain protein 3),Homo sapiens (Human),59.4,483.0,9.3e-152,539.3,sp|Q14149|MORC3_HUMAN MORC family CW-type zinc finger protein 3 OS=Homo sapiens OX=9606 GN=MORC3 PE=1 SV=3,GO:0000122; GO:0000785; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006468; GO:0008270; GO:0009791; GO:0016363; GO:0016605; GO:0016887; GO:0018105; GO:0030674; GO:0032688; GO:0035064; GO:0048147; GO:0050821; GO:0051457; GO:0140002; GO:0140374; GO:2000774,antiviral innate immune response [GO:0140374]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular senescence [GO:2000774]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821],chromatin [GO:0000785]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; histone H3K4me3 reader activity [GO:0140002]; methylated histone binding [GO:0035064]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016787; GO:0043226; GO:0060090; GO:0098542,immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; hydrolase activity; organelle; molecular adaptor activity; defense response to other organism
OG_05501,0.3252041302058969,OG_05501,FUN_024564-T1,Peve_00009968,Pocillopora_meandrina_HIv1___RNAseq.g18662.t1,three_way,88.02933333333334,,,,,,,,,,,,,,,,,
OG_02190,0.3251533461736871,OG_02190,FUN_008544-T1,Peve_00013775,Pocillopora_meandrina_HIv1___RNAseq.g6331.t2,three_way,81.17266666666667,FUN_008544-T1,Q99MD6,TRXR3_MOUSE,,Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2),Mus musculus (Mouse),60.5,588.0,1.7000000000000002e-209,730.3,sp|Q99MD6|TRXR3_MOUSE Thioredoxin reductase 3 OS=Mus musculus OX=10090 GN=Txnrd3 PE=1 SV=3,GO:0001825; GO:0004791; GO:0005634; GO:0005783; GO:0006749; GO:0007283; GO:0030154; GO:0045454; GO:0050660,blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],flavin adenine dinucleotide binding [GO:0050660]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005783; GO:0006575; GO:0006790; GO:0016209; GO:0016491; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; modified amino acid metabolic process; sulfur compound metabolic process; antioxidant activity; oxidoreductase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_02378,0.3251325711658161,OG_02378,FUN_008989-T1,Peve_00001693,Pocillopora_meandrina_HIv1___RNAseq.g3898.t1,three_way,97.019,FUN_008989-T1,Q9Y3B4,SF3B6_HUMAN,,"Splicing factor 3B subunit 6 (Pre-mRNA branch site protein p14) (SF3b 14 kDa subunit) (SF3B14a) (Spliceosome-associated protein, 14-kDa) (Splicing factor 3b, subunit 6, 14kDa)",Homo sapiens (Human),78.7,122.0,3.7e-53,208.8,sp|Q9Y3B4|SF3B6_HUMAN Splicing factor 3B subunit 6 OS=Homo sapiens OX=9606 GN=SF3B6 PE=1 SV=1,GO:0000398; GO:0001825; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:1903241,"blastocyst formation [GO:0001825]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_01193,0.325070597216879,OG_01193,FUN_004851-T1,Peve_00043739,Pocillopora_meandrina_HIv1___RNAseq.g8640.t1,three_way,62.76883333333333,FUN_004851-T1,Q04912,RON_HUMAN,,Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain],Homo sapiens (Human),35.8,293.0,2.2e-49,198.7,sp|Q04912|RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens OX=9606 GN=MST1R PE=1 SV=3,GO:0001725; GO:0004714; GO:0005011; GO:0005524; GO:0005773; GO:0005886; GO:0006909; GO:0006952; GO:0007165; GO:0007169; GO:0007338; GO:0007399; GO:0008284; GO:0009615; GO:0009986; GO:0016477; GO:0019899; GO:0043235; GO:0043406; GO:0045087; GO:0051897,cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338],cell surface [GO:0009986]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005773; GO:0005886; GO:0016192; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0098542; GO:0140096,"immune system process; catalytic activity; vacuole; plasma membrane; vesicle-mediated transport; transferase activity; reproductive process; organelle; anatomical structure development; cell motility; molecular transducer activity; defense response to other organism; catalytic activity, acting on a protein"
OG_06772,0.3249724591400094,OG_06772,FUN_031637-T1,Peve_00032681,Pocillopora_meandrina_HIv1___RNAseq.g5689.t1,three_way,76.88733333333333,FUN_031637-T1,Q5HZE0,S2529_RAT,,Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29),Rattus norvegicus (Rat),52.4,288.0,1.7e-80,300.8,sp|Q5HZE0|S2529_RAT Mitochondrial basic amino acids transporter OS=Rattus norvegicus OX=10116 GN=Slc25a29 PE=2 SV=1,GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0015174; GO:0015227; GO:0015822; GO:0089709; GO:1903401; GO:1903826; GO:1990575,L-arginine transmembrane transport [GO:1903826]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; ornithine transport [GO:0015822],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity L-arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_04241,0.3248919994713359,OG_04241,FUN_017762-T1,Peve_00003285,Pocillopora_meandrina_HIv1___RNAseq.g441.t1,three_way,80.27833333333334,FUN_017762-T1,Q8BPM2,,,,,46.1,857.0,7.6e-203,708.8,sp|Q8BPM2|M4K5_MOUSE Mitogen-activated protein kinase kinase kinase kinase 5 OS=Mus musculus OX=10090 GN=Map4k5 PE=1 SV=2,,,,,,
OG_09789,0.3248381900448278,OG_09789,FUN_042591-T1,Peve_00012673,Pocillopora_meandrina_HIv1___RNAseq.g16869.t1,three_way,79.75733333333334,FUN_042591-T1,Q87PP5,,,,,36.3,535.0,8.499999999999999e-92,339.7,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_07948,0.3245473216509517,OG_07948,FUN_035469-T1,Peve_00012131,Pocillopora_meandrina_HIv1___RNAseq.g27047.t1,three_way,52.6305,FUN_035469-T1,P17706,PTN2_HUMAN,,Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP),Homo sapiens (Human),52.8,307.0,2e-82,308.1,sp|P17706|PTN2_HUMAN Tyrosine-protein phosphatase non-receptor type 2 OS=Homo sapiens OX=9606 GN=PTPN2 PE=1 SV=2,GO:0000122; GO:0004725; GO:0004726; GO:0005178; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0031904; GO:0035335; GO:0038020; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046426; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060334; GO:0060336; GO:0060339; GO:0070104; GO:0070373; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587,B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor recycling [GO:0038020]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of type II interferon-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome lumen [GO:0031904]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; endoplasmic reticulum; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_09412,0.3244316171346037,OG_09412,FUN_040923-T1,Peve_00012313,Pocillopora_meandrina_HIv1___RNAseq.g27560.t1,three_way,85.5445,FUN_040923-T1,Q4G0P3,HYDIN_HUMAN,,Hydrocephalus-inducing protein homolog,Homo sapiens (Human),43.3,3001.0,0.0,2169.8,sp|Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens OX=9606 GN=HYDIN PE=1 SV=3,GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718,axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0043226; GO:0048856,cilium; microtubule-based movement; organelle; anatomical structure development
OG_00601,0.3243743463996754,OG_00601,FUN_001749-T1,Peve_00019400,Pocillopora_meandrina_HIv1___RNAseq.g2654.t1,three_way,72.93033333333334,FUN_001749-T1,Q0V8G2,GABP2_BOVIN,,GA-binding protein subunit beta-2 (GABP subunit beta-2) (GABPB-2),Bos taurus (Bovine),88.4,69.0,1.2e-25,120.2,sp|Q0V8G2|GABP2_BOVIN GA-binding protein subunit beta-2 OS=Bos taurus OX=9913 GN=GABPB2 PE=2 SV=2,GO:0000976; GO:0005634; GO:0042802; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],nucleus [GO:0005634],identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_00211,0.3243341268199645,OG_00211,FUN_000930-T1,Peve_00009721,Pocillopora_meandrina_HIv1___RNAseq.g29463.t1,three_way,75.37,FUN_000930-T1,A0LJ16,,,,,43.9,269.0,7.6e-61,235.7,sp|A0LJ16|PHNXL_SYNFM Phosphonoacetaldehyde hydrolase-like protein OS=Syntrophobacter fumaroxidans (strain DSM 10017 / MPOB) OX=335543 GN=phnX2 PE=3 SV=1,,,,,,
OG_02607,0.3242166609487796,OG_02607,FUN_010736-T1,Peve_00038978,Pocillopora_meandrina_HIv1___RNAseq.g20940.t1,three_way,50.23233333333334,FUN_010736-T1,Q95209,SORL_RABIT,,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),Oryctolagus cuniculus (Rabbit),28.3,762.0,9.3e-88,327.4,sp|Q95209|SORL_RABIT Sortilin-related receptor OS=Oryctolagus cuniculus OX=9986 GN=SORL1 PE=1 SV=1,GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0045053; GO:0046628; GO:0055038; GO:1904179; GO:1990845,adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658],,GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226,extracellular space; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_07076,0.324195220825553,OG_07076,FUN_032313-T1,Peve_00002570,Pocillopora_meandrina_HIv1___RNAseq.g24766.t1,three_way,78.20966666666666,FUN_032313-T1,Q99729,ROAA_HUMAN,,Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (APOBEC1-binding protein 1) (ABBP-1),Homo sapiens (Human),46.6,193.0,2.3999999999999998e-43,177.6,sp|Q99729|ROAA_HUMAN Heterogeneous nuclear ribonucleoprotein A/B OS=Homo sapiens OX=9606 GN=HNRNPAB PE=1 SV=2,GO:0000785; GO:0001837; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0010468; GO:0016556; GO:0030425; GO:0044877; GO:0045293; GO:0045893; GO:0071230; GO:0071598; GO:0090575; GO:0141166; GO:1904580; GO:1990837; GO:1990904; GO:2000623,"cellular response to amino acid stimulus [GO:0071230]; chromosomal 5-methylcytosine DNA demethylation pathway [GO:0141166]; epithelial to mesenchymal transition [GO:0001837]; mRNA modification [GO:0016556]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mRNA editing complex [GO:0045293]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575],mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0030154; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; organelle
OG_08877,0.323922494987928,OG_08877,FUN_038276-T1,Peve_00041699,Pocillopora_meandrina_HIv1___RNAseq.g28317.t1,three_way,92.74166666666666,FUN_038276-T1,Q8IV36,HID1_HUMAN,,Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog),Homo sapiens (Human),67.8,793.0,1.2e-311,1070.1,sp|Q8IV36|HID1_HUMAN Protein HID1 OS=Homo sapiens OX=9606 GN=HID1 PE=1 SV=1,GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0009749; GO:0016020; GO:0030070; GO:0042144; GO:0061792; GO:0070062; GO:0098548,"insulin processing [GO:0030070]; response to glucose [GO:0009749]; secretory granule maturation [GO:0061792]; vacuole fusion, non-autophagic [GO:0042144]",cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic side of Golgi membrane [GO:0098548]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020],,GO:0005794; GO:0005829; GO:0043226; GO:0051604,Golgi apparatus; cytosol; organelle; protein maturation
OG_01560,0.3238808072093613,OG_01560,FUN_006441-T1,Peve_00038428,Pocillopora_meandrina_HIv1___RNAseq.g20299.t1,three_way,62.89866666666667,,,,,,,,,,,,,,,,,
OG_04990,0.3238772922212763,OG_04990,FUN_023120-T1,Peve_00021101,Pocillopora_meandrina_HIv1___RNAseq.g1691.t1,three_way,66.651,,,,,,,,,,,,,,,,,
OG_02734,0.3238379044107183,OG_02734,FUN_011264-T1,Peve_00030536,Pocillopora_meandrina_HIv1___RNAseq.g22310.t1,three_way,79.29683333333332,FUN_011264-T1,P02401,,,,,70.6,68.0,7.3e-19,94.7,sp|P02401|RLA2_RAT Large ribosomal subunit protein P2 OS=Rattus norvegicus OX=10116 GN=Rplp2 PE=1 SV=2,,,,,,
OG_08419,0.3237345120192478,OG_08419,FUN_037077-T1,Peve_00004730,Pocillopora_meandrina_HIv1___RNAseq.g11154.t1,three_way,74.945,FUN_037077-T1,Q8WV41,SNX33_HUMAN,,Sorting nexin-33 (SH3 and PX domain-containing protein 3),Homo sapiens (Human),39.2,576.0,3.0000000000000003e-107,390.6,sp|Q8WV41|SNX33_HUMAN Sorting nexin-33 OS=Homo sapiens OX=9606 GN=SNX33 PE=1 SV=1,GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010,cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038],cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0000910; GO:0005829; GO:0005886; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,cytokinesis; cytosol; plasma membrane; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_00692,0.3235910692835402,OG_00692,FUN_002379-T1,Peve_00034020,Pocillopora_meandrina_HIv1___RNAseq.g20.t2,three_way,83.75166666666667,FUN_002379-T1,Q00537,CDK17_HUMAN,,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),Homo sapiens (Human),57.9,525.0,3.6e-160,566.2,sp|Q00537|CDK17_HUMAN Cyclin-dependent kinase 17 OS=Homo sapiens OX=9606 GN=CDK17 PE=1 SV=2,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310; GO:1901987,protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00685,0.3234719059470033,OG_00685,FUN_002352-T1,Peve_00022332,Pocillopora_meandrina_HIv1___RNAseq.g33.t1,three_way,56.47666666666667,FUN_002352-T1,Q69ZL1,,,,,41.2,658.0,7.2e-121,437.6,"sp|Q69ZL1|FGD6_MOUSE FYVE, RhoGEF and PH domain-containing protein 6 OS=Mus musculus OX=10090 GN=Fgd6 PE=1 SV=2",,,,,,
OG_08945,0.3234693545444155,OG_08945,FUN_038418-T1,Peve_00000006,Pocillopora_meandrina_HIv1___RNAseq.g1186.t1,three_way,79.584,FUN_038418-T1,P17844,DDX5_HUMAN,,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),Homo sapiens (Human),68.1,470.0,2.1999999999999997e-192,673.7,sp|P17844|DDX5_HUMAN Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens OX=9606 GN=DDX5 PE=1 SV=1,GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003729; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0009299; GO:0016020; GO:0016607; GO:0016887; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0031053; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0046332; GO:0048306; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1990841; GO:1990904; GO:2001014,"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; primary miRNA processing [GO:0031053]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006351; GO:0006355; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05011,0.3233680903506988,OG_05011,FUN_023163-T1,Peve_00018795,Pocillopora_meandrina_HIv1___TS.g25340.t2c,three_way,74.67866666666667,FUN_023163-T1,Q8K4G5,ABLM1_MOUSE,,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1),Mus musculus (Mouse),48.6,253.0,8.9e-78,292.0,sp|Q8K4G5|ABLM1_MOUSE Actin-binding LIM protein 1 OS=Mus musculus OX=10090 GN=Ablim1 PE=1 SV=1,GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0060271,axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725],actin binding [GO:0003779]; metal ion binding [GO:0046872],GO:0005856; GO:0006351; GO:0006355; GO:0007010; GO:0008092; GO:0043226; GO:0044782,cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; organelle; cilium organization
OG_09400,0.3233366593887425,OG_09400,FUN_040714-T1,Peve_00002273,Pocillopora_meandrina_HIv1___RNAseq.g6550.t1,three_way,90.7025,FUN_040714-T1,A1L3F4,,,,,49.5,552.0,8.6e-96,352.4,sp|A1L3F4|MEX3B_XENLA RNA-binding protein MEX3B OS=Xenopus laevis OX=8355 GN=mex3b PE=2 SV=1,,,,,,
OG_03849,0.3232924379397046,OG_03849,FUN_015340-T1,Peve_00011273,Pocillopora_meandrina_HIv1___RNAseq.g21716.t1,three_way,56.37466666666666,FUN_015340-T1,Q6NTW1,,,,,36.2,343.0,6.6e-45,183.3,sp|Q6NTW1|BSC1B_XENLA BSD domain-containing protein 1-B OS=Xenopus laevis OX=8355 GN=bsdc1-b PE=2 SV=1,,,,,,
OG_09748,0.3232626581442978,OG_09748,FUN_042017-T1,Peve_00044151,Pocillopora_meandrina_HIv1___RNAseq.g15194.t1,three_way,79.5055,FUN_042017-T1,B5FXE5,FSP1_TAEGU,,Ferroptosis suppressor protein 1 (FSP1) (EC 1.6.5.-) (Apoptosis-inducing factor homologous mitochondrion-associated inducer of death) (AMID) (p53-responsive gene 3 protein),Taeniopygia guttata (Zebra finch) (Poephila guttata),39.4,373.0,2.0999999999999998e-70,267.7,sp|B5FXE5|FSP1_TAEGU Ferroptosis suppressor protein 1 OS=Taeniopygia guttata OX=59729 GN=AIFM2 PE=2 SV=1,GO:0004174; GO:0005634; GO:0005811; GO:0005886; GO:0008637; GO:0016655; GO:0031966; GO:0042373; GO:0043065; GO:0050660,apoptotic mitochondrial changes [GO:0008637]; positive regulation of apoptotic process [GO:0043065]; vitamin K metabolic process [GO:0042373],lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]",GO:0003824; GO:0005634; GO:0005811; GO:0005886; GO:0007005; GO:0016491; GO:0043226,catalytic activity; nucleus; lipid droplet; plasma membrane; mitochondrion organization; oxidoreductase activity; organelle
OG_04186,0.3231611968691699,OG_04186,FUN_016706-T1,Peve_00034244,Pocillopora_meandrina_HIv1___RNAseq.g282.t2,three_way,70.44399999999999,FUN_016706-T1,Q8VDM6,HNRL1_MOUSE,,Heterogeneous nuclear ribonucleoprotein U-like protein 1,Mus musculus (Mouse),50.9,399.0,8.3e-112,406.4,sp|Q8VDM6|HNRL1_MOUSE Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Mus musculus OX=10090 GN=Hnrnpul1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0005654; GO:0019899; GO:0045202; GO:1990904,,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],enzyme binding [GO:0019899]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0043226,RNA binding; nucleus; nucleoplasm; organelle
OG_06819,0.3231087691129742,OG_06819,FUN_031725-T1,Peve_00040632,Pocillopora_meandrina_HIv1___RNAseq.g5493.t1,three_way,86.41283333333334,FUN_031725-T1,Q6P2K6,P4R3A_MOUSE,,Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1),Mus musculus (Mouse),62.4,675.0,1.2e-239,830.9,sp|Q6P2K6|P4R3A_MOUSE Serine/threonine-protein phosphatase 4 regulatory subunit 3A OS=Mus musculus OX=10090 GN=Ppp4r3a PE=1 SV=1,GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006094; GO:0016607; GO:0019888; GO:0030289; GO:0045722,gluconeogenesis [GO:0006094]; positive regulation of gluconeogenesis [GO:0045722],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289],protein phosphatase regulator activity [GO:0019888],GO:0005634; GO:0005815; GO:0005829; GO:0005975; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; carbohydrate metabolic process; organelle; molecular function regulator activity
OG_00231,0.323078322975921,OG_00231,FUN_000977-T1,Peve_00007809,Pocillopora_meandrina_HIv1___RNAseq.g29137.t1,three_way,71.25866666666667,FUN_000977-T1,P70451,,,,,38.0,843.0,1.8999999999999998e-153,544.7,sp|P70451|FER_MOUSE Tyrosine-protein kinase Fer OS=Mus musculus OX=10090 GN=Fer PE=1 SV=2,,,,,,
OG_02929,0.3230203116877008,OG_02929,FUN_012028-T1,Peve_00030379,Pocillopora_meandrina_HIv1___RNAseq.g24047.t2,three_way,77.09433333333334,FUN_012028-T1,Q14192,FHL2_HUMAN,,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),Homo sapiens (Human),42.1,273.0,1.7000000000000002e-74,282.0,sp|Q14192|FHL2_HUMAN Four and a half LIM domains protein 2 OS=Homo sapiens OX=9606 GN=FHL2 PE=1 SV=3,GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885,atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018],bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06980,0.3230186661209634,OG_06980,FUN_032117-T1,Peve_00030232,Pocillopora_meandrina_HIv1___TS.g24094.t1,three_way,95.08266666666668,FUN_032117-T1,Q80U96,XPO1_RAT,,Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog),Rattus norvegicus (Rat),78.0,1074.0,0.0,1682.5,sp|Q80U96|XPO1_RAT Exportin-1 OS=Rattus norvegicus OX=10116 GN=Xpo1 PE=1 SV=1,GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0005829; GO:0006406; GO:0006611; GO:0006913; GO:0009410; GO:0010824; GO:0015030; GO:0019904; GO:0031267; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0046825; GO:0071401; GO:0140297; GO:1902075; GO:1990904,cellular response to salt [GO:1902075]; cellular response to triglyceride [GO:0071401]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to xenobiotic stimulus [GO:0009410]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254],annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],DNA-binding transcription factor binding [GO:0140297]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006886; GO:0006913; GO:0042254; GO:0043226; GO:0140104,RNA binding; nucleus; nucleolus; cytosol; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; ribosome biogenesis; organelle; molecular carrier activity
OG_09438,0.3227228882427099,OG_09438,FUN_041410-T1,Peve_00017540,Pocillopora_meandrina_HIv1___RNAseq.g15731.t1,three_way,64.53566666666667,FUN_041410-T1,Q95241,A4_SAISC,,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],Saimiri sciureus (Common squirrel monkey),24.4,737.0,3.4e-45,184.5,sp|Q95241|A4_SAISC Amyloid-beta precursor protein OS=Saimiri sciureus OX=9521 GN=APP PE=2 SV=1,GO:0003677; GO:0004867; GO:0005102; GO:0005576; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005905; GO:0006417; GO:0006878; GO:0006897; GO:0006915; GO:0007155; GO:0007219; GO:0007409; GO:0007417; GO:0007617; GO:0007626; GO:0008088; GO:0008201; GO:0008344; GO:0008542; GO:0009986; GO:0016020; GO:0016199; GO:0016322; GO:0016358; GO:0030198; GO:0030424; GO:0030426; GO:0030546; GO:0031175; GO:0035235; GO:0040014; GO:0043204; GO:0045121; GO:0045931; GO:0046914; GO:0048669; GO:0050803; GO:0055037,adult locomotory behavior [GO:0008344]; apoptotic process [GO:0006915]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; collateral sprouting in absence of injury [GO:0048669]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; intracellular copper ion homeostasis [GO:0006878]; ionotropic glutamate receptor signaling pathway [GO:0035235]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; neuron projection development [GO:0031175]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of multicellular organism growth [GO:0040014]; regulation of synapse structure or activity [GO:0050803]; regulation of translation [GO:0006417]; visual learning [GO:0008542],axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],DNA binding [GO:0003677]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914],GO:0003677; GO:0005576; GO:0005634; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0007018; GO:0007155; GO:0012501; GO:0016192; GO:0022414; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0098772,DNA binding; extracellular region; nucleus; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; microtubule-based movement; cell adhesion; programmed cell death; vesicle-mediated transport; reproductive process; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular function regulator activity
OG_08010,0.3225865302120264,OG_08010,FUN_035663-T1,Peve_00038557,Pocillopora_meandrina_HIv1___RNAseq.g28119.t3,three_way,87.50766666666667,FUN_035663-T1,O75081,MTG16_HUMAN,,Protein CBFA2T3 (MTG8-related protein 2) (Myeloid translocation gene on chromosome 16 protein) (hMTG16) (Zinc finger MYND domain-containing protein 4),Homo sapiens (Human),42.8,549.0,6.600000000000001e-80,299.7,sp|O75081|MTG16_HUMAN Protein CBFA2T3 OS=Homo sapiens OX=9606 GN=CBFA2T3 PE=1 SV=2,GO:0000139; GO:0001666; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0008270; GO:0008285; GO:0030851; GO:0032436; GO:0045820; GO:0045892; GO:1903715,DNA-templated transcription [GO:0006351]; granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glycolytic process [GO:0045820]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666],Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; nucleolus; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_07950,0.3223559634009247,OG_07950,FUN_035473-T1,Peve_00033973,Pocillopora_meandrina_HIv1___RNAseq.g26982.t1,three_way,62.86833333333333,FUN_035473-T1,A4ZNR5,NKD2L_DANRE,,Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B),Danio rerio (Zebrafish) (Brachydanio rerio),30.5,236.0,1.9e-14,82.0,sp|A4ZNR5|NKD2L_DANRE Protein naked cuticle homolog 2-like OS=Danio rerio OX=7955 GN=nkd2l PE=2 SV=1,GO:0005509; GO:0005737; GO:0005886; GO:0016055; GO:0030178; GO:0090090,negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886,plasma membrane
OG_09840,0.3223076364595934,OG_09840,FUN_042821-T1,Peve_00019575,Pocillopora_meandrina_HIv1___RNAseq.g7439.t2,three_way,61.8725,FUN_042821-T1,A2RV61,,,,,30.5,1466.0,5.5e-152,540.4,sp|A2RV61|GAPD1_XENLA GTPase-activating protein and VPS9 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=gapvd1 PE=2 SV=1,,,,,,
OG_01444,0.3222638110475516,OG_01444,FUN_005890-T1,Peve_00015769,Pocillopora_meandrina_HIv1___RNAseq.g19679.t1,three_way,69.12316666666668,FUN_005890-T1,O94868,,,,,36.6,673.0,7.4e-94,346.7,sp|O94868|FCSD2_HUMAN F-BAR and double SH3 domains protein 2 OS=Homo sapiens OX=9606 GN=FCHSD2 PE=1 SV=3,,,,,,
OG_04440,0.3222148521195994,OG_04440,FUN_018842-T1,Peve_00035790,Pocillopora_meandrina_HIv1___RNAseq.g9855.t1,three_way,61.89533333333333,FUN_018842-T1,Q5U4Q0,,,,,31.7,221.0,1.2e-12,76.6,sp|Q5U4Q0|WAC_XENTR WW domain-containing adapter protein with coiled-coil OS=Xenopus tropicalis OX=8364 GN=wac PE=2 SV=1,,,,,,
OG_09509,0.3221760075226839,OG_09509,FUN_041557-T1,Peve_00033125,Pocillopora_meandrina_HIv1___RNAseq.g16079.t1,three_way,82.36866666666667,FUN_041557-T1,F1LP64,TRIPC_RAT,,E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),Rattus norvegicus (Rat),52.2,1669.0,0.0,1587.8,sp|F1LP64|TRIPC_RAT E3 ubiquitin-protein ligase TRIP12 OS=Rattus norvegicus OX=10116 GN=Trip12 PE=1 SV=1,GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0033696; GO:0043161; GO:0045995; GO:0046966; GO:0061630; GO:0140861,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],nuclear thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; DNA repair; chromatin organization; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09198,0.3221733461669948,OG_09198,FUN_039883-T1,Peve_00011734,Pocillopora_meandrina_HIv1___RNAseq.g7356.t1,three_way,74.50316666666667,FUN_039883-T1,Q6GQB9,EDEM3_XENLA,,"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)",Xenopus laevis (African clawed frog),59.0,761.0,5.3e-264,912.1,sp|Q6GQB9|EDEM3_XENLA ER degradation-enhancing alpha-mannosidase-like protein 3 OS=Xenopus laevis OX=8355 GN=edem3 PE=2 SV=2,GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006058; GO:0006486; GO:0016020; GO:0030968; GO:0044322; GO:0097466; GO:1904380,carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; mannoprotein catabolic process [GO:0006058]; protein glycosylation [GO:0006486]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005975; GO:0006486; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; protein glycosylation; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_06763,0.3221657694514874,OG_06763,FUN_031595-T1,Peve_00012520,Pocillopora_meandrina_HIv1___RNAseq.g5058.t1,three_way,67.68833333333333,FUN_031595-T1,A2CG63,ARI4B_MOUSE,,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180),Mus musculus (Mouse),27.0,562.0,3e-13,79.0,sp|A2CG63|ARI4B_MOUSE AT-rich interactive domain-containing protein 4B OS=Mus musculus OX=10090 GN=Arid4b PE=1 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006366; GO:0007283; GO:0030336; GO:0030512; GO:0045944; GO:0070822; GO:0071514; GO:0097368; GO:1902455; GO:1902459,chromatin organization [GO:0006325]; establishment of Sertoli cell barrier [GO:0097368]; genomic imprinting [GO:0071514]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleus; mitochondrion; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development
OG_09749,0.3219873558455486,OG_09749,FUN_042018-T1,Peve_00044152,Pocillopora_meandrina_HIv1___RNAseq.g15193.t1,three_way,65.04350000000001,FUN_042018-T1,Q7Z589,EMSY_HUMAN,,BRCA2-interacting transcriptional repressor EMSY,Homo sapiens (Human),63.2,106.0,5.899999999999999e-31,138.3,sp|Q7Z589|EMSY_HUMAN BRCA2-interacting transcriptional repressor EMSY OS=Homo sapiens OX=9606 GN=EMSY PE=1 SV=2,GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0042802,chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of DNA-templated transcription [GO:0006355],nucleoplasm [GO:0005654],identical protein binding [GO:0042802],GO:0005654; GO:0006281; GO:0006325; GO:0006355,nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription
OG_01390,0.3218899385708427,OG_01390,FUN_005365-T1,Peve_00016036,Pocillopora_meandrina_HIv1___RNAseq.g8222.t1,three_way,83.86883333333333,FUN_005365-T1,O01727,,,,,80.4,189.0,2.900000000000001e-86,319.7,sp|O01727|RS6_BRAFL Small ribosomal subunit protein eS6 OS=Branchiostoma floridae OX=7739 GN=RPS6 PE=3 SV=1,,,,,,
OG_02741,0.3217473922604726,OG_02741,FUN_011284-T1,Peve_00033625,Pocillopora_meandrina_HIv1___RNAseq.g22145.t2,three_way,53.47266666666667,FUN_011284-T1,Q5M775,CYTSB_HUMAN,,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),Homo sapiens (Human),46.2,106.0,1.9e-21,106.3,sp|Q5M775|CYTSB_HUMAN Cytospin-B OS=Homo sapiens OX=9606 GN=SPECC1 PE=1 SV=1,GO:0001650; GO:0001824; GO:0005654; GO:0005815; GO:0005829; GO:0008306; GO:0016020; GO:0030036; GO:0031941; GO:0043231; GO:0045177,actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824],apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0043226; GO:0048856; GO:0050877,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; organelle; anatomical structure development; nervous system process
OG_10121,0.3216758662166927,OG_10121,FUN_043499-T1,Peve_00024907,Pocillopora_meandrina_HIv1___RNAseq.g7964.t1,three_way,56.86333333333334,FUN_043499-T1,P82279,CRUM1_HUMAN,,Protein crumbs homolog 1,Homo sapiens (Human),23.8,741.0,3.6e-48,196.4,sp|P82279|CRUM1_HUMAN Protein crumbs homolog 1 OS=Homo sapiens OX=9606 GN=CRB1 PE=1 SV=2,GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0008104; GO:0010001; GO:0010467; GO:0010842; GO:0016324; GO:0032991; GO:0035003; GO:0035845; GO:0042462; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0071482; GO:0097386,blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; protein localization [GO:0008104]; retina layer formation [GO:0010842],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003],calcium ion binding [GO:0005509],GO:0005576; GO:0005886; GO:0007155; GO:0007163; GO:0023052; GO:0030154; GO:0048856; GO:0061024,extracellular region; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; signaling; cell differentiation; anatomical structure development; membrane organization
OG_01156,0.3214660000028382,OG_01156,FUN_004767-T1,Peve_00007781,Pocillopora_meandrina_HIv1___RNAseq.g6697.t1,three_way,76.52799999999999,FUN_004767-T1,O57457,,,,,44.1,474.0,3.5e-96,354.4,sp|O57457|E41LA_DANRE Band 4.1-like protein 4 OS=Danio rerio OX=7955 GN=epb41l4a PE=2 SV=1,,,,,,
OG_00042,0.3214519453153536,OG_00042,FUN_000265-T1,Peve_00027789,Pocillopora_meandrina_HIv1___RNAseq.g28979.t1,three_way,91.153,FUN_000265-T1,P84023,SMAD3_CHICK,,Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (SMAD family member 3) (SMAD 3) (Smad3),Gallus gallus (Chicken),74.9,430.0,5.4e-189,661.8,sp|P84023|SMAD3_CHICK Mothers against decapentaplegic homolog 3 OS=Gallus gallus OX=9031 GN=SMAD3 PE=2 SV=1,GO:0000978; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0009653; GO:0030154; GO:0032924; GO:0045944; GO:0046872; GO:0060395; GO:0070411; GO:0071141; GO:0071144,activin receptor signaling pathway [GO:0032924]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_07128,0.3214425055754186,OG_07128,FUN_032428-T1,Peve_00007849,Pocillopora_meandrina_HIv1___RNAseq.g24119.t1,three_way,84.269,FUN_032428-T1,P14148,RL7_MOUSE,,Large ribosomal subunit protein uL30 (60S ribosomal protein L7),Mus musculus (Mouse),78.3,180.0,4.8e-79,295.8,sp|P14148|RL7_MOUSE Large ribosomal subunit protein uL30 OS=Mus musculus OX=10090 GN=Rpl7 PE=1 SV=2,GO:0000463; GO:0002181; GO:0003677; GO:0003729; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0022625; GO:0042802; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242; GO:1990904,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202],DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003677; GO:0003723; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; DNA binding; RNA binding; structural molecule activity; cytosol; ribosome; organelle
OG_03925,0.3212548322094335,OG_03925,FUN_016037-T1,Peve_00011810,Pocillopora_meandrina_HIv1___RNAseq.g21651.t1,three_way,74.29166666666667,FUN_016037-T1,F6ZDS4,TPR_MOUSE,,Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein),Mus musculus (Mouse),40.7,1012.0,4.0000000000000014e-74,282.7,sp|F6ZDS4|TPR_MOUSE Nucleoprotein TPR OS=Mus musculus OX=10090 GN=Tpr PE=1 SV=1,GO:0000122; GO:0000775; GO:0003682; GO:0003729; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006913; GO:0007094; GO:0010965; GO:0015031; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673,cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein transport [GO:0015031]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]",chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056],GO:0003723; GO:0005198; GO:0005635; GO:0006355; GO:0006913; GO:0043226,RNA binding; structural molecule activity; nuclear envelope; regulation of DNA-templated transcription; nucleocytoplasmic transport; organelle
OG_03925,0.3212548322094335,OG_03925,FUN_016037-T1,Peve_00011810,Pocillopora_meandrina_HIv1___RNAseq.g21651.t1,three_way,74.29166666666667,FUN_016037-T1,F6ZDS4,TPR_MOUSE,,Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein),Mus musculus (Mouse),34.5,145.0,1.9e-07,61.2,sp|F6ZDS4|TPR_MOUSE Nucleoprotein TPR OS=Mus musculus OX=10090 GN=Tpr PE=1 SV=1,GO:0000122; GO:0000775; GO:0003682; GO:0003729; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006913; GO:0007094; GO:0010965; GO:0015031; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673,cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein transport [GO:0015031]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]",chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056],GO:0003723; GO:0005198; GO:0005635; GO:0006355; GO:0006913; GO:0043226,RNA binding; structural molecule activity; nuclear envelope; regulation of DNA-templated transcription; nucleocytoplasmic transport; organelle
OG_05471,0.3211593019836144,OG_05471,FUN_024454-T1,Peve_00010316,Pocillopora_meandrina_HIv1___RNAseq.g18577.t1,three_way,67.4025,FUN_024454-T1,Q5DTZ6,,,,,45.4,273.0,1.5e-58,228.4,sp|Q5DTZ6|RN150_MOUSE RING finger protein 150 OS=Mus musculus OX=10090 GN=Rnf150 PE=2 SV=2,,,,,,
OG_02958,0.3211370502525042,OG_02958,FUN_012103-T1,Peve_00007420,Pocillopora_meandrina_HIv1___TS.g16819.t1,three_way,55.96083333333333,FUN_012103-T1,B1WAS2,HUNK_XENTR,,Hormonally up-regulated neu tumor-associated kinase homolog (EC 2.7.11.1) (Serine/threonine-protein kinase MAK-V),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),41.5,135.0,5.5e-23,110.9,sp|B1WAS2|HUNK_XENTR Hormonally up-regulated neu tumor-associated kinase homolog OS=Xenopus tropicalis OX=8364 GN=hunk PE=2 SV=1,GO:0004674; GO:0005524; GO:0106310,,,ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_03251,0.3211006103605944,OG_03251,FUN_012973-T1,Peve_00026801,Pocillopora_meandrina_HIv1___RNAseq.g12974.t1,three_way,78.81466666666667,FUN_012973-T1,B1AJZ9,FHAD1_HUMAN,,Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1),Homo sapiens (Human),25.4,1528.0,7.0000000000000006e-34,148.3,sp|B1AJZ9|FHAD1_HUMAN Forkhead-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHAD1 PE=1 SV=2,GO:0036126,,sperm flagellum [GO:0036126],,GO:0005929; GO:0043226,cilium; organelle
OG_05971,0.3210548239588589,OG_05971,FUN_026385-T1,Peve_00010504,Pocillopora_meandrina_HIv1___RNAseq.g2955.t1,three_way,77.00399999999999,FUN_026385-T1,Q27960,NPT2B_BOVIN,,Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2),Bos taurus (Bovine),56.3,545.0,5.3e-150,532.7,sp|Q27960|NPT2B_BOVIN Sodium-dependent phosphate transport protein 2B OS=Bos taurus OX=9913 GN=SLC34A2 PE=1 SV=1,GO:0005436; GO:0005903; GO:0006817; GO:0016020; GO:0016324; GO:0030643; GO:0031402; GO:0031982; GO:0042301; GO:0044341,intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium-dependent phosphate transport [GO:0044341],apical plasma membrane [GO:0016324]; brush border [GO:0005903]; membrane [GO:0016020]; vesicle [GO:0031982],phosphate ion binding [GO:0042301]; sodium ion binding [GO:0031402]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0043226,transporter activity; organelle
OG_06478,0.3210334252375519,OG_06478,FUN_029246-T1,Peve_00013747,Pocillopora_meandrina_HIv1___RNAseq.g25404.t1,three_way,78.42166666666667,FUN_029246-T1,Q9Y2I9,TBC30_HUMAN,,TBC1 domain family member 30,Homo sapiens (Human),49.0,569.0,8.899999999999999e-139,496.1,sp|Q9Y2I9|TBC30_HUMAN TBC1 domain family member 30 OS=Homo sapiens OX=9606 GN=TBC1D30 PE=1 SV=2,GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0016604; GO:0031267; GO:0036064; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; nuclear body [GO:0016604]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; plasma membrane; cilium; organelle; molecular function regulator activity
OG_06612,0.3210264081694102,OG_06612,FUN_029763-T1,Peve_00019504,Pocillopora_meandrina_HIv1___RNAseq.g17323.t1,three_way,61.1925,FUN_029763-T1,Q6PCS4,,,,,36.2,716.0,2.9e-92,342.0,sp|Q6PCS4|RHG29_DANRE Rho GTPase-activating protein 29 OS=Danio rerio OX=7955 GN=arhgap29 PE=2 SV=1,,,,,,
OG_01322,0.3209902379916188,OG_01322,FUN_005189-T1,Peve_00017153,Pocillopora_meandrina_HIv1___TS.g19845.t2b,three_way,59.13133333333333,FUN_005189-T1,Q6PD21,SHB_MOUSE,,SH2 domain-containing adapter protein B,Mus musculus (Mouse),57.5,106.0,1.9e-31,138.7,sp|Q6PD21|SHB_MOUSE SH2 domain-containing adapter protein B OS=Mus musculus OX=10090 GN=Shb PE=1 SV=2,GO:0001525; GO:0001568; GO:0001784; GO:0005654; GO:0005829; GO:0005886; GO:0006915; GO:0030097; GO:0030159; GO:0036464; GO:0042100; GO:0045624; GO:0045931; GO:0048514; GO:0050852; GO:0071425; GO:1900194,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; T cell receptor signaling pathway [GO:0050852],cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],phosphotyrosine residue binding [GO:0001784]; signaling receptor complex adaptor activity [GO:0030159],GO:0002376; GO:0005654; GO:0005829; GO:0005886; GO:0012501; GO:0043226; GO:0048856; GO:0060090,immune system process; nucleoplasm; cytosol; plasma membrane; programmed cell death; organelle; anatomical structure development; molecular adaptor activity
OG_10082,0.3209654327464277,OG_10082,FUN_043399-T1,Peve_00024256,Pocillopora_meandrina_HIv1___RNAseq.g9063.t2,three_way,80.929,FUN_043399-T1,Q9NVG8,,,,,60.4,356.0,4.2e-118,426.0,sp|Q9NVG8|TBC13_HUMAN TBC1 domain family member 13 OS=Homo sapiens OX=9606 GN=TBC1D13 PE=1 SV=3,,,,,,
OG_08289,0.3209017581853382,OG_08289,FUN_036224-T1,Peve_00025944,Pocillopora_meandrina_HIv1___RNAseq.g27547.t1,three_way,76.61933333333333,FUN_036224-T1,P41123,,,,,62.6,211.0,9e-68,258.1,sp|P41123|RL13_RAT Large ribosomal subunit protein eL13 OS=Rattus norvegicus OX=10116 GN=Rpl13 PE=1 SV=2,,,,,,
OG_04491,0.3207146755160997,OG_04491,FUN_021922-T1,Peve_00016338,Pocillopora_meandrina_HIv1___RNAseq.g2917.t1,three_way,68.88416666666666,,,,,,,,,,,,,,,,,
OG_01951,0.3206864513503626,OG_01951,FUN_008016-T1,Peve_00031315,Pocillopora_meandrina_HIv1___RNAseq.g30338.t1,three_way,69.895,FUN_008016-T1,Q6GYQ0,RGPA1_HUMAN,,Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240),Homo sapiens (Human),36.5,2122.0,0.0,1175.6,sp|Q6GYQ0|RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1 PE=1 SV=1,GO:0005096; GO:0005634; GO:0005737; GO:0046982; GO:0051056; GO:0090630,activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; nucleus [GO:0005634],GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982],GO:0005634; GO:0043226; GO:0098772,nucleus; organelle; molecular function regulator activity
OG_01076,0.3206723572610929,OG_01076,FUN_004562-T1,Peve_00016040,Pocillopora_meandrina_HIv1___RNAseq.g8226.t1,three_way,71.31733333333334,,,,,,,,,,,,,,,,,
OG_08920,0.3205731210641542,OG_08920,FUN_038376-T1,Peve_00000077,Pocillopora_meandrina_HIv1___RNAseq.g1090.t1,three_way,74.45483333333334,FUN_038376-T1,F1LQX4,RHG44_RAT,,Rho GTPase-activating protein 44 (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2),Rattus norvegicus (Rat),43.8,486.0,3.8e-108,393.7,sp|F1LQX4|RHG44_RAT Rho GTPase-activating protein 44 OS=Rattus norvegicus OX=10116 GN=Arhgap44 PE=1 SV=2,GO:0005096; GO:0005543; GO:0005886; GO:0006887; GO:0007165; GO:0014069; GO:0030425; GO:0031256; GO:0031267; GO:0032956; GO:0035021; GO:0043087; GO:0043197; GO:0048786; GO:0050804; GO:0051490; GO:0055037; GO:0061001; GO:0098793; GO:0098794; GO:0098978; GO:0099010; GO:0099152,"exocytosis [GO:0006887]; modification of postsynaptic structure [GO:0099010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]",dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037],GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0098772,endosome; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; molecular function regulator activity
OG_05728,0.3203847348256107,OG_05728,FUN_025651-T1,Peve_00002530,Pocillopora_meandrina_HIv1___RNAseq.g23086.t1,three_way,78.245,FUN_025651-T1,Q9Z1L0,PK3CB_RAT,,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) (Serine/threonine protein kinase PIK3CB) (EC 2.7.11.1)",Rattus norvegicus (Rat),46.3,1059.0,4.4e-264,912.5,"sp|Q9Z1L0|PK3CB_RAT Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform OS=Rattus norvegicus OX=10116 GN=Pik3cb PE=2 SV=1",GO:0001935; GO:0001952; GO:0002931; GO:0003376; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006874; GO:0006897; GO:0006914; GO:0007156; GO:0010595; GO:0010628; GO:0016303; GO:0016477; GO:0030168; GO:0031526; GO:0033031; GO:0035005; GO:0035022; GO:0036092; GO:0040016; GO:0042267; GO:0043409; GO:0043491; GO:0043560; GO:0045429; GO:0046854; GO:0046934; GO:0048015; GO:0051898; GO:0060055; GO:0106310; GO:1900747; GO:1903298; GO:1903671,angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intracellular calcium ion homeostasis [GO:0006874]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet activation [GO:0030168]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; response to ischemia [GO:0002931]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376],"brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]","1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; protein serine kinase activity [GO:0106310]",GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006629; GO:0006914; GO:0007155; GO:0016192; GO:0016740; GO:0043226; GO:0048870; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; lipid metabolic process; autophagy; cell adhesion; vesicle-mediated transport; transferase activity; organelle; cell motility; defense response to other organism; catalytic activity, acting on a protein"
OG_07066,0.3203403018372949,OG_07066,FUN_032299-T1,Peve_00020128,Pocillopora_meandrina_HIv1___RNAseq.g24900.t1,three_way,50.632333333333335,FUN_032299-T1,Q3ZT31,SNX25_MOUSE,,Sorting nexin-25,Mus musculus (Mouse),27.2,125.0,1.3e-07,60.8,sp|Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus musculus OX=10090 GN=Snx25 PE=1 SV=3,GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091,negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801],endosome [GO:0005768]; endosome membrane [GO:0010008],phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713],GO:0005768; GO:0008289; GO:0031410; GO:0043226,endosome; lipid binding; cytoplasmic vesicle; organelle
OG_07645,0.3202961706908604,OG_07645,FUN_034460-T1,Peve_00025955,Pocillopora_meandrina_HIv1___RNAseq.g25842.t2,three_way,66.28216666666667,FUN_034460-T1,Q8QGX4,PRKDC_CHICK,,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1),Gallus gallus (Chicken),40.0,1500.0,3.2e-308,1059.7,sp|Q8QGX4|PRKDC_CHICK DNA-dependent protein kinase catalytic subunit OS=Gallus gallus OX=9031 GN=PRKDC PE=2 SV=1,GO:0000723; GO:0000724; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0006303; GO:0008630; GO:0031571; GO:0033152; GO:0035979; GO:0042254; GO:0070419; GO:0106310,double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; ribosome biogenesis [GO:0042254]; telomere maintenance [GO:0000723],nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016740; GO:0032200; GO:0042254; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; transferase activity; telomere organization; ribosome biogenesis; organelle; catalytic activity, acting on a protein"
OG_06738,0.3199510742233945,OG_06738,FUN_031525-T1,Peve_00022761,Pocillopora_meandrina_HIv1___TS.g23851.t1,three_way,69.21566666666666,FUN_031525-T1,O75445,USH2A_HUMAN,,Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein),Homo sapiens (Human),31.2,5403.0,0.0,2352.8,sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3,GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696,establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696],collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022],GO:0005576; GO:0005815; GO:0008092; GO:0030154; GO:0030312; GO:0031012; GO:0050877,extracellular region; microtubule organizing center; cytoskeletal protein binding; cell differentiation; external encapsulating structure; extracellular matrix; nervous system process
OG_01159,0.3198440392907637,OG_01159,FUN_004777-T1,Peve_00037749,Pocillopora_meandrina_HIv1___RNAseq.g6694.t2,three_way,76.02633333333334,FUN_004777-T1,P46859,,,,,34.6,179.0,1.2e-21,104.8,sp|P46859|GNTK_ECOLI Thermoresistant gluconokinase OS=Escherichia coli (strain K12) OX=83333 GN=gntK PE=1 SV=4,,,,,,
OG_10090,0.3196210509611963,OG_10090,FUN_043420-T1,Peve_00005576,Pocillopora_meandrina_HIv1___TS.g1600.t1,three_way,92.59866666666667,FUN_043420-T1,Q13813,,,,,59.0,2468.0,0.0,2752.6,"sp|Q13813|SPTN1_HUMAN Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTAN1 PE=1 SV=3",,,,,,
OG_03946,0.319569577994305,OG_03946,FUN_016083-T1,Peve_00021930,Pocillopora_meandrina_HIv1___RNAseq.g21608.t1,three_way,63.108,FUN_016083-T1,Q503L9,NXN_DANRE,,Nucleoredoxin (EC 1.8.1.8),Danio rerio (Zebrafish) (Brachydanio rerio),44.6,413.0,5.8e-95,349.4,sp|Q503L9|NXN_DANRE Nucleoredoxin OS=Danio rerio OX=7955 GN=nxn PE=2 SV=1,GO:0004791; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0072359,cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleus [GO:0005634],thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005829; GO:0016209; GO:0016491; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; antioxidant activity; oxidoreductase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01087,0.318814983774158,OG_01087,FUN_004580-T1,Peve_00016266,Pocillopora_meandrina_HIv1___RNAseq.g6606.t1,three_way,55.715,FUN_004580-T1,Q6NXI6,RPRD2_MOUSE,,Regulation of nuclear pre-mRNA domain-containing protein 2,Mus musculus (Mouse),33.6,387.0,5.4e-46,188.3,sp|Q6NXI6|RPRD2_MOUSE Regulation of nuclear pre-mRNA domain-containing protein 2 OS=Mus musculus OX=10090 GN=Rprd2 PE=1 SV=1,GO:0097550; GO:0099122,,transcription preinitiation complex [GO:0097550],RNA polymerase II C-terminal domain binding [GO:0099122],,
OG_03076,0.3188014607082031,OG_03076,FUN_012348-T1,Peve_00029070,Pocillopora_meandrina_HIv1___RNAseq.g24069.t1,three_way,66.19800000000001,FUN_012348-T1,P0C8E4,M3K7_RAT,,Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25),Rattus norvegicus (Rat),36.2,796.0,1.6e-112,408.7,sp|P0C8E4|M3K7_RAT Mitogen-activated protein kinase kinase kinase 7 OS=Rattus norvegicus OX=10116 GN=Map3k7 PE=1 SV=1,GO:0000165; GO:0000287; GO:0001223; GO:0001525; GO:0001649; GO:0001666; GO:0001841; GO:0002726; GO:0004674; GO:0004707; GO:0004708; GO:0004709; GO:0005114; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0006955; GO:0007179; GO:0007249; GO:0007252; GO:0007254; GO:0008349; GO:0010508; GO:0010629; GO:0014069; GO:0016239; GO:0030971; GO:0031625; GO:0032743; GO:0034142; GO:0035173; GO:0038066; GO:0038172; GO:0038173; GO:0042742; GO:0042802; GO:0043123; GO:0043276; GO:0043410; GO:0043507; GO:0045787; GO:0045793; GO:0046330; GO:0051403; GO:0060348; GO:0060546; GO:0070498; GO:0071356; GO:0071456; GO:0071560; GO:0097110; GO:0097190; GO:0106310; GO:0120283; GO:0140297; GO:0140672; GO:1901224; GO:1902443; GO:1904385; GO:1904707; GO:1904754; GO:1990450; GO:1990776; GO:2000377; GO:2000378; GO:2001234,angiogenesis [GO:0001525]; anoikis [GO:0043276]; apoptotic signaling pathway [GO:0097190]; bone development [GO:0060348]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; defense response to bacterium [GO:0042742]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression [GO:0010629]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; osteoblast differentiation [GO:0001649]; p38MAPK cascade [GO:0038066]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell size [GO:0045793]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to angiotensin [GO:1990776]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; toll-like receptor 4 signaling pathway [GO:0034142]; transforming growth factor beta receptor signaling pathway [GO:0007179],ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; histone kinase activity [GO:0035173]; identical protein binding [GO:0042802]; linear polyubiquitin binding [GO:1990450]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625],GO:0002376; GO:0003824; GO:0005829; GO:0005886; GO:0006954; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; catalytic activity; cytosol; plasma membrane; inflammatory response; programmed cell death; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01712,0.3187953012525303,OG_01712,FUN_006986-T1,Peve_00009622,Pocillopora_meandrina_HIv1___RNAseq.g20224.t1,three_way,77.79516666666666,FUN_006986-T1,O60841,IF2P_HUMAN,,Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2),Homo sapiens (Human),72.7,593.0,6e-261,902.5,sp|O60841|IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=4,GO:0000049; GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0042255; GO:0045202; GO:0046872,regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0016787,RNA binding; catalytic activity; GTPase activity; cytosol; hydrolase activity
OG_05146,0.3186574010523267,OG_05146,FUN_023423-T1,Peve_00019215,Pocillopora_meandrina_HIv1___RNAseq.g583.t1,three_way,90.14433333333334,FUN_023423-T1,Q5R416,CTNA2_PONAB,,Catenin alpha-2 (Alpha N-catenin),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),41.2,1200.0,2.9000000000000003e-214,747.3,sp|Q5R416|CTNA2_PONAB Catenin alpha-2 OS=Pongo abelii OX=9601 GN=CTNNA2 PE=2 SV=3,GO:0005198; GO:0005634; GO:0005737; GO:0005912; GO:0007409; GO:0008013; GO:0010975; GO:0015629; GO:0016342; GO:0021942; GO:0030424; GO:0034316; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:2001222,axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; nucleus [GO:0005634],actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198],GO:0005198; GO:0005634; GO:0005856; GO:0007155; GO:0008092; GO:0043226; GO:0048870,structural molecule activity; nucleus; cytoskeleton; cell adhesion; cytoskeletal protein binding; organelle; cell motility
OG_08542,0.3185362240640995,OG_08542,FUN_037495-T1,Peve_00028567,Pocillopora_meandrina_HIv1___TS.g22722.t1,three_way,69.01516666666667,FUN_037495-T1,Q60431,CASP3_MESAU,,Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12],Mesocricetus auratus (Golden hamster),44.7,255.0,1.6e-54,214.9,sp|Q60431|CASP3_MESAU Caspase-3 OS=Mesocricetus auratus OX=10036 GN=CASP3 PE=2 SV=1,GO:0004175; GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0030182; GO:0030216; GO:0030218; GO:0031264; GO:0031647; GO:0043525; GO:1902004,apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of neuron apoptotic process [GO:0043525]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytoplasm [GO:0005737]; death-inducing signaling complex [GO:0031264],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175],GO:0003824; GO:0012501; GO:0016787; GO:0030154; GO:0140096,"catalytic activity; programmed cell death; hydrolase activity; cell differentiation; catalytic activity, acting on a protein"
OG_08647,0.3183458033504777,OG_08647,FUN_037838-T1,Peve_00000575,Pocillopora_meandrina_HIv1___TS.g22869.t1,three_way,95.46833333333332,FUN_037838-T1,P62265,,,,,88.2,152.0,1.3e-68,260.4,sp|P62265|RS14_CRIGR Small ribosomal subunit protein uS11 OS=Cricetulus griseus OX=10029 GN=RPS14 PE=2 SV=3,,,,,,
OG_01105,0.3182114520897128,OG_01105,FUN_004624-T1,Peve_00039250,Pocillopora_meandrina_HIv1___RNAseq.g8088.t1,three_way,67.861,FUN_004624-T1,Q3UHC2,LRRK1_MOUSE,,Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1),Mus musculus (Mouse),29.8,1808.0,4.400000000000001e-211,737.6,sp|Q3UHC2|LRRK1_MOUSE Leucine-rich repeat serine/threonine-protein kinase 1 OS=Mus musculus OX=10090 GN=Lrrk1 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533,bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533],cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005739; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; plasma membrane; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03889,0.3181738506706324,OG_03889,FUN_015442-T1,Peve_00024428,Pocillopora_meandrina_HIv1___RNAseq.g22272.t2,three_way,80.65666666666667,FUN_015442-T1,Q7KZ85,SPT6H_HUMAN,,Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),Homo sapiens (Human),55.5,1411.0,0.0,1521.5,sp|Q7KZ85|SPT6H_HUMAN Transcription elongation factor SPT6 OS=Homo sapiens OX=9606 GN=SUPT6H PE=1 SV=2,GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0031491; GO:0034728; GO:0042393; GO:0045191; GO:0051028; GO:0051147; GO:0140673,blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nucleosome organization [GO:0034728]; regulation of isotype switching [GO:0045191]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673],nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023],DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005654; GO:0006325; GO:0016071; GO:0042393,DNA binding; RNA binding; nucleoplasm; chromatin organization; mRNA metabolic process; histone binding
OG_06809,0.3181472676622498,OG_06809,FUN_031708-T1,Peve_00002669,Pocillopora_meandrina_HIv1___RNAseq.g5756.t1,three_way,77.23333333333333,FUN_031708-T1,P26642,,,,,62.6,436.0,1.7000000000000001e-134,480.7,sp|P26642|EF1GA_XENLA Elongation factor 1-gamma-A OS=Xenopus laevis OX=8355 GN=eef1g-a PE=1 SV=1,,,,,,
OG_04849,0.3181346257569252,OG_04849,FUN_022861-T1,Peve_00025611,Pocillopora_meandrina_HIv1___RNAseq.g3605.t1,three_way,79.88833333333334,FUN_022861-T1,O55003,BNIP3_MOUSE,,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,Mus musculus (Mouse),33.5,188.0,1.5e-15,84.3,sp|O55003|BNIP3_MOUSE BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 OS=Mus musculus OX=10090 GN=Bnip3 PE=1 SV=1,GO:0000423; GO:0001666; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005789; GO:0006915; GO:0009617; GO:0010637; GO:0010659; GO:0010666; GO:0010917; GO:0014069; GO:0016239; GO:0021987; GO:0030425; GO:0031966; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043069; GO:0043243; GO:0043653; GO:0045837; GO:0046902; GO:0048102; GO:0048678; GO:0048709; GO:0050873; GO:0051020; GO:0051402; GO:0051561; GO:0051607; GO:0055093; GO:0061709; GO:0070301; GO:0071260; GO:0071279; GO:0071456; GO:0072593; GO:0090141; GO:0090200; GO:0090649; GO:0097193; GO:0097345; GO:0140506; GO:0140507; GO:0140580; GO:1902109; GO:1903599; GO:1990144,apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; mitophagy [GO:0000423]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of programmed cell death [GO:0043069]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane permeability [GO:0046902]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; reticulophagy [GO:0061709],cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; mitochondrion autophagosome adaptor activity [GO:0140580]; protein homodimerization activity [GO:0042803],GO:0005634; GO:0005635; GO:0005654; GO:0005739; GO:0006914; GO:0007005; GO:0012501; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0061024,nucleus; nuclear envelope; nucleoplasm; mitochondrion; autophagy; mitochondrion organization; programmed cell death; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; membrane organization
OG_05916,0.3178666379316056,OG_05916,FUN_026108-T1,Peve_00014996,Pocillopora_meandrina_HIv1___RNAseq.g10317.t1,three_way,87.78083333333333,FUN_026108-T1,Q9HD67,MYO10_HUMAN,,Unconventional myosin-X (Unconventional myosin-10),Homo sapiens (Human),45.4,2065.0,0.0,1582.8,sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3,GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002,cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165],cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]",GO:0003774; GO:0003824; GO:0005730; GO:0005829; GO:0005886; GO:0008092; GO:0008289; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleolus; cytosol; plasma membrane; cytoskeletal protein binding; lipid binding; isomerase activity; organelle; ATP-dependent activity
OG_05572,0.3175415201447629,OG_05572,FUN_024815-T1,Peve_00026076,Pocillopora_meandrina_HIv1___RNAseq.g18772.t1,three_way,69.34433333333334,FUN_024815-T1,Q96PE2,ARHGH_HUMAN,,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),Homo sapiens (Human),40.1,1066.0,9.2e-179,630.2,sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056,actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0007010; GO:0098772,cytosol; cytoskeleton organization; molecular function regulator activity
OG_09850,0.3175413191313495,OG_09850,FUN_042841-T1,Peve_00007267,Pocillopora_meandrina_HIv1___RNAseq.g7258.t1,three_way,84.73333333333333,FUN_042841-T1,Q2TBQ5,RL7A_BOVIN,,Large ribosomal subunit protein eL8 (60S ribosomal protein L7a),Bos taurus (Bovine),63.1,263.0,3.5e-85,316.2,sp|Q2TBQ5|RL7A_BOVIN Large ribosomal subunit protein eL8 OS=Bos taurus OX=9913 GN=RPL7A PE=2 SV=3,GO:0000470; GO:0003723; GO:0003735; GO:0005730; GO:0016020; GO:0022625; GO:0045202,maturation of LSU-rRNA [GO:0000470],cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; synapse [GO:0045202],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005730; GO:0043226,RNA binding; structural molecule activity; nucleolus; organelle
OG_09471,0.3174359026893476,OG_09471,FUN_041497-T1,Peve_00017073,Pocillopora_meandrina_HIv1___RNAseq.g15661.t1,three_way,80.51666666666667,FUN_041497-T1,P62046,,,,,32.5,711.0,2.7e-36,155.2,sp|P62046|LRCH1_MOUSE Leucine-rich repeat and calponin homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrch1 PE=1 SV=2,,,,,,
OG_00512,0.3172749964258388,OG_00512,FUN_001504-T1,Peve_00012115,Pocillopora_meandrina_HIv1___RNAseq.g1890.t1,three_way,97.17433333333334,FUN_001504-T1,A5PJW8,RPB2_BOVIN,,DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (RNA-directed RNA polymerase II subunit RPB2) (EC 2.7.7.48),Bos taurus (Bovine),87.3,1174.0,0.0,2134.4,sp|A5PJW8|RPB2_BOVIN DNA-directed RNA polymerase II subunit RPB2 OS=Bos taurus OX=9913 GN=POLR2B PE=1 SV=1,GO:0000781; GO:0003677; GO:0003682; GO:0003899; GO:0003968; GO:0005665; GO:0005739; GO:0006366; GO:0008270; GO:0016787; GO:0032549; GO:0071667,transcription by RNA polymerase II [GO:0006366],"chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; RNA polymerase II, core complex [GO:0005665]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; hydrolase activity [GO:0016787]; ribonucleoside binding [GO:0032549]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005739; GO:0006351; GO:0016740; GO:0016787; GO:0043226; GO:0140098,"DNA binding; catalytic activity; mitochondrion; DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_05498,0.3172000355433329,OG_05498,FUN_024557-T1,Peve_00039513,Pocillopora_meandrina_HIv1___RNAseq.g18656.t1,three_way,51.671,,,,,,,,,,,,,,,,,
OG_01150,0.316989080758197,OG_01150,FUN_004749-T1,Peve_00007765,Pocillopora_meandrina_HIv1___RNAseq.g8815.t3,three_way,45.58733333333333,FUN_004749-T1,P27447,,,,,37.6,93.0,4.9e-07,57.8,sp|P27447|YES_XIPHE Tyrosine-protein kinase Yes OS=Xiphophorus hellerii OX=8084 GN=yes PE=2 SV=3,,,,,,
OG_03558,0.3169460102762279,OG_03558,FUN_014704-T1,Peve_00021212,Pocillopora_meandrina_HIv1___RNAseq.g22535.t1,three_way,50.87083333333333,,,,,,,,,,,,,,,,,
OG_04416,0.3169274000238177,OG_04416,FUN_018523-T1,Peve_00038651,Pocillopora_meandrina_HIv1___RNAseq.g10183.t1,three_way,87.47866666666667,FUN_018523-T1,Q9NZN3,EHD3_HUMAN,,EH domain-containing protein 3 (PAST homolog 3),Homo sapiens (Human),63.8,536.0,4.8e-198,692.2,sp|Q9NZN3|EHD3_HUMAN EH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=EHD3 PE=1 SV=2,GO:0001881; GO:0003676; GO:0005509; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0005925; GO:0006897; GO:0010008; GO:0015031; GO:0020018; GO:0030139; GO:0032456; GO:0034498; GO:0048471; GO:0051260; GO:0055038; GO:0055117; GO:0060271; GO:0072659; GO:0086036; GO:0090160; GO:1903358; GO:1903779,cilium assembly [GO:0060271]; early endosome to Golgi transport [GO:0034498]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; Golgi to lysosome transport [GO:0090160]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of Golgi organization [GO:1903358],ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676],GO:0005634; GO:0005768; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0044782; GO:0065003; GO:0072659,nucleus; endosome; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; cilium organization; protein-containing complex assembly; protein localization to plasma membrane
OG_04893,0.3169254208394229,OG_04893,FUN_022937-T1,Peve_00026752,Pocillopora_meandrina_HIv1___RNAseq.g3737.t1,three_way,87.12,FUN_022937-T1,P67827,KC1A_BOVIN,,Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1),Bos taurus (Bovine),87.7,277.0,5.1000000000000005e-145,515.4,sp|P67827|KC1A_BOVIN Casein kinase I isoform alpha OS=Bos taurus OX=9913 GN=CSNK1A1 PE=1 SV=1,GO:0000139; GO:0000776; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007165; GO:0016055; GO:0016607; GO:0018105; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1900226,cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; kinetochore [GO:0000776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08541,0.3168726857443218,OG_08541,FUN_037492-T1,Peve_00028569,Pocillopora_meandrina_HIv1___RNAseq.g1308.t1,three_way,98.157,FUN_037492-T1,Q7L9L4,MOB1B_HUMAN,,MOB kinase activator 1B (Mob1 homolog 1A) (Mob1A) (Mob1B) (Mps one binder kinase activator-like 1A),Homo sapiens (Human),87.5,216.0,3.6e-112,405.6,sp|Q7L9L4|MOB1B_HUMAN MOB kinase activator 1B OS=Homo sapiens OX=9606 GN=MOB1B PE=1 SV=3,GO:0005634; GO:0005737; GO:0005829; GO:0019209; GO:0019900; GO:0030295; GO:0031952; GO:0035329; GO:0043539; GO:0046872; GO:0070062,hippo signaling [GO:0035329]; regulation of protein autophosphorylation [GO:0031952],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],kinase activator activity [GO:0019209]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005634; GO:0005829; GO:0043226; GO:0098772,nucleus; cytosol; organelle; molecular function regulator activity
OG_07880,0.3168388573884292,OG_07880,FUN_035243-T1,Peve_00042228,Pocillopora_meandrina_HIv1___RNAseq.g27896.t1,three_way,91.40466666666669,FUN_035243-T1,Q6Q137,SEPT7_BOVIN,,Septin-7 (CDC10 protein homolog),Bos taurus (Bovine),67.9,330.0,2.1999999999999997e-129,463.8,sp|Q6Q137|SEPT7_BOVIN Septin-7 OS=Bos taurus OX=9913 GN=SEPTIN7 PE=2 SV=2,GO:0000776; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005930; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0042802; GO:0060090; GO:0060271; GO:0061640; GO:0097227; GO:0097730; GO:1902857,cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090],GO:0000910; GO:0003824; GO:0003924; GO:0005634; GO:0005856; GO:0005929; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0060090,cytokinesis; catalytic activity; GTPase activity; nucleus; cytoskeleton; cilium; hydrolase activity; reproductive process; cell differentiation; organelle; cilium organization; molecular adaptor activity
OG_03145,0.3168133686129252,OG_03145,FUN_012531-T1,Peve_00013910,Pocillopora_meandrina_HIv1___RNAseq.g23956.t1c,three_way,73.822,FUN_012531-T1,Q32LP2,RADI_BOVIN,,Radixin,Bos taurus (Bovine),71.5,583.0,2.8e-132,473.8,sp|Q32LP2|RADI_BOVIN Radixin OS=Bos taurus OX=9913 GN=RDX PE=2 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005912; GO:0008360; GO:0030175; GO:0032154; GO:0045177; GO:0050839; GO:0051693; GO:0120044; GO:1902115; GO:1902966; GO:2000643,actin filament capping [GO:0051693]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; stereocilium base [GO:0120044],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839],GO:0005856; GO:0005886; GO:0008092; GO:0043226,cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_09754,0.3167905884199727,OG_09754,FUN_042025-T1,Peve_00030370,Pocillopora_meandrina_HIv1___RNAseq.g15170.t1,three_way,94.194,FUN_042025-T1,G3MZY8,RPB1_BOVIN,,DNA-directed RNA polymerase II subunit RPB1 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),Bos taurus (Bovine),77.4,1533.0,0.0,2438.7,sp|G3MZY8|RPB1_BOVIN DNA-directed RNA polymerase II subunit RPB1 OS=Bos taurus OX=9913 GN=POLR2A PE=1 SV=2,GO:0000287; GO:0000791; GO:0001046; GO:0003899; GO:0003968; GO:0005665; GO:0005739; GO:0006366; GO:0008270; GO:0016787; GO:0071667,transcription by RNA polymerase II [GO:0006366],"euchromatin [GO:0000791]; mitochondrion [GO:0005739]; RNA polymerase II, core complex [GO:0005665]",core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005739; GO:0006351; GO:0016740; GO:0016787; GO:0043226; GO:0140098,"DNA binding; catalytic activity; mitochondrion; DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_09362,0.3167164542438805,OG_09362,FUN_040477-T1,Peve_00015410,Pocillopora_meandrina_HIv1___RNAseq.g6522.t1,three_way,73.125,FUN_040477-T1,Q3UHD6,SNX27_MOUSE,,Sorting nexin-27,Mus musculus (Mouse),49.7,503.0,5.2e-142,506.1,sp|Q3UHD6|SNX27_MOUSE Sorting nexin-27 OS=Mus musculus OX=10090 GN=Snx27 PE=1 SV=2,GO:0001772; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0008333; GO:0016197; GO:0030904; GO:0031901; GO:0032266; GO:0032456; GO:0071203; GO:0090128; GO:0098685; GO:0098794; GO:0098837; GO:0098842; GO:0098978; GO:0099072,endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165],cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; postsynapse [GO:0098794]; postsynaptic early endosome [GO:0098842]; postsynaptic recycling endosome [GO:0098837]; retromer complex [GO:0030904]; Schaffer collateral - CA1 synapse [GO:0098685]; WASH complex [GO:0071203],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0005768; GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_01080,0.3166341714075143,OG_01080,FUN_004568-T1,Peve_00041493,Pocillopora_meandrina_HIv1___RNAseq.g6639.t1,three_way,81.07966666666665,FUN_004568-T1,Q9JHS4,CLPX_MOUSE,,"ATP-dependent clpX-like chaperone, mitochondrial (EC 3.6.4.10) (ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial) (Caseinolytic mitochondrial matrix peptidase chaperone subunit)",Mus musculus (Mouse),56.7,527.0,5.9e-152,539.3,"sp|Q9JHS4|CLPX_MOUSE ATP-dependent clpX-like chaperone, mitochondrial OS=Mus musculus OX=10090 GN=Clpx PE=1 SV=2",GO:0004176; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662,ATP metabolic process [GO:0046034]; proteolysis involved in protein catabolic process [GO:0051603],cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; ATP-dependent protein folding chaperone [GO:0140662]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0044183; GO:0055086; GO:0098772; GO:0140096; GO:0140657; GO:1901135,"catalytic activity; nucleoplasm; mitochondrion; cytosol; hydrolase activity; organelle; protein folding chaperone; nucleobase-containing small molecule metabolic process; molecular function regulator activity; catalytic activity, acting on a protein; ATP-dependent activity; carbohydrate derivative metabolic process"
OG_03336,0.3166080955870372,OG_03336,FUN_013557-T1,Peve_00038567,Pocillopora_meandrina_HIv1___RNAseq.g22961.t1,three_way,93.49333333333334,FUN_013557-T1,Q62074,KPCI_MOUSE,,Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (nPKC-iota),Mus musculus (Mouse),69.2,591.0,1.4999999999999999e-245,850.1,sp|Q62074|KPCI_MOUSE Protein kinase C iota type OS=Mus musculus OX=10090 GN=Prkci PE=1 SV=3,GO:0000139; GO:0004672; GO:0004674; GO:0004699; GO:0005524; GO:0005543; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005903; GO:0005923; GO:0005929; GO:0007015; GO:0008270; GO:0010976; GO:0015630; GO:0016324; GO:0016477; GO:0031252; GO:0032869; GO:0034351; GO:0035089; GO:0042462; GO:0043220; GO:0043524; GO:0045171; GO:0045177; GO:0045197; GO:0045216; GO:0046326; GO:0048194; GO:0051092; GO:0060252; GO:0070555; GO:0098685; GO:0098978; GO:0099072; GO:0106310; GO:0120157; GO:1903078; GO:2000353,actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to insulin stimulus [GO:0032869]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220],"ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005634; GO:0005768; GO:0005829; GO:0005856; GO:0005929; GO:0006355; GO:0007163; GO:0008289; GO:0016740; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0061024; GO:0140096,"catalytic activity; nucleus; endosome; cytosol; cytoskeleton; cilium; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; lipid binding; transferase activity; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_07564,0.3164226305621941,OG_07564,FUN_034211-T1,Peve_00027535,Pocillopora_meandrina_HIv1___RNAseq.g26168.t1,three_way,46.269333333333336,,,,,,,,,,,,,,,,,
OG_00355,0.316376840503644,OG_00355,FUN_001185-T1,Peve_00040986,Pocillopora_meandrina_HIv1___RNAseq.g29540.t1,three_way,52.84166666666667,FUN_001185-T1,C0HL13,LRP2_PIG,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Sus scrofa (Pig),41.7,412.0,3.4e-63,245.0,sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1,GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167,coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223],apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0016192; GO:0022414; GO:0048856; GO:0050877; GO:0055085,vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process; transmembrane transport
OG_06485,0.3163525154621838,OG_06485,FUN_029259-T1,Peve_00024365,Pocillopora_meandrina_HIv1___RNAseq.g15031.t1b,three_way,71.01783333333333,FUN_029259-T1,Q6DN90,IQEC1_HUMAN,,IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2),Homo sapiens (Human),42.1,447.0,1.1e-74,283.1,sp|Q6DN90|IQEC1_HUMAN IQ motif and SEC7 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IQSEC1 PE=1 SV=1,GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0008021; GO:0008289; GO:0014069; GO:0016020; GO:0030036; GO:0032012; GO:0043231; GO:0051549; GO:0060996; GO:0120183,actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012],centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021],guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_09235,0.3163065824768356,OG_09235,FUN_039980-T1,Peve_00014321,Pocillopora_meandrina_HIv1___RNAseq.g7547.t1,three_way,79.15883333333333,FUN_039980-T1,Q55G75,,,,,35.5,265.0,6.200000000000001e-44,179.5,sp|Q55G75|Y7786_DICDI PH domain-containing protein DDB_G0267786 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0267786 PE=4 SV=1,,,,,,
OG_02198,0.3162957426137069,OG_02198,FUN_008562-T1,Peve_00044733,Pocillopora_meandrina_HIv1___TS.g25491.t1,three_way,80.36,,,,,,,,,,,,,,,,,
OG_01177,0.316234946322949,OG_01177,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_04954,0.3161096050508244,OG_04954,FUN_023044-T1,Peve_00008510,Pocillopora_meandrina_HIv1___TS.g10041.t2,three_way,72.67383333333333,FUN_023044-T1,Q01085,TIAR_HUMAN,,Nucleolysin TIAR (TIA-1-related protein),Homo sapiens (Human),41.0,373.0,1e-67,258.8,sp|Q01085|TIAR_HUMAN Nucleolysin TIAR OS=Homo sapiens OX=9606 GN=TIAL1 PE=1 SV=1,GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006357; GO:0006915; GO:0006952; GO:0008285; GO:0010494; GO:0035332; GO:0044194; GO:0140517; GO:2000637,apoptotic process [GO:0006915]; defense response [GO:0006952]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hippo signaling [GO:0035332]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of transcription by RNA polymerase II [GO:0006357],cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; protein-RNA adaptor activity [GO:0140517]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0005829; GO:0006355; GO:0012501; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; nucleoplasm; lysosome; vacuole; cytosol; regulation of DNA-templated transcription; programmed cell death; organelle; molecular adaptor activity
OG_05241,0.3159481596187976,OG_05241,FUN_023682-T1,Peve_00014139,Pocillopora_meandrina_HIv1___RNAseq.g17753.t1,three_way,78.52883333333334,FUN_023682-T1,A7SK48,EIF3A_NEMVE,,Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10),Nematostella vectensis (Starlet sea anemone),73.3,786.0,8.7e-296,1018.1,sp|A7SK48|EIF3A_NEMVE Eukaryotic translation initiation factor 3 subunit A OS=Nematostella vectensis OX=45351 GN=v1g190699 PE=3 SV=2,GO:0001732; GO:0002188; GO:0003729; GO:0003743; GO:0016282; GO:0033290; GO:0043614; GO:0071540; GO:0071541,formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188],"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]",mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_07865,0.3159413098472713,OG_07865,FUN_035222-T1,Peve_00035887,Pocillopora_meandrina_HIv1___RNAseq.g27609.t1,three_way,55.40566666666666,FUN_035222-T1,Q501V0,KPSH1_DANRE,,Serine/threonine-protein kinase H1 homolog (EC 2.7.11.1),Danio rerio (Zebrafish) (Brachydanio rerio),66.9,323.0,4.8e-116,419.9,sp|Q501V0|KPSH1_DANRE Serine/threonine-protein kinase H1 homolog OS=Danio rerio OX=7955 GN=pskh1 PE=2 SV=2,GO:0004674; GO:0005524; GO:0005737; GO:0106310,,cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_07117,0.3159199303977602,OG_07117,FUN_032394-T1,Peve_00018856,Pocillopora_meandrina_HIv1___RNAseq.g29832.t1,three_way,75.89816666666667,FUN_032394-T1,P40123,CAP2_HUMAN,,Adenylyl cyclase-associated protein 2 (CAP 2),Homo sapiens (Human),40.3,467.0,2.3e-79,297.7,sp|P40123|CAP2_HUMAN Adenylyl cyclase-associated protein 2 OS=Homo sapiens OX=9606 GN=CAP2 PE=1 SV=1,GO:0000902; GO:0003779; GO:0005737; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007190; GO:0008179; GO:0014069; GO:0019933; GO:0042802; GO:0099140,actin filament organization [GO:0007015]; activation of adenylate cyclase activity [GO:0007190]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; presynaptic actin cytoskeleton organization [GO:0099140]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802],GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0043226,plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; organelle
OG_08627,0.3157387602795904,OG_08627,FUN_037795-T1,Peve_00026136,Pocillopora_meandrina_HIv1___RNAseq.g1555.t3,three_way,71.708,FUN_037795-T1,P51960,,,,,33.6,758.0,4.3e-85,317.4,sp|P51960|MYBA_MOUSE Myb-related protein A OS=Mus musculus OX=10090 GN=Mybl1 PE=1 SV=2,,,,,,
OG_07102,0.3157147290373687,OG_07102,FUN_032363-T1,Peve_00045030,Pocillopora_meandrina_HIv1___RNAseq.g29819.t1,three_way,59.871500000000005,FUN_032363-T1,Q6N021,TET2_HUMAN,,Methylcytosine dioxygenase TET2 (EC 1.14.11.80),Homo sapiens (Human),32.8,825.0,5.8e-99,364.4,sp|Q6N021|TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2 PE=1 SV=3,GO:0002521; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006493; GO:0008198; GO:0008270; GO:0030099; GO:0044029; GO:0045944; GO:0070579; GO:0141167,"chromosomal 5-methylcytosine DNA demethylation, oxidation pathway [GO:0141167]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]",chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0009101; GO:0016491; GO:0030154; GO:0043226; GO:0140097; GO:1901135,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; glycoprotein biosynthetic process; oxidoreductase activity; cell differentiation; organelle; catalytic activity, acting on DNA; carbohydrate derivative metabolic process"
OG_00103,0.3156470681103314,OG_00103,FUN_000489-T1,Peve_00043825,Pocillopora_meandrina_HIv1___TS.g4918.t1,three_way,64.97083333333333,FUN_000489-T1,Q12923,,,,,26.7,2887.0,7.2e-210,733.8,sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2,,,,,,
OG_02688,0.3155459879507888,OG_02688,FUN_010948-T1,Peve_00040396,Pocillopora_meandrina_HIv1___RNAseq.921_t,three_way,64.41233333333334,FUN_010948-T1,O89001,,,,,51.3,392.0,5.8e-115,416.0,sp|O89001|CBPD_MOUSE Carboxypeptidase D OS=Mus musculus OX=10090 GN=Cpd PE=1 SV=2,,,,,,
OG_03470,0.3152753288091573,OG_03470,FUN_014556-T1,Peve_00035993,Pocillopora_meandrina_HIv1___RNAseq.g22695.t1,three_way,72.46883333333334,FUN_014556-T1,E1BLT8,ZDHC5_BOVIN,,Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5),Bos taurus (Bovine),52.3,243.0,9.599999999999999e-70,265.4,sp|E1BLT8|ZDHC5_BOVIN Palmitoyltransferase ZDHHC5 OS=Bos taurus OX=9913 GN=ZDHHC5 PE=3 SV=1,GO:0005654; GO:0005886; GO:0006869; GO:0016409; GO:0019706; GO:0030425; GO:0045087; GO:0045335; GO:0062208; GO:0072659; GO:0098794; GO:0098978; GO:0140639; GO:1900227; GO:1903078; GO:1905171,innate immune response [GO:0045087]; lipid transport [GO:0006869]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein localization to plasma membrane [GO:0072659],dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0002376; GO:0003824; GO:0005654; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0072659; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleoplasm; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; protein localization to plasma membrane; defense response to other organism; catalytic activity, acting on a protein"
OG_01214,0.3152439911633803,OG_01214,FUN_004895-T1,Peve_00043720,Pocillopora_meandrina_HIv1___RNAseq.15695_t,three_way,69.655,FUN_004895-T1,Q61532,MK06_MOUSE,,Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) (Extracellular signal-regulated kinase 3) (ERK-3),Mus musculus (Mouse),44.8,330.0,5.8e-81,303.1,sp|Q61532|MK06_MOUSE Mitogen-activated protein kinase 6 OS=Mus musculus OX=10090 GN=Mapk6 PE=1 SV=3,GO:0004672; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0019901; GO:0032156; GO:0032991; GO:0046982; GO:0060999; GO:0106310,positive regulation of dendritic spine development [GO:0060999]; protein phosphorylation [GO:0006468],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156],ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; cytoskeleton; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01840,0.3151695530067394,OG_01840,FUN_007786-T1,Peve_00022059,Pocillopora_meandrina_HIv1___RNAseq.g5903.t1,three_way,66.8125,,,,,,,,,,,,,,,,,
OG_00710,0.3151166864789239,OG_00710,FUN_002577-T1,Peve_00025545,Pocillopora_meandrina_HIv1___RNAseq.g25716.t1,three_way,77.45466666666667,FUN_002577-T1,Q6NU27,,,,,52.6,196.0,2.5000000000000002e-58,226.9,sp|Q6NU27|I4E3B_XENLA Eukaryotic translation initiation factor 4E type 3-B OS=Xenopus laevis OX=8355 GN=eif4e3-b PE=2 SV=1,,,,,,
OG_05035,0.3150075822421145,OG_05035,FUN_023216-T1,Peve_00029820,Pocillopora_meandrina_HIv1___RNAseq.g691.t1,three_way,77.107,FUN_023216-T1,Q90XN9,,,,,68.3,126.0,2e-36,154.1,sp|Q90XN9|HMX3B_ORYLA Homeobox protein HMX3-B OS=Oryzias latipes OX=8090 GN=hmx3b PE=2 SV=1,,,,,,
OG_00880,0.3148217478342971,OG_00880,FUN_004174-T1,Peve_00019597,Pocillopora_meandrina_HIv1___TS.g17559.t2,three_way,57.525333333333336,FUN_004174-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),35.1,1661.0,5.0999999999999996e-250,867.1,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_03431,0.3147369727801565,OG_03431,FUN_014487-T1,Peve_00037295,Pocillopora_meandrina_HIv1___RNAseq.1965_t,three_way,57.88816666666667,FUN_014487-T1,Q9D4H7,,,,,33.6,619.0,5e-91,337.0,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_04010,0.3147183652157139,OG_04010,FUN_016311-T1,Peve_00032324,Pocillopora_meandrina_HIv1___RNAseq.g10035.t1,three_way,78.09949999999999,FUN_016311-T1,Q76L87,,,,,37.8,259.0,3.8e-27,124.0,sp|Q76L87|DMTA2_ORYLA Doublesex- and mab-3-related transcription factor A2 OS=Oryzias latipes OX=8090 GN=dmrta2 PE=3 SV=1,,,,,,
OG_05382,0.314687013143216,OG_05382,FUN_024199-T1,Peve_00031882,Pocillopora_meandrina_HIv1___RNAseq.g18898.t1,three_way,95.62316666666666,FUN_024199-T1,A5WWB0,,,,,75.2,375.0,3.8e-162,572.4,sp|A5WWB0|UBP46_DANRE Ubiquitin carboxyl-terminal hydrolase 46 OS=Danio rerio OX=7955 GN=usp46 PE=3 SV=2,,,,,,
OG_02237,0.3146773978065545,OG_02237,FUN_008649-T1,Peve_00035682,Pocillopora_meandrina_HIv1___RNAseq.g15.t1,three_way,97.37233333333332,FUN_008649-T1,Q32LN1,UBE2H_BOVIN,,Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (Ubiquitin carrier protein H) (Ubiquitin-protein ligase H),Bos taurus (Bovine),73.8,183.0,4.0000000000000004e-72,272.3,sp|Q32LN1|UBE2H_BOVIN Ubiquitin-conjugating enzyme E2 H OS=Bos taurus OX=9913 GN=UBE2H PE=2 SV=1,GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_07272,0.3146085802905148,OG_07272,FUN_033210-T1,Peve_00043517,Pocillopora_meandrina_HIv1___RNAseq.g29763.t1,three_way,93.34833333333331,FUN_033210-T1,P63328,PP2BA_MOUSE,,Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform),Mus musculus (Mouse),80.6,407.0,2.1e-201,703.0,sp|P63328|PP2BA_MOUSE Protein phosphatase 3 catalytic subunit alpha OS=Mus musculus OX=10090 GN=Ppp3ca PE=1 SV=1,GO:0000082; GO:0004721; GO:0004723; GO:0005516; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008287; GO:0008544; GO:0009898; GO:0010613; GO:0010628; GO:0010629; GO:0014883; GO:0014898; GO:0019722; GO:0023057; GO:0030018; GO:0030216; GO:0030335; GO:0033173; GO:0033192; GO:0033555; GO:0042104; GO:0042383; GO:0043197; GO:0045669; GO:0045672; GO:0045807; GO:0045944; GO:0046872; GO:0046878; GO:0046983; GO:0048741; GO:0048813; GO:0050774; GO:0050804; GO:0051117; GO:0051592; GO:0060079; GO:0061006; GO:0070886; GO:0090193; GO:0097205; GO:0098685; GO:0098978; GO:0099170; GO:0110062; GO:1903244; GO:1905205; GO:1905665; GO:1905949,calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy in response to stress [GO:0014898]; dendrite morphogenesis [GO:0048813]; epidermis development [GO:0008544]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiotensin-activated signaling pathway [GO:0110062]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of signaling [GO:0023057]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of saliva secretion [GO:0046878]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; regulation of cell proliferation involved in kidney morphogenesis [GO:0061006]; renal filtration [GO:0097205]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883],calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein serine/threonine phosphatase complex [GO:0008287]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; Z disc [GO:0030018],ATPase binding [GO:0051117]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein dimerization activity [GO:0046983],GO:0003012; GO:0003014; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"muscle system process; renal system process; catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08410,0.3145909769129684,OG_08410,FUN_037061-T1,Peve_00018395,Pocillopora_meandrina_HIv1___RNAseq.g26778.t1,three_way,63.92483333333333,FUN_037061-T1,Q5U2U2,CRKL_RAT,,Crk-like protein,Rattus norvegicus (Rat),37.5,293.0,5.8e-46,186.0,sp|Q5U2U2|CRKL_RAT Crk-like protein OS=Rattus norvegicus OX=10116 GN=Crkl PE=1 SV=1,GO:0001558; GO:0001568; GO:0001655; GO:0001764; GO:0001783; GO:0001784; GO:0002685; GO:0003151; GO:0005654; GO:0005737; GO:0005829; GO:0006629; GO:0007167; GO:0007283; GO:0007338; GO:0007389; GO:0007507; GO:0008284; GO:0008543; GO:0008584; GO:0009887; GO:0009952; GO:0010468; GO:0010629; GO:0016358; GO:0016477; GO:0021766; GO:0021987; GO:0030010; GO:0030971; GO:0031594; GO:0032991; GO:0033628; GO:0035022; GO:0035591; GO:0035685; GO:0038026; GO:0042802; GO:0043410; GO:0045202; GO:0048384; GO:0048538; GO:0050773; GO:0050852; GO:0060017; GO:0060326; GO:0060392; GO:0061629; GO:0070374; GO:0071466; GO:0071560; GO:0071774; GO:0086100; GO:0095500; GO:0098698; GO:0098749; GO:0098761; GO:0098890; GO:0160093; GO:1900026; GO:1903977; GO:1904393; GO:1904395; GO:1904888; GO:2000404,acetylcholine receptor signaling pathway [GO:0095500]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; chordate pharynx development [GO:0160093]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of gene expression [GO:0010468]; regulation of leukocyte migration [GO:0002685]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; regulation of T cell migration [GO:2000404]; response to fibroblast growth factor [GO:0071774]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; synapse [GO:0045202],identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591],GO:0002376; GO:0005654; GO:0005829; GO:0006629; GO:0007163; GO:0012501; GO:0022414; GO:0048856; GO:0048870; GO:0060090,immune system process; nucleoplasm; cytosol; lipid metabolic process; establishment or maintenance of cell polarity; programmed cell death; reproductive process; anatomical structure development; cell motility; molecular adaptor activity
OG_02649,0.3144902044003438,OG_02649,FUN_010831-T1,Peve_00017536,Pocillopora_meandrina_HIv1___RNAseq.g20914.t1,three_way,75.07333333333334,FUN_010831-T1,P09057,DCOR_RAT,,Ornithine decarboxylase (ODC) (EC 4.1.1.17),Rattus norvegicus (Rat),53.1,409.0,6.7e-132,472.2,sp|P09057|DCOR_RAT Ornithine decarboxylase OS=Rattus norvegicus OX=10116 GN=Odc1 PE=1 SV=1,GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008283; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471,"cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from arginine, via ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471],ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006520; GO:0016829; GO:0048856,catalytic activity; cytosol; amino acid metabolic process; lyase activity; anatomical structure development
OG_00938,0.3144890985971994,OG_00938,FUN_004288-T1,Peve_00029197,Pocillopora_meandrina_HIv1___RNAseq.g11767.t1,three_way,35.059,,,,,,,,,,,,,,,,,
OG_06611,0.3144633923574392,OG_06611,FUN_029761-T1,Peve_00019503,Pocillopora_meandrina_HIv1___RNAseq.g17322.t1,three_way,61.18983333333333,FUN_029761-T1,Q8NC51,SERB1_HUMAN,,SERPINE1 mRNA-binding protein 1 (PAI1 RNA-binding protein 1) (PAI-RBP1) (Plasminogen activator inhibitor 1 RNA-binding protein),Homo sapiens (Human),31.6,152.0,5e-06,53.9,sp|Q8NC51|SERB1_HUMAN SERPINE1 mRNA-binding protein 1 OS=Homo sapiens OX=9606 GN=SERBP1 PE=1 SV=2,GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0017148; GO:0030371; GO:0030578; GO:0032183; GO:0043022; GO:0043488; GO:0045296; GO:0048471; GO:0061770; GO:0070062; GO:0141014,negative regulation of translation [GO:0017148]; PML body organization [GO:0030578]; regulation of mRNA stability [GO:0043488]; ribosome hibernation [GO:0141014],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; translation elongation factor binding [GO:0061770]; translation repressor activity [GO:0030371],GO:0003723; GO:0005634; GO:0005829; GO:0043226; GO:0045182,RNA binding; nucleus; cytosol; organelle; translation regulator activity
OG_04694,0.3144353752070423,OG_04694,FUN_022486-T1,Peve_00002926,Pocillopora_meandrina_HIv1___RNAseq.g4292.t1,three_way,75.504,FUN_022486-T1,P15882,CHIN_HUMAN,,N-chimaerin (A-chimaerin) (Alpha-chimerin) (N-chimerin) (NC) (Rho GTPase-activating protein 2),Homo sapiens (Human),55.8,457.0,7e-142,505.4,sp|P15882|CHIN_HUMAN N-chimaerin OS=Homo sapiens OX=9606 GN=CHN1 PE=1 SV=3,GO:0005096; GO:0005829; GO:0008045; GO:0008270; GO:0046875; GO:0048013; GO:0050770; GO:0051056,ephrin receptor signaling pathway [GO:0048013]; motor neuron axon guidance [GO:0008045]; regulation of axonogenesis [GO:0050770]; regulation of small GTPase mediated signal transduction [GO:0051056],cytosol [GO:0005829],ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005829; GO:0098772,cytosol; molecular function regulator activity
OG_01160,0.314423052895357,OG_01160,FUN_004779-T1,Peve_00037747,Pocillopora_meandrina_HIv1___RNAseq.g6693.t1,three_way,80.62566666666666,FUN_004779-T1,A2A2Y4,FRMD3_HUMAN,,FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O),Homo sapiens (Human),49.3,341.0,6.399999999999999e-96,352.8,sp|A2A2Y4|FRMD3_HUMAN FERM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FRMD3 PE=1 SV=1,GO:0005856; GO:0008092; GO:0016020; GO:0031032,actomyosin structure organization [GO:0031032],cytoskeleton [GO:0005856]; membrane [GO:0016020],cytoskeletal protein binding [GO:0008092],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_09573,0.3142338381468577,OG_09573,FUN_041705-T1,Peve_00001480,Pocillopora_meandrina_HIv1___RNAseq.g13973.t1,three_way,45.37833333333334,FUN_041705-T1,Q95VY2,,,,,43.7,174.0,1.7000000000000002e-32,140.6,sp|Q95VY2|TCTP_BRABE Translationally-controlled tumor protein homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1,,,,,,
OG_05401,0.3142311558908569,OG_05401,FUN_024332-T1,Peve_00016315,Pocillopora_meandrina_HIv1___RNAseq.g18928.t1,three_way,91.02566666666668,FUN_024332-T1,A7S3J7,,,,,82.1,263.0,2.4e-123,443.0,sp|A7S3J7|RS3A_NEMVE Small ribosomal subunit protein eS1 OS=Nematostella vectensis OX=45351 GN=v1g242621 PE=3 SV=1,,,,,,
OG_06844,0.3141859908593494,OG_06844,FUN_031784-T1,Peve_00010429,Pocillopora_meandrina_HIv1___TS.g24287.t1,three_way,83.68866666666666,FUN_031784-T1,Q9ULT8,HECD1_HUMAN,,E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1),Homo sapiens (Human),52.0,2736.0,0.0,2536.5,sp|Q9ULT8|HECD1_HUMAN E3 ubiquitin-protein ligase HECTD1 OS=Homo sapiens OX=9606 GN=HECTD1 PE=1 SV=4,GO:0003170; GO:0003281; GO:0006511; GO:0016567; GO:0032436; GO:0035904; GO:0046872; GO:0061630,aorta development [GO:0035904]; heart valve development [GO:0003170]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281],,metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_07952,0.3141787654359486,OG_07952,FUN_035478-T1,Peve_00033970,Pocillopora_meandrina_HIv1___TS.g14339.t1,three_way,81.2215,FUN_035478-T1,P08487,,,,,46.2,825.0,3.7e-203,709.9,"sp|P08487|PLCG1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Bos taurus OX=9913 GN=PLCG1 PE=1 SV=1",,,,,,
OG_07361,0.3140580729607227,OG_07361,FUN_033773-T1,Peve_00005280,Pocillopora_meandrina_HIv1___RNAseq.g26658.t2,three_way,82.50433333333334,FUN_033773-T1,B9EJ86,OSBL8_MOUSE,,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),Mus musculus (Mouse),46.7,803.0,3.8e-197,689.9,sp|B9EJ86|OSBL8_MOUSE Oxysterol-binding protein-related protein 8 OS=Mus musculus OX=10090 GN=Osbpl8 PE=1 SV=1,GO:0001786; GO:0005789; GO:0015485; GO:0015914; GO:0030336; GO:0031965; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0070328; GO:0090204; GO:0140343,fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; phospholipid transport [GO:0015914]; positive regulation of D-glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein localization to nuclear pore [GO:0090204]; triglyceride homeostasis [GO:0070328],endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965],cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343],GO:0005215; GO:0008289; GO:0030154,transporter activity; lipid binding; cell differentiation
OG_09562,0.3140304480916039,OG_09562,FUN_041672-T1,Peve_00007760,Pocillopora_meandrina_HIv1___RNAseq.g14001.t1,three_way,59.1795,,,,,,,,,,,,,,,,,
OG_01400,0.3139953992978916,OG_01400,FUN_005389-T1,Peve_00042934,Pocillopora_meandrina_HIv1___RNAseq.g7680.t1,three_way,74.071,,,,,,,,,,,,,,,,,
OG_02111,0.3139919549163434,OG_02111,FUN_008396-T1,Peve_00043608,Pocillopora_meandrina_HIv1___RNAseq.g6175.t1,three_way,71.88550000000001,FUN_008396-T1,Q9EQC5,SCYL1_MOUSE,,N-terminal kinase-like protein (105 kDa kinase-like protein) (Mitosis-associated kinase-like protein NTKL) (SCY1-like protein 1),Mus musculus (Mouse),51.4,675.0,2.1e-182,641.0,sp|Q9EQC5|SCYL1_MOUSE N-terminal kinase-like protein OS=Mus musculus OX=10090 GN=Scyl1 PE=1 SV=1,GO:0004672; GO:0005524; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005813; GO:0005829; GO:0006890; GO:0006954; GO:0008104; GO:0021522; GO:0030126; GO:0048666,"inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]",centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; protein kinase activity [GO:0004672],GO:0003824; GO:0005794; GO:0005815; GO:0005829; GO:0006954; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; microtubule organizing center; cytosol; inflammatory response; vesicle-mediated transport; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08400,0.3139380655564746,OG_08400,FUN_037048-T1,Peve_00032330,Pocillopora_meandrina_HIv1___RNAseq.g26794.t1,three_way,85.69433333333333,FUN_037048-T1,Q56JU9,,,,,76.4,127.0,1e-40,167.5,sp|Q56JU9|RS24_BOVIN Small ribosomal subunit protein eS24 OS=Bos taurus OX=9913 GN=RPS24 PE=2 SV=2,,,,,,
OG_07897,0.3138491505684519,OG_07897,FUN_035276-T1,Peve_00044995,Pocillopora_meandrina_HIv1___RNAseq.g27859.t1,three_way,66.694,,,,,,,,,,,,,,,,,
OG_09640,0.3137886395558098,OG_09640,FUN_041835-T1,Peve_00009638,Pocillopora_meandrina_HIv1___RNAseq.g15085.t1,three_way,89.23433333333334,FUN_041835-T1,Q2HJ40,BACE1_BOVIN,,Beta-secretase 1 (EC 3.4.23.46) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2),Bos taurus (Bovine),47.6,429.0,8.5e-117,422.2,sp|Q2HJ40|BACE1_BOVIN Beta-secretase 1 OS=Bos taurus OX=9913 GN=BACE1 PE=2 SV=1,GO:0004175; GO:0004190; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006508; GO:0006509; GO:0009986; GO:0030424; GO:0030425; GO:0030659; GO:0045121; GO:0050435; GO:0055037,amyloid-beta metabolic process [GO:0050435]; membrane protein ectodomain proteolysis [GO:0006509]; proteolysis [GO:0006508],axon [GO:0030424]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05430,0.3136821010877206,OG_05430,FUN_024376-T1,Peve_00020239,Pocillopora_meandrina_HIv1___RNAseq.g18601.t1,three_way,98.059,FUN_024376-T1,Q3T169,RS3_BOVIN,,Small ribosomal subunit protein uS3 (EC 4.2.99.18) (40S ribosomal protein S3),Bos taurus (Bovine),90.4,239.0,1.4e-120,433.7,sp|Q3T169|RS3_BOVIN Small ribosomal subunit protein uS3 OS=Bos taurus OX=9913 GN=RPS3 PE=2 SV=1,GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235,apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412],cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003677; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005730; GO:0006281; GO:0012501; GO:0016829; GO:0043226; GO:0140097,"DNA binding; RNA binding; catalytic activity; structural molecule activity; nucleus; nucleolus; DNA repair; programmed cell death; lyase activity; organelle; catalytic activity, acting on DNA"
OG_00972,0.3136593826605107,OG_00972,FUN_004346-T1,Peve_00016493,Pocillopora_meandrina_HIv1___RNAseq.g16896.t1,three_way,82.173,FUN_004346-T1,Q8BRK8,AAPK2_MOUSE,,5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31),Mus musculus (Mouse),58.6,561.0,3.1e-179,629.8,sp|Q8BRK8|AAPK2_MOUSE 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Mus musculus OX=10090 GN=Prkaa2 PE=1 SV=3,GO:0003682; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010468; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031588; GO:0031669; GO:0032007; GO:0034599; GO:0036064; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:0140823; GO:1903829; GO:1903944; GO:1904262; GO:1904428; GO:1905691; GO:1990044,autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634],[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone H2BS36 kinase activity [GO:0140823]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712],GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; lipid metabolic process; autophagy; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09707,0.3134263828647988,OG_09707,FUN_041944-T1,Peve_00023595,Pocillopora_meandrina_HIv1___RNAseq.g15636.t1,three_way,61.59033333333333,FUN_041944-T1,P25169,,,,,28.7,293.0,1.3e-21,105.1,sp|P25169|AT1B1_ARTSF Sodium/potassium-transporting ATPase subunit beta OS=Artemia franciscana OX=6661 PE=2 SV=1,,,,,,
OG_05467,0.3134233488763164,OG_05467,FUN_024450-T1,Peve_00025472,Pocillopora_meandrina_HIv1___RNAseq.g18853.t1,three_way,86.50233333333333,FUN_024450-T1,P51790,CLCN3_HUMAN,,H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3),Homo sapiens (Human),61.5,808.0,1.8e-281,969.9,sp|P51790|CLCN3_HUMAN H(+)/Cl(-) exchange transporter 3 OS=Homo sapiens OX=9606 GN=CLCN3 PE=1 SV=2,GO:0000139; GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0006885; GO:0006911; GO:0008021; GO:0008344; GO:0009897; GO:0009986; GO:0010008; GO:0012506; GO:0015297; GO:0016020; GO:0030141; GO:0030165; GO:0030672; GO:0031410; GO:0031901; GO:0031902; GO:0032587; GO:0035249; GO:0042581; GO:0043231; GO:0043679; GO:0045335; GO:0045494; GO:0045794; GO:0048388; GO:0051932; GO:0055037; GO:0062158; GO:0072320; GO:0097401; GO:0098978; GO:0098982; GO:1902476; GO:1903428,"adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; endosomal lumen acidification [GO:0048388]; negative regulation of cell volume [GO:0045794]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of pH [GO:0006885]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401]",axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle membrane [GO:0012506],antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride:proton antiporter activity [GO:0062158]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]; volume-sensitive chloride channel activity [GO:0072320],GO:0005215; GO:0005768; GO:0005794; GO:0005886; GO:0023052; GO:0031410; GO:0043226; GO:0055085; GO:0061024,transporter activity; endosome; Golgi apparatus; plasma membrane; signaling; cytoplasmic vesicle; organelle; transmembrane transport; membrane organization
OG_00439,0.313411381436728,OG_00439,FUN_001350-T1,Peve_00023405,Pocillopora_meandrina_HIv1___RNAseq.g1875.t1,three_way,48.55,FUN_001350-T1,Q8BM75,ARI5B_MOUSE,,AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (Developmentally and sexually retarded with transient immune abnormalities protein) (Desrt) (MRF1-like) (Modulator recognition factor protein 2) (MRF-2),Mus musculus (Mouse),24.0,758.0,3.2999999999999998e-43,179.1,sp|Q8BM75|ARI5B_MOUSE AT-rich interactive domain-containing protein 5B OS=Mus musculus OX=10090 GN=Arid5b PE=1 SV=3,GO:0000122; GO:0000976; GO:0001822; GO:0003713; GO:0005634; GO:0008584; GO:0008585; GO:0009791; GO:0010761; GO:0030325; GO:0035264; GO:0045444; GO:0048008; GO:0048468; GO:0048644; GO:0048705; GO:0060021; GO:0060325; GO:0060612; GO:0060613; GO:1990830,adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705],nucleus [GO:0005634],transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; molecular adaptor activity; transcription regulator activity
OG_09619,0.3133459989089189,OG_09619,FUN_041779-T1,Peve_00042838,Pocillopora_meandrina_HIv1___RNAseq.g15878.t1,three_way,82.13516666666666,FUN_041779-T1,P23098,,,,,25.2,3572.0,0.0,1097.8,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_06522,0.313210216159513,OG_06522,FUN_029339-T1,Peve_00023361,Pocillopora_meandrina_HIv1___RNAseq.g17301.t1,three_way,61.434333333333335,FUN_029339-T1,Q01973,ROR1_HUMAN,,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",Homo sapiens (Human),31.6,773.0,1.1000000000000001e-118,429.1,sp|Q01973|ROR1_HUMAN Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens OX=9606 GN=ROR1 PE=1 SV=2,GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0007169; GO:0007605; GO:0008283; GO:0009986; GO:0014002; GO:0015026; GO:0017147; GO:0030424; GO:0038023; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092,astrocyte development [GO:0014002]; cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0006355; GO:0016740; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_03230,0.3131846156846731,OG_03230,FUN_012772-T1,Peve_00007600,Pocillopora_meandrina_HIv1___RNAseq.g13653.t1,three_way,86.02266666666667,FUN_012772-T1,Q9DFQ7,,,,,76.6,111.0,5.199999999999999e-43,175.6,sp|Q9DFQ7|RL24_GILMI Large ribosomal subunit protein eL24 OS=Gillichthys mirabilis OX=8222 GN=rpl24 PE=2 SV=2,,,,,,
OG_05204,0.3131180212701238,OG_05204,FUN_023588-T1,Peve_00028963,Pocillopora_meandrina_HIv1___TS.g17411.t1,three_way,68.98,FUN_023588-T1,Q5ZK33,LETM1_CHICK,,Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1),Gallus gallus (Chicken),40.7,644.0,2.9999999999999993e-105,384.4,sp|Q5ZK33|LETM1_CHICK Mitochondrial proton/calcium exchanger protein OS=Gallus gallus OX=9031 GN=LETM1 PE=2 SV=1,GO:0005509; GO:0005739; GO:0005743; GO:0006813; GO:0006816; GO:0006851; GO:0007005; GO:0007007; GO:0015369; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0099093,calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; potassium ion transport [GO:0006813]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022],GO:0005215; GO:0005739; GO:0007005; GO:0043226; GO:0055085; GO:0061024; GO:0065003,transporter activity; mitochondrion; mitochondrion organization; organelle; transmembrane transport; membrane organization; protein-containing complex assembly
OG_03513,0.3130972432839756,OG_03513,FUN_014624-T1,Peve_00002411,Pocillopora_meandrina_HIv1___RNAseq.g22781.t1,three_way,98.58133333333332,FUN_014624-T1,P48727,,,,,90.4,332.0,5e-182,638.3,sp|P48727|GLC7B_CAEEL Serine/threonine-protein phosphatase PP1-beta OS=Caenorhabditis elegans OX=6239 GN=gsp-2 PE=1 SV=1,,,,,,
OG_03668,0.3130925109529782,OG_03668,FUN_014908-T1,Peve_00003535,Pocillopora_meandrina_HIv1___RNAseq.g21073.t1,three_way,82.90766666666666,FUN_014908-T1,P62253,UB2G1_HUMAN,,"Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed]",Homo sapiens (Human),76.2,164.0,5.2e-74,278.5,sp|P62253|UB2G1_HUMAN Ubiquitin-conjugating enzyme E2 G1 OS=Homo sapiens OX=9606 GN=UBE2G1 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0031625; GO:0043161; GO:0061631; GO:0070062; GO:0070534; GO:0070936,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; extracellular exosome [GO:0070062],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_05274,0.3130506205443985,OG_05274,FUN_023928-T1,Peve_00026565,Pocillopora_meandrina_HIv1___TS.g27906.t1a,three_way,36.54933333333333,FUN_023928-T1,Q3V2Q8,N42L1_MOUSE,,NEDD4-binding protein 2-like 1,Mus musculus (Mouse),51.4,175.0,3.6999999999999997e-41,172.2,sp|Q3V2Q8|N42L1_MOUSE NEDD4-binding protein 2-like 1 OS=Mus musculus OX=10090 GN=N4bp2l1 PE=1 SV=1,,,,,,
OG_04735,0.313025053274281,OG_04735,FUN_022604-T1,Peve_00012247,Pocillopora_meandrina_HIv1___RNAseq.g4419.t1,three_way,56.8415,FUN_022604-T1,Q8VCH8,,,,,36.6,514.0,1.1e-42,176.0,sp|Q8VCH8|UBXN4_MOUSE UBX domain-containing protein 4 OS=Mus musculus OX=10090 GN=Ubxn4 PE=1 SV=1,,,,,,
OG_07862,0.3129990128933266,OG_07862,FUN_035217-T1,Peve_00035882,Pocillopora_meandrina_HIv1___TS.g14965.t1,three_way,86.42566666666667,FUN_035217-T1,O43747,,,,,62.9,851.0,9.3e-281,967.6,sp|O43747|AP1G1_HUMAN AP-1 complex subunit gamma-1 OS=Homo sapiens OX=9606 GN=AP1G1 PE=1 SV=5,,,,,,
OG_06781,0.3129705097818974,OG_06781,FUN_031648-T1,Peve_00043574,Pocillopora_meandrina_HIv1___RNAseq.g5681.t1,three_way,93.75783333333334,FUN_031648-T1,Q6PD03,2A5A_MOUSE,,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha),Mus musculus (Mouse),75.4,443.0,6.199999999999999e-189,661.8,sp|Q6PD03|2A5A_MOUSE Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform OS=Mus musculus OX=10090 GN=Ppp2r5a PE=1 SV=1,GO:0000159; GO:0000775; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0007165; GO:0019210; GO:0019900; GO:0030018; GO:0031430; GO:0072542; GO:1903077,negative regulation of protein localization to plasma membrane [GO:1903077]; signal transduction [GO:0007165],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]",kinase binding [GO:0019900]; kinase inhibitor activity [GO:0019210]; protein phosphatase activator activity [GO:0072542],GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; plasma membrane; organelle; molecular function regulator activity
OG_00071,0.3127651062601428,OG_00071,FUN_000393-T1,Peve_00033591,Pocillopora_meandrina_HIv1___RNAseq.g2528.t1,three_way,82.34016666666666,FUN_000393-T1,P08429,,,,,65.9,349.0,9.9e-131,468.0,sp|P08429|RL4A_XENLA Large ribosomal subunit protein uL4A OS=Xenopus laevis OX=8355 GN=rpl4-a PE=2 SV=2,,,,,,
OG_02599,0.3127404295887905,OG_02599,FUN_010720-T1,Peve_00029905,Pocillopora_meandrina_HIv1___RNAseq.g20949.t2,three_way,83.7885,FUN_010720-T1,P58197,AP2A_RAT,,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),Rattus norvegicus (Rat),63.4,227.0,3.3e-68,260.8,sp|P58197|AP2A_RAT Transcription factor AP-2-alpha OS=Rattus norvegicus OX=10116 GN=Tfap2a PE=1 SV=1,GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001501; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005905; GO:0006355; GO:0006357; GO:0006366; GO:0007173; GO:0007399; GO:0007423; GO:0007605; GO:0008283; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010761; GO:0010763; GO:0010842; GO:0010944; GO:0014032; GO:0014044; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030501; GO:0032496; GO:0035115; GO:0035136; GO:0042059; GO:0042127; GO:0042472; GO:0042802; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0051402; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:1990837; GO:2000378,anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cell population proliferation [GO:0008283]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; fibroblast migration [GO:0010761]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559],clathrin-coated pit [GO:0005905]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0012501; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; extracellular matrix organization; organelle; anatomical structure development; cell motility; nervous system process; molecular adaptor activity; transcription regulator activity
OG_03648,0.3127402261850857,OG_03648,FUN_014880-T1,Peve_00013648,Pocillopora_meandrina_HIv1___RNAseq.g21049.t1,three_way,87.48833333333333,FUN_014880-T1,Q8WPW2,,,,,74.9,275.0,5.2e-112,405.6,sp|Q8WPW2|PDX1_SUBDO Pyridoxal 5'-phosphate synthase subunit SNZERR OS=Suberites domuncula OX=55567 GN=SNZERR PE=2 SV=2,,,,,,
OG_04633,0.3127210060950297,OG_04633,FUN_022346-T1,Peve_00018538,Pocillopora_meandrina_HIv1___RNAseq.g4661.t1,three_way,98.06033333333332,FUN_022346-T1,Q3T057,RL23_BOVIN,,Large ribosomal subunit protein uL14 (60S ribosomal protein L23),Bos taurus (Bovine),92.1,139.0,2.0999999999999997e-68,259.6,sp|Q3T057|RL23_BOVIN Large ribosomal subunit protein uL14 OS=Bos taurus OX=9913 GN=RPL23 PE=2 SV=2,GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0045202; GO:0050821; GO:0070180; GO:0070314; GO:0072717; GO:1901798; GO:1903450; GO:1990948; GO:2000059,cellular response to actinomycin D [GO:0072717]; G1 to G0 transition [GO:0070314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; regulation of G1 to G0 transition [GO:1903450]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202],large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005198; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0098772,RNA binding; structural molecule activity; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_04243,0.3126484622274173,OG_04243,FUN_017765-T1,Peve_00003282,Pocillopora_meandrina_HIv1___RNAseq.g446.t1,three_way,79.75516666666667,FUN_017765-T1,Q5RD44,B3A2_PONAB,,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Solute carrier family 4 member 2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),43.1,1043.0,1.9e-207,724.5,sp|Q5RD44|B3A2_PONAB Anion exchange protein 2 OS=Pongo abelii OX=9601 GN=SLC4A2 PE=2 SV=2,GO:0016323; GO:0016324; GO:0030316; GO:0032956; GO:0043377; GO:0045124; GO:0051453; GO:0140900; GO:2000565,"negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of intracellular pH [GO:0051453]",apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323],chloride:bicarbonate antiporter activity [GO:0140900],GO:0005215; GO:0030154,transporter activity; cell differentiation
OG_07921,0.3124929653977196,OG_07921,FUN_035406-T1,Peve_00002646,Pocillopora_meandrina_HIv1___TS.g3529.t1,three_way,75.06933333333333,FUN_035406-T1,O43312,,,,,48.1,239.0,4.2000000000000004e-60,234.2,sp|O43312|MTSS1_HUMAN Protein MTSS 1 OS=Homo sapiens OX=9606 GN=MTSS1 PE=1 SV=2,,,,,,
OG_00483,0.3123479743634151,OG_00483,FUN_001447-T1,Peve_00019961,Pocillopora_meandrina_HIv1___RNAseq.g1952.t1,three_way,57.163,FUN_001447-T1,Q61824,,,,,37.3,714.0,8.5e-130,466.5,sp|Q61824|ADA12_MOUSE Disintegrin and metalloproteinase domain-containing protein 12 OS=Mus musculus OX=10090 GN=Adam12 PE=1 SV=2,,,,,,
OG_01155,0.3123104621569134,OG_01155,FUN_004766-T1,Peve_00019319,Pocillopora_meandrina_HIv1___RNAseq.g6698.t2,three_way,68.8935,FUN_004766-T1,Q5R4N8,,,,,40.4,779.0,6.3e-146,519.6,sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii OX=9601 GN=A2M PE=2 SV=1,,,,,,
OG_03206,0.3122333589722714,OG_03206,FUN_012698-T1,Peve_00016828,Pocillopora_meandrina_HIv1___RNAseq.g22855.t1,three_way,79.2805,FUN_012698-T1,Q62901,RERE_RAT,,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-related protein),Rattus norvegicus (Rat),46.5,514.0,8.900000000000001e-124,446.4,sp|Q62901|RERE_RAT Arginine-glutamic acid dipeptide repeats protein OS=Rattus norvegicus OX=10116 GN=Rere PE=1 SV=2,GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0008270; GO:0016605; GO:0021549; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813,branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942],histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605],chromatin binding [GO:0003682]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006325; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; chromatin organization; organelle; anatomical structure development; cell motility; molecular adaptor activity; transcription regulator activity
OG_08396,0.3121669904748645,OG_08396,FUN_037010-T1,Peve_00032338,Pocillopora_meandrina_HIv1___RNAseq.g26698.t1,three_way,85.58966666666667,FUN_037010-T1,Q8N2G6,,,,,56.0,234.0,5.3e-63,242.7,sp|Q8N2G6|ZCH24_HUMAN Zinc finger CCHC domain-containing protein 24 OS=Homo sapiens OX=9606 GN=ZCCHC24 PE=1 SV=1,,,,,,
OG_02882,0.3120321373272195,OG_02882,FUN_011932-T1,Peve_00039643,Pocillopora_meandrina_HIv1___RNAseq.g23333.t1,three_way,85.123,FUN_011932-T1,Q8AVQ6,,,,,57.1,231.0,5.8e-66,252.3,sp|Q8AVQ6|SYF2_XENLA Pre-mRNA-splicing factor syf2 OS=Xenopus laevis OX=8355 GN=syf2 PE=2 SV=1,,,,,,
OG_09086,0.3119438416418282,OG_09086,FUN_038833-T1,Peve_00028686,Pocillopora_meandrina_HIv1___RNAseq.21094_t,three_way,62.954166666666666,FUN_038833-T1,O15169,AXIN1_HUMAN,,Axin-1 (Axis inhibition protein 1) (hAxin),Homo sapiens (Human),27.2,904.0,3.3e-52,208.4,sp|O15169|AXIN1_HUMAN Axin-1 OS=Homo sapiens OX=9606 GN=AXIN1 PE=1 SV=2,GO:0000209; GO:0001701; GO:0002039; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0009950; GO:0010629; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043539; GO:0044725; GO:0045599; GO:0045732; GO:0046330; GO:0046332; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:0120283; GO:1904885; GO:1990756; GO:1990909; GO:2000060,apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; beta-catenin destruction complex assembly [GO:1904885]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; epigenetic programming in the zygotic pronuclei [GO:0044725]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605],beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0006325; GO:0006355; GO:0006913; GO:0007010; GO:0012501; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0065003; GO:0098772,nucleus; nucleolus; cytosol; cytoskeleton; plasma membrane; chromatin organization; regulation of DNA-templated transcription; nucleocytoplasmic transport; cytoskeleton organization; programmed cell death; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity
OG_09630,0.311866634270711,OG_09630,FUN_041815-T1,Peve_00025189,Pocillopora_meandrina_HIv1___RNAseq.g15799.t1,three_way,65.50633333333333,FUN_041815-T1,Q92551,IP6K1_HUMAN,,Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1),Homo sapiens (Human),42.7,433.0,1.4e-86,321.6,sp|Q92551|IP6K1_HUMAN Inositol hexakisphosphate kinase 1 OS=Homo sapiens OX=9606 GN=IP6K1 PE=1 SV=3,GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0032958; GO:0043647; GO:0046854; GO:0052836; GO:0052839; GO:0120163,inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"ATP binding [GO:0005524]; diphosphoinositol pentakisphosphate kinase activity [GO:0000829]; diphosphoinositol tetrakisphosphate kinase activity [GO:0052839]; inositol 5-diphosphate pentakisphosphate 5-kinase activity [GO:0052836]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]",GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0016740; GO:0043226,catalytic activity; nucleus; nucleoplasm; cytosol; lipid metabolic process; transferase activity; organelle
OG_00296,0.3118498808933027,OG_00296,FUN_001087-T1,Peve_00003172,Pocillopora_meandrina_HIv1___RNAseq.g29386.t1,three_way,70.96266666666666,,,,,,,,,,,,,,,,,
OG_10010,0.3118496102104596,OG_10010,FUN_043245-T1,Peve_00001456,Pocillopora_meandrina_HIv1___TS.g20570.t1,three_way,67.59233333333333,FUN_043245-T1,Q60695,,,,,39.4,754.0,3.9e-110,400.6,sp|Q60695|RGL1_MOUSE Ral guanine nucleotide dissociation stimulator-like 1 OS=Mus musculus OX=10090 GN=Rgl1 PE=1 SV=2,,,,,,
OG_04689,0.3117855823795429,OG_04689,FUN_022480-T1,Peve_00002919,Pocillopora_meandrina_HIv1___RNAseq.g4299.t1,three_way,73.78766666666667,FUN_022480-T1,Q9UH92,MLX_HUMAN,,Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4),Homo sapiens (Human),61.2,188.0,1.8e-56,220.7,sp|Q9UH92|MLX_HUMAN Max-like protein X OS=Homo sapiens OX=9606 GN=MLX PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:0061629; GO:1990837,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_05307,0.3117443673688089,OG_05307,FUN_023981-T1,Peve_00020886,Pocillopora_meandrina_HIv1___RNAseq.g19442.t1,three_way,77.2305,FUN_023981-T1,P21440,MDR3_MOUSE,,Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 2) (Multidrug resistance protein 3) (P-glycoprotein 2) (P-glycoprotein 3),Mus musculus (Mouse),52.3,1273.0,0.0,1234.6,sp|P21440|MDR3_MOUSE Phosphatidylcholine translocator ABCB4 OS=Mus musculus OX=10090 GN=Abcb4 PE=1 SV=2,GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0016020; GO:0016324; GO:0016887; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0045121; GO:0045332; GO:0046581; GO:0055088; GO:0061092; GO:0090554; GO:0140359; GO:1901557; GO:1903413; GO:2001140,bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557],apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554],GO:0003824; GO:0005215; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0061024; GO:0140657,catalytic activity; transporter activity; nucleoplasm; cytosol; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; membrane organization; ATP-dependent activity
OG_03719,0.3116959118361205,OG_03719,FUN_014995-T1,Peve_00010955,Pocillopora_meandrina_HIv1___RNAseq.g21158.t1,three_way,83.375,FUN_014995-T1,Q23979,MY61F_DROME,,Unconventional myosin IC (MyoIC) (Brush border myosin IB) (BBMIB) (Myosin-IB) (MIB) (Unconventional myosin 1C) (Myo1C),Drosophila melanogaster (Fruit fly),55.3,1014.0,0.0,1112.4,sp|Q23979|MY61F_DROME Unconventional myosin IC OS=Drosophila melanogaster OX=7227 GN=Myo61F PE=1 SV=3,GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030048; GO:0032528; GO:0042742; GO:0048803; GO:0051015,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; endocytosis [GO:0006897]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; microvillus organization [GO:0032528],actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0003774; GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0016192; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; isomerase activity; reproductive process; organelle; anatomical structure development; ATP-dependent activity
OG_01489,0.3115997633695202,OG_01489,FUN_006165-T1,Peve_00023607,Pocillopora_meandrina_HIv1___RNAseq.g20426.t1,three_way,60.60533333333333,FUN_006165-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),33.7,5014.0,0.0,2299.2,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_08481,0.311529850491487,OG_08481,FUN_037310-T1,Peve_00011736,Pocillopora_meandrina_HIv1___RNAseq.g10709.t1,three_way,72.46583333333334,FUN_037310-T1,Q08CX1,,,,,28.3,853.0,6.6e-61,237.3,sp|Q08CX1|RASEF_XENTR Ras and EF-hand domain-containing protein OS=Xenopus tropicalis OX=8364 GN=rasef PE=2 SV=1,,,,,,
OG_07988,0.3113059066760112,OG_07988,FUN_035618-T1,Peve_00029653,Pocillopora_meandrina_HIv1___TS.g15425.t1,three_way,87.45883333333333,FUN_035618-T1,Q9Y5B9,,,,,59.7,937.0,0.0,1174.5,sp|Q9Y5B9|SP16H_HUMAN FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1,,,,,,
OG_07823,0.3112065320789299,OG_07823,FUN_035093-T1,Peve_00005803,Pocillopora_meandrina_HIv1___RNAseq.g27701.t1,three_way,95.78933333333332,FUN_035093-T1,Q7PD79,,,,,76.3,384.0,1.1e-172,607.4,sp|Q7PD79|GNAS_ANOGA Guanine nucleotide-binding protein G(s) subunit alpha OS=Anopheles gambiae OX=7165 GN=G-s-alpha-60A PE=2 SV=1,,,,,,
OG_09774,0.3111388081527417,OG_09774,FUN_042060-T1,Peve_00019715,Pocillopora_meandrina_HIv1___RNAseq.g22263.t1,three_way,39.5205,,,,,,,,,,,,,,,,,
OG_00513,0.3111335547581225,OG_00513,FUN_001505-T1,Peve_00012116,Pocillopora_meandrina_HIv1___RNAseq.g1889.t1,three_way,55.97966666666667,,,,,,,,,,,,,,,,,
OG_09236,0.3110779215874774,OG_09236,FUN_039982-T1,Peve_00014323,Pocillopora_meandrina_HIv1___RNAseq.g7548.t1,three_way,78.11166666666666,FUN_039982-T1,Q9R0C8,VAV3_MOUSE,,Guanine nucleotide exchange factor VAV3 (VAV-3),Mus musculus (Mouse),36.8,766.0,1.9e-123,444.9,sp|Q9R0C8|VAV3_MOUSE Guanine nucleotide exchange factor VAV3 OS=Mus musculus OX=10090 GN=Vav3 PE=1 SV=2,GO:0001525; GO:0001772; GO:0005085; GO:0005154; GO:0005737; GO:0005886; GO:0006906; GO:0006974; GO:0007229; GO:0007264; GO:0008270; GO:0008361; GO:0009410; GO:0016477; GO:0030031; GO:0030032; GO:0030593; GO:0030890; GO:0045785; GO:0050853; GO:0051897,angiogenesis [GO:0001525]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; DNA damage response [GO:0006974]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; neutrophil chemotaxis [GO:0030593]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell adhesion [GO:0045785]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of cell size [GO:0008361]; response to xenobiotic stimulus [GO:0009410]; small GTPase-mediated signal transduction [GO:0007264]; vesicle fusion [GO:0006906],cytoplasm [GO:0005737]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886],epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270],GO:0002376; GO:0005886; GO:0048870; GO:0061024; GO:0098772,immune system process; plasma membrane; cell motility; membrane organization; molecular function regulator activity
OG_00214,0.3110140645823679,OG_00214,FUN_000933-T1,Peve_00009727,Pocillopora_meandrina_HIv1___RNAseq.g29459.t1,three_way,43.35483333333333,,,,,,,,,,,,,,,,,
OG_07351,0.3109181364146422,OG_07351,FUN_033759-T1,Peve_00009253,Pocillopora_meandrina_HIv1___RNAseq.g28744.t1,three_way,61.443,FUN_033759-T1,Q28005,LSHR_BOVIN,,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R),Bos taurus (Bovine),36.1,498.0,3.2000000000000003e-80,301.6,sp|Q28005|LSHR_BOVIN Lutropin-choriogonadotropic hormone receptor OS=Bos taurus OX=9913 GN=LHCGR PE=2 SV=1,GO:0001541; GO:0004964; GO:0005886; GO:0007189; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0042700; GO:0071373,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_03941,0.31074582909005,OG_03941,FUN_016076-T1,Peve_00021921,Pocillopora_meandrina_HIv1___RNAseq.g21616.t1,three_way,70.497,FUN_016076-T1,Q9C9C6,,,,,49.4,180.0,1.2e-34,147.9,sp|Q9C9C6|RL62_ARATH Large ribosomal subunit protein eL6y OS=Arabidopsis thaliana OX=3702 GN=RPL6B PE=2 SV=1,,,,,,
OG_04345,0.3106833431864663,OG_04345,FUN_017967-T1,Peve_00000394,Pocillopora_meandrina_HIv1___RNAseq.g25247.t1,three_way,83.32000000000001,FUN_017967-T1,Q0IID7,DUS10_BOVIN,,Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48),Bos taurus (Bovine),40.2,323.0,1.2e-64,248.4,sp|Q0IID7|DUS10_BOVIN Dual specificity protein phosphatase 10 OS=Bos taurus OX=9913 GN=DUSP10 PE=2 SV=1,GO:0002819; GO:0004722; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008330; GO:0008432; GO:0010633; GO:0017017; GO:0032496; GO:0032873; GO:0033549; GO:0033550; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0050680; GO:0051403; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042,negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; negative regulation of stress-activated MAPK cascade [GO:0032873]; oligodendrocyte differentiation [GO:0048709]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0030154; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; cell differentiation; catalytic activity, acting on a protein"
OG_04571,0.3106676641419366,OG_04571,FUN_022218-T1,Peve_00028321,Pocillopora_meandrina_HIv1___RNAseq.g4733.t1c,three_way,83.12133333333334,FUN_022218-T1,Q6QN10,,,,,66.3,181.0,2.999999999999999e-47,189.9,sp|Q6QN10|NACA_CHILA Nascent polypeptide-associated complex subunit alpha OS=Chinchilla lanigera OX=34839 PE=2 SV=1,,,,,,
OG_00081,0.310634663082087,OG_00081,FUN_000409-T1,Peve_00033505,Pocillopora_meandrina_HIv1___RNAseq.g2517.t1,three_way,55.74733333333334,FUN_000409-T1,Q6A044,,,,,26.9,312.0,9.8e-18,93.2,sp|Q6A044|EREP2_MOUSE Protein ENTREP2 OS=Mus musculus OX=10090 GN=Entrep2 PE=2 SV=3,,,,,,
OG_09170,0.3105073112502451,OG_09170,FUN_039836-T1,Peve_00006312,Pocillopora_meandrina_HIv1___RNAseq.g7301.t1,three_way,84.05966666666666,FUN_039836-T1,Q5R971,HEM2_PONAB,,Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),66.0,326.0,4.3e-125,449.1,sp|Q5R971|HEM2_PONAB Delta-aminolevulinic acid dehydratase OS=Pongo abelii OX=9601 GN=ALAD PE=2 SV=2,GO:0004655; GO:0005829; GO:0006782; GO:0006783; GO:0008270,heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],cytosol [GO:0005829],porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016829,catalytic activity; cytosol; lyase activity
OG_01033,0.3104956505306259,OG_01033,FUN_004468-T1,Peve_00007166,Pocillopora_meandrina_HIv1___RNAseq.g4953.t1,three_way,63.32233333333333,FUN_004468-T1,P23727,P85A_BOVIN,,Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha),Bos taurus (Bovine),32.1,636.0,1.2e-79,299.7,sp|P23727|P85A_BOVIN Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Bos taurus OX=9913 GN=PIK3R1 PE=1 SV=1,GO:0001678; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005942; GO:0005943; GO:0008286; GO:0015031; GO:0032869; GO:0033120; GO:0034446; GO:0034976; GO:0035014; GO:0042307; GO:0042802; GO:0043066; GO:0043125; GO:0043491; GO:0043548; GO:0043560; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0140767; GO:0141038; GO:1900103; GO:1903078,cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular glucose homeostasis [GO:0001678]; negative regulation of apoptotic process [GO:0043066]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446],"nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]",1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; enzyme-substrate adaptor activity [GO:0140767]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0005634; GO:0006355; GO:0006629; GO:0007155; GO:0043226; GO:0060090; GO:0098772,nucleus; regulation of DNA-templated transcription; lipid metabolic process; cell adhesion; organelle; molecular adaptor activity; molecular function regulator activity
OG_08012,0.3104916645817995,OG_08012,FUN_035665-T1,Peve_00002788,Pocillopora_meandrina_HIv1___RNAseq.g28121.t1,three_way,70.55033333333334,FUN_035665-T1,Q9NRH2,,,,,66.7,330.0,4.4e-126,453.8,sp|Q9NRH2|SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=SNRK PE=1 SV=2,,,,,,
OG_00479,0.3102954272081127,OG_00479,FUN_001418-T1,Peve_00008742,Pocillopora_meandrina_HIv1___RNAseq.g2097.t1,three_way,81.65133333333334,FUN_001418-T1,P32198,CPT1A_RAT,,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",Rattus norvegicus (Rat),49.2,765.0,3.5e-218,759.6,"sp|P32198|CPT1A_RAT Carnitine O-palmitoyltransferase 1, liver isoform OS=Rattus norvegicus OX=10116 GN=Cpt1a PE=1 SV=2",GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0007584; GO:0009410; GO:0009437; GO:0030674; GO:0030855; GO:0031667; GO:0031998; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0046320; GO:0050796; GO:0071398; GO:0097421; GO:1904772,aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006629; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; lipid metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity
OG_05718,0.3101480295987837,OG_05718,FUN_025610-T1,Peve_00009537,Pocillopora_meandrina_HIv1___RNAseq.g23128.t1,three_way,58.688833333333335,FUN_025610-T1,Q07497,,,,,34.9,935.0,3.6999999999999996e-147,523.9,sp|Q07497|EPHB5_CHICK Ephrin type-B receptor 5 OS=Gallus gallus OX=9031 GN=EPHB5 PE=2 SV=1,,,,,,
OG_02298,0.3100911651515157,OG_02298,FUN_008877-T1,Peve_00043352,Pocillopora_meandrina_HIv1___TS.g30031.t1,three_way,72.87216666666667,FUN_008877-T1,Q8IZQ1,WDFY3_HUMAN,,WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy),Homo sapiens (Human),36.1,2785.0,0.0,1567.7,sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2,GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204,aggrephagy [GO:0035973],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605],1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270],GO:0005635; GO:0005654; GO:0005730; GO:0005773; GO:0005829; GO:0005886; GO:0006914; GO:0008289; GO:0043226,nuclear envelope; nucleoplasm; nucleolus; vacuole; cytosol; plasma membrane; autophagy; lipid binding; organelle
OG_07951,0.3100517891112678,OG_07951,FUN_035476-T1,Peve_00033971,Pocillopora_meandrina_HIv1___TS.g14334.t1b,three_way,75.7615,FUN_035476-T1,Q58EX7,PKHG4_HUMAN,,Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1),Homo sapiens (Human),31.9,906.0,1.4e-119,433.0,sp|Q58EX7|PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056,axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0098772,cytosol; plasma membrane; molecular function regulator activity
OG_05942,0.3099062692573012,OG_05942,FUN_026179-T1,Peve_00012698,Pocillopora_meandrina_HIv1___RNAseq.g3034.t1,three_way,82.133,FUN_026179-T1,O02695,,,,,58.0,440.0,8.500000000000001e-133,476.1,sp|O02695|PTPR2_MACNE Receptor-type tyrosine-protein phosphatase N2 OS=Macaca nemestrina OX=9545 GN=PTPRN2 PE=2 SV=1,,,,,,
OG_01884,0.3098846387052493,OG_01884,FUN_007860-T1,Peve_00044448,Pocillopora_meandrina_HIv1___TS.g21287.t1,three_way,81.536,FUN_007860-T1,Q6ZPV2,,,,,48.0,1450.0,1.3e-305,1051.2,sp|Q6ZPV2|INO80_MOUSE Chromatin-remodeling ATPase INO80 OS=Mus musculus OX=10090 GN=Ino80 PE=1 SV=2,,,,,,
OG_02292,0.3096209879769365,OG_02292,FUN_008860-T1,Peve_00002936,Pocillopora_meandrina_HIv1___RNAseq.g30.t1,three_way,63.93383333333333,FUN_008860-T1,Q96M96,,,,,41.2,556.0,2.9e-110,401.4,"sp|Q96M96|FGD4_HUMAN FYVE, RhoGEF and PH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=FGD4 PE=1 SV=2",,,,,,
OG_04299,0.3094834426767288,OG_04299,FUN_017868-T1,Peve_00020409,Pocillopora_meandrina_HIv1___RNAseq.g9556.t1,three_way,92.76516666666666,FUN_017868-T1,Q6DKN2,,,,,73.3,86.0,6.7e-28,125.6,sp|Q6DKN2|OTX2B_XENLA Homeobox protein OTX2-B OS=Xenopus laevis OX=8355 GN=otx2-b PE=2 SV=1,,,,,,
OG_00853,0.3094427826234696,OG_00853,FUN_004115-T1,Peve_00008071,Pocillopora_meandrina_HIv1___RNAseq.g11666.t1,three_way,69.32233333333333,FUN_004115-T1,O94632,EGT1_SCHPO,,Ergothioneine biosynthesis protein 1 (Meiotically up-regulated gene 158 protein) [Includes: L-histidine N(alpha)-methyltransferase (EC 2.1.1.44); Hercynylcysteine S-oxide synthase (EC 1.21.3.10)],Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),28.3,184.0,1.9e-09,66.2,sp|O94632|EGT1_SCHPO Ergothioneine biosynthesis protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=egt1 PE=1 SV=4,GO:0004497; GO:0005509; GO:0005634; GO:0005829; GO:0032259; GO:0051321; GO:0052699; GO:0052706; GO:0061686; GO:1903257,ergothioneine biosynthetic process [GO:0052699]; meiotic cell cycle [GO:0051321]; methylation [GO:0032259]; selenoneine biosynthetic process [GO:1903257],cytosol [GO:0005829]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; hercynylcysteine sulfoxide synthase activity [GO:0061686]; L-histidine N(alpha)-methyltransferase activity [GO:0052706]; monooxygenase activity [GO:0004497],GO:0003824; GO:0005634; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740; GO:0022414; GO:0043226,catalytic activity; nucleus; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity; reproductive process; organelle
OG_07701,0.3093188719472758,OG_07701,FUN_034835-T1,Peve_00007812,Pocillopora_meandrina_HIv1___RNAseq.g27183.t1,three_way,81.74166666666667,FUN_034835-T1,Q8N4L2,PP4P2_HUMAN,,"Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 2 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase II) (Transmembrane protein 55A)",Homo sapiens (Human),49.7,197.0,3.5e-48,193.4,"sp|Q8N4L2|PP4P2_HUMAN Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase OS=Homo sapiens OX=9606 GN=PIP4P2 PE=1 SV=1",GO:0005765; GO:0005886; GO:0030670; GO:0031902; GO:0034597; GO:0046856; GO:0050765,negative regulation of phagocytosis [GO:0050765]; phosphatidylinositol dephosphorylation [GO:0046856],late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886],"phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]",GO:0003824; GO:0005886; GO:0006629; GO:0016787,catalytic activity; plasma membrane; lipid metabolic process; hydrolase activity
OG_00445,0.3092588186076844,OG_00445,FUN_001364-T1,Peve_00036776,Pocillopora_meandrina_HIv1___RNAseq.g2147.t1,three_way,89.03099999999999,FUN_001364-T1,Q9BSF8,,,,,69.5,272.0,4.999999999999999e-112,406.0,sp|Q9BSF8|BTBDA_HUMAN BTB/POZ domain-containing protein 10 OS=Homo sapiens OX=9606 GN=BTBD10 PE=1 SV=2,,,,,,
OG_02448,0.3089315344516506,OG_02448,FUN_009519-T1,Peve_00014186,Pocillopora_meandrina_HIv1___RNAseq.g24501.t1,three_way,81.64666666666666,FUN_009519-T1,Q02874,H2AY_RAT,,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (H2A.y) (H2A/y),Rattus norvegicus (Rat),55.9,381.0,1.7e-101,370.9,sp|Q02874|H2AY_RAT Core histone macro-H2A.1 OS=Rattus norvegicus OX=10116 GN=Macroh2a1 PE=1 SV=5,GO:0000122; GO:0000182; GO:0000228; GO:0000785; GO:0000786; GO:0000793; GO:0000976; GO:0000977; GO:0001740; GO:0002082; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006281; GO:0006334; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0030527; GO:0031490; GO:0031492; GO:0031507; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0071169; GO:0072570; GO:0090734; GO:0160002; GO:1901837; GO:1902688; GO:1902750; GO:1902882; GO:1903226; GO:1904815; GO:1990841,"DNA repair [GO:0006281]; epigenetic regulation of gene expression [GO:0040029]; establishment of protein localization to chromatin [GO:0071169]; heterochromatin formation [GO:0031507]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of NAD metabolic process [GO:1902688]; regulation of oxidative phosphorylation [GO:0002082]; regulation of response to oxidative stress [GO:1902882]; sex-chromosome dosage compensation [GO:0007549]; transcription initiation-coupled chromatin remodeling [GO:0045815]",Barr body [GO:0001740]; chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734],ADP-D-ribose binding [GO:0072570]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; structural constituent of chromatin [GO:0030527]; transcription cis-regulatory region binding [GO:0000976],GO:0000228; GO:0003677; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006325; GO:0006355; GO:0043226; GO:0065003; GO:0098772,nuclear chromosome; DNA binding; structural molecule activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; chromatin organization; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; molecular function regulator activity
OG_01114,0.3088983355084616,OG_01114,FUN_004657-T1,Peve_00035095,Pocillopora_meandrina_HIv1___RNAseq.g8740.t1,three_way,89.96,FUN_004657-T1,P21575,,,,,67.2,589.0,7.3e-232,804.7,sp|P21575|DYN1_RAT Dynamin-1 OS=Rattus norvegicus OX=10116 GN=Dnm1 PE=1 SV=2,,,,,,
OG_03695,0.3088316809377619,OG_03695,FUN_014964-T1,Peve_00006258,Pocillopora_meandrina_HIv1___RNAseq.g21128.t1,three_way,88.101,FUN_014964-T1,A7S338,LIS1_NEMVE,,Lissencephaly-1 homolog,Nematostella vectensis (Starlet sea anemone),86.2,348.0,4.0000000000000006e-80,300.1,sp|A7S338|LIS1_NEMVE Lissencephaly-1 homolog OS=Nematostella vectensis OX=45351 GN=v1g242515 PE=3 SV=1,GO:0000132; GO:0000776; GO:0005635; GO:0005813; GO:0005875; GO:0005881; GO:0007097; GO:0031023; GO:0047496; GO:0051010; GO:0051012; GO:0051301; GO:0070840; GO:1990234,cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; vesicle transport along microtubule [GO:0047496],centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; nuclear envelope [GO:0005635]; transferase complex [GO:1990234],dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010],GO:0005635; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0043226,nuclear envelope; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; organelle
OG_08829,0.3088298818580773,OG_08829,FUN_038166-T1,Peve_00025794,Pocillopora_meandrina_HIv1___RNAseq.g1069.t1,three_way,75.97183333333332,FUN_038166-T1,P85037,FOXK1_HUMAN,,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),Homo sapiens (Human),48.9,499.0,9.7e-110,399.1,sp|P85037|FOXK1_HUMAN Forkhead box protein K1 OS=Homo sapiens OX=9606 GN=FOXK1 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007517; GO:0010507; GO:0010906; GO:0030154; GO:0042594; GO:0045892; GO:0045893; GO:0061621; GO:0071889; GO:1990837,canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; intracellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005975; GO:0006091; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0140110; GO:1901135,DNA binding; nucleus; nucleoplasm; carbohydrate metabolic process; generation of precursor metabolites and energy; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; transcription regulator activity; carbohydrate derivative metabolic process
OG_04256,0.3088222986244284,OG_04256,FUN_017787-T1,Peve_00040530,Pocillopora_meandrina_HIv1___RNAseq.g9522.t1,three_way,41.8165,FUN_017787-T1,Q5VT06,CE350_HUMAN,,Centrosome-associated protein 350 (Cep350) (Centrosome-associated protein of 350 kDa),Homo sapiens (Human),39.4,66.0,1.1e-06,56.2,sp|Q5VT06|CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens OX=9606 GN=CEP350 PE=1 SV=1,GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0008017; GO:0016020; GO:0034453; GO:0036064; GO:0043231; GO:0071539; GO:1905515,microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008092; GO:0043226; GO:0044782,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; cytoskeletal protein binding; organelle; cilium organization
OG_09324,0.3088154625843746,OG_09324,FUN_040241-T1,Peve_00018573,Pocillopora_meandrina_HIv1___RNAseq.g7782.t1,three_way,95.93533333333332,FUN_040241-T1,Q7ZVZ7,,,,,75.6,287.0,3.9e-138,492.3,sp|Q7ZVZ7|AB17C_DANRE Alpha/beta hydrolase domain-containing protein 17C OS=Danio rerio OX=7955 GN=abhd17c PE=2 SV=1,,,,,,
OG_04664,0.3087170199024644,OG_04664,FUN_022412-T1,Peve_00037635,Pocillopora_meandrina_HIv1___RNAseq.18822_t,three_way,91.77833333333334,FUN_022412-T1,Q15382,,,,,70.5,156.0,5.100000000000001e-59,228.8,sp|Q15382|RHEB_HUMAN GTP-binding protein Rheb OS=Homo sapiens OX=9606 GN=RHEB PE=1 SV=1,,,,,,
OG_10111,0.3086899731727049,OG_10111,FUN_043481-T1,Peve_00021726,Pocillopora_meandrina_HIv1___RNAseq.g7917.t1,three_way,78.01516666666667,FUN_043481-T1,Q6GLQ4,,,,,30.6,710.0,2.3999999999999998e-39,165.6,sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1,,,,,,
OG_05599,0.3086735154024639,OG_05599,FUN_025140-T1,Peve_00020870,Pocillopora_meandrina_HIv1___RNAseq.g19432.t1,three_way,82.82633333333334,FUN_025140-T1,Q14135,,,,,29.6,287.0,6.5e-11,69.3,sp|Q14135|VGLL4_HUMAN Transcription cofactor vestigial-like protein 4 OS=Homo sapiens OX=9606 GN=VGLL4 PE=1 SV=5,,,,,,
OG_01846,0.3085867155612845,OG_01846,FUN_007795-T1,Peve_00022050,Pocillopora_meandrina_HIv1___TS.g21334.t1,three_way,60.86366666666667,FUN_007795-T1,Q9NR09,BIRC6_HUMAN,,Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),Homo sapiens (Human),29.0,4083.0,0.0,1173.3,sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3,GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237,apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802],cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; nucleus; endosome; microtubule organizing center; cytosol; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06846,0.3084745884011641,OG_06846,FUN_031787-T1,Peve_00019324,Pocillopora_meandrina_HIv1___RNAseq.g5568.t1,three_way,65.77866666666667,FUN_031787-T1,A7Z026,,,,,44.6,294.0,6.300000000000001e-65,250.4,sp|A7Z026|PPR37_BOVIN Protein phosphatase 1 regulatory subunit 37 OS=Bos taurus OX=9913 GN=PPP1R37 PE=2 SV=1,,,,,,
OG_05875,0.3084310486699895,OG_05875,FUN_026024-T1,Peve_00026729,Pocillopora_meandrina_HIv1___RNAseq.g10496.t1,three_way,59.858,FUN_026024-T1,O46392,,,,,37.0,216.0,5.4e-35,152.1,sp|O46392|CO1A2_CANLF Collagen alpha-2(I) chain OS=Canis lupus familiaris OX=9615 GN=COL1A2 PE=2 SV=2,,,,,,
OG_03593,0.3084234523681574,OG_03593,FUN_014751-T1,Peve_00039157,Pocillopora_meandrina_HIv1___RNAseq.g22448.t2,three_way,67.324,,,,,,,,,,,,,,,,,
OG_01419,0.3082616997363056,OG_01419,FUN_005730-T1,Peve_00004979,Pocillopora_meandrina_HIv1___RNAseq.3034_t,three_way,61.8795,FUN_005730-T1,Q6BEA0,PLXA4_DANRE,,Plexin-A4,Danio rerio (Zebrafish) (Brachydanio rerio),37.4,1904.0,3.2e-310,1066.6,sp|Q6BEA0|PLXA4_DANRE Plexin-A4 OS=Danio rerio OX=7955 GN=plxna4 PE=2 SV=1,GO:0001763; GO:0002116; GO:0005886; GO:0007411; GO:0007414; GO:0007416; GO:0016020; GO:0017154; GO:0030334; GO:0071526,axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416],membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116],semaphorin receptor activity [GO:0017154],GO:0005886; GO:0034330; GO:0060089,plasma membrane; cell junction organization; molecular transducer activity
OG_01796,0.3081554205945923,OG_01796,FUN_007181-T1,Peve_00015050,Pocillopora_meandrina_HIv1___RNAseq.g19781.t1,three_way,79.889,FUN_007181-T1,Q80UM3,NAA15_MOUSE,,"N-alpha-acetyltransferase 15, NatA auxiliary subunit (N-terminal acetyltransferase 1) (NMDA receptor-regulated protein 1) (Protein tubedown-1)",Mus musculus (Mouse),59.2,833.0,7.7e-267,921.4,"sp|Q80UM3|NAA15_MOUSE N-alpha-acetyltransferase 15, NatA auxiliary subunit OS=Mus musculus OX=10090 GN=Naa15 PE=1 SV=1",GO:0001525; GO:0005634; GO:0005737; GO:0008080; GO:0030154; GO:0048471,angiogenesis [GO:0001525]; cell differentiation [GO:0030154],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],N-acetyltransferase activity [GO:0008080],GO:0003824; GO:0005634; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nucleus; transferase activity; cell differentiation; organelle
OG_05047,0.3081491846401081,OG_05047,FUN_023236-T1,Peve_00029852,Pocillopora_meandrina_HIv1___TS.g16967.t1,three_way,66.868,FUN_023236-T1,Q8AW42,,,,,44.2,353.0,1.7e-70,268.1,sp|Q8AW42|S39AD_DANRE Zinc transporter ZIP13 OS=Danio rerio OX=7955 GN=slc39a13 PE=2 SV=1,,,,,,
OG_08142,0.3081326863191063,OG_08142,FUN_035907-T1,Peve_00006737,Pocillopora_meandrina_HIv1___RNAseq.g12031.t1,three_way,87.19116666666667,FUN_035907-T1,Q5RE09,DC1L2_PONAB,,"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),51.2,477.0,2.9e-122,440.3,sp|Q5RE09|DC1L2_PONAB Cytoplasmic dynein 1 light intermediate chain 2 OS=Pongo abelii OX=9601 GN=DYNC1LI2 PE=2 SV=1,GO:0000226; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045504,microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874],ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504],GO:0005815; GO:0007010; GO:0007018,microtubule organizing center; cytoskeleton organization; microtubule-based movement
OG_01494,0.3081008240824038,OG_01494,FUN_006172-T1,Peve_00028675,Pocillopora_meandrina_HIv1___RNAseq.g20432.t1,three_way,61.756,FUN_006172-T1,Q9QXG2,,,,,42.3,684.0,1.2000000000000002e-124,448.7,sp|Q9QXG2|RAE1_MOUSE Rab proteins geranylgeranyltransferase component A 1 OS=Mus musculus OX=10090 GN=Chm PE=1 SV=1,,,,,,
OG_09617,0.3080715529551923,OG_09617,FUN_041777-T1,Peve_00042840,Pocillopora_meandrina_HIv1___RNAseq.g15886.t1,three_way,86.59949999999999,FUN_041777-T1,Q13627,DYR1A_HUMAN,,Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.11.23) (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB),Homo sapiens (Human),78.0,410.0,2.1e-190,667.2,sp|Q13627|DYR1A_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Homo sapiens OX=9606 GN=DYRK1A PE=1 SV=2,GO:0000381; GO:0003713; GO:0003779; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007399; GO:0007623; GO:0008092; GO:0008353; GO:0015631; GO:0016607; GO:0018108; GO:0030424; GO:0030425; GO:0031115; GO:0031452; GO:0033120; GO:0042802; GO:0043518; GO:0045893; GO:0046777; GO:0048025; GO:0048156; GO:0050321; GO:0106310; GO:0140857; GO:1902003; GO:1902996; GO:1990904; GO:1990935,"circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of heterochromatin formation [GO:0031452]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of RNA splicing [GO:0033120]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of amyloid-beta formation [GO:1902003]; regulation of neurofibrillary tangle assembly [GO:1902996]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; histone H3T45 kinase activity [GO:0140857]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; splicing factor binding [GO:1990935]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_05850,0.3079926187709055,OG_05850,FUN_025923-T1,Peve_00018907,Pocillopora_meandrina_HIv1___TS.g13940.t2,three_way,74.94983333333333,FUN_025923-T1,A1A5K2,CLA1B_XENLA,,CLIP-associating protein 1-B (Cytoplasmic linker-associated protein 1-B) (Protein Orbit homolog) (Xorbit) (Xorbit/CLASP),Xenopus laevis (African clawed frog),42.2,756.0,1.2e-134,482.3,sp|A1A5K2|CLA1B_XENLA CLIP-associating protein 1-B OS=Xenopus laevis OX=8355 GN=clasp1b PE=1 SV=1,GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0008017; GO:0031023; GO:0031110; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307; GO:1902903,cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of supramolecular fiber organization [GO:1902903],basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876],kinetochore binding [GO:0043515]; microtubule binding [GO:0008017],GO:0005794; GO:0005815; GO:0007010; GO:0008092; GO:0043226,Golgi apparatus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_07049,0.3078034687563954,OG_07049,FUN_032255-T1,Peve_00014264,Pocillopora_meandrina_HIv1___RNAseq.g24905.t1,three_way,70.49433333333333,FUN_032255-T1,O43909,EXTL3_HUMAN,,Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3),Homo sapiens (Human),46.1,855.0,2.3e-207,723.8,sp|O43909|EXTL3_HUMAN Exostosin-like 3 OS=Homo sapiens OX=9606 GN=EXTL3 PE=1 SV=1,GO:0000287; GO:0001888; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006486; GO:0010838; GO:0015012; GO:0016500; GO:0016757; GO:0030307; GO:0045617; GO:0050728; GO:0051897; GO:0106015; GO:1900016; GO:2000972,heparan sulfate proteoglycan biosynthetic process [GO:0015012]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of keratinocyte differentiation [GO:0045617]; positive regulation of cell growth [GO:0030307]; positive regulation of detection of glucose [GO:2000972]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein glycosylation [GO:0006486],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886],glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; magnesium ion binding [GO:0000287]; protein-hormone receptor activity [GO:0016500],GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0005886; GO:0006486; GO:0009101; GO:0016740; GO:0043226; GO:0060089; GO:1901135,catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; plasma membrane; protein glycosylation; glycoprotein biosynthetic process; transferase activity; organelle; molecular transducer activity; carbohydrate derivative metabolic process
OG_03402,0.3075672622593164,OG_03402,FUN_014441-T1,Peve_00009614,Pocillopora_meandrina_HIv1___RNAseq.g22836.t1,three_way,66.44333333333333,FUN_014441-T1,Q6PDY2,AEDO_MOUSE,,2-aminoethanethiol dioxygenase (EC 1.13.11.19) (Cysteamine dioxygenase),Mus musculus (Mouse),34.8,264.0,2.0000000000000002e-29,131.0,sp|Q6PDY2|AEDO_MOUSE 2-aminoethanethiol dioxygenase OS=Mus musculus OX=10090 GN=Ado PE=1 SV=2,GO:0005506; GO:0005739; GO:0047800; GO:0071456,cellular response to hypoxia [GO:0071456],mitochondrion [GO:0005739],cysteamine dioxygenase activity [GO:0047800]; iron ion binding [GO:0005506],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_05649,0.3074891657470619,OG_05649,FUN_025372-T1,Peve_00040522,Pocillopora_meandrina_HIv1___RNAseq.g13329.t1,three_way,85.562,FUN_025372-T1,Q92997,DVL3_HUMAN,,Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3),Homo sapiens (Human),61.0,485.0,3.2e-124,447.2,sp|Q92997|DVL3_HUMAN Segment polarity protein dishevelled homolog DVL-3 OS=Homo sapiens OX=9606 GN=DVL3 PE=1 SV=2,GO:0000785; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0009410; GO:0031267; GO:0032880; GO:0032956; GO:0035556; GO:0035567; GO:0043547; GO:0045893; GO:0045944; GO:0046330; GO:0050821; GO:0060070; GO:0060071; GO:0150012,"canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein localization [GO:0032880]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",chromatin [GO:0000785]; cytosol [GO:0005829],beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267],GO:0005829; GO:0006355,cytosol; regulation of DNA-templated transcription
OG_00599,0.3073258682140911,OG_00599,FUN_001747-T1,Peve_00023224,Pocillopora_meandrina_HIv1___RNAseq.13551_t,three_way,50.601,,,,,,,,,,,,,,,,,
OG_06080,0.307249005339979,OG_06080,FUN_027065-T1,Peve_00012227,Pocillopora_meandrina_HIv1___RNAseq.g2816.t1,three_way,66.86916666666667,FUN_027065-T1,A2AG06,MEIOC_MOUSE,,Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein),Mus musculus (Mouse),46.5,114.0,4.8e-14,80.9,sp|A2AG06|MEIOC_MOUSE Meiosis-specific coiled-coil domain-containing protein MEIOC OS=Mus musculus OX=10090 GN=Meioc PE=1 SV=1,GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192,"chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase chromosome alignment [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]",cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0006281; GO:0022414; GO:0043226; GO:0048856; GO:0140013,nucleus; DNA repair; reproductive process; organelle; anatomical structure development; meiotic nuclear division
OG_06574,0.3072300980370676,OG_06574,FUN_029519-T1,Peve_00022876,Pocillopora_meandrina_HIv1___TS.g2888.t1,three_way,93.70616666666666,FUN_029519-T1,Q9JHU4,DYHC1_MOUSE,,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",Mus musculus (Mouse),73.3,4665.0,0.0,6825.7,sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2,GO:0003341; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0008569; GO:0016887; GO:0030175; GO:0030286; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1905832,cell division [GO:0051301]; cilium movement [GO:0003341]; establishment of spindle localization [GO:0051293]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; filopodium [GO:0030175]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0016787; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; hydrolase activity; isomerase activity; ATP-dependent activity
OG_03368,0.3070943585529975,OG_03368,FUN_013613-T1,Peve_00002659,Pocillopora_meandrina_HIv1___RNAseq.g13533.t1,three_way,54.56916666666667,FUN_013613-T1,Q9P2K9,DISP3_HUMAN,,Protein dispatched homolog 3 (Patched domain-containing protein 2),Homo sapiens (Human),35.0,1203.0,7.2e-160,566.6,sp|Q9P2K9|DISP3_HUMAN Protein dispatched homolog 3 OS=Homo sapiens OX=9606 GN=DISP3 PE=1 SV=2,GO:0005737; GO:0005783; GO:0005789; GO:0007224; GO:0008203; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0032368; GO:0042632; GO:0045665; GO:0045834; GO:2000179,cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of lipid transport [GO:0032368]; smoothened signaling pathway [GO:0007224],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965],,GO:0005783; GO:0006629; GO:0030154; GO:0043226,endoplasmic reticulum; lipid metabolic process; cell differentiation; organelle
OG_07684,0.307043226254365,OG_07684,FUN_034803-T1,Peve_00007553,Pocillopora_meandrina_HIv1___RNAseq.g12304.t1,three_way,77.09400000000001,FUN_034803-T1,Q4R4P4,FA2H_MACFA,,Fatty acid 2-hydroxylase (EC 1.14.18.-) (Fatty acid alpha-hydroxylase),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),45.3,364.0,2.4e-84,313.9,sp|Q4R4P4|FA2H_MACFA Fatty acid 2-hydroxylase OS=Macaca fascicularis OX=9541 GN=FA2H PE=2 SV=1,GO:0005506; GO:0005789; GO:0006633; GO:0006679; GO:0006682; GO:0016020; GO:0020037; GO:0044857; GO:0046513; GO:0061436; GO:0080132; GO:0120520,ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid biosynthetic process [GO:0006633]; galactosylceramide biosynthetic process [GO:0006682]; glucosylceramide biosynthetic process [GO:0006679]; plasma membrane raft organization [GO:0044857],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],fatty acid 2-hydroxylase activity [GO:0080132]; free fatty acid 2-hydroxylase activity [GO:0120520]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0048856; GO:0061024; GO:1901135,catalytic activity; lipid metabolic process; oxidoreductase activity; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_06708,0.3070416032798678,OG_06708,FUN_031289-T1,Peve_00026529,Pocillopora_meandrina_HIv1___RNAseq.g5169.t1,three_way,74.811,FUN_031289-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),58.3,599.0,8.2e-179,629.8,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_08952,0.3068240929635915,OG_08952,FUN_038426-T1,Peve_00000114,Pocillopora_meandrina_HIv1___RNAseq.g1178.t1,three_way,77.04633333333334,FUN_038426-T1,F1R8Z9,FXJ1B_DANRE,,Forkhead box protein J1-B,Danio rerio (Zebrafish) (Brachydanio rerio),45.4,282.0,2.2e-51,204.5,sp|F1R8Z9|FXJ1B_DANRE Forkhead box protein J1-B OS=Danio rerio OX=7955 GN=foxj1b PE=2 SV=1,GO:0000978; GO:0000981; GO:0001947; GO:0003146; GO:0005634; GO:0006357; GO:0007368; GO:0044458; GO:0060088; GO:0060271,auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0044782; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cilium organization; transcription regulator activity
OG_09169,0.30666571334513,OG_09169,FUN_039835-T1,Peve_00005154,Pocillopora_meandrina_HIv1___RNAseq.4974_t,three_way,57.41133333333333,,,,,,,,,,,,,,,,,
OG_06201,0.3065765890077995,OG_06201,FUN_028135-T1,Peve_00004259,Pocillopora_meandrina_HIv1___RNAseq.g15553.t1,three_way,87.28,FUN_028135-T1,P53619,COPD_BOVIN,,Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP),Bos taurus (Bovine),59.6,512.0,5.2e-170,599.0,sp|P53619|COPD_BOVIN Coatomer subunit delta OS=Bos taurus OX=9913 GN=ARCN1 PE=1 SV=1,GO:0000139; GO:0005783; GO:0006888; GO:0006890; GO:0006891; GO:0008344; GO:0015031; GO:0021691; GO:0030126; GO:0043473; GO:0051645,"adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intra-Golgi vesicle-mediated transport [GO:0006891]; pigmentation [GO:0043473]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139],,GO:0005783; GO:0016192; GO:0043226,endoplasmic reticulum; vesicle-mediated transport; organelle
OG_08861,0.3065533234662047,OG_08861,FUN_038247-T1,Peve_00007988,Pocillopora_meandrina_HIv1___RNAseq.g923.t1,three_way,78.74566666666666,FUN_038247-T1,P15170,ERF3A_HUMAN,,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (EC 3.6.5.-) (G1 to S phase transition protein 1 homolog),Homo sapiens (Human),71.9,427.0,3.8e-190,666.0,sp|P15170|ERF3A_HUMAN Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Homo sapiens OX=9606 GN=GSPT1 PE=1 SV=1,GO:0000082; GO:0000184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006412; GO:0006415; GO:0006449; GO:0006479; GO:0018444; GO:0022626,"G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; translation release factor complex [GO:0018444],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747],GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0005840; GO:0016071; GO:0016787; GO:0043226,RNA binding; catalytic activity; GTPase activity; cytosol; ribosome; mRNA metabolic process; hydrolase activity; organelle
OG_00499,0.3065255817149008,OG_00499,FUN_001472-T1,Peve_00026259,Pocillopora_meandrina_HIv1___RNAseq.g1911.t1,three_way,72.17666666666666,FUN_001472-T1,Q8VHT6,AS3MT_RAT,,Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase),Rattus norvegicus (Rat),46.2,366.0,6.1e-86,319.3,sp|Q8VHT6|AS3MT_RAT Arsenite methyltransferase OS=Rattus norvegicus OX=10116 GN=As3mt PE=1 SV=1,GO:0005829; GO:0008276; GO:0008757; GO:0009404; GO:0018872; GO:0030791; GO:0032259; GO:0046685,arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; response to arsenic-containing substance [GO:0046685]; toxin metabolic process [GO:0009404],cytosol [GO:0005829],arsenite methyltransferase activity [GO:0030791]; protein methyltransferase activity [GO:0008276]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_05616,0.3065116898700014,OG_05616,FUN_025304-T1,Peve_00040949,Pocillopora_meandrina_HIv1___RNAseq.g13460.t1,three_way,85.93833333333333,FUN_025304-T1,Q9I7S6,,,,,53.0,372.0,3.1e-112,407.1,"sp|Q9I7S6|PDE9A_DROME High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A OS=Drosophila melanogaster OX=7227 GN=Pde9 PE=2 SV=2",,,,,,
OG_09511,0.3062455863435275,OG_09511,FUN_041565-T1,Peve_00033117,Pocillopora_meandrina_HIv1___RNAseq.g15976.t1,three_way,84.76766666666667,FUN_041565-T1,O70589,,,,,55.9,942.0,1.7e-296,1020.0,sp|O70589|CSKP_MOUSE Peripheral plasma membrane protein CASK OS=Mus musculus OX=10090 GN=Cask PE=1 SV=2,,,,,,
OG_01505,0.306241701943467,OG_01505,FUN_006237-T1,Peve_00030695,Pocillopora_meandrina_HIv1___RNAseq.g20447.t1,three_way,90.30166666666666,FUN_006237-T1,Q9GP16,,,,,72.4,123.0,3.5e-48,192.2,sp|Q9GP16|RL31_HELVI Large ribosomal subunit protein eL31 OS=Heliothis virescens OX=7102 GN=RpL31 PE=2 SV=1,,,,,,
OG_05328,0.306209790282278,OG_05328,FUN_024026-T1,Peve_00024951,Pocillopora_meandrina_HIv1___RNAseq.g19281.t1,three_way,75.564,FUN_024026-T1,Q5S1U6,,,,,41.0,390.0,1.3e-78,295.0,sp|Q5S1U6|IFRD1_PIG Interferon-related developmental regulator 1 OS=Sus scrofa OX=9823 GN=IFRD1 PE=2 SV=1,,,,,,
OG_09670,0.3061673990011258,OG_09670,FUN_041888-T1,Peve_00033407,Pocillopora_meandrina_HIv1___RNAseq.g15416.t1,three_way,83.91333333333334,FUN_041888-T1,Q3SZ65,,,,,83.1,397.0,6.8999999999999995e-189,661.4,sp|Q3SZ65|IF4A2_BOVIN Eukaryotic initiation factor 4A-II OS=Bos taurus OX=9913 GN=EIF4A2 PE=2 SV=1,,,,,,
OG_04367,0.3060085242316426,OG_04367,FUN_018023-T1,Peve_00005730,Pocillopora_meandrina_HIv1___RNAseq.g25298.t1,three_way,70.57966666666667,FUN_018023-T1,Q9WU06,AVIL_RAT,,Advillin (Peripheral nervous system villin-like protein) (Pervin),Rattus norvegicus (Rat),40.0,834.0,9e-156,552.4,sp|Q9WU06|AVIL_RAT Advillin OS=Rattus norvegicus OX=10116 GN=Avil PE=2 SV=2,GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480,actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005856; GO:0008092; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeletal protein binding; lipid binding; organelle; cilium organization; anatomical structure development
OG_06516,0.3059530197681428,OG_06516,FUN_029317-T1,Peve_00038259,Pocillopora_meandrina_HIv1___RNAseq.g12575.t1,three_way,56.52,FUN_029317-T1,Q8IY67,,,,,37.9,269.0,1.4e-40,169.9,sp|Q8IY67|RAVR1_HUMAN Ribonucleoprotein PTB-binding 1 OS=Homo sapiens OX=9606 GN=RAVER1 PE=1 SV=1,,,,,,
OG_01311,0.3058642577016456,OG_01311,FUN_005173-T1,Peve_00004279,Pocillopora_meandrina_HIv1___RNAseq.g7577.t1b,three_way,72.15116666666667,FUN_005173-T1,Q8WXI9,P66B_HUMAN,,Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68),Homo sapiens (Human),42.0,143.0,4.5e-21,104.8,sp|Q8WXI9|P66B_HUMAN Transcriptional repressor p66-beta OS=Homo sapiens OX=9606 GN=GATAD2B PE=1 SV=1,GO:0000122; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0006338; GO:0008270; GO:0016581; GO:0016607; GO:0032991; GO:0042659; GO:0043565; GO:0045892; GO:0045893; GO:2000736,chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]",sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_01367,0.3058635933859497,OG_01367,FUN_005315-T1,Peve_00003311,Pocillopora_meandrina_HIv1___RNAseq.g8175.t1,three_way,70.18966666666667,FUN_005315-T1,Q9UPR3,SMG5_HUMAN,,Nonsense-mediated mRNA decay factor SMG5 (EST1-like protein B) (LPTS-RP1) (LPTS-interacting protein) (SMG-5 homolog) (hSMG-5),Homo sapiens (Human),31.7,851.0,3.6e-72,274.6,sp|Q9UPR3|SMG5_HUMAN Nonsense-mediated mRNA decay factor SMG5 OS=Homo sapiens OX=9606 GN=SMG5 PE=1 SV=3,GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0031625; GO:0032204; GO:0032210; GO:0035303; GO:0036464; GO:0042162; GO:0042826; GO:0051721; GO:0070034,"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625],GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0006913; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; cytosol; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_05799,0.3058410858067327,OG_05799,FUN_025784-T1,Peve_00003062,Pocillopora_meandrina_HIv1___TS.g13806.t1,three_way,71.1365,FUN_025784-T1,Q80TG1,KANL1_MOUSE,,KAT8 regulatory NSL complex subunit 1 (NSL complex protein NSL1) (Non-specific lethal 1 homolog),Mus musculus (Mouse),27.1,535.0,5e-21,105.1,sp|Q80TG1|KANL1_MOUSE KAT8 regulatory NSL complex subunit 1 OS=Mus musculus OX=10090 GN=Kansl1 PE=1 SV=1,GO:0000123; GO:0000776; GO:0005739; GO:0006325; GO:0044545; GO:0045893; GO:0071339; GO:1903108,chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitochondrial transcription [GO:1903108],histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545],,GO:0005739; GO:0006325; GO:0006355; GO:0043226,mitochondrion; chromatin organization; regulation of DNA-templated transcription; organelle
OG_09390,0.3058243982274572,OG_09390,FUN_040686-T1,Peve_00007674,Pocillopora_meandrina_HIv1___RNAseq.g6452.t1,three_way,90.56466666666668,FUN_040686-T1,G1U0Q2,,,,,80.8,146.0,1.8e-62,240.0,sp|G1U0Q2|RS15_RABIT Small ribosomal subunit protein uS19 OS=Oryctolagus cuniculus OX=9986 GN=RPS15 PE=1 SV=1,,,,,,
OG_08623,0.3057410097833218,OG_08623,FUN_037778-T1,Peve_00040702,Pocillopora_meandrina_HIv1___RNAseq.g1514.t1,three_way,68.98816666666667,,,,,,,,,,,,,,,,,
OG_00048,0.3056710839173338,OG_00048,FUN_000285-T1,Peve_00033562,Pocillopora_meandrina_HIv1___RNAseq.g29071.t1,three_way,75.66833333333334,FUN_000285-T1,Q8BYH7,,,,,30.3,307.0,1.2e-37,159.1,sp|Q8BYH7|TBC17_MOUSE TBC1 domain family member 17 OS=Mus musculus OX=10090 GN=Tbc1d17 PE=1 SV=2,,,,,,
OG_03940,0.305658841820544,OG_03940,FUN_016075-T1,Peve_00021919,Pocillopora_meandrina_HIv1___RNAseq.g21617.t1,three_way,62.84066666666667,FUN_016075-T1,Q43470,,,,,64.7,238.0,7.3e-72,271.9,sp|Q43470|1433B_HORVU 14-3-3-like protein B OS=Hordeum vulgare OX=4513 PE=2 SV=1,,,,,,
OG_08539,0.3056269785900994,OG_08539,FUN_037489-T1,Peve_00020410,Pocillopora_meandrina_HIv1___RNAseq.g1305.t1,three_way,76.29033333333334,FUN_037489-T1,A2VEI2,MICU1_DROME,,"Calcium uptake protein 1 homolog, mitochondrial (Mitochondrial calcium uptake 1)",Drosophila melanogaster (Fruit fly),53.7,376.0,1.5e-108,394.8,"sp|A2VEI2|MICU1_DROME Calcium uptake protein 1 homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=MICU1 PE=2 SV=1",GO:0005509; GO:0005758; GO:0007615; GO:0036444; GO:0051560; GO:0051561; GO:0072375; GO:1990246,anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246],calcium ion binding [GO:0005509],GO:0050877; GO:0055085,nervous system process; transmembrane transport
OG_01982,0.3055721310956942,OG_01982,FUN_008090-T1,Peve_00033656,Pocillopora_meandrina_HIv1___RNAseq.g30101.t1,three_way,80.22983333333333,FUN_008090-T1,P58405,STRN3_RAT,,Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen),Rattus norvegicus (Rat),44.9,824.0,2.0999999999999996e-171,604.4,sp|P58405|STRN3_RAT Striatin-3 OS=Rattus norvegicus OX=10116 GN=Strn3 PE=1 SV=2,GO:0005516; GO:0005654; GO:0005794; GO:0005886; GO:0019901; GO:0030425; GO:0030674; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0035331; GO:0043025; GO:0044877; GO:0045892; GO:0051721; GO:0070016; GO:0090443; GO:0098794,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; response to estradiol [GO:0032355],dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267],GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0043226; GO:0060090,nucleoplasm; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; organelle; molecular adaptor activity
OG_04582,0.305556376364534,OG_04582,FUN_022245-T1,Peve_00037428,Pocillopora_meandrina_HIv1___RNAseq.g4760.t1,three_way,54.247166666666665,FUN_022245-T1,Q96DN6,MBD6_HUMAN,,Methyl-CpG-binding domain protein 6 (Methyl-CpG-binding protein MBD6),Homo sapiens (Human),41.4,99.0,6.5e-16,88.6,sp|Q96DN6|MBD6_HUMAN Methyl-CpG-binding domain protein 6 OS=Homo sapiens OX=9606 GN=MBD6 PE=1 SV=2,GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0010369,,chromocenter [GO:0010369]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0005654; GO:0005694; GO:0043226,nucleus; nucleoplasm; chromosome; organelle
OG_00533,0.3054124692451222,OG_00533,FUN_001547-T1,Peve_00020470,Pocillopora_meandrina_HIv1___RNAseq.g2064.t1,three_way,91.406,FUN_001547-T1,E9Q8T7,DYH1_MOUSE,,Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7),Mus musculus (Mouse),64.2,4208.0,0.0,5480.6,sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1,GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0007288; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288],extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; cytoskeleton organization; microtubule-based movement; isomerase activity; reproductive process; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_06429,0.3052588711869493,OG_06429,FUN_029122-T1,Peve_00016285,Pocillopora_meandrina_HIv1___RNAseq.g25777.t1,three_way,63.29733333333333,FUN_029122-T1,C5FP68,,,,,30.2,202.0,2.1e-24,116.3,sp|C5FP68|SCONB_ARTOC Probable E3 ubiquitin ligase complex SCF subunit sconB OS=Arthroderma otae (strain ATCC MYA-4605 / CBS 113480) OX=554155 GN=sconB PE=3 SV=1,,,,,,
OG_04227,0.3052471617528874,OG_04227,FUN_017022-T1,Peve_00018298,Pocillopora_meandrina_HIv1___RNAseq.g20360.t1,three_way,58.69716666666667,FUN_017022-T1,Q8BV79,,,,,28.2,2731.0,2.9e-254,881.7,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_05394,0.3052286011403504,OG_05394,FUN_024220-T1,Peve_00031896,Pocillopora_meandrina_HIv1___RNAseq.g18913.t1,three_way,90.01333333333334,FUN_024220-T1,Q99612,,,,,90.0,90.0,6.5e-17,89.4,sp|Q99612|KLF6_HUMAN Krueppel-like factor 6 OS=Homo sapiens OX=9606 GN=KLF6 PE=1 SV=3,,,,,,
OG_00135,0.3051650770665244,OG_00135,FUN_000569-T1,Peve_00034755,Pocillopora_meandrina_HIv1___RNAseq.g2452.t1,three_way,73.191,FUN_000569-T1,Q9CXF4,,,,,39.4,632.0,6.3e-121,436.4,sp|Q9CXF4|TBC15_MOUSE TBC1 domain family member 15 OS=Mus musculus OX=10090 GN=Tbc1d15 PE=1 SV=1,,,,,,
OG_02682,0.3051396825605387,OG_02682,FUN_010940-T1,Peve_00005965,Pocillopora_meandrina_HIv1___RNAseq.g20987.t1,three_way,71.95466666666667,FUN_010940-T1,Q6P1V4,,,,,58.3,841.0,1.9e-226,787.3,sp|Q6P1V4|EIF3C_XENTR Eukaryotic translation initiation factor 3 subunit C OS=Xenopus tropicalis OX=8364 GN=eif3c PE=2 SV=1,,,,,,
OG_02420,0.305110650668026,OG_02420,FUN_009308-T1,Peve_00021835,Pocillopora_meandrina_HIv1___RNAseq.g14442.t1,three_way,91.04433333333331,FUN_009308-T1,Q0MQI6,,,,,83.0,442.0,4.8e-226,785.0,"sp|Q0MQI6|NDUV1_PANTR NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial OS=Pan troglodytes OX=9598 GN=NDUFV1 PE=2 SV=1",,,,,,
OG_04814,0.3050638454015422,OG_04814,FUN_022778-T1,Peve_00021168,Pocillopora_meandrina_HIv1___RNAseq.g4772.t1,three_way,76.42866666666667,,,,,,,,,,,,,,,,,
OG_05000,0.3050406516662098,OG_05000,FUN_023136-T1,Peve_00008523,Pocillopora_meandrina_HIv1___RNAseq.g1752.t1,three_way,64.003,,,,,,,,,,,,,,,,,
OG_07095,0.304973490924129,OG_07095,FUN_032353-T1,Peve_00026256,Pocillopora_meandrina_HIv1___RNAseq.g29804.t1,three_way,66.072,FUN_032353-T1,Q8BL06,,,,,55.3,342.0,2.5e-110,401.7,sp|Q8BL06|UBP54_MOUSE Ubiquitin carboxyl-terminal hydrolase 54 OS=Mus musculus OX=10090 GN=Usp54 PE=1 SV=2,,,,,,
OG_07046,0.304927000823097,OG_07046,FUN_032249-T1,Peve_00042108,Pocillopora_meandrina_HIv1___TS.g12806.t2,three_way,79.56116666666667,FUN_032249-T1,Q4H4B6,SCRIB_DANRE,,Protein scribble homolog (Scribble1),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,938.0,2.3e-130,468.8,sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1,GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887,"activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944]",adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793],protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0005886; GO:0006886; GO:0007010; GO:0007155; GO:0007163; GO:0012501; GO:0016192; GO:0043226; GO:0048856; GO:0048870; GO:0072659,plasma membrane; intracellular protein transport; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; programmed cell death; vesicle-mediated transport; organelle; anatomical structure development; cell motility; protein localization to plasma membrane
OG_01082,0.3048791585143084,OG_01082,FUN_004570-T1,Peve_00041478,Pocillopora_meandrina_HIv1___RNAseq.g6646.t1a,three_way,78.209,FUN_004570-T1,Q6NRZ4,,,,,43.9,640.0,5.6e-150,532.7,sp|Q6NRZ4|CERT_XENLA Ceramide transfer protein OS=Xenopus laevis OX=8355 GN=cert1 PE=2 SV=1,,,,,,
OG_01425,0.3048294059128657,OG_01425,FUN_005812-T1,Peve_00039600,Pocillopora_meandrina_HIv1___RNAseq.g19558.t1,three_way,91.84433333333334,FUN_005812-T1,Q8WXX0,DYH7_HUMAN,,Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2),Homo sapiens (Human),54.7,4000.0,0.0,4338.5,sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2,GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0016887; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729,cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159],9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_03186,0.3047700901219491,OG_03186,FUN_012655-T1,Peve_00022124,Pocillopora_meandrina_HIv1___RNAseq.g22896.t1,three_way,83.30833333333334,FUN_012655-T1,B3TP03,CTR2_CHICK,,Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2),Gallus gallus (Chicken),41.7,653.0,5.0000000000000004e-130,466.5,sp|B3TP03|CTR2_CHICK Cationic amino acid transporter 2 OS=Gallus gallus OX=9031 GN=SLC7A2 PE=2 SV=1,GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015189; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352,L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064],GO:0005215; GO:0005794; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; Golgi apparatus; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_04078,0.3046448140758948,OG_04078,FUN_016408-T1,Peve_00018205,Pocillopora_meandrina_HIv1___TS.g23317.t1,three_way,74.89666666666666,FUN_016408-T1,Q98TY9,,,,,63.8,469.0,2.1e-170,600.1,sp|Q98TY9|AKT1_XENLA RAC-alpha serine/threonine-protein kinase OS=Xenopus laevis OX=8355 GN=akt1 PE=2 SV=1,,,,,,
OG_05593,0.3045596547603489,OG_05593,FUN_025100-T1,Peve_00038383,Pocillopora_meandrina_HIv1___RNAseq.g19443.t1,three_way,68.198,FUN_025100-T1,Q8C8U0,,,,,33.6,961.0,3.5e-107,391.0,sp|Q8C8U0|LIPB1_MOUSE Liprin-beta-1 OS=Mus musculus OX=10090 GN=Ppfibp1 PE=1 SV=3,,,,,,
OG_02114,0.3044566316203962,OG_02114,FUN_008399-T1,Peve_00043600,Pocillopora_meandrina_HIv1___RNAseq.g6181.t1,three_way,83.61133333333333,FUN_008399-T1,P41823,,,,,35.0,300.0,9.3e-43,176.4,sp|P41823|SY65_APLCA Synaptotagmin-1 OS=Aplysia californica OX=6500 GN=SYT1 PE=1 SV=2,,,,,,
OG_01955,0.3042783513750075,OG_01955,FUN_008021-T1,Peve_00031303,Pocillopora_meandrina_HIv1___RNAseq.g30342.t1,three_way,69.569,,,,,,,,,,,,,,,,,
OG_03926,0.3042500619645406,OG_03926,FUN_016038-T1,Peve_00011807,Pocillopora_meandrina_HIv1___RNAseq.g21648.t2,three_way,64.21833333333333,FUN_016038-T1,Q8TDN4,CABL1_HUMAN,,CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1),Homo sapiens (Human),43.4,295.0,2.7e-61,237.7,sp|Q8TDN4|CABL1_HUMAN CDK5 and ABL1 enzyme substrate 1 OS=Homo sapiens OX=9606 GN=CABLES1 PE=1 SV=2,GO:0005634; GO:0005829; GO:0007399; GO:0051301; GO:0051726,cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726],cytosol [GO:0005829]; nucleus [GO:0005634],,GO:0005634; GO:0005829; GO:0043226; GO:0048856,nucleus; cytosol; organelle; anatomical structure development
OG_01399,0.304248593851667,OG_01399,FUN_005387-T1,Peve_00044223,Pocillopora_meandrina_HIv1___RNAseq.g6614.t1,three_way,86.572,FUN_005387-T1,Q32LQ4,,,,,68.3,262.0,1.9e-105,384.0,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_08589,0.3042191762876483,OG_08589,FUN_037698-T1,Peve_00044125,Pocillopora_meandrina_HIv1___TS.g22767.t1b,three_way,68.75333333333333,FUN_037698-T1,F1QC45,XRP2_DANRE,,Protein XRP2,Danio rerio (Zebrafish) (Brachydanio rerio),56.6,325.0,8.6e-84,312.0,sp|F1QC45|XRP2_DANRE Protein XRP2 OS=Danio rerio OX=7955 GN=rp2 PE=1 SV=1,GO:0001947; GO:0005096; GO:0005525; GO:0005929; GO:0006892; GO:0010842; GO:0015031; GO:0035845; GO:0042461; GO:0045494; GO:0048793; GO:0060041; GO:0061371; GO:1990075,determination of heart left/right asymmetry [GO:0061371]; heart looping [GO:0001947]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; post-Golgi vesicle-mediated transport [GO:0006892]; pronephros development [GO:0048793]; protein transport [GO:0015031]; retina development in camera-type eye [GO:0060041]; retina layer formation [GO:0010842],cilium [GO:0005929]; periciliary membrane compartment [GO:1990075],GTP binding [GO:0005525]; GTPase activator activity [GO:0005096],GO:0005929; GO:0016192; GO:0043226; GO:0048856; GO:0098772,cilium; vesicle-mediated transport; organelle; anatomical structure development; molecular function regulator activity
OG_05502,0.3041300064550055,OG_05502,FUN_024566-T1,Peve_00009964,Pocillopora_meandrina_HIv1___RNAseq.g19087.t1,three_way,94.32233333333332,FUN_024566-T1,P81436,OGT1_RABIT,,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT),Oryctolagus cuniculus (Rabbit),77.1,1013.0,5.3000000000000025e-211,736.1,sp|P81436|OGT1_RABIT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Oryctolagus cuniculus OX=9986 GN=OGT PE=1 SV=2,GO:0000123; GO:0005547; GO:0005634; GO:0005737; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016485; GO:0017122; GO:0031397; GO:0032922; GO:0045944; GO:0071333; GO:0097363; GO:0160076; GO:1904263,apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122],"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein O-acetylglucosaminyltransferase activity [GO:0097363]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0006355; GO:0008289; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; nucleus; plasma membrane; chromatin organization; regulation of DNA-templated transcription; lipid binding; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03554,0.3040117537789851,OG_03554,FUN_014690-T1,Peve_00028116,Pocillopora_meandrina_HIv1___RNAseq.g22821.t1,three_way,83.69500000000001,FUN_014690-T1,Q8NFA0,UBP32_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32),Homo sapiens (Human),44.8,1747.0,0.0,1401.3,sp|Q8NFA0|UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens OX=9606 GN=USP32 PE=1 SV=1,GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263,positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005794; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02998,0.3039667248447877,OG_02998,FUN_012177-T1,Peve_00040996,Pocillopora_meandrina_HIv1___RNAseq.g23859.t1,three_way,91.90766666666669,FUN_012177-T1,P18654,KS6A3_MOUSE,,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),Mus musculus (Mouse),67.4,742.0,1e-291,1003.8,sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2,GO:0000287; GO:0002224; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0019901; GO:0032496; GO:0035556; GO:0043066; GO:0045944; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04003,0.3039575592751024,OG_04003,FUN_016299-T1,Peve_00025246,Pocillopora_meandrina_HIv1___RNAseq.g9888.t1,three_way,47.610166666666665,FUN_016299-T1,Q64337,SQSTM_MOUSE,,Sequestosome-1 (STONE14) (Ubiquitin-binding protein p62),Mus musculus (Mouse),47.7,44.0,4.8e-06,55.5,sp|Q64337|SQSTM_MOUSE Sequestosome-1 OS=Mus musculus OX=10090 GN=Sqstm1 PE=1 SV=1,GO:0000122; GO:0000407; GO:0000423; GO:0000425; GO:0000932; GO:0001659; GO:0002376; GO:0002931; GO:0003712; GO:0005080; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006366; GO:0006606; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0010508; GO:0016235; GO:0016236; GO:0016605; GO:0030017; GO:0030154; GO:0030163; GO:0030674; GO:0031397; GO:0031625; GO:0034144; GO:0035255; GO:0035591; GO:0035973; GO:0038023; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0043232; GO:0044753; GO:0044754; GO:0044877; GO:0061635; GO:0070342; GO:0070530; GO:0071211; GO:0097009; GO:0097225; GO:0097413; GO:0098780; GO:0098978; GO:0110076; GO:0140036; GO:0140311; GO:0140693; GO:0140694; GO:1900273; GO:1903078; GO:1905719,aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; membraneless organelle assembly [GO:0140694]; mitophagy [GO:0000423]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pexophagy [GO:0000425]; positive regulation of autophagy [GO:0010508]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366],aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; intracellular membraneless organelle [GO:0043232]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225],identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular condensate scaffold activity [GO:0140693]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]; transcription coregulator activity [GO:0003712]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],GO:0002376; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006914; GO:0012501; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0060089; GO:0060090; GO:0140110; GO:0140313,immune system process; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; autophagy; programmed cell death; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity; molecular adaptor activity; transcription regulator activity; molecular sequestering activity
OG_00141,0.3039491544683277,OG_00141,FUN_000580-T1,Peve_00034764,Pocillopora_meandrina_HIv1___RNAseq.g29301.t1,three_way,44.83516666666667,FUN_000580-T1,Q7KM13,,,,,30.5,164.0,6.6e-08,60.5,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_02357,0.3038544457482509,OG_02357,FUN_008960-T1,Peve_00021628,Pocillopora_meandrina_HIv1___RNAseq.g4043.t1,three_way,50.3,,,,,,,,,,,,,,,,,
OG_08347,0.303815200962301,OG_08347,FUN_036881-T1,Peve_00006965,Pocillopora_meandrina_HIv1___TS.g13145.t5a,three_way,67.16199999999999,FUN_036881-T1,O94988,,,,,26.8,1111.0,2.2000000000000008e-59,232.6,sp|O94988|FA13A_HUMAN Protein FAM13A OS=Homo sapiens OX=9606 GN=FAM13A PE=1 SV=2,,,,,,
OG_04207,0.3038063239384819,OG_04207,FUN_016779-T1,Peve_00032301,Pocillopora_meandrina_HIv1___RNAseq.g10031.t1,three_way,80.821,FUN_016779-T1,Q8BTW9,PAK4_MOUSE,,Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4),Mus musculus (Mouse),45.4,597.0,1.4e-119,431.4,sp|Q8BTW9|PAK4_MOUSE Serine/threonine-protein kinase PAK 4 OS=Mus musculus OX=10090 GN=Pak4 PE=1 SV=1,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006915; GO:0045766; GO:0060996; GO:0106310; GO:2000352,apoptotic process [GO:0006915]; dendritic spine development [GO:0060996]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766],cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0012501; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; programmed cell death; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_02990,0.3037937322485664,OG_02990,FUN_012166-T1,Peve_00008632,Pocillopora_meandrina_HIv1___RNAseq.g23449.t1,three_way,81.14583333333333,FUN_012166-T1,Q9HU55,,,,,37.2,78.0,2.7e-11,71.6,sp|Q9HU55|GLRX_PSEAE Glutaredoxin OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=grx PE=3 SV=1,,,,,,
OG_01221,0.3037461985902134,OG_01221,FUN_004903-T1,Peve_00028646,Pocillopora_meandrina_HIv1___RNAseq.g8331.t1,three_way,93.306,FUN_004903-T1,A5PK63,,,,,79.9,134.0,9.9e-55,214.2,sp|A5PK63|RS17_BOVIN Small ribosomal subunit protein eS17 OS=Bos taurus OX=9913 GN=RPS17 PE=2 SV=1,,,,,,
OG_08603,0.3037432023615775,OG_08603,FUN_037746-T1,Peve_00037365,Pocillopora_meandrina_HIv1___RNAseq.g1336.t1,three_way,86.29599999999999,FUN_037746-T1,P12003,,,,,38.8,1139.0,2.9999999999999998e-182,640.6,sp|P12003|VINC_CHICK Vinculin OS=Gallus gallus OX=9031 GN=VCL PE=1 SV=4,,,,,,
OG_01889,0.3037034704712636,OG_01889,FUN_007871-T1,Peve_00009886,Pocillopora_meandrina_HIv1___RNAseq.g18307.t1,three_way,66.36216666666667,FUN_007871-T1,Q13613,,,,,32.8,466.0,6.600000000000003e-60,234.2,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_01914,0.3036339513164149,OG_01914,FUN_007939-T1,Peve_00040694,Pocillopora_meandrina_HIv1___RNAseq.g18118.t1,three_way,57.98416666666667,FUN_007939-T1,Q5RET9,SDE2_PONAB,,Splicing regulator SDE2 (Replication stress response regulator SDE2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),34.2,415.0,1.7e-38,161.8,sp|Q5RET9|SDE2_PONAB Splicing regulator SDE2 OS=Pongo abelii OX=9601 GN=SDE2 PE=2 SV=1,GO:0000479; GO:0003677; GO:0005634; GO:0005737; GO:0006260; GO:0030515; GO:0045292; GO:0051301,"cell division [GO:0051301]; DNA replication [GO:0006260]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; mRNA cis splicing, via spliceosome [GO:0045292]",cytoplasm [GO:0005737]; nucleus [GO:0005634],DNA binding [GO:0003677]; snoRNA binding [GO:0030515],GO:0003677; GO:0003723; GO:0005634; GO:0006260; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; DNA replication; mRNA metabolic process; organelle
OG_09369,0.3035104264546641,OG_09369,FUN_040493-T1,Peve_00015398,Pocillopora_meandrina_HIv1___RNAseq.g6529.t1,three_way,81.2965,FUN_040493-T1,Q69ZF3,GBA2_MOUSE,,Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase) (EC 3.2.1.46) (Non-lysosomal glycosylceramidase),Mus musculus (Mouse),52.7,827.0,2.4e-249,863.2,sp|Q69ZF3|GBA2_MOUSE Non-lysosomal glucosylceramidase OS=Mus musculus OX=10090 GN=Gba2 PE=1 SV=2,GO:0000139; GO:0004336; GO:0004348; GO:0005789; GO:0005829; GO:0005975; GO:0006680; GO:0008203; GO:0008422; GO:0016139; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0046527; GO:0050295; GO:0097035,carbohydrate metabolic process [GO:0005975]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295],GO:0003824; GO:0005829; GO:0005975; GO:0006629; GO:0016740; GO:0016787; GO:0048856; GO:0061024; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; lipid metabolic process; transferase activity; hydrolase activity; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_08051,0.3033676586798239,OG_08051,FUN_035742-T1,Peve_00026223,Pocillopora_meandrina_HIv1___RNAseq.g11866.t1,three_way,82.196,FUN_035742-T1,Q9W1Y1,,,,,43.8,130.0,5.1e-26,119.0,sp|Q9W1Y1|EMC89_DROME ER membrane protein complex subunit 8/9 homolog OS=Drosophila melanogaster OX=7227 GN=EMC8-9 PE=1 SV=1,,,,,,
OG_04525,0.3033668940442962,OG_04525,FUN_022066-T1,Peve_00012093,Pocillopora_meandrina_HIv1___RNAseq.g4616.t1,three_way,73.00566666666667,FUN_022066-T1,Q32L53,LFG1_BOVIN,,Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit),Bos taurus (Bovine),43.7,222.0,1.4e-38,161.8,sp|Q32L53|LFG1_BOVIN Protein lifeguard 1 OS=Bos taurus OX=9913 GN=GRINA PE=2 SV=1,GO:0005262; GO:0005783; GO:0005794; GO:0016020; GO:0043524; GO:0097190; GO:1902042,apoptotic signaling pathway [GO:0097190]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524],endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],calcium channel activity [GO:0005262],GO:0005215; GO:0005783; GO:0005794; GO:0043226,transporter activity; endoplasmic reticulum; Golgi apparatus; organelle
OG_02316,0.3033420956911852,OG_02316,FUN_008907-T1,Peve_00027548,Pocillopora_meandrina_HIv1___RNAseq.g3972.t1,three_way,56.05233333333333,FUN_008907-T1,Q8CH34,ZP4_RAT,,Zona pellucida sperm-binding protein 4 (Zona pellucida glycoprotein 4) (Zp-4) (Zona pellucida protein B) [Cleaved into: Processed zona pellucida sperm-binding protein 4],Rattus norvegicus (Rat),27.7,332.0,4.3e-14,80.5,sp|Q8CH34|ZP4_RAT Zona pellucida sperm-binding protein 4 OS=Rattus norvegicus OX=10116 GN=Zp4 PE=2 SV=1,GO:0002922; GO:0005576; GO:0005886; GO:0007339; GO:0032190; GO:0035804; GO:0035805; GO:0042102; GO:0042802; GO:0060468; GO:0060478; GO:0062023; GO:2000344; GO:2000360,acrosomal vesicle exocytosis [GO:0060478]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of humoral immune response [GO:0002922]; positive regulation of T cell proliferation [GO:0042102]; prevention of polyspermy [GO:0060468],collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],acrosin binding [GO:0032190]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804],GO:0005198; GO:0005576; GO:0005886; GO:0016192; GO:0030312; GO:0031012,structural molecule activity; extracellular region; plasma membrane; vesicle-mediated transport; external encapsulating structure; extracellular matrix
OG_08249,0.3032433496211806,OG_08249,FUN_036158-T1,Peve_00039218,Pocillopora_meandrina_HIv1___RNAseq.g27493.t1,three_way,85.587,FUN_036158-T1,Q5PQY6,,,,,58.8,838.0,6.9e-268,924.9,"sp|Q5PQY6|LONP2_DANRE Lon protease homolog 2, peroxisomal OS=Danio rerio OX=7955 GN=lonp2 PE=2 SV=1",,,,,,
OG_05629,0.3031201429049142,OG_05629,FUN_025324-T1,Peve_00027096,Pocillopora_meandrina_HIv1___RNAseq.g13420.t1,three_way,68.96249999999999,FUN_025324-T1,Q9Y6Y1,CMTA1_HUMAN,,Calmodulin-binding transcription activator 1,Homo sapiens (Human),29.5,1137.0,2.1e-90,335.9,sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4,GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886,neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712],GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; nervous system process; molecular adaptor activity; transcription regulator activity
OG_08031,0.3030315925723156,OG_08031,FUN_035689-T1,Peve_00041293,Pocillopora_meandrina_HIv1___RNAseq.g11805.t1,three_way,90.49,FUN_035689-T1,Q13884,SNTB1_HUMAN,,Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43),Homo sapiens (Human),47.2,527.0,2.4e-127,457.2,sp|Q13884|SNTB1_HUMAN Beta-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTB1 PE=1 SV=3,GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202,muscle contraction [GO:0006936],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202],actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198],GO:0003012; GO:0005198; GO:0005856; GO:0005886; GO:0008092; GO:0043226,muscle system process; structural molecule activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_04293,0.3029746973483643,OG_04293,FUN_017859-T1,Peve_00014752,Pocillopora_meandrina_HIv1___RNAseq.g9574.t2,three_way,59.749500000000005,FUN_017859-T1,Q04205,,,,,47.0,285.0,3.1e-68,261.9,sp|Q04205|TENS1_CHICK Tensin-1 OS=Gallus gallus OX=9031 GN=TNS1 PE=1 SV=3,,,,,,
OG_09240,0.3028827531445324,OG_09240,FUN_040028-T1,Peve_00004957,Pocillopora_meandrina_HIv1___RNAseq.g8435.t1,three_way,50.78683333333333,FUN_040028-T1,Q8C1B2,PARPT_MOUSE,,Protein mono-ADP-ribosyltransferase TIPARP (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (TCDD-inducible poly [ADP-ribose] polymerase),Mus musculus (Mouse),32.0,453.0,8.3e-47,190.3,sp|Q8C1B2|PARPT_MOUSE Protein mono-ADP-ribosyltransferase TIPARP OS=Mus musculus OX=10090 GN=Tiparp PE=2 SV=1,GO:0000987; GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0008209; GO:0008210; GO:0008270; GO:0008585; GO:0009791; GO:0010629; GO:0016779; GO:0030097; GO:0045732; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0140803; GO:0140806; GO:0140807; GO:1904612,"androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570]",nucleus [GO:0005634],cis-regulatory region sequence-specific DNA binding [GO:0000987]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006629; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; lipid metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09664,0.3027915249981173,OG_09664,FUN_041875-T1,Peve_00040575,Pocillopora_meandrina_HIv1___RNAseq.g15107.t1,three_way,97.13533333333334,FUN_041875-T1,P49841,GSK3B_HUMAN,,Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1),Homo sapiens (Human),88.7,212.0,1.4000000000000005e-111,403.7,sp|P49841|GSK3B_HUMAN Glycogen synthase kinase-3 beta OS=Homo sapiens OX=9606 GN=GSK3B PE=1 SV=2,GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0003170; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007005; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010629; GO:0010719; GO:0010975; GO:0016055; GO:0016301; GO:0018105; GO:0019082; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030154; GO:0030336; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031398; GO:0031625; GO:0032007; GO:0032092; GO:0032436; GO:0032886; GO:0034236; GO:0034452; GO:0034976; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043161; GO:0043525; GO:0045597; GO:0045668; GO:0045719; GO:0045724; GO:0045732; GO:0046777; GO:0046825; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060070; GO:0060079; GO:0061629; GO:0070507; GO:0070885; GO:0071109; GO:0071300; GO:0090090; GO:0097110; GO:0097191; GO:0097192; GO:0098793; GO:0098794; GO:0098978; GO:0099171; GO:0106027; GO:0106310; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1902042; GO:1903566; GO:1903940; GO:1904339; GO:1904646; GO:1904781; GO:1990909; GO:2000077; GO:2000466; GO:2000740,canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glycogen metabolic process [GO:0005977]; heart valve development [GO:0003170]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC2 signaling [GO:1903940]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of autophagy [GO:0010508]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of protein-containing complex assembly [GO:0031334]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; response to endoplasmic reticulum stress [GO:0034976]; superior temporal gyrus development [GO:0071109]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Wnt signalosome [GO:1990909],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005975; GO:0006091; GO:0007005; GO:0007163; GO:0008092; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0061024; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; mitochondrion organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; membrane organization; catalytic activity, acting on a protein"
OG_09962,0.3027895382380692,OG_09962,FUN_043143-T1,Peve_00034956,Pocillopora_meandrina_HIv1___RNAseq.g6885.t1,three_way,65.38133333333333,FUN_043143-T1,O89110,CASP8_MOUSE,,Caspase-8 (CASP-8) (EC 3.4.22.61) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10],Mus musculus (Mouse),26.6,533.0,8.6e-51,203.0,sp|O89110|CASP8_MOUSE Caspase-8 OS=Mus musculus OX=10090 GN=Casp8 PE=1 SV=1,GO:0001525; GO:0001817; GO:0001841; GO:0004175; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005886; GO:0006915; GO:0007507; GO:0008233; GO:0008625; GO:0008656; GO:0016485; GO:0030225; GO:0030690; GO:0043065; GO:0045088; GO:0048738; GO:0051603; GO:0060546; GO:0070243; GO:0070266; GO:0070269; GO:0097190; GO:0097191; GO:0097194; GO:0097264; GO:0097284; GO:0097342; GO:1900119; GO:2001233; GO:2001238,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cardiac muscle tissue development [GO:0048738]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; heart development [GO:0007507]; hepatocyte apoptotic process [GO:0097284]; macrophage differentiation [GO:0030225]; necroptotic process [GO:0070266]; negative regulation of necroptotic process [GO:0060546]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein processing [GO:0016485]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptotic inflammatory response [GO:0070269]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of cytokine production [GO:0001817]; regulation of innate immune response [GO:0045088]; regulation of thymocyte apoptotic process [GO:0070243]; self proteolysis [GO:0097264],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; Noc1p-Noc2p complex [GO:0030690]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ripoptosome [GO:0097342],cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233],GO:0003824; GO:0005634; GO:0005739; GO:0005886; GO:0006954; GO:0012501; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; nucleus; mitochondrion; plasma membrane; inflammatory response; programmed cell death; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05387,0.3027659884878094,OG_05387,FUN_024208-T1,Peve_00031873,Pocillopora_meandrina_HIv1___RNAseq.g18905.t1b,three_way,71.887,FUN_024208-T1,O09167,RL21_MOUSE,,Large ribosomal subunit protein eL21 (60S ribosomal protein L21),Mus musculus (Mouse),65.0,160.0,4.7e-52,206.1,sp|O09167|RL21_MOUSE Large ribosomal subunit protein eL21 OS=Mus musculus OX=10090 GN=Rpl21 PE=1 SV=4,GO:0002181; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098794,cytoplasmic translation [GO:0002181],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; postsynapse [GO:0098794]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005783; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; endoplasmic reticulum; cytosol; ribosome; organelle
OG_07733,0.3027514698176652,OG_07733,FUN_034894-T1,Peve_00030258,Pocillopora_meandrina_HIv1___RNAseq.g27804.t1,three_way,78.94566666666667,FUN_034894-T1,Q62737,CY24A_RAT,,Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox) (p22phox),Rattus norvegicus (Rat),52.1,140.0,2.100000000000001e-33,143.7,sp|Q62737|CY24A_RAT Cytochrome b-245 light chain OS=Rattus norvegicus OX=10116 GN=Cyba PE=1 SV=3,GO:0001666; GO:0001725; GO:0001938; GO:0003106; GO:0005737; GO:0005768; GO:0005886; GO:0005925; GO:0006801; GO:0006954; GO:0009055; GO:0009410; GO:0014823; GO:0014895; GO:0016175; GO:0016324; GO:0017004; GO:0017124; GO:0020037; GO:0030307; GO:0030425; GO:0031667; GO:0032755; GO:0032760; GO:0032930; GO:0034137; GO:0042554; GO:0043020; GO:0043025; GO:0045087; GO:0045730; GO:0045777; GO:0046872; GO:0046982; GO:0048661; GO:0050665; GO:0050766; GO:0051279; GO:0051649; GO:0070254; GO:0070257; GO:0070555; GO:0071260; GO:0071333; GO:0071356; GO:0071480; GO:0072593; GO:0097038; GO:1900426; GO:1903428; GO:1904044; GO:1904385; GO:1904628; GO:1904845,cellular response to angiotensin [GO:1904385]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to L-glutamine [GO:1904845]; cellular response to mechanical stimulus [GO:0071260]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to tumor necrosis factor [GO:0071356]; cytochrome complex assembly [GO:0017004]; establishment of localization in cell [GO:0051649]; hydrogen peroxide biosynthetic process [GO:0050665]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of glomerular filtration by angiotensin [GO:0003106]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell growth [GO:0030307]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mucus secretion [GO:0070257]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; reactive oxygen species metabolic process [GO:0072593]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; respiratory burst [GO:0045730]; response to activity [GO:0014823]; response to aldosterone [GO:1904044]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; smooth muscle hypertrophy [GO:0014895]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801],apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; focal adhesion [GO:0005925]; NADPH oxidase complex [GO:0043020]; neuronal cell body [GO:0043025]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; stress fiber [GO:0001725],electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]; superoxide-generating NAD(P)H oxidase activity [GO:0016175],GO:0002376; GO:0003012; GO:0003824; GO:0005768; GO:0005886; GO:0006954; GO:0016491; GO:0031410; GO:0043226; GO:0050886; GO:0065003; GO:0098542,immune system process; muscle system process; catalytic activity; endosome; plasma membrane; inflammatory response; oxidoreductase activity; cytoplasmic vesicle; organelle; endocrine process; protein-containing complex assembly; defense response to other organism
OG_02374,0.302734931102028,OG_02374,FUN_008984-T1,Peve_00029644,Pocillopora_meandrina_HIv1___RNAseq.g3905.t1,three_way,78.63966666666667,FUN_008984-T1,Q9NSN8,,,,,34.6,448.0,3e-69,264.2,sp|Q9NSN8|SNTG1_HUMAN Gamma-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTG1 PE=1 SV=1,,,,,,
OG_08053,0.302632942160902,OG_08053,FUN_035748-T1,Peve_00014368,Pocillopora_meandrina_HIv1___TS.g3212.t1,three_way,61.029833333333336,FUN_035748-T1,Q9P2E3,ZNFX1_HUMAN,,NFX1-type zinc finger-containing protein 1,Homo sapiens (Human),38.2,1862.0,1.3e-311,1071.2,sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2,GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0006325; GO:0016853; GO:0031047; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; chromatin organization; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; defense response to other organism; ATP-dependent activity
OG_05256,0.3026020609432778,OG_05256,FUN_023759-T1,Peve_00044461,Pocillopora_meandrina_HIv1___RNAseq.g3497.t1,three_way,51.79566666666666,FUN_023759-T1,E7FBY6,AGRA2_DANRE,,Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124),Danio rerio (Zebrafish) (Brachydanio rerio),26.0,889.0,4.7e-66,255.4,sp|E7FBY6|AGRA2_DANRE Adhesion G protein-coupled receptor A2 OS=Danio rerio OX=7955 GN=adgra2 PE=1 SV=2,GO:0001525; GO:0004930; GO:0005886; GO:0007399; GO:0060070; GO:1990909,angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; nervous system development [GO:0007399],plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0048856; GO:0060089,plasma membrane; anatomical structure development; molecular transducer activity
OG_06820,0.3025204171337555,OG_06820,FUN_031726-T1,Peve_00040633,Pocillopora_meandrina_HIv1___RNAseq.g5506.t1,three_way,64.57666666666667,FUN_031726-T1,Q3ZC62,,,,,34.1,179.0,1.8000000000000001e-22,108.6,sp|Q3ZC62|CFA36_BOVIN Cilia- and flagella-associated protein 36 OS=Bos taurus OX=9913 GN=CFAP36 PE=2 SV=1,,,,,,
OG_00876,0.3024452894287381,OG_00876,FUN_004165-T1,Peve_00031563,Pocillopora_meandrina_HIv1___RNAseq.g16742.t1,three_way,88.557,FUN_004165-T1,Q8N6S4,AN13C_HUMAN,,Ankyrin repeat domain-containing protein 13C,Homo sapiens (Human),64.4,430.0,1.1000000000000002e-165,584.3,sp|Q8N6S4|AN13C_HUMAN Ankyrin repeat domain-containing protein 13C OS=Homo sapiens OX=9606 GN=ANKRD13C PE=1 SV=2,GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006612; GO:0006621; GO:0048471; GO:0071799; GO:0140597; GO:2000209,cellular response to prostaglandin D stimulus [GO:0071799]; protein retention in ER lumen [GO:0006621]; protein targeting to membrane [GO:0006612]; regulation of anoikis [GO:2000209],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471],protein carrier chaperone [GO:0140597]; signaling receptor binding [GO:0005102],GO:0005783; GO:0043226; GO:0140104,endoplasmic reticulum; organelle; molecular carrier activity
OG_07364,0.3024251973576785,OG_07364,FUN_033776-T1,Peve_00005287,Pocillopora_meandrina_HIv1___RNAseq.g26654.t1,three_way,88.918,FUN_033776-T1,P47830,,,,,77.0,148.0,7.8e-42,171.4,sp|P47830|RL27A_XENLA Large ribosomal subunit protein uL15 OS=Xenopus laevis OX=8355 GN=rpl27a PE=2 SV=2,,,,,,
OG_02889,0.3023594462519646,OG_02889,FUN_011944-T1,Peve_00016922,Pocillopora_meandrina_HIv1___RNAseq.g9188.t1,three_way,71.43466666666666,FUN_011944-T1,Q6Q759,SPG17_HUMAN,,Sperm-associated antigen 17 (Projection protein PF6 homolog),Homo sapiens (Human),31.0,2357.0,6.9000000000000005e-174,614.0,sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1,GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953,axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514],,GO:0005576; GO:0005794; GO:0005929; GO:0006886; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0044782,extracellular region; Golgi apparatus; cilium; intracellular protein transport; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cilium organization
OG_08490,0.3023186829897747,OG_08490,FUN_037327-T1,Peve_00006233,Pocillopora_meandrina_HIv1___RNAseq.g10694.t1,three_way,65.693,FUN_037327-T1,Q90YK3,,,,,49.0,437.0,2.1e-133,477.2,sp|Q90YK3|GGLO_SCYTO L-gulonolactone oxidase OS=Scyliorhinus torazame OX=75743 GN=GULO PE=2 SV=1,,,,,,
OG_06433,0.3022409553247716,OG_06433,FUN_029127-T1,Peve_00004665,Pocillopora_meandrina_HIv1___RNAseq.g25779.t1,three_way,50.135333333333335,,,,,,,,,,,,,,,,,
OG_08050,0.3021271853218762,OG_08050,FUN_035738-T1,Peve_00026220,Pocillopora_meandrina_HIv1___TS.g3202.t2,three_way,93.476,FUN_035738-T1,Q05975,,,,,92.9,212.0,1.9000000000000002e-110,399.8,sp|Q05975|RAB2_LYMST Ras-related protein Rab-2 OS=Lymnaea stagnalis OX=6523 GN=RAB2 PE=2 SV=1,,,,,,
OG_01158,0.3020463458828462,OG_01158,FUN_004776-T1,Peve_00037750,Pocillopora_meandrina_HIv1___RNAseq.g6695.t1,three_way,65.822,FUN_004776-T1,Q2TBA3,MALT1_MOUSE,,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase),Mus musculus (Mouse),29.1,709.0,3.5e-63,244.6,sp|Q2TBA3|MALT1_MOUSE Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog OS=Mus musculus OX=10090 GN=Malt1 PE=1 SV=2,GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005829; GO:0006508; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051168; GO:0051603; GO:0061133; GO:0071222; GO:2000321,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; cellular response to lipopolysaccharide [GO:0071222]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kinase activator activity [GO:0019209]; protease binding [GO:0002020]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005829; GO:0006913; GO:0016740; GO:0016787; GO:0030154; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; cytosol; nucleocytoplasmic transport; transferase activity; hydrolase activity; cell differentiation; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07665,0.3020421476926678,OG_07665,FUN_034720-T1,Peve_00033269,Pocillopora_meandrina_HIv1___RNAseq.g28723.t1,three_way,62.28366666666667,FUN_034720-T1,P82094,TMF1_HUMAN,,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),Homo sapiens (Human),40.1,685.0,2.8999999999999997e-43,179.1,sp|P82094|TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens OX=9606 GN=TMF1 PE=1 SV=2,GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003713; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0007289; GO:0010629; GO:0030317; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845,acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006355; GO:0007018; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; regulation of DNA-templated transcription; microtubule-based movement; programmed cell death; reproductive process; cell differentiation; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_00194,0.301984085616958,OG_00194,FUN_000900-T1,Peve_00009738,Pocillopora_meandrina_HIv1___RNAseq.g29451.t1,three_way,81.18366666666667,FUN_000900-T1,Q5R787,,,,,37.9,533.0,2.6e-76,287.7,sp|Q5R787|ARFG3_PONAB ADP-ribosylation factor GTPase-activating protein 3 OS=Pongo abelii OX=9601 GN=ARFGAP3 PE=2 SV=1,,,,,,
OG_01465,0.3019738568866422,OG_01465,FUN_006001-T1,Peve_00036061,Pocillopora_meandrina_HIv1___RNAseq.g19928.t1,three_way,87.754,FUN_006001-T1,P38024,,,,,60.3,330.0,1.3e-116,421.0,sp|P38024|PUR6_CHICK Multifunctional protein ADE2 OS=Gallus gallus OX=9031 GN=AIRC PE=2 SV=1,,,,,,
OG_10160,0.3018640123328632,OG_10160,FUN_043558-T1,Peve_00022071,Pocillopora_meandrina_HIv1___RNAseq.g8044.t1,three_way,60.96266666666666,,,,,,,,,,,,,,,,,
OG_07978,0.3017407751067418,OG_07978,FUN_035600-T1,Peve_00027480,Pocillopora_meandrina_HIv1___RNAseq.g28038.t1,three_way,84.73833333333333,FUN_035600-T1,Q9T043,,,,,54.9,133.0,1.4e-32,140.6,sp|Q9T043|RL142_ARATH Large ribosomal subunit protein eL14y OS=Arabidopsis thaliana OX=3702 GN=RPL14B PE=1 SV=1,,,,,,
OG_04634,0.3017229678784309,OG_04634,FUN_022354-T1,Peve_00021995,Pocillopora_meandrina_HIv1___RNAseq.g4584.t1,three_way,73.46366666666667,FUN_022354-T1,Q8LQJ9,,,,,52.9,592.0,1e-161,572.0,"sp|Q8LQJ9|FTSH4_ORYSJ ATP-dependent zinc metalloprotease FTSH 4, mitochondrial OS=Oryza sativa subsp. japonica OX=39947 GN=FTSH4 PE=3 SV=1",,,,,,
OG_03944,0.30169256354128,OG_03944,FUN_016081-T1,Peve_00021927,Pocillopora_meandrina_HIv1___RNAseq.g21612.t1,three_way,72.43566666666666,,,,,,,,,,,,,,,,,
OG_04533,0.3016309628299962,OG_04533,FUN_022079-T1,Peve_00038279,Pocillopora_meandrina_HIv1___TS.g19620.t1,three_way,56.668,FUN_022079-T1,Q3TZ87,MARH9_MOUSE,,E3 ubiquitin-protein ligase MARCHF9 (EC 2.3.2.27) (Membrane-associated RING finger protein 9) (Membrane-associated RING-CH protein IX) (MARCH-IX) (RING-type E3 ubiquitin transferase MARCHF9),Mus musculus (Mouse),33.2,187.0,1.4e-21,105.5,sp|Q3TZ87|MARH9_MOUSE E3 ubiquitin-protein ligase MARCHF9 OS=Mus musculus OX=10090 GN=Marchf9 PE=2 SV=1,GO:0000139; GO:0004842; GO:0005765; GO:0005795; GO:0005802; GO:0008270; GO:0016567,protein ubiquitination [GO:0016567],Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; trans-Golgi network [GO:0005802],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_01039,0.3015928571362479,OG_01039,FUN_004474-T1,Peve_00007173,Pocillopora_meandrina_HIv1___RNAseq.g4947.t1,three_way,57.66016666666667,FUN_004474-T1,Q7TN02,MED26_MOUSE,,Mediator of RNA polymerase II transcription subunit 26 (Cofactor required for Sp1 transcriptional activation subunit 7) (CRSP complex subunit 7) (Mediator complex subunit 26),Mus musculus (Mouse),62.8,78.0,3.2e-18,94.4,sp|Q7TN02|MED26_MOUSE Mediator of RNA polymerase II transcription subunit 26 OS=Mus musculus OX=10090 GN=Med26 PE=1 SV=1,GO:0003712; GO:0005634; GO:0005654; GO:0006357; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847,positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123],core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_08405,0.3015899613695602,OG_08405,FUN_037056-T1,Peve_00018389,Pocillopora_meandrina_HIv1___RNAseq.g26785.t1,three_way,92.43566666666666,FUN_037056-T1,P23358,,,,,79.1,163.0,2.6e-70,266.2,sp|P23358|RL12_RAT Large ribosomal subunit protein uL11 OS=Rattus norvegicus OX=10116 GN=Rpl12 PE=2 SV=1,,,,,,
OG_06217,0.3015602298911095,OG_06217,FUN_028158-T1,Peve_00024808,Pocillopora_meandrina_HIv1___RNAseq.g16501.t1,three_way,79.09966666666666,FUN_028158-T1,Q9Y5P8,,,,,48.1,459.0,2.1e-120,434.1,sp|Q9Y5P8|P2R3B_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta OS=Homo sapiens OX=9606 GN=PPP2R3B PE=1 SV=2,,,,,,
OG_04092,0.3015172719349767,OG_04092,FUN_016432-T1,Peve_00004351,Pocillopora_meandrina_HIv1___RNAseq.g9813.t3,three_way,72.73966666666666,FUN_016432-T1,P10894,PLCB1_BOVIN,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1)",Bos taurus (Bovine),58.2,490.0,5.7e-156,553.1,"sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1",GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498,G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607],"calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]",GO:0003824; GO:0005829; GO:0006629; GO:0008289; GO:0016787; GO:0043226; GO:0050877; GO:0055085; GO:0098772,catalytic activity; cytosol; lipid metabolic process; lipid binding; hydrolase activity; organelle; nervous system process; transmembrane transport; molecular function regulator activity
OG_03932,0.3014912221276459,OG_03932,FUN_016048-T1,Peve_00011790,Pocillopora_meandrina_HIv1___RNAseq.g26043.t1,three_way,52.87083333333334,,,,,,,,,,,,,,,,,
OG_07749,0.3014711838231643,OG_07749,FUN_034938-T1,Peve_00036685,Pocillopora_meandrina_HIv1___RNAseq.g27832.t1,three_way,69.10716666666667,FUN_034938-T1,Q7Z614,SNX20_HUMAN,,Sorting nexin-20 (Selectin ligand-interactor cytoplasmic 1) (SLIC-1),Homo sapiens (Human),35.0,246.0,3.5000000000000005e-22,107.1,sp|Q7Z614|SNX20_HUMAN Sorting nexin-20 OS=Homo sapiens OX=9606 GN=SNX20 PE=1 SV=1,GO:0005546; GO:0005654; GO:0005886; GO:0015031; GO:0031901; GO:0032266; GO:1901981,protein transport [GO:0015031],early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005654; GO:0005886; GO:0008289,nucleoplasm; plasma membrane; lipid binding
OG_02324,0.3014591770832505,OG_02324,FUN_008916-T1,Peve_00033003,Pocillopora_meandrina_HIv1___RNAseq.g3981.t1,three_way,69.72566666666667,FUN_008916-T1,Q8JHF4,,,,,30.0,120.0,1.1e-07,59.3,sp|Q8JHF4|PAL1A_DANRE Protein PALS1 OS=Danio rerio OX=7955 GN=pals1a PE=1 SV=2,,,,,,
OG_06573,0.3014261541707532,OG_06573,FUN_029518-T1,Peve_00008555,Pocillopora_meandrina_HIv1___RNAseq.g17117.t1,three_way,79.40516666666666,FUN_029518-T1,Q00438,,,,,47.7,558.0,2.7e-132,473.8,sp|Q00438|PTBP1_RAT Polypyrimidine tract-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Ptbp1 PE=1 SV=2,,,,,,
OG_05648,0.3012625975134337,OG_05648,FUN_025368-T1,Peve_00040520,Pocillopora_meandrina_HIv1___RNAseq.g13331.t1,three_way,95.874,FUN_025368-T1,Q6PH57,,,,,91.4,339.0,2.9e-140,499.6,sp|Q6PH57|GBB1_DANRE Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1,,,,,,
OG_07520,0.3011178569188646,OG_07520,FUN_034090-T1,Peve_00037070,Pocillopora_meandrina_HIv1___RNAseq.g26061.t1,three_way,75.31133333333334,FUN_034090-T1,Q9I9H8,,,,,36.6,1258.0,6.2000000000000005e-146,520.4,sp|Q9I9H8|APAF_DANRE Apoptotic protease-activating factor 1 OS=Danio rerio OX=7955 GN=apaf1 PE=2 SV=1,,,,,,
OG_03792,0.3009851015647106,OG_03792,FUN_015158-T1,Peve_00001862,Pocillopora_meandrina_HIv1___RNAseq.g21765.t1,three_way,81.74516666666666,FUN_015158-T1,Q96DH6,,,,,47.2,335.0,2.3e-67,257.7,sp|Q96DH6|MSI2H_HUMAN RNA-binding protein Musashi homolog 2 OS=Homo sapiens OX=9606 GN=MSI2 PE=1 SV=1,,,,,,
OG_01991,0.3009177933042061,OG_01991,FUN_008099-T1,Peve_00038883,Pocillopora_meandrina_HIv1___RNAseq.g30140.t1,three_way,82.39933333333333,FUN_008099-T1,O94806,KPCD3_HUMAN,,Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu),Homo sapiens (Human),56.9,822.0,2.4e-263,909.8,sp|O94806|KPCD3_HUMAN Serine/threonine-protein kinase D3 OS=Homo sapiens OX=9606 GN=PRKD3 PE=1 SV=1,GO:0004674; GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006468; GO:0007200; GO:0008270; GO:0016301; GO:0030148; GO:0035556; GO:0036064; GO:0106310,intracellular signal transduction [GO:0035556]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148],ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0006629; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; microtubule organizing center; cytosol; plasma membrane; lipid metabolic process; transferase activity; catalytic activity, acting on a protein"
OG_04514,0.3008579844484463,OG_04514,FUN_022047-T1,Peve_00017133,Pocillopora_meandrina_HIv1___RNAseq.g4597.t1,three_way,56.1085,FUN_022047-T1,Q8JZM8,,,,,27.0,852.0,8.8e-68,261.5,sp|Q8JZM8|MUC4_MOUSE Mucin-4 OS=Mus musculus OX=10090 GN=Muc4 PE=2 SV=2,,,,,,
OG_01248,0.3008422464823765,OG_01248,FUN_004947-T1,Peve_00043267,Pocillopora_meandrina_HIv1___RNAseq.g8394.t1,three_way,76.3205,FUN_004947-T1,Q9BY12,SCAPE_HUMAN,,S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291),Homo sapiens (Human),41.5,1440.0,9.2e-140,500.0,sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2,GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917,antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827],nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0005654; GO:0005783; GO:0005829; GO:0022414; GO:0043226; GO:0048856,nucleoplasm; endoplasmic reticulum; cytosol; reproductive process; organelle; anatomical structure development
OG_02918,0.3008280265811702,OG_02918,FUN_012001-T1,Peve_00000536,Pocillopora_meandrina_HIv1___RNAseq.g24024.t1,three_way,59.24283333333334,FUN_012001-T1,Q60902,EP15R_MOUSE,,Epidermal growth factor receptor substrate 15-like 1 (Epidermal growth factor receptor pathway substrate 15-related sequence) (Eps15-rs) (Eps15-related protein) (Eps15R),Mus musculus (Mouse),34.3,137.0,4.6e-13,78.6,sp|Q60902|EP15R_MOUSE Epidermal growth factor receptor substrate 15-like 1 OS=Mus musculus OX=10090 GN=Eps15l1 PE=1 SV=3,GO:0005509; GO:0005634; GO:0030132; GO:0048488; GO:0098793,synaptic vesicle endocytosis [GO:0048488],clathrin coat of coated pit [GO:0030132]; nucleus [GO:0005634]; presynapse [GO:0098793],calcium ion binding [GO:0005509],GO:0005634; GO:0016192; GO:0043226,nucleus; vesicle-mediated transport; organelle
OG_04632,0.3008239296040074,OG_04632,FUN_022345-T1,Peve_00018540,Pocillopora_meandrina_HIv1___RNAseq.g4659.t1,three_way,72.2795,FUN_022345-T1,Q5R9X9,,,,,39.2,332.0,1.7e-45,185.7,sp|Q5R9X9|3BP5L_PONAB SH3 domain-binding protein 5-like OS=Pongo abelii OX=9601 GN=SH3BP5L PE=2 SV=1,,,,,,
OG_09858,0.300807324052421,OG_09858,FUN_042852-T1,Peve_00023270,Pocillopora_meandrina_HIv1___RNAseq.g7247.t1,three_way,60.656666666666666,FUN_042852-T1,Q15527,,,,,37.4,163.0,5.4e-20,99.8,sp|Q15527|SURF2_HUMAN Surfeit locus protein 2 OS=Homo sapiens OX=9606 GN=SURF2 PE=1 SV=4,,,,,,
OG_08850,0.3007872082079029,OG_08850,FUN_038213-T1,Peve_00038850,Pocillopora_meandrina_HIv1___RNAseq.g897.t1,three_way,68.68866666666666,FUN_038213-T1,Q7Z402,,,,,32.1,639.0,1e-79,299.7,sp|Q7Z402|TMC7_HUMAN Transmembrane channel-like protein 7 OS=Homo sapiens OX=9606 GN=TMC7 PE=1 SV=1,,,,,,
OG_00582,0.3006862206354433,OG_00582,FUN_001655-T1,Peve_00038364,Pocillopora_meandrina_HIv1___RNAseq.g29406.t1,three_way,93.90866666666666,FUN_001655-T1,P53621,COPA_HUMAN,,Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin],Homo sapiens (Human),75.2,1228.0,0.0,1507.7,sp|P53621|COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens OX=9606 GN=COPA PE=1 SV=2,GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062; GO:0099612; GO:1902463,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133],hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198],GO:0003723; GO:0005198; GO:0005615; GO:0005829; GO:0006886; GO:0016192; GO:0022600; GO:0031410; GO:0043226; GO:0048018; GO:0098772,RNA binding; structural molecule activity; extracellular space; cytosol; intracellular protein transport; vesicle-mediated transport; digestive system process; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_05219,0.3006725789271015,OG_05219,FUN_023631-T1,Peve_00017456,Pocillopora_meandrina_HIv1___RNAseq.g526.t1,three_way,75.54283333333333,FUN_023631-T1,P57073,SOX8_HUMAN,,Transcription factor SOX-8,Homo sapiens (Human),59.1,110.0,6.7e-28,126.7,sp|P57073|SOX8_HUMAN Transcription factor SOX-8 OS=Homo sapiens OX=9606 GN=SOX8 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001649; GO:0001701; GO:0001755; GO:0002009; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0007165; GO:0007283; GO:0007422; GO:0008584; GO:0010628; GO:0010817; GO:0014015; GO:0014032; GO:0033690; GO:0035914; GO:0043066; GO:0045165; GO:0045444; GO:0045662; GO:0045892; GO:0045893; GO:0045944; GO:0046533; GO:0048469; GO:0048484; GO:0048709; GO:0060009; GO:0060018; GO:0060041; GO:0060221; GO:0060612; GO:0061138; GO:0072034; GO:0072197; GO:0072289; GO:0090184; GO:0090190; GO:0140297; GO:1990837,adipose tissue development [GO:0060612]; astrocyte fate commitment [GO:0060018]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; enteric nervous system development [GO:0048484]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of kidney development [GO:0090184]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hormone levels [GO:0010817]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; ureter morphogenesis [GO:0072197],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_07679,0.3006114183740982,OG_07679,FUN_034797-T1,Peve_00007517,Pocillopora_meandrina_HIv1___RNAseq.g12297.t1,three_way,79.21333333333334,FUN_034797-T1,D3ZDI6,MYLIP_RAT,,E3 ubiquitin-protein ligase MYLIP (EC 2.3.2.27) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain interacting protein) (MIR) (RING-type E3 ubiquitin transferase MYLIP),Rattus norvegicus (Rat),43.0,440.0,5.1e-96,353.2,sp|D3ZDI6|MYLIP_RAT E3 ubiquitin-protein ligase MYLIP OS=Rattus norvegicus OX=10116 GN=Mylip PE=2 SV=1,GO:0004842; GO:0005737; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0008270; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0061630,cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886],cytoskeletal protein binding [GO:0008092]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03451,0.3004215341810716,OG_03451,FUN_014525-T1,Peve_00044380,Pocillopora_meandrina_HIv1___RNAseq.g22618.t1,three_way,89.524,FUN_014525-T1,Q7PPA5,,,,,70.7,996.0,0.0,1408.7,sp|Q7PPA5|ATC1_ANOGA Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type OS=Anopheles gambiae OX=7165 GN=SERCA PE=3 SV=5,,,,,,
OG_06445,0.3004135729272026,OG_06445,FUN_029156-T1,Peve_00041032,Pocillopora_meandrina_HIv1___RNAseq.g25738.t1,three_way,72.0625,FUN_029156-T1,Q6DEZ2,,,,,32.0,977.0,4.3e-129,464.2,sp|Q6DEZ2|F120A_XENTR Constitutive coactivator of PPAR-gamma-like protein 1 homolog OS=Xenopus tropicalis OX=8364 GN=fam120a PE=2 SV=1,,,,,,
OG_05140,0.3003582783358559,OG_05140,FUN_023416-T1,Peve_00017406,Pocillopora_meandrina_HIv1___RNAseq.g17587.t2,three_way,86.484,FUN_023416-T1,Q9UHX1,,,,,45.5,569.0,4.5e-115,416.8,sp|Q9UHX1|PUF60_HUMAN Poly(U)-binding-splicing factor PUF60 OS=Homo sapiens OX=9606 GN=PUF60 PE=1 SV=1,,,,,,
OG_01597,0.3002974196411629,OG_01597,FUN_006639-T1,Peve_00033034,Pocillopora_meandrina_HIv1___RNAseq.g20239.t1,three_way,79.87783333333333,FUN_006639-T1,P53992,SC24C_HUMAN,,Protein transport protein Sec24C (SEC24-related protein C),Homo sapiens (Human),58.8,770.0,3.3e-276,953.0,sp|P53992|SC24C_HUMAN Protein transport protein Sec24C OS=Homo sapiens OX=9606 GN=SEC24C PE=1 SV=3,GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0070971; GO:0090110,COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507],SNARE binding [GO:0000149]; zinc ion binding [GO:0008270],GO:0005829; GO:0006886; GO:0016192; GO:0048856,cytosol; intracellular protein transport; vesicle-mediated transport; anatomical structure development
OG_07714,0.300263275546749,OG_07714,FUN_034867-T1,Peve_00005778,Pocillopora_meandrina_HIv1___RNAseq.g27146.t1,three_way,75.34383333333334,FUN_034867-T1,Q28193,FURIN_BOVIN,,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Trans Golgi network protease furin),Bos taurus (Bovine),49.8,616.0,5.7e-165,582.8,sp|Q28193|FURIN_BOVIN Furin OS=Bos taurus OX=9913 GN=FURIN PE=1 SV=1,GO:0000139; GO:0004252; GO:0005576; GO:0005802; GO:0005886; GO:0008201; GO:0010008; GO:0016486; GO:0046872; GO:0140447; GO:1904399,cytokine precursor processing [GO:0140447]; peptide hormone processing [GO:0016486],endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_09347,0.3002620228338047,OG_09347,FUN_040402-T1,Peve_00014984,Pocillopora_meandrina_HIv1___RNAseq.g6531.t1,three_way,64.912,FUN_040402-T1,P19137,LAMA1_MOUSE,,Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha),Mus musculus (Mouse),22.5,3355.0,9.5e-78,295.0,sp|P19137|LAMA1_MOUSE Laminin subunit alpha-1 OS=Mus musculus OX=10090 GN=Lama1 PE=1 SV=2,GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0031175; GO:0043208; GO:0043256; GO:0045198; GO:0045785; GO:0045995; GO:0051149; GO:0060041; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046,branching involved in salivary gland morphogenesis [GO:0060445]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888],basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637],extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; signaling receptor binding [GO:0005102],GO:0005198; GO:0005576; GO:0005615; GO:0007155; GO:0007163; GO:0008289; GO:0030154; GO:0030312; GO:0031012; GO:0048856,structural molecule activity; extracellular region; extracellular space; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_01445,0.3002601338911269,OG_01445,FUN_005893-T1,Peve_00015773,Pocillopora_meandrina_HIv1___RNAseq.g19681.t1,three_way,81.42,FUN_005893-T1,G5EBX9,PPE_CAEEL,,Serine/threonine-protein phosphatase with EF-hands pef-1 (CePPEF) (EC 3.1.3.16) (Phosphatase with EF hands 1),Caenorhabditis elegans,49.7,580.0,1.8000000000000001e-162,574.3,sp|G5EBX9|PPE_CAEEL Serine/threonine-protein phosphatase with EF-hands pef-1 OS=Caenorhabditis elegans OX=6239 GN=pef-1 PE=1 SV=1,GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0030145; GO:0030424; GO:0030425; GO:0043025; GO:0043204; GO:0050906,detection of stimulus involved in sensory perception [GO:0050906],axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; cilium; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_04503,0.3001718386644197,OG_04503,FUN_022013-T1,Peve_00042673,Pocillopora_meandrina_HIv1___RNAseq.g3139.t1,three_way,74.30833333333334,FUN_022013-T1,Q05360,,,,,43.6,676.0,1.9e-149,531.2,sp|Q05360|WHITE_LUCCU Protein white OS=Lucilia cuprina OX=7375 GN=W PE=2 SV=2,,,,,,
OG_06512,0.3001404464338975,OG_06512,FUN_029309-T1,Peve_00038265,Pocillopora_meandrina_HIv1___RNAseq.g12582.t1,three_way,42.67516666666667,FUN_029309-T1,Q921R4,,,,,33.1,314.0,3e-36,155.6,sp|Q921R4|DJC14_MOUSE DnaJ homolog subfamily C member 14 OS=Mus musculus OX=10090 GN=Dnajc14 PE=2 SV=2,,,,,,
OG_00808,0.2999785290195534,OG_00808,FUN_004007-T1,Peve_00044893,Pocillopora_meandrina_HIv1___RNAseq.g11703.t1b,three_way,74.065,FUN_004007-T1,O95405,,,,,43.3,743.0,2.8000000000000003e-161,571.2,sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2,,,,,,
OG_03708,0.2999223009951725,OG_03708,FUN_014981-T1,Peve_00039942,Pocillopora_meandrina_HIv1___TS.g25894.t1,three_way,81.89766666666667,FUN_014981-T1,Q8CCN5,BCAS3_MOUSE,,BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3 homolog) (K20D4) (Protein rudhira),Mus musculus (Mouse),47.1,768.0,1.1e-178,628.6,sp|Q8CCN5|BCAS3_MOUSE BCAS3 microtubule associated cell migration factor OS=Mus musculus OX=10090 GN=Bcas3 PE=1 SV=2,GO:0000407; GO:0000791; GO:0001525; GO:0003682; GO:0005634; GO:0005737; GO:0005881; GO:0006914; GO:0007267; GO:0010595; GO:0031252; GO:0032956; GO:0035091; GO:0043085; GO:0045111; GO:0045944; GO:0048487; GO:0071391; GO:0071944,angiogenesis [GO:0001525]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956],cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; euchromatin [GO:0000791]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407],beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; phosphatidylinositol binding [GO:0035091],GO:0005634; GO:0005856; GO:0006355; GO:0006914; GO:0008092; GO:0008289; GO:0023052; GO:0043226,nucleus; cytoskeleton; regulation of DNA-templated transcription; autophagy; cytoskeletal protein binding; lipid binding; signaling; organelle
OG_01259,0.2996455457487026,OG_01259,FUN_005018-T1,Peve_00015875,Pocillopora_meandrina_HIv1___RNAseq.g8677.t1,three_way,82.69383333333333,FUN_005018-T1,Q6GPM1,,,,,45.6,799.0,4e-132,474.2,sp|Q6GPM1|ZFR_XENLA Zinc finger RNA-binding protein OS=Xenopus laevis OX=8355 GN=zfr PE=2 SV=1,,,,,,
OG_09500,0.2995427680732517,OG_09500,FUN_041544-T1,Peve_00021436,Pocillopora_meandrina_HIv1___RNAseq.g15993.t1,three_way,85.34433333333334,FUN_041544-T1,Q9Z2W1,STK25_MOUSE,,Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1),Mus musculus (Mouse),63.5,417.0,2.7e-143,510.0,sp|Q9Z2W1|STK25_MOUSE Serine/threonine-protein kinase 25 OS=Mus musculus OX=10090 GN=Stk25 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005794; GO:0007163; GO:0007409; GO:0032874; GO:0036481; GO:0042803; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0090168; GO:0090443; GO:0106310,axonogenesis [GO:0007409]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874],FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005794; GO:0007163; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; establishment or maintenance of cell polarity; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09466,0.2993818400501407,OG_09466,FUN_041490-T1,Peve_00004073,Pocillopora_meandrina_HIv1___RNAseq.g15669.t1,three_way,79.144,FUN_041490-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),33.6,420.0,1.3e-68,262.3,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_07729,0.2993306254506322,OG_07729,FUN_034890-T1,Peve_00037340,Pocillopora_meandrina_HIv1___TS.g15152.t1,three_way,81.66833333333334,FUN_034890-T1,O61585,,,,,55.5,714.0,5.000000000000001e-80,300.4,sp|O61585|KTNB1_STRPU Katanin p80 WD40 repeat-containing subunit B1 OS=Strongylocentrotus purpuratus OX=7668 GN=KATNB1 PE=1 SV=1,,,,,,
OG_02323,0.2992009399088153,OG_02323,FUN_008915-T1,Peve_00033002,Pocillopora_meandrina_HIv1___RNAseq.g3980.t1,three_way,93.944,FUN_008915-T1,P58375,,,,,80.4,112.0,2.2e-45,183.0,sp|P58375|RL30_SPOFR Large ribosomal subunit protein eL30 OS=Spodoptera frugiperda OX=7108 GN=RpL30 PE=3 SV=1,,,,,,
OG_01653,0.2991185592657397,OG_01653,FUN_006821-T1,Peve_00023763,Pocillopora_meandrina_HIv1___RNAseq.g20482.t1,three_way,90.73766666666668,FUN_006821-T1,Q9HD45,,,,,69.3,554.0,6.7e-206,718.4,sp|Q9HD45|TM9S3_HUMAN Transmembrane 9 superfamily member 3 OS=Homo sapiens OX=9606 GN=TM9SF3 PE=1 SV=2,,,,,,
OG_05290,0.2990634811389966,OG_05290,FUN_023956-T1,Peve_00017997,Pocillopora_meandrina_HIv1___RNAseq.g18522.t1,three_way,84.48,FUN_023956-T1,O60271,,,,,49.1,642.0,1.4e-149,531.2,sp|O60271|JIP4_HUMAN C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=4,,,,,,
OG_06125,0.2989386648857397,OG_06125,FUN_027903-T1,Peve_00020107,Pocillopora_meandrina_HIv1___RNAseq.g13881.t1,three_way,48.315666666666665,FUN_027903-T1,O75487,GPC4_HUMAN,,Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4],Homo sapiens (Human),33.5,507.0,6.5e-73,276.6,sp|O75487|GPC4_HUMAN Glypican-4 OS=Homo sapiens OX=9606 GN=GPC4 PE=1 SV=4,GO:0005634; GO:0005796; GO:0005886; GO:0009897; GO:0009966; GO:0009986; GO:0015026; GO:0016055; GO:0016477; GO:0043202; GO:0045202; GO:0070062; GO:0098696; GO:0098978; GO:0099560; GO:1905606,cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],coreceptor activity [GO:0015026],GO:0005634; GO:0005886; GO:0007155; GO:0043226; GO:0048870; GO:0060089,nucleus; plasma membrane; cell adhesion; organelle; cell motility; molecular transducer activity
OG_04041,0.2988691495246333,OG_04041,FUN_016350-T1,Peve_00004331,Pocillopora_meandrina_HIv1___RNAseq.16312_t,three_way,70.639,FUN_016350-T1,Q90WR8,SP3_CHICK,,Transcription factor Sp3,Gallus gallus (Chicken),48.7,117.0,7.9e-20,100.1,sp|Q90WR8|SP3_CHICK Transcription factor Sp3 OS=Gallus gallus OX=9031 GN=SP3 PE=1 SV=1,GO:0000978; GO:0000981; GO:0001227; GO:0001503; GO:0001779; GO:0001889; GO:0002318; GO:0003682; GO:0005829; GO:0006357; GO:0008270; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0043353; GO:0045944; GO:0048596; GO:0048706; GO:0060216; GO:0061629,B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; myeloid progenitor cell differentiation [GO:0002318]; natural killer cell differentiation [GO:0001779]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217],cytosol [GO:0005829]; PML body [GO:0016605]; transcription repressor complex [GO:0017053],"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06491,0.2987108881676439,OG_06491,FUN_029269-T1,Peve_00002504,Pocillopora_meandrina_HIv1___RNAseq.g25417.t1,three_way,91.27916666666668,FUN_029269-T1,P08110,,,,,69.4,779.0,1.7e-282,973.4,sp|P08110|ENPL_CHICK Endoplasmin OS=Gallus gallus OX=9031 GN=HSP90B1 PE=1 SV=1,,,,,,
OG_05444,0.2986987772114622,OG_05444,FUN_024399-T1,Peve_00021813,Pocillopora_meandrina_HIv1___RNAseq.g18632.t1,three_way,82.354,FUN_024399-T1,Q9QZN3,,,,,52.8,267.0,1.5e-81,304.3,sp|Q9QZN3|FBX8_MOUSE F-box only protein 8 OS=Mus musculus OX=10090 GN=Fbxo8 PE=2 SV=2,,,,,,
OG_06754,0.2986919792816038,OG_06754,FUN_031565-T1,Peve_00021513,Pocillopora_meandrina_HIv1___RNAseq.g5072.t1,three_way,87.24600000000001,FUN_031565-T1,Q01728,,,,,54.5,932.0,1.8e-266,920.2,sp|Q01728|NAC1_RAT Sodium/calcium exchanger 1 OS=Rattus norvegicus OX=10116 GN=Slc8a1 PE=1 SV=3,,,,,,
OG_07863,0.2986747265526102,OG_07863,FUN_035220-T1,Peve_00035885,Pocillopora_meandrina_HIv1___RNAseq.g27612.t1,three_way,83.25133333333333,FUN_035220-T1,D3YXS5,,,,,37.8,932.0,1.3e-153,545.4,sp|D3YXS5|KIF28_MOUSE Kinesin-like protein KIF28 OS=Mus musculus OX=10090 GN=Kif28 PE=3 SV=1,,,,,,
OG_01682,0.2986481377231658,OG_01682,FUN_006898-T1,Peve_00024786,Pocillopora_meandrina_HIv1___RNAseq.g19811.t1,three_way,86.23733333333332,FUN_006898-T1,Q28GW8,MELK_XENTR,,Maternal embryonic leucine zipper kinase (EC 2.7.11.1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),44.6,673.0,2.2e-154,547.4,sp|Q28GW8|MELK_XENTR Maternal embryonic leucine zipper kinase OS=Xenopus tropicalis OX=8364 GN=melk PE=2 SV=1,GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005886; GO:0005938; GO:0006915; GO:0008016; GO:0008283; GO:0008289; GO:0030097; GO:0043065; GO:0046777; GO:0048821; GO:0061351; GO:0106310,apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; erythrocyte development [GO:0048821]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; regulation of heart contraction [GO:0008016],cell cortex [GO:0005938]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005886; GO:0008289; GO:0012501; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; lipid binding; programmed cell death; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_05479,0.2985992260666975,OG_05479,FUN_024473-T1,Peve_00002830,Pocillopora_meandrina_HIv1___RNAseq.g18567.t1,three_way,52.34666666666666,FUN_024473-T1,P97460,NPAS2_MOUSE,,Neuronal PAS domain-containing protein 2 (Neuronal PAS2),Mus musculus (Mouse),34.6,413.0,1.1999999999999999e-46,190.7,sp|P97460|NPAS2_MOUSE Neuronal PAS domain-containing protein 2 OS=Mus musculus OX=10090 GN=Npas2 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006974; GO:0007623; GO:0009410; GO:0032922; GO:0042745; GO:0042752; GO:0045475; GO:0045739; GO:0045893; GO:0045944; GO:0046872; GO:0046983; GO:0051775; GO:2000987,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; DNA damage response [GO:0006974]; locomotor rhythm [GO:0045475]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; response to redox state [GO:0051775]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_09944,0.2985798375090727,OG_09944,FUN_043111-T1,Peve_00014954,Pocillopora_meandrina_HIv1___RNAseq.g7894.t1,three_way,96.616,FUN_043111-T1,Q8JGS9,,,,,89.1,101.0,5.5e-47,188.0,sp|Q8JGS9|RS18_DANRE Small ribosomal subunit protein uS13 OS=Danio rerio OX=7955 GN=rps18 PE=1 SV=1,,,,,,
OG_06778,0.2985330992890378,OG_06778,FUN_031644-T1,Peve_00043582,Pocillopora_meandrina_HIv1___RNAseq.g5685.t1,three_way,76.86,FUN_031644-T1,Q3EBF7,SLD2_ARATH,,Delta(8)-fatty-acid desaturase 2 (EC 1.14.19.29) (Delta(8)-sphingolipid desaturase 2) (Sphingoid long-chain base desaturase 2) (Sphingoid LCB desaturase 2) (Sphingolipid 8-(E/Z)-desaturase 2),Arabidopsis thaliana (Mouse-ear cress),41.9,451.0,8.5e-100,365.5,sp|Q3EBF7|SLD2_ARATH Delta(8)-fatty-acid desaturase 2 OS=Arabidopsis thaliana OX=3702 GN=SLD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0030148; GO:0046872; GO:0052631; GO:0070417,cellular response to cold [GO:0070417]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; sphingolipid 8-(E/Z)-desaturase activity [GO:0052631],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle
OG_00028,0.2985107168318917,OG_00028,FUN_000231-T1,Peve_00012025,Pocillopora_meandrina_HIv1___RNAseq.g28946.t1,three_way,54.33083333333334,FUN_000231-T1,Q1ZXH8,GXCDD_DICDI,,Guanine exchange factor for Rac 30,Dictyostelium discoideum (Social amoeba),36.5,203.0,4.3e-26,122.5,sp|Q1ZXH8|GXCDD_DICDI Guanine exchange factor for Rac 30 OS=Dictyostelium discoideum OX=44689 GN=gxcDD PE=4 SV=3,GO:0005085; GO:0005096; GO:0005547; GO:0005737; GO:0005856; GO:0005938; GO:0008270; GO:0016020; GO:0030587; GO:0030670; GO:0031152; GO:0031267; GO:0032009; GO:0035556,aggregation involved in sorocarp development [GO:0031152]; intracellular signal transduction [GO:0035556]; sorocarp development [GO:0030587],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early phagosome [GO:0032009]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670],"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0005856; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,cytoskeleton; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_00145,0.2984711247212493,OG_00145,FUN_000588-T1,Peve_00025320,Pocillopora_meandrina_HIv1___RNAseq.g29293.t3,three_way,87.40333333333334,FUN_000588-T1,P28347,TEAD1_HUMAN,,Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13),Homo sapiens (Human),65.6,450.0,3.6000000000000002e-146,519.6,sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837,embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_00116,0.2984017319166707,OG_00116,FUN_000534-T1,Peve_00039809,Pocillopora_meandrina_HIv1___TS.g4886.t2,three_way,79.79933333333334,FUN_000534-T1,O75386,TULP3_HUMAN,,Tubby-related protein 3 (Tubby-like protein 3),Homo sapiens (Human),44.4,342.0,1.1000000000000001e-60,235.3,sp|O75386|TULP3_HUMAN Tubby-related protein 3 OS=Homo sapiens OX=9606 GN=TULP3 PE=1 SV=2,GO:0001664; GO:0001843; GO:0005546; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005886; GO:0005929; GO:0005930; GO:0006355; GO:0007186; GO:0007420; GO:0008277; GO:0009952; GO:0019899; GO:0021953; GO:0031076; GO:0035091; GO:0036064; GO:0042733; GO:0044877; GO:0045879; GO:0048702; GO:0060348; GO:0060434; GO:0060831; GO:0061512; GO:0061548; GO:0097546; GO:0097731; GO:0120160,anterior/posterior pattern specification [GO:0009952]; bone development [GO:0060348]; brain development [GO:0007420]; bronchus morphogenesis [GO:0060434]; central nervous system neuron differentiation [GO:0021953]; embryonic camera-type eye development [GO:0031076]; embryonic digit morphogenesis [GO:0042733]; embryonic neurocranium morphogenesis [GO:0048702]; G protein-coupled receptor signaling pathway [GO:0007186]; ganglion development [GO:0061548]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; protein localization to cilium [GO:0061512]; regulation of DNA-templated transcription [GO:0006355]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],9+0 non-motile cilium [GO:0097731]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; intraciliary transport particle A binding [GO:0120160]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]",GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0008289; GO:0030154; GO:0043226; GO:0048856,extracellular region; nucleus; nucleoplasm; nucleolus; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; lipid binding; cell differentiation; organelle; anatomical structure development
OG_04107,0.2980025116615378,OG_04107,FUN_016472-T1,Peve_00015305,Pocillopora_meandrina_HIv1___TS.g6873.t1,three_way,61.89483333333333,FUN_016472-T1,A4IJ06,GRP1_XENTR,,RAS guanyl-releasing protein 1,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),44.0,234.0,1.6e-47,191.4,sp|A4IJ06|GRP1_XENTR RAS guanyl-releasing protein 1 OS=Xenopus tropicalis OX=8364 GN=rasgrp1 PE=2 SV=1,GO:0000139; GO:0005085; GO:0005509; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0008270; GO:0030154,cell differentiation [GO:0030154]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270],GO:0005829; GO:0005886; GO:0030154; GO:0098772,cytosol; plasma membrane; cell differentiation; molecular function regulator activity
OG_04874,0.2979815675343614,OG_04874,FUN_022903-T1,Peve_00001842,Pocillopora_meandrina_HIv1___RNAseq.g3702.t1,three_way,81.031,FUN_022903-T1,Q6ZQN7,SO4C1_HUMAN,,Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (OATP-H) (Organic anion transporter M1) (OATP-M1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20),Homo sapiens (Human),35.1,615.0,6.1e-111,403.3,sp|Q6ZQN7|SO4C1_HUMAN Solute carrier organic anion transporter family member 4C1 OS=Homo sapiens OX=9606 GN=SLCO4C1 PE=1 SV=1,GO:0005886; GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0016323; GO:0030154; GO:0035577; GO:0035579; GO:0043252; GO:0070062,cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283],azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347],GO:0005215; GO:0005886; GO:0022414; GO:0030154; GO:0043226,transporter activity; plasma membrane; reproductive process; cell differentiation; organelle
OG_06985,0.2979760787157113,OG_06985,FUN_032124-T1,Peve_00040714,Pocillopora_meandrina_HIv1___TS.g24079.t3,three_way,68.271,FUN_032124-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),24.2,715.0,4.2e-45,184.9,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_07424,0.297910481151504,OG_07424,FUN_033886-T1,Peve_00043301,Pocillopora_meandrina_HIv1___RNAseq.20826_t,three_way,52.64116666666667,FUN_033886-T1,Q6ZQ03,,,,,35.6,219.0,1.8000000000000002e-28,129.4,sp|Q6ZQ03|FNBP4_MOUSE Formin-binding protein 4 OS=Mus musculus OX=10090 GN=Fnbp4 PE=1 SV=2,,,,,,
OG_07424,0.297910481151504,OG_07424,FUN_033886-T1,Peve_00043301,Pocillopora_meandrina_HIv1___RNAseq.20826_t,three_way,52.64116666666667,FUN_033886-T1,Q6ZQ03,,,,,52.8,36.0,0.0003,48.9,sp|Q6ZQ03|FNBP4_MOUSE Formin-binding protein 4 OS=Mus musculus OX=10090 GN=Fnbp4 PE=1 SV=2,,,,,,
OG_07251,0.2978528220909924,OG_07251,FUN_032993-T1,Peve_00014539,Pocillopora_meandrina_HIv1___RNAseq.g24472.t1,three_way,86.36833333333334,FUN_032993-T1,P47826,,,,,72.1,280.0,9.999999999999999e-116,417.9,sp|P47826|RLA0_CHICK Large ribosomal subunit protein uL10 OS=Gallus gallus OX=9031 GN=RPLP0 PE=1 SV=1,,,,,,
OG_00687,0.2978475412342349,OG_00687,FUN_002358-T1,Peve_00014905,Pocillopora_meandrina_HIv1___RNAseq.g42.t1,three_way,69.67566666666666,FUN_002358-T1,Q19297,,,,,43.6,94.0,8.4e-17,88.2,sp|Q19297|YZ73_CAEEL Uncharacterized monothiol glutaredoxin F10D7.3 OS=Caenorhabditis elegans OX=6239 GN=F10D7.3 PE=3 SV=2,,,,,,
OG_03189,0.2978380307226151,OG_03189,FUN_012660-T1,Peve_00020497,Pocillopora_meandrina_HIv1___RNAseq.g22893.t1,three_way,86.607,FUN_012660-T1,Q8C811,,,,,49.4,265.0,7.899999999999999e-62,238.8,sp|Q8C811|S35E2_MOUSE Solute carrier family 35 member E2A OS=Mus musculus OX=10090 GN=Slc35e2a PE=2 SV=1,,,,,,
OG_02663,0.297702213211088,OG_02663,FUN_010879-T1,Peve_00035832,Pocillopora_meandrina_HIv1___RNAseq.g21030.t1,three_way,86.78866666666667,FUN_010879-T1,Q2KJI3,CYRIB_BOVIN,,CYFIP-related Rac1 interactor B (Protein FAM49B),Bos taurus (Bovine),65.7,327.0,8.4e-116,418.3,sp|Q2KJI3|CYRIB_BOVIN CYFIP-related Rac1 interactor B OS=Bos taurus OX=9913 GN=CYRIB PE=2 SV=1,GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031267; GO:0032729; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568,cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of type II interferon production [GO:0032729]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140],cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739],"MHC class Ib protein binding, via antigen binding groove [GO:0023030]; small GTPase binding [GO:0031267]",GO:0005739; GO:0005929; GO:0043226,mitochondrion; cilium; organelle
OG_07375,0.2976921042481647,OG_07375,FUN_033797-T1,Peve_00029703,Pocillopora_meandrina_HIv1___RNAseq.g26319.t1,three_way,67.2325,FUN_033797-T1,O95071,,,,,39.0,318.0,1.5e-52,211.1,sp|O95071|UBR5_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens OX=9606 GN=UBR5 PE=1 SV=2,,,,,,
OG_05986,0.2976766202668104,OG_05986,FUN_026472-T1,Peve_00002340,Pocillopora_meandrina_HIv1___TS.g21592.t2,three_way,76.41433333333333,FUN_026472-T1,Q8K3I9,,,,,36.6,306.0,1.1000000000000001e-27,125.9,sp|Q8K3I9|GLCI1_MOUSE Glucocorticoid-induced transcript 1 protein OS=Mus musculus OX=10090 GN=Glcci1 PE=1 SV=1,,,,,,
OG_05396,0.2975684798786612,OG_05396,FUN_024223-T1,Peve_00031888,Pocillopora_meandrina_HIv1___RNAseq.g18916.t1,three_way,89.404,FUN_024223-T1,P49596,,,,,62.5,309.0,1.6e-113,410.6,sp|P49596|PP2C2_CAEEL Probable protein phosphatase 2C T23F11.1 OS=Caenorhabditis elegans OX=6239 GN=ppm-2 PE=3 SV=2,,,,,,
OG_04468,0.2975647817859874,OG_04468,FUN_019560-T1,Peve_00032909,Pocillopora_meandrina_HIv1___RNAseq.g20816.t1,three_way,74.66783333333333,FUN_019560-T1,Q90941,,,,,38.3,1523.0,1.2e-280,968.4,sp|Q90941|PB1_CHICK Protein polybromo-1 OS=Gallus gallus OX=9031 GN=PBRM1 PE=1 SV=1,,,,,,
OG_08733,0.2975539514257455,OG_08733,FUN_037990-T1,Peve_00023488,Pocillopora_meandrina_HIv1___RNAseq.g26269.t1,three_way,90.14733333333334,FUN_037990-T1,A5PKG7,,,,,68.2,198.0,5.2e-73,275.4,sp|A5PKG7|KCTD5_BOVIN BTB/POZ domain-containing protein KCTD5 OS=Bos taurus OX=9913 GN=KCTD5 PE=2 SV=1,,,,,,
OG_03658,0.2975211725047514,OG_03658,FUN_014895-T1,Peve_00003547,Pocillopora_meandrina_HIv1___RNAseq.g21105.t1,three_way,67.7525,FUN_014895-T1,Q0VH32,,,,,50.8,122.0,6.3999999999999975e-25,116.3,sp|Q0VH32|MNT_XENLA Max-binding protein MNT OS=Xenopus laevis OX=8355 GN=mnt PE=2 SV=1,,,,,,
OG_03962,0.297518439468254,OG_03962,FUN_016111-T1,Peve_00013359,Pocillopora_meandrina_HIv1___RNAseq.g21553.t2,three_way,68.24533333333333,FUN_016111-T1,Q8WXX7,,,,,35.2,162.0,1.2e-07,60.5,sp|Q8WXX7|AUTS2_HUMAN Autism susceptibility gene 2 protein OS=Homo sapiens OX=9606 GN=AUTS2 PE=1 SV=1,,,,,,
OG_07072,0.2974622180350279,OG_07072,FUN_032308-T1,Peve_00001539,Pocillopora_meandrina_HIv1___RNAseq.g24763.t1,three_way,65.20216666666667,FUN_032308-T1,Q3B8Q1,DDX21_RAT,,Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu),Rattus norvegicus (Rat),49.4,579.0,2.1999999999999998e-147,524.2,sp|Q3B8Q1|DDX21_RAT Nucleolar RNA helicase 2 OS=Rattus norvegicus OX=10116 GN=Ddx21 PE=2 SV=1,GO:0002735; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006364; GO:0006366; GO:0009615; GO:0016887; GO:0019843; GO:0030515; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045945; GO:0051607; GO:0062176; GO:0097322; GO:0110016,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop processing [GO:0062176]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366],B-WICH complex [GO:0110016]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515],GO:0002376; GO:0003723; GO:0003824; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0098542; GO:0140098; GO:0140657,"immune system process; RNA binding; catalytic activity; nucleoplasm; nucleolus; mitochondrion; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05546,0.2974607762796534,OG_05546,FUN_024753-T1,Peve_00041145,Pocillopora_meandrina_HIv1___RNAseq.g18834.t1,three_way,70.904,,,,,,,,,,,,,,,,,
OG_06431,0.2973375360209701,OG_06431,FUN_029125-T1,Peve_00024870,Pocillopora_meandrina_HIv1___RNAseq.g25775.t1,three_way,64.52616666666667,FUN_029125-T1,A4IHD2,,,,,50.8,846.0,7.7e-237,822.4,sp|A4IHD2|ARIP4_XENTR Helicase ARIP4 OS=Xenopus tropicalis OX=8364 GN=rad54l2 PE=2 SV=1,,,,,,
OG_03803,0.2971646460057754,OG_03803,FUN_015187-T1,Peve_00013021,Pocillopora_meandrina_HIv1___RNAseq.g22307.t1,three_way,65.45766666666667,FUN_015187-T1,O88845,AKA10_MOUSE,,"A-kinase anchor protein 10, mitochondrial (AKAP-10) (Dual specificity A kinase-anchoring protein 2) (D-AKAP-2) (Protein kinase A-anchoring protein 10) (PRKA10)",Mus musculus (Mouse),33.2,596.0,9.3e-79,296.2,"sp|O88845|AKA10_MOUSE A-kinase anchor protein 10, mitochondrial OS=Mus musculus OX=10090 GN=Akap10 PE=1 SV=3",GO:0005739; GO:0005829; GO:0005886; GO:0008104; GO:0032991; GO:0051018,protein localization [GO:0008104],cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],protein kinase A binding [GO:0051018],GO:0005739; GO:0005829; GO:0005886; GO:0043226,mitochondrion; cytosol; plasma membrane; organelle
OG_05144,0.297091756380078,OG_05144,FUN_023420-T1,Peve_00019213,Pocillopora_meandrina_HIv1___RNAseq.g581.t1,three_way,86.11033333333333,FUN_023420-T1,Q5ZIG2,SLU7_CHICK,,Pre-mRNA-splicing factor SLU7,Gallus gallus (Chicken),65.2,543.0,4.0999999999999996e-181,636.0,sp|Q5ZIG2|SLU7_CHICK Pre-mRNA-splicing factor SLU7 OS=Gallus gallus OX=9031 GN=SLU7 PE=2 SV=1,GO:0000398; GO:0005681; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0030628,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681],pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270],GO:0003723; GO:0016071; GO:0043226,RNA binding; mRNA metabolic process; organelle
OG_04615,0.2970660808870663,OG_04615,FUN_022314-T1,Peve_00021691,Pocillopora_meandrina_HIv1___TS.g22047.t1,three_way,61.79866666666667,,,,,,,,,,,,,,,,,
OG_10052,0.2970566147032194,OG_10052,FUN_043326-T1,Peve_00043041,Pocillopora_meandrina_HIv1___RNAseq.g8953.t1,three_way,56.76033333333333,FUN_043326-T1,D3ZAZ5,BCAR3_RAT,,"Breast cancer anti-estrogen resistance protein 3 homolog (BCAR3 adapter protein, NSP family member) (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B) (p130Cas-binding protein AND-34)",Rattus norvegicus (Rat),23.4,785.0,4.2e-25,118.2,sp|D3ZAZ5|BCAR3_RAT Breast cancer anti-estrogen resistance protein 3 homolog OS=Rattus norvegicus OX=10116 GN=Bcar3 PE=1 SV=1,GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007173; GO:0007264; GO:0008284; GO:0008286; GO:0016020; GO:0019900; GO:0043410; GO:0043547; GO:0086100,endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020],guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784],GO:0098772,molecular function regulator activity
OG_08722,0.2970540312483051,OG_08722,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),36.1,280.0,6.1e-42,174.9,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08722,0.2970540312483051,OG_08722,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),43.2,148.0,5.4e-22,108.6,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_09775,0.2970486875887083,OG_09775,FUN_042071-T1,Peve_00038496,Pocillopora_meandrina_HIv1___RNAseq.g6232.t1,three_way,63.51566666666667,FUN_042071-T1,Q96MM6,,,,,35.6,643.0,1.3e-106,388.7,sp|Q96MM6|HS12B_HUMAN Heat shock 70 kDa protein 12B OS=Homo sapiens OX=9606 GN=HSPA12B PE=1 SV=2,,,,,,
OG_08906,0.2969877531058851,OG_08906,FUN_038337-T1,Peve_00000101,Pocillopora_meandrina_HIv1___RNAseq.g1113.t1,three_way,71.11383333333333,FUN_038337-T1,Q553D3,,,,,30.7,212.0,2.5e-20,102.4,sp|Q553D3|GXCJJ_DICDI Rac guanine nucleotide exchange factor JJ OS=Dictyostelium discoideum OX=44689 GN=gxcJJ PE=1 SV=1,,,,,,
OG_05871,0.2969420795463044,OG_05871,FUN_025986-T1,Peve_00002322,Pocillopora_meandrina_HIv1___TS.g13918.t1,three_way,61.095,FUN_025986-T1,Q8K2A1,,,,,50.5,186.0,1e-43,179.1,sp|Q8K2A1|GULP1_MOUSE PTB domain-containing engulfment adapter protein 1 OS=Mus musculus OX=10090 GN=Gulp1 PE=1 SV=1,,,,,,
OG_02849,0.2969391765767941,OG_02849,FUN_011876-T1,Peve_00018839,Pocillopora_meandrina_HIv1___RNAseq.g23400.t1,three_way,55.41233333333333,FUN_011876-T1,Q9C0D7,ZC12C_HUMAN,,Probable ribonuclease ZC3H12C (EC 3.1.-.-) (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C),Homo sapiens (Human),45.0,351.0,3.5999999999999997e-69,264.6,sp|Q9C0D7|ZC12C_HUMAN Probable ribonuclease ZC3H12C OS=Homo sapiens OX=9606 GN=ZC3H12C PE=1 SV=2,GO:0003729; GO:0004521; GO:0005634; GO:0008270; GO:0036464,,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; organelle; catalytic activity, acting on RNA"
OG_04624,0.2969197109931418,OG_04624,FUN_022332-T1,Peve_00028602,Pocillopora_meandrina_HIv1___RNAseq.g4651.t2,three_way,52.3965,FUN_022332-T1,P26008,,,,,27.8,994.0,3.3000000000000003e-81,305.1,sp|P26008|ITAV_CHICK Integrin alpha-V OS=Gallus gallus OX=9031 GN=ITGAV PE=2 SV=1,,,,,,
OG_05470,0.2968900949971261,OG_05470,FUN_024453-T1,Peve_00010317,Pocillopora_meandrina_HIv1___RNAseq.g18578.t1,three_way,82.89666666666666,FUN_024453-T1,Q3SYR7,,,,,65.0,177.0,1.7e-59,230.3,sp|Q3SYR7|RL9_BOVIN Large ribosomal subunit protein uL6 OS=Bos taurus OX=9913 GN=RPL9 PE=2 SV=1,,,,,,
OG_02560,0.2968499528246567,OG_02560,FUN_010659-T1,Peve_00031472,Pocillopora_meandrina_HIv1___RNAseq.g21313.t1,three_way,90.361,FUN_010659-T1,Q76I81,,,,,81.8,121.0,1.5999999999999996e-53,209.9,sp|Q76I81|RS12_BOVIN Small ribosomal subunit protein eS12 OS=Bos taurus OX=9913 GN=RPS12 PE=2 SV=1,,,,,,
OG_09545,0.2968087633369841,OG_09545,FUN_041642-T1,Peve_00007386,Pocillopora_meandrina_HIv1___RNAseq.g14207.t1,three_way,91.14133333333334,FUN_041642-T1,Q13620,,,,,73.3,580.0,1.9e-245,849.7,sp|Q13620|CUL4B_HUMAN Cullin-4B OS=Homo sapiens OX=9606 GN=CUL4B PE=1 SV=4,,,,,,
OG_05055,0.2968036425594242,OG_05055,FUN_023251-T1,Peve_00019255,Pocillopora_meandrina_HIv1___RNAseq.g1743.t1,three_way,82.61816666666667,FUN_023251-T1,Q6PCJ1,DCTN1_XENLA,,Dynactin subunit 1,Xenopus laevis (African clawed frog),41.7,763.0,1.9e-112,409.1,sp|Q6PCJ1|DCTN1_XENLA Dynactin subunit 1 OS=Xenopus laevis OX=8355 GN=dctn1 PE=2 SV=1,GO:0000132; GO:0000776; GO:0000922; GO:0005813; GO:0005814; GO:0005874; GO:0005875; GO:0005938; GO:0007097; GO:0008017; GO:0030286; GO:0030424; GO:0031122; GO:0035371; GO:0051301; GO:0060236; GO:0090316; GO:0099738,cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; nuclear migration [GO:0007097]; positive regulation of intracellular protein transport [GO:0090316]; regulation of mitotic spindle organization [GO:0060236],axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; spindle pole [GO:0000922],microtubule binding [GO:0008017],GO:0005815; GO:0007010; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_04541,0.296665513904037,OG_04541,FUN_022098-T1,Peve_00038678,Pocillopora_meandrina_HIv1___RNAseq.g4106.t1,three_way,67.46583333333334,FUN_022098-T1,Q9IA31,,,,,31.5,523.0,6.9e-32,141.4,sp|Q9IA31|GLI3_CHICK Transcriptional activator GLI3 (Fragment) OS=Gallus gallus OX=9031 GN=GLI3 PE=1 SV=1,,,,,,
OG_05169,0.2966541862297009,OG_05169,FUN_023497-T1,Peve_00017459,Pocillopora_meandrina_HIv1___RNAseq.g539.t1,three_way,83.72433333333333,FUN_023497-T1,Q7T292,,,,,56.8,301.0,4.9e-98,359.4,sp|Q7T292|MFRN2_DANRE Mitoferrin-2 OS=Danio rerio OX=7955 GN=slc25a28 PE=2 SV=1,,,,,,
OG_07344,0.2966315064801259,OG_07344,FUN_033751-T1,Peve_00004933,Pocillopora_meandrina_HIv1___TS.g8542.t1,three_way,79.90966666666667,FUN_033751-T1,O95461,,,,,60.2,689.0,6.4e-254,878.2,sp|O95461|LARG1_HUMAN Xylosyl- and glucuronyltransferase LARGE1 OS=Homo sapiens OX=9606 GN=LARGE1 PE=1 SV=1,,,,,,
OG_02883,0.2965033537011438,OG_02883,FUN_011933-T1,Peve_00039642,Pocillopora_meandrina_HIv1___RNAseq.g23334.t1,three_way,74.492,FUN_011933-T1,Q9TZM3,,,,,26.5,2417.0,9.3e-178,627.1,sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6,,,,,,
OG_01730,0.2964909147745989,OG_01730,FUN_007024-T1,Peve_00032896,Pocillopora_meandrina_HIv1___RNAseq.g20020.t1,three_way,90.27,FUN_007024-T1,O49447,ADT3_ARATH,,"ADP,ATP carrier protein 3, mitochondrial (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3)",Arabidopsis thaliana (Mouse-ear cress),66.6,308.0,3.2e-110,399.8,"sp|O49447|ADT3_ARATH ADP,ATP carrier protein 3, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=AAC3 PE=1 SV=1",GO:0005471; GO:0005739; GO:0005743; GO:0005886; GO:0009941; GO:0015865; GO:0016020; GO:0140021; GO:1990544,mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; purine nucleotide transport [GO:0015865],chloroplast envelope [GO:0009941]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],ATP:ADP antiporter activity [GO:0005471],GO:0005215; GO:0005739; GO:0005886; GO:0043226; GO:0055085,transporter activity; mitochondrion; plasma membrane; organelle; transmembrane transport
OG_06268,0.2963774627472615,OG_06268,FUN_028299-T1,Peve_00000718,Pocillopora_meandrina_HIv1___RNAseq.g15542.t2,three_way,70.94366666666667,,,,,,,,,,,,,,,,,
OG_02720,0.2963764678102055,OG_02720,FUN_011048-T1,Peve_00013435,Pocillopora_meandrina_HIv1___RNAseq.g21483.t1,three_way,68.41766666666666,FUN_011048-T1,Q5PQT2,MTMR3_RAT,,"Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase)",Rattus norvegicus (Rat),37.4,1193.0,2.4e-206,720.7,"sp|Q5PQT2|MTMR3_RAT Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Rattus norvegicus OX=10116 GN=Mtmr3 PE=1 SV=1",GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0008138; GO:0008270; GO:0016020; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785,cellular response to glucose starvation [GO:0042149]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],"molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0060090; GO:0061024; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; hydrolase activity; molecular adaptor activity; membrane organization; catalytic activity, acting on a protein"
OG_03374,0.2963530577089905,OG_03374,FUN_013620-T1,Peve_00014987,Pocillopora_meandrina_HIv1___RNAseq.g13541.t1,three_way,88.12266666666667,FUN_013620-T1,B9GCH9,UREA_ORYSJ,,Urease (EC 3.5.1.5) (Urea amidohydrolase),Oryza sativa subsp. japonica (Rice),62.3,862.0,3.4e-307,1055.4,sp|B9GCH9|UREA_ORYSJ Urease OS=Oryza sativa subsp. japonica OX=39947 GN=Os12g0234800 PE=3 SV=2,GO:0009039; GO:0016151; GO:0035550; GO:0043419,urea catabolic process [GO:0043419],urease complex [GO:0035550],nickel cation binding [GO:0016151]; urease activity [GO:0009039],GO:0003824; GO:0016787; GO:0071941,catalytic activity; hydrolase activity; nitrogen cycle metabolic process
OG_00543,0.2962963362988014,OG_00543,FUN_001577-T1,Peve_00010785,Pocillopora_meandrina_HIv1___RNAseq.g2029.t1,three_way,69.47,FUN_001577-T1,Q6A039,,,,,55.0,453.0,3.1e-134,480.7,sp|Q6A039|TBC12_MOUSE TBC1 domain family member 12 OS=Mus musculus OX=10090 GN=Tbc1d12 PE=1 SV=2,,,,,,
OG_07673,0.2962522838699997,OG_07673,FUN_034780-T1,Peve_00029729,Pocillopora_meandrina_HIv1___RNAseq.g12275.t1,three_way,82.57533333333333,FUN_034780-T1,Q9Y4W6,AFG32_HUMAN,,Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) (Paraplegin-like protein),Homo sapiens (Human),68.9,637.0,6.099999999999999e-247,855.1,sp|Q9Y4W6|AFG32_HUMAN Mitochondrial inner membrane m-AAA protease component AFG3L2 OS=Homo sapiens OX=9606 GN=AFG3L2 PE=1 SV=2,GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0021675; GO:0030163; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0051082; GO:0051560; GO:0051604; GO:0055001; GO:0060013; GO:0072753; GO:0110097; GO:0141164,axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0055085; GO:0061024; GO:0140096; GO:0140657,"catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; cell junction organization; organelle; anatomical structure development; protein maturation; transmembrane transport; membrane organization; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07108,0.295888600716723,OG_07108,FUN_032378-T1,Peve_00041776,Pocillopora_meandrina_HIv1___RNAseq.7604_t,three_way,89.479,FUN_032378-T1,Q5R7J8,TP4A1_PONAB,,Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),64.7,167.0,1.4000000000000001e-59,230.7,sp|Q5R7J8|TP4A1_PONAB Protein tyrosine phosphatase type IVA 1 OS=Pongo abelii OX=9601 GN=PTP4A1 PE=2 SV=1,GO:0004725; GO:0005634; GO:0005769; GO:0005783; GO:0005819; GO:0005886,,early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819],protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005634; GO:0005768; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05688,0.2958607193185374,OG_05688,FUN_025539-T1,Peve_00013053,Pocillopora_meandrina_HIv1___RNAseq.g13801.t1,three_way,63.6775,FUN_025539-T1,O75381,PEX14_HUMAN,,Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14),Homo sapiens (Human),31.0,261.0,1.1e-16,89.4,sp|O75381|PEX14_HUMAN Peroxisomal membrane protein PEX14 OS=Homo sapiens OX=9606 GN=PEX14 PE=1 SV=1,GO:0001650; GO:0003714; GO:0005102; GO:0005634; GO:0005777; GO:0005778; GO:0005829; GO:0007031; GO:0008017; GO:0008320; GO:0016020; GO:0016558; GO:0016560; GO:0016561; GO:0030674; GO:0032091; GO:0032991; GO:0034453; GO:0034614; GO:0036250; GO:0042802; GO:0043433; GO:0044721; GO:0045892; GO:0048487; GO:0065003; GO:1990429,"cellular response to reactive oxygen species [GO:0034614]; microtubule anchoring [GO:0034453]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein binding [GO:0032091]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein-containing complex assembly [GO:0065003]",cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein transmembrane transporter activity [GO:0008320]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714],GO:0005215; GO:0005634; GO:0005777; GO:0005829; GO:0006355; GO:0006886; GO:0007010; GO:0007018; GO:0007031; GO:0008092; GO:0043226; GO:0055085; GO:0060090; GO:0065003; GO:0140110,transporter activity; nucleus; peroxisome; cytosol; regulation of DNA-templated transcription; intracellular protein transport; cytoskeleton organization; microtubule-based movement; peroxisome organization; cytoskeletal protein binding; organelle; transmembrane transport; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_04407,0.2957117532109253,OG_04407,FUN_018425-T1,Peve_00031687,Pocillopora_meandrina_HIv1___RNAseq.g10172.t1,three_way,90.69833333333332,FUN_018425-T1,Q9GT45,,,,,81.4,113.0,5.400000000000001e-44,178.3,sp|Q9GT45|RS26_ANOGA Small ribosomal subunit protein eS26 OS=Anopheles gambiae OX=7165 GN=RpS26 PE=3 SV=2,,,,,,
OG_07826,0.2956177585605005,OG_07826,FUN_035122-T1,Peve_00005905,Pocillopora_meandrina_HIv1___RNAseq.g27642.t1,three_way,59.37683333333334,FUN_035122-T1,Q7T6X2,,,,,32.0,278.0,2.7e-20,102.1,sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R826 PE=3 SV=2,,,,,,
OG_09847,0.2955852046847841,OG_09847,FUN_042837-T1,Peve_00007263,Pocillopora_meandrina_HIv1___RNAseq.g7264.t1,three_way,78.92983333333333,FUN_042837-T1,Q32S26,BRD2_BOVIN,,Bromodomain-containing protein 2,Bos taurus (Bovine),50.9,737.0,1.5e-137,492.3,sp|Q32S26|BRD2_BOVIN Bromodomain-containing protein 2 OS=Bos taurus OX=9913 GN=BRD2 PE=3 SV=1,GO:0000785; GO:0005634; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0070577; GO:0071168; GO:0140012; GO:0140588; GO:2000330,chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; nucleosome assembly [GO:0006334]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; protein localization to chromatin [GO:0071168]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],histone H4K5ac reader activity [GO:0140012]; lysine-acetylated histone binding [GO:0070577],GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0065003,nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly
OG_03837,0.2955478737902891,OG_03837,FUN_015294-T1,Peve_00022864,Pocillopora_meandrina_HIv1___RNAseq.g22110.t1,three_way,50.94466666666667,FUN_015294-T1,Q5EBL4,RIPL1_HUMAN,,RILP-like protein 1 (Rab-interacting lysosomal-like protein 1),Homo sapiens (Human),34.1,217.0,6.2e-22,107.1,sp|Q5EBL4|RIPL1_HUMAN RILP-like protein 1 OS=Homo sapiens OX=9606 GN=RILPL1 PE=1 SV=1,GO:0003382; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0007263; GO:0031267; GO:0036064; GO:0046983; GO:0051959; GO:0060271; GO:1903445,cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; nitric oxide mediated signal transduction [GO:0007263]; protein transport from ciliary membrane to plasma membrane [GO:1903445],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0006886; GO:0043226; GO:0044782; GO:0061024; GO:0072659,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; cilium; intracellular protein transport; organelle; cilium organization; membrane organization; protein localization to plasma membrane
OG_07514,0.2954903730508292,OG_07514,FUN_034059-T1,Peve_00031737,Pocillopora_meandrina_HIv1___RNAseq.g26048.t1,three_way,65.53866666666667,FUN_034059-T1,Q3ZCC3,TRAF6_BOVIN,,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Bos taurus (Bovine),40.0,490.0,3.3e-95,350.5,sp|Q3ZCC3|TRAF6_BOVIN TNF receptor-associated factor 6 OS=Bos taurus OX=9913 GN=TRAF6 PE=2 SV=1,GO:0000045; GO:0000122; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002753; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005938; GO:0006974; GO:0007249; GO:0008270; GO:0009898; GO:0019886; GO:0023035; GO:0030316; GO:0031624; GO:0031663; GO:0031666; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0033209; GO:0034142; GO:0034450; GO:0035591; GO:0035631; GO:0038061; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0045087; GO:0045453; GO:0045672; GO:0045944; GO:0046330; GO:0048471; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0097400; GO:0098696; GO:0098978; GO:0140374; GO:0141198; GO:1904996,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; DNA damage response [GO:0006974]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005811; GO:0005829; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; lipid droplet; cytosol; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_06931,0.2954882609673852,OG_06931,FUN_032022-T1,Peve_00029553,Pocillopora_meandrina_HIv1___RNAseq.g5694.t1,three_way,65.54733333333333,FUN_032022-T1,O43854,EDIL3_HUMAN,,EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1),Homo sapiens (Human),32.5,114.0,1.9e-06,56.6,sp|O43854|EDIL3_HUMAN EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Homo sapiens OX=9606 GN=EDIL3 PE=1 SV=1,GO:0005178; GO:0005509; GO:0005576; GO:0007155; GO:0010811; GO:0062023; GO:0070062; GO:1903561,cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811],collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561],calcium ion binding [GO:0005509]; integrin binding [GO:0005178],GO:0005576; GO:0007155; GO:0043226,extracellular region; cell adhesion; organelle
OG_02761,0.2951310527617216,OG_02761,FUN_011698-T1,Peve_00018061,Pocillopora_meandrina_HIv1___RNAseq.g23828.t1,three_way,91.74833333333332,FUN_011698-T1,P31365,,,,,51.6,320.0,9.500000000000001e-71,268.9,"sp|P31365|P3F2A_XENLA POU domain, class 3, transcription factor 2-A OS=Xenopus laevis OX=8355 GN=pou3f2-a PE=2 SV=2",,,,,,
OG_02366,0.2951276316936846,OG_02366,FUN_008973-T1,Peve_00044338,Pocillopora_meandrina_HIv1___RNAseq.g3943.t1,three_way,66.187,FUN_008973-T1,P70057,,,,,37.0,573.0,1.5999999999999999e-83,312.4,sp|P70057|KCNQ1_XENLA Potassium voltage-gated channel subfamily KQT member 1 OS=Xenopus laevis OX=8355 GN=kcnq1 PE=1 SV=2,,,,,,
OG_01121,0.2951245183076131,OG_01121,FUN_004684-T1,Peve_00035122,Pocillopora_meandrina_HIv1___RNAseq.g8765.t1,three_way,65.35983333333333,FUN_004684-T1,Q07008,NOTC1_RAT,,Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],Rattus norvegicus (Rat),42.2,628.0,7.7e-77,291.2,sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3,GO:0000122; GO:0000987; GO:0001228; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006915; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008283; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027,"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cell population proliferation [GO:0008283]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]",acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685],"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003677; GO:0005634; GO:0005783; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006954; GO:0012501; GO:0016192; GO:0022414; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; nucleus; endoplasmic reticulum; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; inflammatory response; programmed cell death; vesicle-mediated transport; reproductive process; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular transducer activity; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_06978,0.2948972411739505,OG_06978,FUN_032113-T1,Peve_00030230,Pocillopora_meandrina_HIv1___RNAseq.g5388.t1,three_way,75.95,,,,,,,,,,,,,,,,,
OG_08346,0.2948244428358073,OG_08346,FUN_036879-T1,Peve_00006949,Pocillopora_meandrina_HIv1___RNAseq.g10628.t1,three_way,88.30766666666666,FUN_036879-T1,Q27128,PAPSS_URECA,,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPS synthetase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],Urechis caupo (Innkeeper worm) (Spoonworm),71.9,597.0,1.0999999999999999e-265,917.1,sp|Q27128|PAPSS_URECA Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase OS=Urechis caupo OX=6431 PE=1 SV=1,GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779; GO:0050428,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103],,adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781],GO:0003824; GO:0006790; GO:0016740; GO:0055086; GO:1901135,catalytic activity; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09257,0.2948004337707065,OG_09257,FUN_040059-T1,Peve_00014920,Pocillopora_meandrina_HIv1___RNAseq.g7726.t1,three_way,86.54366666666667,FUN_040059-T1,Q99LC5,,,,,71.0,328.0,1.4000000000000001e-123,444.1,"sp|Q99LC5|ETFA_MOUSE Electron transfer flavoprotein subunit alpha, mitochondrial OS=Mus musculus OX=10090 GN=Etfa PE=1 SV=2",,,,,,
OG_05841,0.2947503119642951,OG_05841,FUN_025889-T1,Peve_00024284,Pocillopora_meandrina_HIv1___RNAseq.g10542.t1,three_way,53.60116666666666,FUN_025889-T1,Q5ZM41,,,,,29.0,728.0,7.4e-64,247.3,sp|Q5ZM41|TEX10_CHICK Testis-expressed protein 10 homolog OS=Gallus gallus OX=9031 GN=TEX10 PE=2 SV=1,,,,,,
OG_08604,0.2947108007616432,OG_08604,FUN_037750-T1,Peve_00038308,Pocillopora_meandrina_HIv1___TS.g22747.t1,three_way,55.69183333333333,FUN_037750-T1,Q5HYC2,,,,,33.3,420.0,9.399999999999999e-55,217.6,sp|Q5HYC2|BRD10_HUMAN Uncharacterized bromodomain-containing protein 10 OS=Homo sapiens OX=9606 GN=BRD10 PE=1 SV=2,,,,,,
OG_00033,0.2946138459291254,OG_00033,FUN_000239-T1,Peve_00033353,Pocillopora_meandrina_HIv1___RNAseq.g28955.t1,three_way,97.61933333333332,FUN_000239-T1,Q2KHT7,,,,,89.3,84.0,1.7e-38,159.5,sp|Q2KHT7|RS27_BOVIN Small ribosomal subunit protein eS27 OS=Bos taurus OX=9913 GN=RPS27 PE=1 SV=3,,,,,,
OG_06962,0.2945511061775617,OG_06962,FUN_032092-T1,Peve_00012820,Pocillopora_meandrina_HIv1___RNAseq.g5276.t1,three_way,74.64983333333333,,,,,,,,,,,,,,,,,
OG_04033,0.2944989508926901,OG_04033,FUN_016341-T1,Peve_00044577,Pocillopora_meandrina_HIv1___RNAseq.g9731.t1,three_way,85.63799999999999,FUN_016341-T1,Q5ZKX6,UBE2F_CHICK,,NEDD8-conjugating enzyme UBE2F (EC 2.3.2.34) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F),Gallus gallus (Chicken),60.9,184.0,1.2e-62,241.1,sp|Q5ZKX6|UBE2F_CHICK NEDD8-conjugating enzyme UBE2F OS=Gallus gallus OX=9031 GN=UBE2F PE=2 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0045116; GO:0061654; GO:0061663,protein neddylation [GO:0045116],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00016,0.2944764740051752,OG_00016,FUN_000210-T1,Peve_00022649,Pocillopora_meandrina_HIv1___TS.g6133.t2,three_way,62.794,FUN_000210-T1,Q9EQH2,ERAP1_MOUSE,,Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (VEGF-induced aminopeptidase),Mus musculus (Mouse),40.9,694.0,1.1e-145,518.8,sp|Q9EQH2|ERAP1_MOUSE Endoplasmic reticulum aminopeptidase 1 OS=Mus musculus OX=10090 GN=Erap1 PE=1 SV=2,GO:0002250; GO:0004177; GO:0005138; GO:0005576; GO:0005737; GO:0005789; GO:0006508; GO:0006509; GO:0008233; GO:0008235; GO:0008270; GO:0045766,adaptive immune response [GO:0002250]; membrane protein ectodomain proteolysis [GO:0006509]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576],aminopeptidase activity [GO:0004177]; interleukin-6 receptor binding [GO:0005138]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005576; GO:0016787; GO:0140096,"immune system process; catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_10059,0.294476078320275,OG_10059,FUN_043355-T1,Peve_00016650,Pocillopora_meandrina_HIv1___TS.g20685.t1a,three_way,62.21816666666667,FUN_043355-T1,A1L1H3,,,,,26.3,758.0,1.4e-48,196.4,sp|A1L1H3|TDRD5_XENLA Tudor domain-containing protein 5 OS=Xenopus laevis OX=8355 GN=tdrd5 PE=2 SV=1,,,,,,
OG_08856,0.2944063971620696,OG_08856,FUN_038241-T1,Peve_00029455,Pocillopora_meandrina_HIv1___RNAseq.g907.t1,three_way,65.7855,FUN_038241-T1,Q8AV58,SDK1_CHICK,,Protein sidekick-1,Gallus gallus (Chicken),30.8,1999.0,6.3e-250,866.7,sp|Q8AV58|SDK1_CHICK Protein sidekick-1 OS=Gallus gallus OX=9031 GN=SDK1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_03628,0.2942451913254739,OG_03628,FUN_014844-T1,Peve_00038815,Pocillopora_meandrina_HIv1___RNAseq.g22389.t1,three_way,69.21433333333333,FUN_014844-T1,C0HL13,LRP2_PIG,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Sus scrofa (Pig),31.5,305.0,4.3e-34,149.8,sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1,GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167,coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223],apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0016192; GO:0022414; GO:0048856; GO:0050877; GO:0055085,vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process; transmembrane transport
OG_09791,0.2942086321249353,OG_09791,FUN_042593-T1,Peve_00008128,Pocillopora_meandrina_HIv1___RNAseq.g16867.t1,three_way,79.72,FUN_042593-T1,Q80TC6,,,,,50.6,1158.0,2.7e-309,1062.8,sp|Q80TC6|ZSWM5_MOUSE Zinc finger SWIM domain-containing protein 5 OS=Mus musculus OX=10090 GN=Zswim5 PE=2 SV=2,,,,,,
OG_09358,0.294014679446212,OG_09358,FUN_040444-T1,Peve_00004018,Pocillopora_meandrina_HIv1___RNAseq.g6519.t1,three_way,96.19533333333334,FUN_040444-T1,P80021,,,,,82.6,552.0,6.3e-254,877.9,"sp|P80021|ATPA_PIG ATP synthase F(1) complex subunit alpha, mitochondrial OS=Sus scrofa OX=9823 GN=ATP5F1A PE=1 SV=2",,,,,,
OG_08846,0.2939764283970137,OG_08846,FUN_038204-T1,Peve_00006771,Pocillopora_meandrina_HIv1___RNAseq.g930.t1,three_way,91.27933333333333,FUN_038204-T1,P26368,U2AF2_HUMAN,,Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit),Homo sapiens (Human),67.7,387.0,2.5e-142,506.9,sp|P26368|U2AF2_HUMAN Splicing factor U2AF 65 kDa subunit OS=Homo sapiens OX=9606 GN=U2AF2 PE=1 SV=4,GO:0000243; GO:0000245; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008187; GO:0016607; GO:0019899; GO:0030628; GO:0031397; GO:0033120; GO:0048025; GO:0070742; GO:0071004; GO:0089701; GO:0140678,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]; spliceosomal complex assembly [GO:0000245]",commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701],C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; molecular function inhibitor activity [GO:0140678]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003; GO:0098772,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly; molecular function regulator activity
OG_06673,0.2938467217094312,OG_06673,FUN_031076-T1,Peve_00028143,Pocillopora_meandrina_HIv1___RNAseq.g30318.t1,three_way,70.30116666666667,FUN_031076-T1,Q14919,NC2A_HUMAN,,Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha),Homo sapiens (Human),77.4,93.0,4.2e-34,146.4,sp|Q14919|NC2A_HUMAN Dr1-associated corepressor OS=Homo sapiens OX=9606 GN=DRAP1 PE=1 SV=3,GO:0000122; GO:0001046; GO:0001091; GO:0005634; GO:0006366; GO:0016251; GO:0017025; GO:0017054; GO:0042802; GO:0046982; GO:0090575,negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription by RNA polymerase II [GO:0006366],negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],core promoter sequence-specific DNA binding [GO:0001046]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TBP-class protein binding [GO:0017025],GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0043226; GO:0140223,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; organelle; general transcription initiation factor activity
OG_09288,0.2937500773272609,OG_09288,FUN_040114-T1,Peve_00019475,Pocillopora_meandrina_HIv1___RNAseq.g8713.t1,three_way,64.46833333333333,FUN_040114-T1,Q6PFL0,,,,,32.9,298.0,2.6e-34,147.5,sp|Q6PFL0|MED27_DANRE Mediator of RNA polymerase II transcription subunit 27 OS=Danio rerio OX=7955 GN=med27 PE=2 SV=1,,,,,,
OG_08072,0.2935533555512404,OG_08072,FUN_035777-T1,Peve_00017722,Pocillopora_meandrina_HIv1___RNAseq.g11902.t1,three_way,56.0365,FUN_035777-T1,Q68ED3,PAPD5_MOUSE,,Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2),Mus musculus (Mouse),56.3,332.0,8.300000000000001e-100,366.3,sp|Q68ED3|PAPD5_MOUSE Terminal nucleotidyltransferase 4B OS=Mus musculus OX=10090 GN=Tent4b PE=1 SV=2,GO:0003677; GO:0003887; GO:0005524; GO:0005730; GO:0005737; GO:0006364; GO:0010587; GO:0031124; GO:0033500; GO:0046872; GO:0051301; GO:0060212; GO:0070568; GO:0071044; GO:0071051; GO:1905870; GO:1990817,carbohydrate homeostasis [GO:0033500]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA 3'-end processing [GO:0031124]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003677; GO:0003824; GO:0005730; GO:0016071; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleolus; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on DNA"
OG_05735,0.2935443468258402,OG_05735,FUN_025661-T1,Peve_00042170,Pocillopora_meandrina_HIv1___RNAseq.g23064.t1,three_way,97.34233333333331,FUN_025661-T1,Q5ZMP6,,,,,81.8,439.0,1.4000000000000001e-211,736.9,sp|Q5ZMP6|AP2M1_CHICK AP-2 complex subunit mu OS=Gallus gallus OX=9031 GN=AP2M1 PE=2 SV=1,,,,,,
OG_00581,0.2935383906268808,OG_00581,FUN_001654-T1,Peve_00038365,Pocillopora_meandrina_HIv1___RNAseq.g29407.t1,three_way,87.83066666666666,FUN_001654-T1,Q4R7Y4,GBLP_MACFA,,"Small ribosomal subunit protein RACK1 (Guanine nucleotide-binding protein subunit beta-2-like 1) [Cleaved into: Small ribosomal subunit protein RACK1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),83.1,313.0,2.1e-132,473.4,sp|Q4R7Y4|GBLP_MACFA Small ribosomal subunit protein RACK1 OS=Macaca fascicularis OX=9541 GN=GNB2L1 PE=2 SV=3,GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005840; GO:0006915; GO:0007369; GO:0030178; GO:0030292; GO:0030308; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032436; GO:0032880; GO:0042169; GO:0042998; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043547; GO:0045182; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051726; GO:0071363; GO:1990904; GO:2000114; GO:2000543,apoptotic process [GO:0006915]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; dendrite [GO:0030425]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840],protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]; translation regulator activity [GO:0045182],GO:0005634; GO:0005840; GO:0012501; GO:0043226; GO:0045182; GO:0098772,nucleus; ribosome; programmed cell death; organelle; translation regulator activity; molecular function regulator activity
OG_09703,0.293465901851885,OG_09703,FUN_041935-T1,Peve_00023583,Pocillopora_meandrina_HIv1___RNAseq.g15701.t2,three_way,79.72516666666667,FUN_041935-T1,Q9ES28,,,,,36.5,902.0,1.6e-131,471.9,sp|Q9ES28|ARHG7_MOUSE Rho guanine nucleotide exchange factor 7 OS=Mus musculus OX=10090 GN=Arhgef7 PE=1 SV=2,,,,,,
OG_08642,0.2934624605950394,OG_08642,FUN_037830-T1,Peve_00002898,Pocillopora_meandrina_HIv1___RNAseq.g1454.t1,three_way,64.4625,FUN_037830-T1,Q5U4T7,,,,,42.1,932.0,1.4e-163,578.6,sp|Q5U4T7|BIC1B_XENLA Protein bicaudal C homolog 1-B OS=Xenopus laevis OX=8355 GN=bicc1-b PE=2 SV=1,,,,,,
OG_08401,0.293376866273447,OG_08401,FUN_037052-T1,Peve_00032336,Pocillopora_meandrina_HIv1___RNAseq.g26789.t1,three_way,75.614,FUN_037052-T1,Q8TBG4,AT2L1_HUMAN,,Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1),Homo sapiens (Human),60.5,435.0,2.200000000000001e-149,530.4,sp|Q8TBG4|AT2L1_HUMAN Ethanolamine-phosphate phospho-lyase OS=Homo sapiens OX=9606 GN=ETNPPL PE=1 SV=1,GO:0005759; GO:0006649; GO:0008483; GO:0016020; GO:0030170; GO:0032094; GO:0050459; GO:0055088; GO:0071385; GO:1905372,cellular response to glucocorticoid stimulus [GO:0071385]; ceramide phosphoethanolamine catabolic process [GO:1905372]; lipid homeostasis [GO:0055088]; phospholipid transfer to membrane [GO:0006649]; response to food [GO:0032094],membrane [GO:0016020]; mitochondrial matrix [GO:0005759],ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],GO:0003824; GO:0006629; GO:0016740; GO:0016829,catalytic activity; lipid metabolic process; transferase activity; lyase activity
OG_09106,0.293371644162802,OG_09106,FUN_038933-T1,Peve_00043963,Pocillopora_meandrina_HIv1___TS.g5573.t1,three_way,82.23966666666666,FUN_038933-T1,S4R2P9,NAC3_MOUSE,,Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3),Mus musculus (Mouse),37.2,888.0,1.1e-137,492.3,sp|S4R2P9|NAC3_MOUSE Sodium/calcium exchanger 3 OS=Mus musculus OX=10090 GN=Slc8a3 PE=1 SV=1,GO:0002244; GO:0005432; GO:0005516; GO:0005654; GO:0005741; GO:0005789; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015368; GO:0016528; GO:0021537; GO:0030001; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070161; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0098815; GO:1902532; GO:1905060; GO:1990034,calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of intracellular signal transduction [GO:1902532]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; telencephalon development [GO:0021537],anchoring junction [GO:0070161]; axon terminus [GO:0043679]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202],calcium:monoatomic cation antiporter activity [GO:0015368]; calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0005215; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0055085,transporter activity; nucleoplasm; microtubule organizing center; cytosol; plasma membrane; cell differentiation; cell junction organization; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_04826,0.2933644829769108,OG_04826,FUN_022818-T1,Peve_00031617,Pocillopora_meandrina_HIv1___RNAseq.g3463.t1,three_way,77.29366666666667,FUN_022818-T1,Q8CDU6,,,,,63.1,640.0,1.2000000000000001e-238,827.8,sp|Q8CDU6|HECD2_MOUSE Probable E3 ubiquitin-protein ligase HECTD2 OS=Mus musculus OX=10090 GN=Hectd2 PE=1 SV=2,,,,,,
OG_05409,0.2932821131266936,OG_05409,FUN_024343-T1,Peve_00016806,Pocillopora_meandrina_HIv1___RNAseq.g18931.t1,three_way,80.135,FUN_024343-T1,Q6BRB4,,,,,37.3,83.0,3.1e-06,53.9,sp|Q6BRB4|NHP6_DEBHA Non-histone chromosomal protein 6 OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) OX=284592 GN=NHP6 PE=3 SV=1,,,,,,
OG_10095,0.2932230469930073,OG_10095,FUN_043427-T1,Peve_00041803,Pocillopora_meandrina_HIv1___RNAseq.g7840.t1,three_way,67.638,,,,,,,,,,,,,,,,,
OG_04917,0.2931898381993842,OG_04917,FUN_022971-T1,Peve_00011907,Pocillopora_meandrina_HIv1___RNAseq.g3757.t1,three_way,63.9935,FUN_022971-T1,A9ULG4,AUP1_XENTR,,Lipid droplet-regulating VLDL assembly factor AUP1 (Ancient ubiquitous protein 1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),35.3,306.0,6.1e-41,169.5,sp|A9ULG4|AUP1_XENTR Lipid droplet-regulating VLDL assembly factor AUP1 OS=Xenopus tropicalis OX=8364 GN=aup1 PE=2 SV=1,GO:0005789; GO:0005811; GO:0034389; GO:0036503; GO:0043130; GO:0140042; GO:1990044,ERAD pathway [GO:0036503]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; protein localization to lipid droplet [GO:1990044],endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811],ubiquitin binding [GO:0043130],GO:0005811; GO:0030163; GO:0043226,lipid droplet; protein catabolic process; organelle
OG_00235,0.2931693888926968,OG_00235,FUN_000989-T1,Peve_00022150,Pocillopora_meandrina_HIv1___TS.g6419.t2,three_way,85.35733333333333,FUN_000989-T1,Q6NWZ9,CDO1_DANRE,,Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I),Danio rerio (Zebrafish) (Brachydanio rerio),61.7,188.0,1.1e-67,257.7,sp|Q6NWZ9|CDO1_DANRE Cysteine dioxygenase type 1 OS=Danio rerio OX=7955 GN=cdo1 PE=2 SV=1,GO:0008198; GO:0008270; GO:0016151; GO:0017172; GO:0019448; GO:0042412,L-cysteine catabolic process [GO:0019448]; taurine biosynthetic process [GO:0042412],,cysteine dioxygenase activity [GO:0017172]; ferrous iron binding [GO:0008198]; nickel cation binding [GO:0016151]; zinc ion binding [GO:0008270],GO:0003824; GO:0006520; GO:0006790; GO:0016491,catalytic activity; amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity
OG_00226,0.2930360564960233,OG_00226,FUN_000961-T1,Peve_00008026,Pocillopora_meandrina_HIv1___TS.g5059.t2,three_way,69.25816666666667,FUN_000961-T1,Q26613,,,,,43.4,632.0,3.5e-159,563.9,sp|Q26613|EMAP_STRPU 77 kDa echinoderm microtubule-associated protein OS=Strongylocentrotus purpuratus OX=7668 GN=EMAP PE=2 SV=1,,,,,,
OG_01628,0.2930201020447762,OG_01628,FUN_006742-T1,Peve_00039577,Pocillopora_meandrina_HIv1___RNAseq.g20528.t1,three_way,72.99733333333333,FUN_006742-T1,A6QLE6,ANO4_BOVIN,,Anoctamin-4 (Transmembrane protein 16D),Bos taurus (Bovine),30.5,846.0,3.9999999999999995e-91,337.8,sp|A6QLE6|ANO4_BOVIN Anoctamin-4 OS=Bos taurus OX=9913 GN=ANO4 PE=2 SV=1,GO:0005229; GO:0005886; GO:0006869; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; lipid transport [GO:0006869],plasma membrane [GO:0005886],intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_09229,0.2929177398259202,OG_09229,FUN_039966-T1,Peve_00039035,Pocillopora_meandrina_HIv1___RNAseq.g7517.t1a,three_way,70.402,,,,,,,,,,,,,,,,,
OG_08517,0.2929112037132124,OG_08517,FUN_037447-T1,Peve_00027251,Pocillopora_meandrina_HIv1___RNAseq.g10986.t1,three_way,85.654,FUN_037447-T1,Q3T0V4,,,,,75.0,156.0,5.1999999999999995e-61,235.3,sp|Q3T0V4|RS11_BOVIN Small ribosomal subunit protein uS17 OS=Bos taurus OX=9913 GN=RPS11 PE=2 SV=3,,,,,,
OG_09436,0.2929093791994727,OG_09436,FUN_041408-T1,Peve_00017539,Pocillopora_meandrina_HIv1___RNAseq.g15729.t1,three_way,62.90833333333333,,,,,,,,,,,,,,,,,
OG_06773,0.2928399176613643,OG_06773,FUN_031638-T1,Peve_00032680,Pocillopora_meandrina_HIv1___TS.g24410.t3a,three_way,91.53766666666668,FUN_031638-T1,P25490,TYY1_HUMAN,,Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1),Homo sapiens (Human),88.5,113.0,4.1e-58,226.5,sp|P25490|TYY1_HUMAN Transcriptional repressor protein YY1 OS=Homo sapiens OX=9606 GN=YY1 PE=1 SV=2,GO:0000122; GO:0000400; GO:0000723; GO:0000724; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005677; GO:0006275; GO:0006282; GO:0006338; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010628; GO:0010629; GO:0016363; GO:0030183; GO:0031011; GO:0031519; GO:0032688; GO:0033044; GO:0034644; GO:0034696; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0046332; GO:0048593; GO:0051726; GO:0060382; GO:0061052; GO:0071347; GO:0071707; GO:0140297; GO:1902894; GO:1904507; GO:1990837,anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723],chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0032200; GO:0043226; GO:0140110,immune system process; DNA binding; RNA binding; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; telomere organization; organelle; transcription regulator activity
OG_03404,0.292600136841383,OG_03404,FUN_014447-T1,Peve_00009610,Pocillopora_meandrina_HIv1___TS.g27599.t1,three_way,86.17,FUN_014447-T1,Q15012,LAP4A_HUMAN,,Lysosomal-associated transmembrane protein 4A (Golgi 4-transmembrane-spanning transporter MTP),Homo sapiens (Human),34.1,217.0,1.2e-28,128.3,sp|Q15012|LAP4A_HUMAN Lysosomal-associated transmembrane protein 4A OS=Homo sapiens OX=9606 GN=LAPTM4A PE=1 SV=1,GO:0005765; GO:0005794; GO:0031902,,Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765],,GO:0005794; GO:0043226,Golgi apparatus; organelle
OG_08765,0.2925139332388473,OG_08765,FUN_038040-T1,Peve_00024877,Pocillopora_meandrina_HIv1___RNAseq.g26549.t1,three_way,88.22833333333332,FUN_038040-T1,Q5DU02,UBP22_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22),Mus musculus (Mouse),61.3,530.0,6.3e-179,628.6,sp|Q5DU02|UBP22_MOUSE Ubiquitin carboxyl-terminal hydrolase 22 OS=Mus musculus OX=10090 GN=Usp22 PE=1 SV=2,GO:0000086; GO:0000124; GO:0003713; GO:0004843; GO:0005737; GO:0006282; GO:0006357; GO:0006511; GO:0008270; GO:0010485; GO:0016579; GO:0019899; GO:0032481; GO:0033276; GO:0043484; GO:0045893; GO:0045931; GO:0140936; GO:0140950,G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of type I interferon production [GO:0032481]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],cysteine-type deubiquitinase activity [GO:0004843]; enzyme binding [GO:0019899]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; histone H4 acetyltransferase activity [GO:0010485]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0006355; GO:0016740; GO:0016787; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; regulation of DNA-templated transcription; transferase activity; hydrolase activity; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_06104,0.2924767662677767,OG_06104,FUN_027805-T1,Peve_00036485,Pocillopora_meandrina_HIv1___RNAseq.g13898.t1,three_way,81.17733333333334,FUN_027805-T1,Q8BHJ5,TBL1R_MOUSE,,F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1),Mus musculus (Mouse),58.4,514.0,4.8e-120,433.0,sp|Q8BHJ5|TBL1R_MOUSE F-box-like/WD repeat-containing protein TBL1XR1 OS=Mus musculus OX=10090 GN=Tbl1xr1 PE=1 SV=1,GO:0000118; GO:0000122; GO:0000976; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0008013; GO:0010468; GO:0016042; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0045892; GO:0045944; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263,adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; fat pad development [GO:0060613]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872],histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0006629; GO:0030154; GO:0030163; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; cell differentiation; protein catabolic process; histone binding; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_01113,0.2923311710809162,OG_01113,FUN_004652-T1,Peve_00035139,Pocillopora_meandrina_HIv1___RNAseq.g8739.t1,three_way,72.61366666666666,,,,,,,,,,,,,,,,,
OG_03047,0.2922618801620067,OG_03047,FUN_012293-T1,Peve_00036366,Pocillopora_meandrina_HIv1___RNAseq.g23562.t1,three_way,84.339,FUN_012293-T1,Q96JB1,,,,,26.2,4649.0,0.0,1572.4,sp|Q96JB1|DYH8_HUMAN Dynein axonemal heavy chain 8 OS=Homo sapiens OX=9606 GN=DNAH8 PE=1 SV=2,,,,,,
OG_09107,0.2922583572399212,OG_09107,FUN_038934-T1,Peve_00043964,Pocillopora_meandrina_HIv1___RNAseq.g1039.t1,three_way,93.333,FUN_038934-T1,Q5ZLL1,KC1E_CHICK,,Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1),Gallus gallus (Chicken),76.2,420.0,1.2e-178,627.5,sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus OX=9031 GN=CSNK1E PE=2 SV=2,GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006897; GO:0007165; GO:0032436; GO:0048511; GO:0090263; GO:0106310,endocytosis [GO:0006897]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; rhythmic process [GO:0048511]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016192; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vesicle-mediated transport; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08293,0.292134209639871,OG_08293,FUN_036231-T1,Peve_00032844,Pocillopora_meandrina_HIv1___RNAseq.g27552.t1,three_way,77.99933333333334,FUN_036231-T1,Q8WTS1,ABHD5_HUMAN,,1-acylglycerol-3-phosphate O-acyltransferase ABHD5 (EC 2.3.1.51) (Abhydrolase domain-containing protein 5) (Lipid droplet-binding protein CGI-58),Homo sapiens (Human),56.8,315.0,1.9000000000000002e-110,400.6,sp|Q8WTS1|ABHD5_HUMAN 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 OS=Homo sapiens OX=9606 GN=ABHD5 PE=1 SV=1,GO:0003841; GO:0005654; GO:0005739; GO:0005811; GO:0005829; GO:0006631; GO:0006654; GO:0010891; GO:0010898; GO:0030154; GO:0042171; GO:0043231; GO:0052689; GO:0055088; GO:0060229,cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; negative regulation of triglyceride storage [GO:0010891]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of triglyceride catabolic process [GO:0010898],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; carboxylic ester hydrolase activity [GO:0052689]; lipase activator activity [GO:0060229]; lysophosphatidic acid acyltransferase activity [GO:0042171],GO:0003824; GO:0005654; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0030154; GO:0043226; GO:0098772,catalytic activity; nucleoplasm; mitochondrion; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; cell differentiation; organelle; molecular function regulator activity
OG_03678,0.2920897110657614,OG_03678,FUN_014932-T1,Peve_00037144,Pocillopora_meandrina_HIv1___RNAseq.g21090.t2,three_way,93.364,FUN_014932-T1,P26818,,,,,66.9,680.0,9.099999999999999e-271,934.1,sp|P26818|ARBK2_BOVIN G protein-coupled receptor kinase 3 OS=Bos taurus OX=9913 GN=GRK3 PE=2 SV=1,,,,,,
OG_06927,0.2920277437147239,OG_06927,FUN_032017-T1,Peve_00041122,Pocillopora_meandrina_HIv1___RNAseq.g30275.t1,three_way,62.1695,FUN_032017-T1,E1C760,,,,,38.0,737.0,2.5e-117,424.5,sp|E1C760|UVSSA_CHICK UV-stimulated scaffold protein A OS=Gallus gallus OX=9031 GN=UVSSA PE=3 SV=1,,,,,,
OG_07533,0.2918893253668838,OG_07533,FUN_034109-T1,Peve_00034853,Pocillopora_meandrina_HIv1___RNAseq.g25962.t1,three_way,67.35366666666667,FUN_034109-T1,P55265,DSRAD_HUMAN,,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),Homo sapiens (Human),33.4,739.0,5.6e-90,334.0,sp|P55265|DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens OX=9606 GN=ADAR PE=1 SV=4,GO:0001649; GO:0002244; GO:0002566; GO:0003677; GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016020; GO:0016553; GO:0030218; GO:0031054; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0097284; GO:0098586; GO:1900369; GO:1903944,adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; hepatocyte apoptotic process [GO:0097284]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530],DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006886; GO:0006913; GO:0012501; GO:0016071; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098542; GO:0140098,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; intracellular protein transport; nucleocytoplasmic transport; programmed cell death; mRNA metabolic process; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA"
OG_08720,0.2918510770444965,OG_08720,FUN_037973-T1,Peve_00013891,Pocillopora_meandrina_HIv1___RNAseq.g26182.t1,three_way,74.1255,FUN_037973-T1,Q9UPN4,CP131_HUMAN,,Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1) (Pre-acrosome localization protein 1),Homo sapiens (Human),42.9,688.0,9.3e-66,253.8,sp|Q9UPN4|CP131_HUMAN Centrosomal protein of 131 kDa OS=Homo sapiens OX=9606 GN=CEP131 PE=1 SV=3,GO:0001669; GO:0002177; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007288; GO:0008284; GO:0010824; GO:0015630; GO:0034451; GO:0035735; GO:0035869; GO:0036064; GO:0042803; GO:0043231; GO:0044877; GO:0045171; GO:0060271; GO:0071539; GO:0090316; GO:0120212; GO:1905198; GO:1905515; GO:1990953,cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288],acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; sperm head-tail coupling apparatus [GO:0120212],protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0006886; GO:0007010; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0044782,microtubule organizing center; cytosol; cytoskeleton; cilium; intracellular protein transport; cytoskeleton organization; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cilium organization
OG_00376,0.2917989086077096,OG_00376,FUN_001219-T1,Peve_00035350,Pocillopora_meandrina_HIv1___RNAseq.g2554.t1,three_way,81.54166666666667,FUN_001219-T1,Q8BGF9,,,,,47.2,307.0,1.1e-74,281.6,sp|Q8BGF9|S2544_MOUSE Solute carrier family 25 member 44 OS=Mus musculus OX=10090 GN=Slc25a44 PE=1 SV=1,,,,,,
OG_08449,0.29176560423751,OG_08449,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),43.2,586.0,1.7999999999999998e-127,459.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08449,0.29176560423751,OG_08449,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),49.5,105.0,7.2e-15,85.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_05075,0.2916868909777629,OG_05075,FUN_023301-T1,Peve_00041311,Pocillopora_meandrina_HIv1___RNAseq.g17777.t1,three_way,77.84916666666666,FUN_023301-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),31.5,371.0,1.6000000000000001e-38,162.5,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_00839,0.291634835228682,OG_00839,FUN_004089-T1,Peve_00024043,Pocillopora_meandrina_HIv1___RNAseq.g12616.t1,three_way,76.65216666666667,FUN_004089-T1,Q7T105,,,,,36.7,349.0,1.8e-48,195.3,sp|Q7T105|MIER1_XENLA Mesoderm induction early response protein 1 OS=Xenopus laevis OX=8355 GN=mier1 PE=2 SV=1,,,,,,
OG_09902,0.2916177978358588,OG_09902,FUN_042998-T1,Peve_00015176,Pocillopora_meandrina_HIv1___RNAseq.g7022.t1,three_way,83.66866666666667,FUN_042998-T1,Q6ZWV7,RL35_MOUSE,,Large ribosomal subunit protein uL29 (60S ribosomal protein L35),Mus musculus (Mouse),78.7,122.0,6.5e-42,171.4,sp|Q6ZWV7|RL35_MOUSE Large ribosomal subunit protein uL29 OS=Mus musculus OX=10090 GN=Rpl35 PE=1 SV=1,GO:0000463; GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; cytosol; ribosome; organelle
OG_04247,0.291600635560559,OG_04247,FUN_017773-T1,Peve_00016058,Pocillopora_meandrina_HIv1___RNAseq.g448.t1,three_way,76.1215,FUN_017773-T1,P48746,,,,,41.1,915.0,2.4000000000000002e-182,641.0,sp|P48746|B3A2_RABIT Anion exchange protein 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC4A2 PE=1 SV=1,,,,,,
OG_05618,0.2915711903359894,OG_05618,FUN_025308-T1,Peve_00027048,Pocillopora_meandrina_HIv1___RNAseq.g13453.t1,three_way,61.894,,,,,,,,,,,,,,,,,
OG_09472,0.2915558591707514,OG_09472,FUN_041498-T1,Peve_00007700,Pocillopora_meandrina_HIv1___TS.g10682.t1,three_way,80.48866666666666,FUN_041498-T1,Q6Q2B2,,,,,39.5,253.0,1.1e-33,145.6,sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1,,,,,,
OG_04462,0.2915040785760667,OG_04462,FUN_019341-T1,Peve_00032918,Pocillopora_meandrina_HIv1___RNAseq.g20861.t1,three_way,61.333333333333336,FUN_019341-T1,Q8NHV4,NEDD1_HUMAN,,Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1),Homo sapiens (Human),34.3,697.0,4.2e-98,360.5,sp|Q8NHV4|NEDD1_HUMAN Protein NEDD1 OS=Homo sapiens OX=9606 GN=NEDD1 PE=1 SV=1,GO:0000242; GO:0000278; GO:0000922; GO:0001650; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007020; GO:0036064; GO:0043015; GO:0045177; GO:0051301,cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278],apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922],gamma-tubulin binding [GO:0043015],GO:0000278; GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008092; GO:0043226,mitotic cell cycle; nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_00810,0.2914630937518122,OG_00810,FUN_004010-T1,Peve_00044898,Pocillopora_meandrina_HIv1___RNAseq.g11691.t1,three_way,58.72366666666667,FUN_004010-T1,Q9BYK8,,,,,26.8,1587.0,5.9e-113,411.4,sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7,,,,,,
OG_01295,0.2914539782794345,OG_01295,FUN_005120-T1,Peve_00026681,Pocillopora_meandrina_HIv1___TS.g20003.t1,three_way,92.25233333333334,FUN_005120-T1,P37380,,,,,81.6,185.0,9.3e-77,287.7,sp|P37380|RL17_PODCA Large ribosomal subunit protein uL22 OS=Podocoryna carnea OX=6096 GN=RPL17 PE=2 SV=1,,,,,,
OG_09530,0.2914359809122225,OG_09530,FUN_041607-T1,Peve_00026860,Pocillopora_meandrina_HIv1___RNAseq.g15307.t1,three_way,78.76933333333334,FUN_041607-T1,P49748,ACADV_HUMAN,,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)",Homo sapiens (Human),64.5,595.0,5.3e-212,738.8,"sp|P49748|ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADVL PE=1 SV=1",GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0042645; GO:0042802; GO:0045717; GO:0046322; GO:0050660; GO:0090181,energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain fatty acyl-CoA dehydrogenase activity [GO:0017099],GO:0003824; GO:0005654; GO:0005730; GO:0005739; GO:0006091; GO:0006629; GO:0008289; GO:0016491; GO:0030154; GO:0043226,catalytic activity; nucleoplasm; nucleolus; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; lipid binding; oxidoreductase activity; cell differentiation; organelle
OG_07746,0.2913134884296054,OG_07746,FUN_034935-T1,Peve_00018031,Pocillopora_meandrina_HIv1___RNAseq.g27829.t1,three_way,62.48333333333333,FUN_034935-T1,A0A8M2,L14AA_XENLA,,Protein LSM14 homolog A-A (RNA-associated protein 55A-A) (RAP55A-A) (xRAP55) (xRAP55A),Xenopus laevis (African clawed frog),34.3,426.0,8.7e-45,183.0,sp|A0A8M2|L14AA_XENLA Protein LSM14 homolog A-A OS=Xenopus laevis OX=8355 GN=lsm14a-a PE=1 SV=1,GO:0000932; GO:0003723; GO:0003729; GO:0005737; GO:0010494; GO:0017148; GO:0017151; GO:0032991; GO:0033962; GO:0034063; GO:1990904,negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; stress granule assembly [GO:0034063],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],DEAD/H-box RNA helicase binding [GO:0017151]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0043226,RNA binding; organelle
OG_00032,0.2912663112039209,OG_00032,FUN_000238-T1,Peve_00033352,Pocillopora_meandrina_HIv1___RNAseq.g28954.t1,three_way,62.998666666666665,FUN_000238-T1,Q5ZI58,,,,,35.3,552.0,1e-61,239.6,sp|Q5ZI58|ATOSA_CHICK Atos homolog protein A OS=Gallus gallus OX=9031 GN=ATOSA PE=2 SV=2,,,,,,
OG_04415,0.2911517429095974,OG_04415,FUN_018522-T1,Peve_00007314,Pocillopora_meandrina_HIv1___RNAseq.g10182.t2,three_way,59.49766666666667,,,,,,,,,,,,,,,,,
OG_05845,0.291137238950892,OG_05845,FUN_025914-T1,Peve_00010173,Pocillopora_meandrina_HIv1___TS.g13966.t1,three_way,69.57366666666667,,,,,,,,,,,,,,,,,
OG_06626,0.291114917640989,OG_06626,FUN_030056-T1,Peve_00040199,Pocillopora_meandrina_HIv1___RNAseq.g17348.t1,three_way,57.199666666666666,,,,,,,,,,,,,,,,,
OG_04353,0.2910689081618711,OG_04353,FUN_018000-T1,Peve_00044834,Pocillopora_meandrina_HIv1___RNAseq.29588_t,three_way,55.3835,FUN_018000-T1,Q8IXF0,NPAS3_HUMAN,,Neuronal PAS domain-containing protein 3 (Neuronal PAS3) (Basic-helix-loop-helix-PAS protein MOP6) (Class E basic helix-loop-helix protein 12) (bHLHe12) (Member of PAS protein 6) (PAS domain-containing protein 6),Homo sapiens (Human),40.8,424.0,9.4e-76,287.0,sp|Q8IXF0|NPAS3_HUMAN Neuronal PAS domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NPAS3 PE=1 SV=1,GO:0000785; GO:0000977; GO:0000981; GO:0005654; GO:0006357; GO:0045893; GO:0046982,positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005654; GO:0006355; GO:0140110,DNA binding; nucleoplasm; regulation of DNA-templated transcription; transcription regulator activity
OG_08523,0.2910385372795245,OG_08523,FUN_037456-T1,Peve_00044116,Pocillopora_meandrina_HIv1___RNAseq.g1370.t1,three_way,87.71366666666667,FUN_037456-T1,Q8BQ89,,,,,65.0,283.0,3.9e-101,369.4,sp|Q8BQ89|LIX1L_MOUSE LIX1-like protein OS=Mus musculus OX=10090 GN=Lix1l PE=2 SV=2,,,,,,
OG_01501,0.2910206877322576,OG_01501,FUN_006227-T1,Peve_00002943,Pocillopora_meandrina_HIv1___TS.g29772.t1,three_way,66.25183333333334,FUN_006227-T1,P49793,,,,,37.4,1753.0,1.3e-226,788.9,sp|P49793|NUP98_RAT Nuclear pore complex protein Nup98-Nup96 OS=Rattus norvegicus OX=10116 GN=Nup98 PE=1 SV=2,,,,,,
OG_03939,0.2909706368295865,OG_03939,FUN_016071-T1,Peve_00021918,Pocillopora_meandrina_HIv1___RNAseq.g21619.t1,three_way,78.3115,FUN_016071-T1,Q8JHJ2,,,,,64.9,470.0,1.8e-177,624.0,sp|Q8JHJ2|DDX55_DANRE ATP-dependent RNA helicase DDX55 OS=Danio rerio OX=7955 GN=ddx55 PE=2 SV=2,,,,,,
OG_02183,0.2907727932489732,OG_02183,FUN_008536-T1,Peve_00044627,Pocillopora_meandrina_HIv1___RNAseq.24098_t,three_way,66.34983333333334,,,,,,,,,,,,,,,,,
OG_00102,0.2907690429276223,OG_00102,FUN_000488-T1,Peve_00038241,Pocillopora_meandrina_HIv1___RNAseq.g2338.t1,three_way,92.94666666666666,FUN_000488-T1,Q5E9E6,,,,,80.0,215.0,6.099999999999999e-96,351.7,sp|Q5E9E6|RL10A_BOVIN Large ribosomal subunit protein uL1 OS=Bos taurus OX=9913 GN=RPL10A PE=2 SV=3,,,,,,
OG_04801,0.2907594339201209,OG_04801,FUN_022758-T1,Peve_00027945,Pocillopora_meandrina_HIv1___RNAseq.g3153.t1,three_way,64.09166666666667,,,,,,,,,,,,,,,,,
OG_02057,0.2907080712755681,OG_02057,FUN_008269-T1,Peve_00001963,Pocillopora_meandrina_HIv1___RNAseq.g17978.t1,three_way,76.93733333333333,FUN_008269-T1,Q803S3,,,,,59.7,293.0,2.1e-99,363.6,sp|Q803S3|MEMO1_DANRE Protein MEMO1 OS=Danio rerio OX=7955 GN=memo1 PE=2 SV=1,,,,,,
OG_03896,0.2906648960539405,OG_03896,FUN_015474-T1,Peve_00009512,Pocillopora_meandrina_HIv1___TS.g26531.t2,three_way,73.673,FUN_015474-T1,Q14CX7,NAA25_HUMAN,,"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)",Homo sapiens (Human),36.3,980.0,6.4000000000000005e-161,569.7,"sp|Q14CX7|NAA25_HUMAN N-alpha-acetyltransferase 25, NatB auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA25 PE=1 SV=1",GO:0005737; GO:0005794; GO:0005829; GO:0007010; GO:0010698; GO:0031416,cytoskeleton organization [GO:0007010],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416],acetyltransferase activator activity [GO:0010698],GO:0005794; GO:0005829; GO:0007010; GO:0043226; GO:0098772,Golgi apparatus; cytosol; cytoskeleton organization; organelle; molecular function regulator activity
OG_05173,0.2906437500119294,OG_05173,FUN_023501-T1,Peve_00017454,Pocillopora_meandrina_HIv1___RNAseq.g534.t1,three_way,56.98533333333334,,,,,,,,,,,,,,,,,
OG_01126,0.2905903853961755,OG_01126,FUN_004695-T1,Peve_00044672,Pocillopora_meandrina_HIv1___RNAseq.g8771.t1,three_way,71.41250000000001,,,,,,,,,,,,,,,,,
OG_09163,0.2905578756349667,OG_09163,FUN_039824-T1,Peve_00005158,Pocillopora_meandrina_HIv1___RNAseq.g7312.t1,three_way,81.45366666666666,FUN_039824-T1,P42700,,,,,51.9,536.0,4.3e-154,546.2,sp|P42700|RO60_XENLA RNA-binding protein RO60 OS=Xenopus laevis OX=8355 GN=ro60 PE=1 SV=1,,,,,,
OG_01456,0.2905314476089036,OG_01456,FUN_005914-T1,Peve_00008476,Pocillopora_meandrina_HIv1___RNAseq.g19568.t1,three_way,83.68299999999999,FUN_005914-T1,Q3T199,,,,,93.0,143.0,3.500000000000001e-71,268.9,sp|Q3T199|RS23_BOVIN Small ribosomal subunit protein uS12 OS=Bos taurus OX=9913 GN=RPS23 PE=1 SV=1,,,,,,
OG_01426,0.2904703965599714,OG_01426,FUN_005814-T1,Peve_00004967,Pocillopora_meandrina_HIv1___RNAseq.g19530.t1,three_way,80.68183333333334,FUN_005814-T1,Q06187,BTK_HUMAN,,Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase),Homo sapiens (Human),41.3,658.0,7.8e-147,522.3,sp|Q06187|BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens OX=9606 GN=BTK PE=1 SV=3,GO:0001780; GO:0001805; GO:0001812; GO:0002250; GO:0002344; GO:0002553; GO:0002639; GO:0002721; GO:0002755; GO:0002902; GO:0004713; GO:0004715; GO:0005524; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007498; GO:0008270; GO:0016004; GO:0018108; GO:0019722; GO:0030167; GO:0030889; GO:0030890; GO:0031410; GO:0032496; GO:0032693; GO:0032755; GO:0032760; GO:0034614; GO:0035556; GO:0038095; GO:0042113; GO:0042802; GO:0043123; GO:0043274; GO:0045087; GO:0045121; GO:0045579; GO:0048469; GO:0048471; GO:0050766; GO:0050852; GO:0050853; GO:0051092; GO:0061516; GO:0071226; GO:0097190; GO:0098761; GO:0141111; GO:0150153; GO:1900227; GO:1901647; GO:1990959,adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; eosinophil homeostasis [GO:1990959]; Fc-epsilon receptor signaling pathway [GO:0038095]; histamine secretion by mast cell [GO:0002553]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; monocyte proliferation [GO:0061516]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; neutrophil homeostasis [GO:0001780]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-17A production [GO:0150153]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of phagocytosis [GO:0050766]; positive regulation of synoviocyte proliferation [GO:1901647]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; proteoglycan catabolic process [GO:0030167]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721]; response to lipopolysaccharide [GO:0032496]; T cell receptor signaling pathway [GO:0050852],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0008289; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0098542; GO:0098772; GO:0140096; GO:1901135,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid binding; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_00947,0.2904651063330072,OG_00947,FUN_004306-T1,Peve_00033931,Pocillopora_meandrina_HIv1___RNAseq.g11777.t1,three_way,85.68866666666666,FUN_004306-T1,Q86VS8,HOOK3_HUMAN,,Protein Hook homolog 3 (h-hook3) (hHK3),Homo sapiens (Human),49.9,711.0,5.7e-82,307.0,sp|Q86VS8|HOOK3_HUMAN Protein Hook homolog 3 OS=Homo sapiens OX=9606 GN=HOOK3 PE=1 SV=2,GO:0000242; GO:0005737; GO:0005801; GO:0005813; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0022027; GO:0030705; GO:0031122; GO:0034451; GO:0034452; GO:0034454; GO:0042802; GO:0045022; GO:0045503; GO:0045505; GO:0050768; GO:0051645; GO:0051959; GO:0070695; GO:0071539; GO:0097150; GO:1905719,cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242],dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017],GO:0005815; GO:0007010; GO:0007040; GO:0008092; GO:0016192; GO:0043226,microtubule organizing center; cytoskeleton organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; organelle
OG_08543,0.2904107359766757,OG_08543,FUN_037496-T1,Peve_00028565,Pocillopora_meandrina_HIv1___RNAseq.g1312.t1,three_way,79.1105,FUN_037496-T1,P36895,BMR1A_MOUSE,,Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (BMP-2/BMP-4 receptor) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292),Mus musculus (Mouse),53.0,487.0,2.7e-145,516.9,sp|P36895|BMR1A_MOUSE Bone morphogenetic protein receptor type-1A OS=Mus musculus OX=10090 GN=Bmpr1a PE=1 SV=1,GO:0001525; GO:0001649; GO:0001701; GO:0001707; GO:0001756; GO:0001880; GO:0002053; GO:0002062; GO:0003007; GO:0003148; GO:0003151; GO:0003161; GO:0003171; GO:0003183; GO:0003186; GO:0003203; GO:0003215; GO:0003222; GO:0003223; GO:0003272; GO:0004674; GO:0005025; GO:0005524; GO:0005901; GO:0006955; GO:0007179; GO:0007389; GO:0007398; GO:0007399; GO:0007492; GO:0007507; GO:0009897; GO:0009950; GO:0009952; GO:0009953; GO:0009986; GO:0010629; GO:0014032; GO:0014912; GO:0021953; GO:0021983; GO:0021998; GO:0030324; GO:0030425; GO:0030501; GO:0030509; GO:0032915; GO:0035019; GO:0035137; GO:0035912; GO:0036122; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0048339; GO:0048352; GO:0048368; GO:0048378; GO:0048382; GO:0048568; GO:0048589; GO:0048598; GO:0048863; GO:0050673; GO:0050679; GO:0050768; GO:0051148; GO:0051216; GO:0060021; GO:0060043; GO:0060045; GO:0060391; GO:0060412; GO:0060896; GO:0060914; GO:0060928; GO:0061626; GO:0098821; GO:1902895; GO:1904414; GO:1904707; GO:1905285; GO:2000772,angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; atrioventricular node cell development [GO:0060928]; atrioventricular valve development [GO:0003171]; BMP signaling pathway [GO:0030509]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cartilage development [GO:0051216]; central nervous system neuron differentiation [GO:0021953]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic morphogenesis [GO:0048598]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; endoderm development [GO:0007492]; epithelial cell proliferation [GO:0050673]; fibrous ring of heart morphogenesis [GO:1905285]; heart development [GO:0007507]; heart formation [GO:0060914]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; neural plate pattern specification [GO:0060896]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm structural organization [GO:0048352]; pattern specification process [GO:0007389]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; stem cell differentiation [GO:0048863]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],caveola [GO:0005901]; cell surface [GO:0009986]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; neuronal cell body [GO:0043025],"ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]",GO:0002376; GO:0003824; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0060089; GO:0140096,"immune system process; catalytic activity; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_06440,0.2903311115055656,OG_06440,FUN_029144-T1,Peve_00000512,Pocillopora_meandrina_HIv1___RNAseq.g25729.t1,three_way,75.978,FUN_029144-T1,Q14BN4,,,,,59.9,289.0,1.6e-89,332.4,sp|Q14BN4|SLMAP_HUMAN Sarcolemmal membrane-associated protein OS=Homo sapiens OX=9606 GN=SLMAP PE=1 SV=1,,,,,,
OG_08474,0.2902497904429117,OG_08474,FUN_037291-T1,Peve_00032666,Pocillopora_meandrina_HIv1___RNAseq.22530_t,three_way,88.56233333333334,FUN_037291-T1,Q5EAD6,RL15_BOVIN,,Large ribosomal subunit protein eL15 (60S ribosomal protein L15),Bos taurus (Bovine),76.0,204.0,2.1e-90,333.2,sp|Q5EAD6|RL15_BOVIN Large ribosomal subunit protein eL15 OS=Bos taurus OX=9913 GN=RPL15 PE=2 SV=3,GO:0002181; GO:0003723; GO:0003735; GO:0022625,cytoplasmic translation [GO:0002181],cytosolic large ribosomal subunit [GO:0022625],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198,cytoplasmic translation; RNA binding; structural molecule activity
OG_08032,0.2902494614918815,OG_08032,FUN_035692-T1,Peve_00041299,Pocillopora_meandrina_HIv1___RNAseq.g11811.t1,three_way,77.73133333333334,FUN_035692-T1,Q6DGQ4,,,,,59.6,57.0,1.1e-10,68.6,sp|Q6DGQ4|CP087_DANRE UPF0547 protein C16orf87 homolog OS=Danio rerio OX=7955 GN=zgc:92818 PE=2 SV=1,,,,,,
OG_02014,0.2901675792413973,OG_02014,FUN_008187-T1,Peve_00010858,Pocillopora_meandrina_HIv1___RNAseq.g29995.t1,three_way,91.01733333333334,FUN_008187-T1,O75582,KS6A5_HUMAN,,Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL),Homo sapiens (Human),63.9,723.0,1.5e-266,920.2,sp|O75582|KS6A5_HUMAN Ribosomal protein S6 kinase alpha-5 OS=Homo sapiens OX=9606 GN=RPS6KA5 PE=1 SV=1,GO:0000287; GO:0001818; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007411; GO:0032793; GO:0035175; GO:0035556; GO:0038202; GO:0043687; GO:0044022; GO:0044024; GO:0045892; GO:0045944; GO:0051092; GO:0070498; GO:0099175; GO:0106310,axon guidance [GO:0007411]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of postsynapse organization [GO:0099175]; TORC1 signaling [GO:0038202],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0006954; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; inflammatory response; transferase activity; organelle; catalytic activity, acting on a protein"
OG_10145,0.2901537370655279,OG_10145,FUN_043535-T1,Peve_00016667,Pocillopora_meandrina_HIv1___RNAseq.g8056.t1,three_way,80.87466666666667,FUN_043535-T1,O14733,,,,,44.9,256.0,1.8e-48,194.5,sp|O14733|MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP2K7 PE=1 SV=2,,,,,,
OG_04647,0.2899453020565408,OG_04647,FUN_022379-T1,Peve_00013225,Pocillopora_meandrina_HIv1___RNAseq.g9304.t1,three_way,65.24716666666666,FUN_022379-T1,Q13439,,,,,31.5,124.0,1.8e-06,57.0,sp|Q13439|GOGA4_HUMAN Golgin subfamily A member 4 OS=Homo sapiens OX=9606 GN=GOLGA4 PE=1 SV=1,,,,,,
OG_00237,0.2898810514984803,OG_00237,FUN_000992-T1,Peve_00004455,Pocillopora_meandrina_HIv1___RNAseq.g29194.t1,three_way,92.068,FUN_000992-T1,P82471,GNAQ_RAT,,Guanine nucleotide-binding protein G(q) subunit alpha (EC 3.6.5.-) (Guanine nucleotide-binding protein alpha-q),Rattus norvegicus (Rat),82.2,353.0,8.9e-169,594.3,sp|P82471|GNAQ_RAT Guanine nucleotide-binding protein G(q) subunit alpha OS=Rattus norvegicus OX=10116 GN=Gnaq PE=2 SV=2,GO:0001501; GO:0001508; GO:0001664; GO:0003924; GO:0003925; GO:0005096; GO:0005525; GO:0005737; GO:0005794; GO:0005834; GO:0005886; GO:0005901; GO:0007186; GO:0007189; GO:0007200; GO:0007206; GO:0007207; GO:0007208; GO:0007215; GO:0007218; GO:0007507; GO:0008217; GO:0009791; GO:0010543; GO:0016020; GO:0016322; GO:0021884; GO:0030234; GO:0030425; GO:0031683; GO:0031965; GO:0032024; GO:0034695; GO:0042711; GO:0042733; GO:0043066; GO:0043267; GO:0044297; GO:0044877; GO:0045634; GO:0046872; GO:0047391; GO:0048066; GO:0050821; GO:0060158; GO:0060828; GO:0086100; GO:0098793; GO:0099524; GO:1904888; GO:1990806,action potential [GO:0001508]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; endothelin receptor signaling pathway [GO:0086100]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; ligand-gated ion channel signaling pathway [GO:1990806]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; neuron remodeling [GO:0016322]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of insulin secretion [GO:0032024]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of blood pressure [GO:0008217]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; regulation of platelet activation [GO:0010543]; response to prostaglandin E [GO:0034695]; skeletal system development [GO:0001501],caveola [GO:0005901]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynapse [GO:0098793],alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; enzyme regulator activity [GO:0030234]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0003924; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772,catalytic activity; GTPase activity; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_05750,0.2898318191323821,OG_05750,FUN_025682-T1,Peve_00000456,Pocillopora_meandrina_HIv1___TS.g2103.t1,three_way,67.785,FUN_025682-T1,Q3UQ28,PXDN_MOUSE,,Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Mus musculus (Mouse),38.9,742.0,5.6000000000000005e-126,454.1,sp|Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus musculus OX=10090 GN=Pxdn PE=1 SV=2,GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],"extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]",GO:0003824; GO:0005198; GO:0005615; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0065003,catalytic activity; structural molecule activity; extracellular space; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein-containing complex assembly
OG_06683,0.2898279194246972,OG_06683,FUN_031186-T1,Peve_00041875,Pocillopora_meandrina_HIv1___RNAseq.g5214.t1,three_way,69.12466666666667,FUN_031186-T1,P25500,,,,,64.8,491.0,5.8e-181,636.0,sp|P25500|PAPOA_BOVIN Poly(A) polymerase alpha OS=Bos taurus OX=9913 GN=PAPOLA PE=1 SV=3,,,,,,
OG_10174,0.2897929282317077,OG_10174,FUN_043583-T1,Peve_00045199,Pocillopora_meandrina_HIv1___RNAseq.g6989.t1,three_way,62.69716666666667,FUN_043583-T1,Q68F67,,,,,45.0,467.0,4.1e-113,410.6,sp|Q68F67|DEN1A_XENLA DENN domain-containing protein 1A OS=Xenopus laevis OX=8355 GN=dennd1a PE=2 SV=1,,,,,,
OG_08983,0.2897661745956667,OG_08983,FUN_038502-T1,Peve_00013538,Pocillopora_meandrina_HIv1___RNAseq.g28192.t1,three_way,75.99333333333333,FUN_038502-T1,Q7RTV0,PHF5A_HUMAN,,PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b),Homo sapiens (Human),97.1,104.0,8.6e-59,229.9,sp|Q7RTV0|PHF5A_HUMAN PHD finger-like domain-containing protein 5A OS=Homo sapiens OX=9606 GN=PHF5A PE=1 SV=1,GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011; GO:1903241,"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of DNA-templated transcription [GO:0045893]; stem cell differentiation [GO:0048863]; U2-type prespliceosome assembly [GO:1903241]",nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684],DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0030154; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_02910,0.289691649387082,OG_02910,FUN_011987-T1,Peve_00000526,Pocillopora_meandrina_HIv1___RNAseq.g23712.t1,three_way,80.10666666666667,FUN_011987-T1,Q9ULU4,,,,,39.1,266.0,5e-53,210.7,sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,,,,,,
OG_02910,0.289691649387082,OG_02910,FUN_011987-T1,Peve_00000526,Pocillopora_meandrina_HIv1___RNAseq.g23712.t1,three_way,80.10666666666667,FUN_011987-T1,Q9ULU4,,,,,55.6,36.0,3.2e-07,58.5,sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,,,,,,
OG_05797,0.2896511612371069,OG_05797,FUN_025780-T1,Peve_00009651,Pocillopora_meandrina_HIv1___RNAseq.g10358.t1,three_way,87.72200000000001,FUN_025780-T1,P18687,,,,,71.6,556.0,2.2e-220,766.5,"sp|P18687|CH60_CRIGR 60 kDa heat shock protein, mitochondrial OS=Cricetulus griseus OX=10029 GN=HSPD1 PE=2 SV=1",,,,,,
OG_07630,0.2895631516424046,OG_07630,FUN_034382-T1,Peve_00027165,Pocillopora_meandrina_HIv1___RNAseq.g26151.t3,three_way,63.092,FUN_034382-T1,Q15723,ELF2_HUMAN,,ETS-related transcription factor Elf-2 (E74-like factor 2) (New ETS-related factor),Homo sapiens (Human),61.7,94.0,5.3e-27,123.6,sp|Q15723|ELF2_HUMAN ETS-related transcription factor Elf-2 OS=Homo sapiens OX=9606 GN=ELF2 PE=1 SV=2,GO:0000785; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016604; GO:0030154; GO:0043565; GO:0045892; GO:0045893; GO:1990837,cell differentiation [GO:0030154]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_01711,0.2895056369551934,OG_01711,FUN_006985-T1,Peve_00045265,Pocillopora_meandrina_HIv1___RNAseq.g20222.t1,three_way,77.84,FUN_006985-T1,Q05086,UBE3A_HUMAN,,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54),Homo sapiens (Human),53.1,755.0,9.8e-221,768.1,sp|Q05086|UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens OX=9606 GN=UBE3A PE=1 SV=4,GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0008021; GO:0008270; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042752; GO:0043161; GO:0045944; GO:0048167; GO:0048511; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061630; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:2000058,androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; proteasome complex [GO:0000502]; synaptic vesicle [GO:0008021],transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016192; GO:0016740; GO:0022414; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; vesicle-mediated transport; transferase activity; reproductive process; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_03654,0.2894562163848228,OG_03654,FUN_014890-T1,Peve_00003524,Pocillopora_meandrina_HIv1___RNAseq.g21063.t1,three_way,80.91116666666667,FUN_014890-T1,Q9BT92,TCHP_HUMAN,,Trichoplein keratin filament-binding protein (Protein TCHP) (Mitochondrial protein with oncostatic activity) (Mitostatin) (Tumor suppressor protein),Homo sapiens (Human),54.1,135.0,7.5e-30,132.5,sp|Q9BT92|TCHP_HUMAN Trichoplein keratin filament-binding protein OS=Homo sapiens OX=9606 GN=TCHP PE=1 SV=1,GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0006915; GO:0030030; GO:0030057; GO:0030308; GO:0031965; GO:0036064; GO:0045095; GO:0045179; GO:1902018,apoptotic process [GO:0006915]; cell projection organization [GO:0030030]; negative regulation of cell growth [GO:0030308]; negative regulation of cilium assembly [GO:1902018],apical cortex [GO:0045179]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],,GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0012501; GO:0043226,mitochondrion; microtubule organizing center; cytosol; plasma membrane; cilium; programmed cell death; organelle
OG_01995,0.2894305051830419,OG_01995,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_06451,0.2893937531405027,OG_06451,FUN_029171-T1,Peve_00042456,Pocillopora_meandrina_HIv1___RNAseq.g25478.t1,three_way,65.962,FUN_029171-T1,Q9UHD2,TBK1_HUMAN,,Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1),Homo sapiens (Human),42.0,628.0,2.1000000000000002e-125,451.4,sp|Q9UHD2|TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens OX=9606 GN=TBK1 PE=1 SV=1,GO:0002218; GO:0002753; GO:0003676; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010508; GO:0010629; GO:0016236; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032481; GO:0032727; GO:0032728; GO:0034142; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060337; GO:0060340; GO:0061470; GO:0061629; GO:0106310; GO:0140374; GO:0140896; GO:1902554; GO:1904262; GO:1904263; GO:1904417; GO:1904515,activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; canonical NF-kappaB signal transduction [GO:0007249]; cGAS/STING signaling pathway [GO:0140896]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of gene expression [GO:0010629]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; T follicular helper cell differentiation [GO:0061470]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0002376; GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0006914; GO:0006954; GO:0016740; GO:0030154; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; autophagy; inflammatory response; transferase activity; cell differentiation; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_00236,0.2893775988233539,OG_00236,FUN_000990-T1,Peve_00022152,Pocillopora_meandrina_HIv1___RNAseq.g29207.t1,three_way,69.63933333333333,,,,,,,,,,,,,,,,,
OG_03265,0.2891888043499386,OG_03265,FUN_013121-T1,Peve_00000437,Pocillopora_meandrina_HIv1___RNAseq.g23034.t1,three_way,98.58766666666668,FUN_013121-T1,Q9GJW7,GBRAP_BOVIN,,Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein),Bos taurus (Bovine),96.6,116.0,7.4000000000000025e-59,227.6,sp|Q9GJW7|GBRAP_BOVIN Gamma-aminobutyric acid receptor-associated protein OS=Bos taurus OX=9913 GN=GABARAP PE=3 SV=2,GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000423; GO:0005764; GO:0005776; GO:0005790; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008429; GO:0008625; GO:0015031; GO:0015629; GO:0031410; GO:0031625; GO:0032436; GO:0035020; GO:0048487; GO:0050811; GO:0097225; GO:0097352; GO:0098696; GO:0098982; GO:1902524,autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; mitophagy [GO:0000423]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein transport [GO:0015031]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rac protein signal transduction [GO:0035020],actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; GABA-ergic synapse [GO:0098982]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225],beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; ubiquitin protein ligase binding [GO:0031625],GO:0005764; GO:0005773; GO:0005783; GO:0005856; GO:0005886; GO:0006914; GO:0007010; GO:0008092; GO:0008289; GO:0031410; GO:0043226,lysosome; vacuole; endoplasmic reticulum; cytoskeleton; plasma membrane; autophagy; cytoskeleton organization; cytoskeletal protein binding; lipid binding; cytoplasmic vesicle; organelle
OG_02000,0.2890227541300084,OG_02000,FUN_008111-T1,Peve_00022340,Pocillopora_meandrina_HIv1___RNAseq.g17893.t1,three_way,53.2585,FUN_008111-T1,B3EWY9,,,,,33.3,1402.0,3.9e-139,498.4,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05113,0.2890198177664369,OG_05113,FUN_023372-T1,Peve_00005358,Pocillopora_meandrina_HIv1___RNAseq.g17530.t1,three_way,85.00200000000001,FUN_023372-T1,Q14582,,,,,37.6,202.0,1.9e-13,77.4,sp|Q14582|MAD4_HUMAN Max dimerization protein 4 OS=Homo sapiens OX=9606 GN=MXD4 PE=1 SV=2,,,,,,
OG_06768,0.288966061567507,OG_06768,FUN_031608-T1,Peve_00012512,Pocillopora_meandrina_HIv1___RNAseq.g5967.t1,three_way,78.76383333333334,FUN_031608-T1,Q92541,RTF1_HUMAN,,RNA polymerase-associated protein RTF1 homolog,Homo sapiens (Human),48.1,349.0,1e-80,302.4,sp|Q92541|RTF1_HUMAN RNA polymerase-associated protein RTF1 homolog OS=Homo sapiens OX=9606 GN=RTF1 PE=1 SV=4,GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0006368; GO:0016055; GO:0016593; GO:0019827,blastocyst growth [GO:0001832]; chromatin organization [GO:0006325]; endodermal cell fate commitment [GO:0001711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0043226,DNA binding; RNA binding; nucleoplasm; nucleolus; chromatin organization; regulation of DNA-templated transcription; organelle
OG_01557,0.2889650123860238,OG_01557,FUN_006438-T1,Peve_00038436,Pocillopora_meandrina_HIv1___RNAseq.g20295.t1,three_way,78.40966666666667,FUN_006438-T1,P29146,,,,,49.8,566.0,8.6e-155,548.9,sp|P29146|NECA_HYDVU PC3-like endoprotease variant A OS=Hydra vulgaris OX=6087 PE=2 SV=1,,,,,,
OG_03785,0.2889541512547896,OG_03785,FUN_015145-T1,Peve_00001083,Pocillopora_meandrina_HIv1___RNAseq.g21746.t2,three_way,73.53316666666667,FUN_015145-T1,Q640I9,,,,,30.3,1123.0,1.7999999999999998e-141,505.0,sp|Q640I9|KDM2B_XENLA Lysine-specific demethylase 2B OS=Xenopus laevis OX=8355 GN=kdm2b PE=2 SV=1,,,,,,
OG_07071,0.2889053695219389,OG_07071,FUN_032307-T1,Peve_00001538,Pocillopora_meandrina_HIv1___RNAseq.g24762.t2,three_way,70.71366666666667,FUN_032307-T1,Q3U0J8,,,,,48.1,480.0,9.9e-126,452.6,sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2,,,,,,
OG_04788,0.2887173157737235,OG_04788,FUN_022702-T1,Peve_00018685,Pocillopora_meandrina_HIv1___TS.g22237.t2,three_way,74.7355,FUN_022702-T1,Q3MJK5,CDK12_RAT,,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (Protein kinase for splicing component)",Rattus norvegicus (Rat),77.8,334.0,3.2e-159,564.3,sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus OX=10116 GN=Cdk12 PE=1 SV=1,GO:0002944; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0006366; GO:0006397; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019901; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0043484; GO:0045944; GO:0106310; GO:2000737,mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],cyclin K-CDK12 complex [GO:0002944]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01521,0.2885524943765005,OG_01521,FUN_006275-T1,Peve_00019725,Pocillopora_meandrina_HIv1___RNAseq.g20370.t1,three_way,75.4355,FUN_006275-T1,Q8R3S6,,,,,43.7,924.0,1.3e-200,701.4,sp|Q8R3S6|EXOC1_MOUSE Exocyst complex component 1 OS=Mus musculus OX=10090 GN=Exoc1 PE=1 SV=4,,,,,,
OG_05374,0.2885505832610785,OG_05374,FUN_024187-T1,Peve_00013614,Pocillopora_meandrina_HIv1___RNAseq.g18887.t1,three_way,88.22666666666666,FUN_024187-T1,Q921G7,ETFD_MOUSE,,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)",Mus musculus (Mouse),75.3,595.0,1.8999999999999998e-280,966.1,"sp|Q921G7|ETFD_MOUSE Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial OS=Mus musculus OX=10090 GN=Etfdh PE=1 SV=1",GO:0004174; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0033539; GO:0046872; GO:0048039; GO:0051539,fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinone binding [GO:0048039]",GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0006629; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; cytosol; lipid metabolic process; oxidoreductase activity; organelle
OG_04588,0.2884713986204287,OG_04588,FUN_022260-T1,Peve_00043990,Pocillopora_meandrina_HIv1___RNAseq.g4718.t1,three_way,93.872,FUN_022260-T1,P61209,,,,,95.0,179.0,3.3e-95,349.0,sp|P61209|ARF1_DROME ADP-ribosylation factor 1 OS=Drosophila melanogaster OX=7227 GN=Arf1 PE=1 SV=2,,,,,,
OG_04532,0.288311385648237,OG_04532,FUN_022076-T1,Peve_00038277,Pocillopora_meandrina_HIv1___RNAseq.g9325.t1,three_way,82.528,FUN_022076-T1,B2GUE2,,,,,35.5,338.0,2.8e-25,117.9,sp|B2GUE2|LRRF2_XENTR Leucine-rich repeat flightless-interacting protein 2 OS=Xenopus tropicalis OX=8364 GN=lrrfip2 PE=2 SV=1,,,,,,
OG_09809,0.2882679334837895,OG_09809,FUN_042631-T1,Peve_00030043,Pocillopora_meandrina_HIv1___RNAseq.g11506.t1,three_way,73.376,FUN_042631-T1,Q5VTB9,RN220_HUMAN,,E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220),Homo sapiens (Human),33.0,657.0,3.9999999999999997e-63,244.2,sp|Q5VTB9|RN220_HUMAN E3 ubiquitin-protein ligase RNF220 OS=Homo sapiens OX=9606 GN=RNF220 PE=1 SV=1,GO:0003358; GO:0004842; GO:0005634; GO:0005652; GO:0005654; GO:0005737; GO:0006513; GO:0008013; GO:0008270; GO:0016567; GO:0021904; GO:0032991; GO:0051091; GO:0051865; GO:0061630; GO:0090263; GO:0098794; GO:0098978; GO:0099149; GO:2000677,dorsal/ventral neural tube patterning [GO:0021904]; noradrenergic neuron development [GO:0003358]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of transcription regulatory region DNA binding [GO:2000677],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],beta-catenin binding [GO:0008013]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02355,0.2882540768637133,OG_02355,FUN_008958-T1,Peve_00021624,Pocillopora_meandrina_HIv1___RNAseq.g4045.t1,three_way,88.27633333333334,FUN_008958-T1,P36241,,,,,80.5,77.0,5.2e-27,121.7,sp|P36241|RL19_DROME Large ribosomal subunit protein eL19 OS=Drosophila melanogaster OX=7227 GN=RpL19 PE=1 SV=2,,,,,,
OG_02351,0.2881148016659378,OG_02351,FUN_008952-T1,Peve_00037679,Pocillopora_meandrina_HIv1___RNAseq.g4051.t1,three_way,70.46833333333333,FUN_008952-T1,Q8TDM6,,,,,31.0,1363.0,9.8e-134,480.3,sp|Q8TDM6|DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens OX=9606 GN=DLG5 PE=1 SV=4,,,,,,
OG_00963,0.2880389834675016,OG_00963,FUN_004332-T1,Peve_00016477,Pocillopora_meandrina_HIv1___RNAseq.g12532.t1,three_way,86.59233333333333,FUN_004332-T1,Q9UNH5,CC14A_HUMAN,,Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A),Homo sapiens (Human),60.3,459.0,1.4000000000000002e-161,570.9,sp|Q9UNH5|CC14A_HUMAN Dual specificity protein phosphatase CDC14A OS=Homo sapiens OX=9606 GN=CDC14A PE=1 SV=1,GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005813; GO:0005829; GO:0007096; GO:0007605; GO:0032426; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0072686; GO:1902636,cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426],protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005730; GO:0005783; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0016787; GO:0043226; GO:0044782; GO:0050877; GO:0140096,"catalytic activity; nucleoplasm; nucleolus; endoplasmic reticulum; microtubule organizing center; cytosol; cilium; cytoskeleton organization; hydrolase activity; organelle; cilium organization; nervous system process; catalytic activity, acting on a protein"
OG_08153,0.2880297882245435,OG_08153,FUN_035930-T1,Peve_00036624,Pocillopora_meandrina_HIv1___RNAseq.g12067.t1,three_way,73.38733333333333,FUN_035930-T1,Q6EDY6,CARL1_MOUSE,,"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)",Mus musculus (Mouse),37.8,1029.0,9.8e-173,609.8,sp|Q6EDY6|CARL1_MOUSE F-actin-uncapping protein LRRC16A OS=Mus musculus OX=10090 GN=Carmil1 PE=1 SV=2,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007163; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:1900026; GO:1902745; GO:2000813,actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886],protein-containing complex binding [GO:0044877],GO:0005634; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0007163; GO:0016192; GO:0031410; GO:0043226; GO:0048870,nucleus; endosome; cytosol; cytoskeleton; plasma membrane; establishment or maintenance of cell polarity; vesicle-mediated transport; cytoplasmic vesicle; organelle; cell motility
OG_01583,0.2879388197007096,OG_01583,FUN_006619-T1,Peve_00040865,Pocillopora_meandrina_HIv1___RNAseq.g20179.t1,three_way,71.24033333333334,FUN_006619-T1,Q92598,HS105_HUMAN,,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein) (Heat shock protein family H member 1),Homo sapiens (Human),51.3,686.0,5.6e-181,636.0,sp|Q92598|HS105_HUMAN Heat shock protein 105 kDa OS=Homo sapiens OX=9606 GN=HSPH1 PE=1 SV=1,GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006457; GO:0006986; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682; GO:0140662,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662],GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0008092; GO:0043226; GO:0044183; GO:0098772; GO:0140657,extracellular region; nucleus; nucleoplasm; cytosol; protein folding; cytoskeletal protein binding; organelle; protein folding chaperone; molecular function regulator activity; ATP-dependent activity
OG_04154,0.2879240050341676,OG_04154,FUN_016621-T1,Peve_00005682,Pocillopora_meandrina_HIv1___RNAseq.g9611.t1,three_way,71.54566666666666,FUN_016621-T1,Q99615,DNJC7_HUMAN,,DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2),Homo sapiens (Human),55.3,414.0,1.4999999999999998e-127,458.0,sp|Q99615|DNJC7_HUMAN DnaJ homolog subfamily C member 7 OS=Homo sapiens OX=9606 GN=DNAJC7 PE=1 SV=2,GO:0001671; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034,chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072],GO:0005654; GO:0005829; GO:0005856; GO:0006457; GO:0043226; GO:0098772,nucleoplasm; cytosol; cytoskeleton; protein folding; organelle; molecular function regulator activity
OG_01058,0.2878819140349574,OG_01058,FUN_004511-T1,Peve_00012956,Pocillopora_meandrina_HIv1___RNAseq.g11643.t1,three_way,75.28316666666667,FUN_004511-T1,P48025,KSYK_MOUSE,,Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase),Mus musculus (Mouse),38.4,688.0,7.699999999999999e-116,419.5,sp|P48025|KSYK_MOUSE Tyrosine-protein kinase SYK OS=Mus musculus OX=10090 GN=Syk PE=1 SV=2,GO:0001525; GO:0001775; GO:0001784; GO:0001819; GO:0001820; GO:0001945; GO:0002092; GO:0002223; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0002752; GO:0004674; GO:0004713; GO:0004715; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006606; GO:0007159; GO:0007166; GO:0007167; GO:0007186; GO:0007229; GO:0010543; GO:0010803; GO:0016170; GO:0018108; GO:0019370; GO:0019722; GO:0019815; GO:0019901; GO:0019902; GO:0030183; GO:0030593; GO:0031334; GO:0031623; GO:0032009; GO:0032481; GO:0032725; GO:0032733; GO:0032735; GO:0032752; GO:0032753; GO:0032755; GO:0032757; GO:0032760; GO:0032765; GO:0032928; GO:0032930; GO:0032991; GO:0033630; GO:0035325; GO:0035556; GO:0038063; GO:0038156; GO:0042101; GO:0042169; GO:0042492; GO:0042742; GO:0043274; GO:0043303; GO:0043306; GO:0043313; GO:0043366; GO:0043410; GO:0045087; GO:0045579; GO:0045588; GO:0045780; GO:0046638; GO:0046641; GO:0048514; GO:0050764; GO:0050850; GO:0050853; GO:0051649; GO:0070372; GO:0071226; GO:0071396; GO:0071404; GO:0071639; GO:0090237; GO:0090330; GO:0097110; GO:0097190; GO:0097242; GO:0120162; GO:1904263; GO:1904646; GO:1990858,adaptive immune response [GO:0002250]; amyloid-beta clearance [GO:0097242]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of localization in cell [GO:0051649]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-delta T cell differentiation [GO:0042492]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-3-mediated signaling pathway [GO:0038156]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; mast cell degranulation [GO:0043303]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokine production [GO:0001819]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; protein import into nucleus [GO:0006606]; receptor internalization [GO:0031623]; regulation of arachidonate secretion [GO:0090237]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion [GO:0001820]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101],ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; Toll-like receptor binding [GO:0035325],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006886; GO:0006913; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; intracellular protein transport; nucleocytoplasmic transport; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; defense response to other organism; catalytic activity, acting on a protein"
OG_06568,0.2878693588076061,OG_06568,FUN_029475-T1,Peve_00028203,Pocillopora_meandrina_HIv1___RNAseq.g17149.t1,three_way,80.37583333333333,FUN_029475-T1,Q5F3F5,,,,,45.8,690.0,1.3e-158,561.6,sp|Q5F3F5|LMBD2_CHICK G-protein coupled receptor-associated protein LMBRD2 OS=Gallus gallus OX=9031 GN=LMBRD2 PE=2 SV=1,,,,,,
OG_02373,0.2878630258778808,OG_02373,FUN_008983-T1,Peve_00017858,Pocillopora_meandrina_HIv1___RNAseq.g3906.t1,three_way,57.8225,FUN_008983-T1,Q63187,ELOA1_RAT,,Elongin-A (EloA) (Elongin 110 kDa subunit) (RNA polymerase II transcription factor SIII subunit A1) (SIII p110) (Transcription elongation factor B polypeptide 3),Rattus norvegicus (Rat),32.7,370.0,1.1999999999999999e-35,152.5,sp|Q63187|ELOA1_RAT Elongin-A OS=Rattus norvegicus OX=10116 GN=Eloa PE=1 SV=1,GO:0003690; GO:0006357; GO:0006367; GO:0006368; GO:0008023; GO:0070449; GO:0090734,regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367],elongin complex [GO:0070449]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023],double-stranded DNA binding [GO:0003690],GO:0003677; GO:0006355,DNA binding; regulation of DNA-templated transcription
OG_01287,0.2878221035677105,OG_01287,FUN_005108-T1,Peve_00007468,Pocillopora_meandrina_HIv1___RNAseq.g8270.t1,three_way,63.20066666666666,FUN_005108-T1,Q96B86,,,,,35.5,361.0,3.8e-52,207.2,sp|Q96B86|RGMA_HUMAN Repulsive guidance molecule A OS=Homo sapiens OX=9606 GN=RGMA PE=1 SV=4,,,,,,
OG_03826,0.2877629301303322,OG_03826,FUN_015256-T1,Peve_00014304,Pocillopora_meandrina_HIv1___RNAseq.g22207.t1,three_way,71.4415,FUN_015256-T1,G1SE76,,,,,76.7,146.0,2.9999999999999995e-54,213.0,sp|G1SE76|RL23A_RABIT Large ribosomal subunit protein uL23 OS=Oryctolagus cuniculus OX=9986 GN=RPL23A PE=1 SV=1,,,,,,
OG_00642,0.2876856188019508,OG_00642,FUN_001883-T1,Peve_00030486,Pocillopora_meandrina_HIv1___RNAseq.g2592.t1,three_way,67.79133333333333,FUN_001883-T1,P55814,,,,,55.6,90.0,3.9e-23,109.8,sp|P55814|OAZ1_XENLA Ornithine decarboxylase antizyme 1 OS=Xenopus laevis OX=8355 GN=oaz1 PE=2 SV=2,,,,,,
OG_09848,0.2876831778946964,OG_09848,FUN_042839-T1,Peve_00007265,Pocillopora_meandrina_HIv1___RNAseq.g7262.t1,three_way,92.87733333333334,FUN_042839-T1,Q3ZBE7,,,,,82.5,114.0,5.2e-49,194.9,sp|Q3ZBE7|YPEL5_BOVIN Protein yippee-like 5 OS=Bos taurus OX=9913 GN=YPEL5 PE=2 SV=1,,,,,,
OG_01299,0.2876443666476052,OG_01299,FUN_005133-T1,Peve_00026671,Pocillopora_meandrina_HIv1___RNAseq.g8258.t1,three_way,85.96366666666667,FUN_005133-T1,Q05116,,,,,70.0,377.0,4.3e-148,525.8,sp|Q05116|MP2K1_XENLA Dual specificity mitogen-activated protein kinase kinase 1 OS=Xenopus laevis OX=8355 GN=map2k1 PE=1 SV=2,,,,,,
OG_03650,0.2876407395150173,OG_03650,FUN_014882-T1,Peve_00013645,Pocillopora_meandrina_HIv1___RNAseq.g21054.t1,three_way,56.43533333333333,FUN_014882-T1,Q5SSG4,GA2L2_MOUSE,,GAS2-like protein 2 (Growth arrest-specific protein 2-like 2),Mus musculus (Mouse),35.9,473.0,1.6999999999999998e-53,213.0,sp|Q5SSG4|GA2L2_MOUSE GAS2-like protein 2 OS=Mus musculus OX=10090 GN=Gas2l2 PE=1 SV=1,GO:0001578; GO:0001725; GO:0001965; GO:0005737; GO:0005884; GO:0005886; GO:0007026; GO:0008017; GO:0008093; GO:0035371; GO:0036064; GO:0045745; GO:0051015; GO:0060296; GO:1904825,microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein localization to microtubule plus-end [GO:1904825]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; plasma membrane [GO:0005886]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; G-protein alpha-subunit binding [GO:0001965]; microtubule binding [GO:0008017],GO:0005815; GO:0005886; GO:0007010; GO:0008092; GO:0060090,microtubule organizing center; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; molecular adaptor activity
OG_03827,0.2876372558094367,OG_03827,FUN_015257-T1,Peve_00014297,Pocillopora_meandrina_HIv1___RNAseq.g22208.t1,three_way,54.744,,,,,,,,,,,,,,,,,
OG_09926,0.2876359772264125,OG_09926,FUN_043040-T1,Peve_00026460,Pocillopora_meandrina_HIv1___RNAseq.g7078.t1,three_way,76.39316666666667,FUN_043040-T1,Q5T8I3,,,,,43.2,359.0,2.5e-57,224.2,sp|Q5T8I3|EEIG2_HUMAN EEIG family member 2 OS=Homo sapiens OX=9606 GN=EEIG2 PE=1 SV=2,,,,,,
OG_08648,0.2875936574684142,OG_08648,FUN_037843-T1,Peve_00025123,Pocillopora_meandrina_HIv1___RNAseq.g1437.t1,three_way,91.50183333333334,FUN_037843-T1,P56701,,,,,72.5,861.0,0.0,1194.9,sp|P56701|PSMD2_BOVIN 26S proteasome non-ATPase regulatory subunit 2 OS=Bos taurus OX=9913 GN=PSMD2 PE=1 SV=2,,,,,,
OG_05338,0.287577598088532,OG_05338,FUN_024054-T1,Peve_00000164,Pocillopora_meandrina_HIv1___RNAseq.g19258.t1,three_way,82.41566666666667,FUN_024054-T1,Q80T69,RSBN1_MOUSE,,Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1) (Rosbin),Mus musculus (Mouse),56.1,271.0,1.0000000000000001e-81,305.4,sp|Q80T69|RSBN1_MOUSE Lysine-specific demethylase 9 OS=Mus musculus OX=10090 GN=Rsbn1 PE=1 SV=3,GO:0005634; GO:0035575; GO:0046872,,nucleus [GO:0005634],histone H4K20 demethylase activity [GO:0035575]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_02978,0.2875024063330174,OG_02978,FUN_012145-T1,Peve_00033299,Pocillopora_meandrina_HIv1___RNAseq.g23871.t1,three_way,72.78233333333333,FUN_012145-T1,Q9Y6R4,M3K4_HUMAN,,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),Homo sapiens (Human),35.0,1732.0,4.6e-247,856.7,sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2,GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745,chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_08888,0.2874763395638918,OG_08888,FUN_038294-T1,Peve_00041731,Pocillopora_meandrina_HIv1___RNAseq.g28300.t1,three_way,63.32116666666666,FUN_038294-T1,Q7YR76,,,,,24.8,440.0,1.6e-15,86.7,sp|Q7YR76|MYCD_PIG Myocardin OS=Sus scrofa OX=9823 GN=MYOCD PE=2 SV=1,,,,,,
OG_02253,0.2874207944582651,OG_02253,FUN_008699-T1,Peve_00035972,Pocillopora_meandrina_HIv1___RNAseq.g6277.t1,three_way,57.66416666666667,FUN_008699-T1,Q9ESV0,,,,,40.4,639.0,1.6e-122,441.8,sp|Q9ESV0|DDX24_MOUSE ATP-dependent RNA helicase DDX24 OS=Mus musculus OX=10090 GN=Ddx24 PE=1 SV=2,,,,,,
OG_10002,0.287364163131576,OG_10002,FUN_043236-T1,Peve_00001435,Pocillopora_meandrina_HIv1___RNAseq.g6748.t1,three_way,69.04316666666666,FUN_043236-T1,Q30D77,COOA1_MOUSE,,Collagen alpha-1(XXIV) chain,Mus musculus (Mouse),41.1,107.0,1.5e-17,94.0,sp|Q30D77|COOA1_MOUSE Collagen alpha-1(XXIV) chain OS=Mus musculus OX=10090 GN=Col24a1 PE=2 SV=2,GO:0002244; GO:0005201; GO:0005576; GO:0005581; GO:0062023,hematopoietic progenitor cell differentiation [GO:0002244],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030154,structural molecule activity; extracellular region; cell differentiation
OG_03205,0.2872636939689104,OG_03205,FUN_012696-T1,Peve_00016827,Pocillopora_meandrina_HIv1___RNAseq.g22856.t1,three_way,62.6505,FUN_012696-T1,Q5F3A1,,,,,56.6,290.0,9.4e-52,205.7,sp|Q5F3A1|SEC62_CHICK Translocation protein SEC62 OS=Gallus gallus OX=9031 GN=SEC62 PE=2 SV=1,,,,,,
OG_08990,0.2872307757858153,OG_08990,FUN_038512-T1,Peve_00041679,Pocillopora_meandrina_HIv1___RNAseq.20620_t,three_way,87.99716666666667,FUN_038512-T1,Q6P1M3,L2GL2_HUMAN,,LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2),Homo sapiens (Human),41.5,959.0,1.6e-203,711.4,sp|Q6P1M3|L2GL2_HUMAN LLGL scribble cell polarity complex component 2 OS=Homo sapiens OX=9606 GN=LLGL2 PE=1 SV=2,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0008593; GO:0009791; GO:0015820; GO:0016332; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0035264; GO:0043231; GO:0045159; GO:0045197; GO:0051294; GO:0051301; GO:0060670; GO:0060716,branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; L-leucine transport [GO:0015820]; labyrinthine layer blood vessel development [GO:0060716]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0043226; GO:0048856; GO:0098772,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; organelle; anatomical structure development; molecular function regulator activity
OG_02834,0.2872266411436268,OG_02834,FUN_011851-T1,Peve_00034359,Pocillopora_meandrina_HIv1___TS.g16263.t1,three_way,69.67533333333333,FUN_011851-T1,Q9PWH2,,,,,45.6,572.0,1.3999999999999999e-140,501.5,sp|Q9PWH2|FZD10_CHICK Frizzled-10 OS=Gallus gallus OX=9031 GN=FZD10 PE=1 SV=1,,,,,,
OG_00528,0.2872003963188182,OG_00528,FUN_001532-T1,Peve_00000627,Pocillopora_meandrina_HIv1___RNAseq.g2048.t1,three_way,76.9355,FUN_001532-T1,Q80W14,,,,,53.5,593.0,3.1e-96,354.8,sp|Q80W14|PR40B_MOUSE Pre-mRNA-processing factor 40 homolog B OS=Mus musculus OX=10090 GN=Prpf40b PE=1 SV=2,,,,,,
OG_08301,0.2871638718203337,OG_08301,FUN_036251-T1,Peve_00045290,Pocillopora_meandrina_HIv1___RNAseq.g27588.t1,three_way,74.035,FUN_036251-T1,P20042,IF2B_HUMAN,,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF2-beta),Homo sapiens (Human),85.7,168.0,3.3000000000000003e-80,300.1,sp|P20042|IF2B_HUMAN Eukaryotic translation initiation factor 2 subunit 2 OS=Homo sapiens OX=9606 GN=EIF2S2 PE=1 SV=2,GO:0001701; GO:0001731; GO:0002176; GO:0002183; GO:0003723; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0008270; GO:0008584; GO:0031369; GO:0045202,cytoplasmic translational initiation [GO:0002183]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; synapse [GO:0045202],"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]",GO:0003723; GO:0005829; GO:0022414; GO:0048856; GO:0065003,RNA binding; cytosol; reproductive process; anatomical structure development; protein-containing complex assembly
OG_07962,0.2871509298154325,OG_07962,FUN_035522-T1,Peve_00007931,Pocillopora_meandrina_HIv1___TS.g14310.t1,three_way,48.43233333333333,FUN_035522-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),35.3,363.0,1.6000000000000002e-48,195.7,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_03407,0.287143198604756,OG_03407,FUN_014451-T1,Peve_00009605,Pocillopora_meandrina_HIv1___RNAseq.g22828.t1,three_way,66.653,FUN_014451-T1,O88831,KKCC2_RAT,,Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta),Rattus norvegicus (Rat),42.3,220.0,2.2e-29,131.0,sp|O88831|KKCC2_RAT Calcium/calmodulin-dependent protein kinase kinase 2 OS=Rattus norvegicus OX=10116 GN=Camkk2 PE=1 SV=1,GO:0004672; GO:0004674; GO:0004683; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0030295; GO:0043005; GO:0046777; GO:0061762; GO:0106310,CAMKK-AMPK signaling cascade [GO:0061762]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04601,0.2870852404918559,OG_04601,FUN_022288-T1,Peve_00003595,Pocillopora_meandrina_HIv1___RNAseq.g4695.t1,three_way,67.76066666666667,FUN_022288-T1,Q9Z340,PARD3_RAT,,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (Atypical PKC-specific-binding protein) (ASBP),Rattus norvegicus (Rat),32.5,805.0,1.7e-76,289.7,sp|Q9Z340|PARD3_RAT Partitioning defective 3 homolog OS=Rattus norvegicus OX=10116 GN=Pard3 PE=1 SV=1,GO:0000226; GO:0002092; GO:0003383; GO:0005546; GO:0005547; GO:0005737; GO:0005819; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007155; GO:0008104; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032970; GO:0032991; GO:0033269; GO:0035091; GO:0042802; GO:0043025; GO:0043219; GO:0043220; GO:0043296; GO:0044295; GO:0044319; GO:0045197; GO:0051301; GO:0051642; GO:0051660; GO:0060341; GO:0070830; GO:0090162; GO:0120157,"apical constriction [GO:0003383]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome localization [GO:0051642]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; positive regulation of receptor internalization [GO:0002092]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; regulation of actin filament-based process [GO:0032970]; regulation of cellular localization [GO:0060341]; wound healing, spreading of cells [GO:0044319]",adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; lateral loop [GO:0043219]; neuronal cell body [GO:0043025]; PAR polarity complex [GO:0120157]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]",GO:0007010; GO:0007155; GO:0007163; GO:0008289; GO:0034330; GO:0043226; GO:0048870,cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell junction organization; organelle; cell motility
OG_05755,0.2870669035521714,OG_05755,FUN_025690-T1,Peve_00005581,Pocillopora_meandrina_HIv1___RNAseq.g13163.t2b,three_way,57.99366666666667,,,,,,,,,,,,,,,,,
OG_00171,0.2870633394942517,OG_00171,FUN_000857-T1,Peve_00004526,Pocillopora_meandrina_HIv1___RNAseq.g1863.t1,three_way,95.30166666666666,FUN_000857-T1,P61162,,,,,85.9,376.0,7.4e-198,691.0,sp|P61162|ACTZ_CANLF Alpha-centractin OS=Canis lupus familiaris OX=9615 GN=ACTR1A PE=2 SV=1,,,,,,
OG_03139,0.2870615730225748,OG_03139,FUN_012521-T1,Peve_00029780,Pocillopora_meandrina_HIv1___RNAseq.g23961.t1,three_way,79.82916666666667,FUN_012521-T1,Q3SZ90,RL13A_BOVIN,,Large ribosomal subunit protein uL13 (60S ribosomal protein L13a),Bos taurus (Bovine),63.1,195.0,5.899999999999999e-68,259.6,sp|Q3SZ90|RL13A_BOVIN Large ribosomal subunit protein uL13 OS=Bos taurus OX=9913 GN=RPL13A PE=2 SV=3,GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0032496; GO:0042592; GO:0045202; GO:0048246; GO:0060425; GO:0071346; GO:0097452; GO:1901194,cellular response to type II interferon [GO:0071346]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; synapse [GO:0045202],mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002376; GO:0003723; GO:0005198; GO:0005840; GO:0043226; GO:0048870,immune system process; RNA binding; structural molecule activity; ribosome; organelle; cell motility
OG_02321,0.2869196065802132,OG_02321,FUN_008913-T1,Peve_00033015,Pocillopora_meandrina_HIv1___RNAseq.g3978.t1,three_way,86.956,FUN_008913-T1,Q56K14,RLA1_BOVIN,,Large ribosomal subunit protein P1 (60S acidic ribosomal protein P1),Bos taurus (Bovine),67.7,65.0,1.8e-17,90.1,sp|Q56K14|RLA1_BOVIN Large ribosomal subunit protein P1 OS=Bos taurus OX=9913 GN=RPLP1 PE=3 SV=1,GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0030295; GO:0043021,cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414],cytosolic large ribosomal subunit [GO:0022625],protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0098772,cytoplasmic translation; structural molecule activity; molecular function regulator activity
OG_04224,0.2868719024830468,OG_04224,FUN_016988-T1,Peve_00025276,Pocillopora_meandrina_HIv1___RNAseq.g9895.t1,three_way,70.32283333333334,FUN_016988-T1,Q8CJ69,BMPER_MOUSE,,BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (mCV2),Mus musculus (Mouse),37.7,446.0,2.6e-92,340.9,sp|Q8CJ69|BMPER_MOUSE BMP-binding endothelial regulator protein OS=Mus musculus OX=10090 GN=Bmper PE=1 SV=1,GO:0001657; GO:0002043; GO:0005576; GO:0005615; GO:0010594; GO:0030509; GO:0030514; GO:0032880; GO:0042118; GO:0048839; GO:0060391; GO:0060395; GO:0062023; GO:0070374; GO:1903672,blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization [GO:0032880]; SMAD protein signal transduction [GO:0060395]; ureteric bud development [GO:0001657],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615],,GO:0005576; GO:0005615; GO:0048856,extracellular region; extracellular space; anatomical structure development
OG_09821,0.2868538845724126,OG_09821,FUN_042654-T1,Peve_00031585,Pocillopora_meandrina_HIv1___RNAseq.g4912.t1,three_way,68.26350000000001,FUN_042654-T1,Q9JJP2,P73_MOUSE,,Tumor protein p73 (p53-like transcription factor) (p53-related protein),Mus musculus (Mouse),45.5,266.0,9.2e-51,202.6,sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0001836; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005886; GO:0006954; GO:0006974; GO:0007346; GO:0009410; GO:0009791; GO:0010468; GO:0019901; GO:0021766; GO:0030054; GO:0030900; GO:0033326; GO:0036064; GO:0042771; GO:0042802; GO:0043410; GO:0043523; GO:0043524; GO:0045665; GO:0045793; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0048666; GO:0048714; GO:0051262; GO:0060044; GO:0061629; GO:0097371; GO:1901248; GO:1902167; GO:2001235,cerebrospinal fluid secretion [GO:0033326]; digestive tract morphogenesis [GO:0048546]; DNA damage response [GO:0006974]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein tetramerization [GO:0051262]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron apoptotic process [GO:0043523]; release of cytochrome c from mitochondria [GO:0001836]; response to xenobiotic stimulus [GO:0009410],cell junction [GO:0030054]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005886; GO:0006355; GO:0006954; GO:0007005; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; plasma membrane; regulation of DNA-templated transcription; inflammatory response; mitochondrion organization; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_06428,0.2868517964996114,OG_06428,FUN_029119-T1,Peve_00024538,Pocillopora_meandrina_HIv1___RNAseq.g25774.t1,three_way,82.585,FUN_029119-T1,C4R7Z3,C9MT_KOMPG,,Sphingolipid C9-methyltransferase (C-9-MT) (EC 2.1.1.317),Komagataella phaffii (strain GS115 / ATCC 20864) (Yeast) (Pichia pastoris),54.4,377.0,3.3e-115,416.8,sp|C4R7Z3|C9MT_KOMPG Sphingolipid C9-methyltransferase OS=Komagataella phaffii (strain GS115 / ATCC 20864) OX=644223 GN=PAS_chr4_0465 PE=1 SV=1,GO:0006665; GO:0008168; GO:0016020; GO:0032259,methylation [GO:0032259]; sphingolipid metabolic process [GO:0006665],membrane [GO:0016020],methyltransferase activity [GO:0008168],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_01294,0.2867238746228923,OG_01294,FUN_005118-T1,Peve_00026683,Pocillopora_meandrina_HIv1___RNAseq.g8264.t1,three_way,92.74866666666668,FUN_005118-T1,Q9VQ93,GOLP3_DROME,,Golgi phosphoprotein 3 homolog sauron (Protein rotini),Drosophila melanogaster (Fruit fly),72.3,267.0,1.4000000000000005e-111,404.1,sp|Q9VQ93|GOLP3_DROME Golgi phosphoprotein 3 homolog sauron OS=Drosophila melanogaster OX=7227 GN=sau PE=1 SV=1,GO:0000139; GO:0000281; GO:0000301; GO:0000915; GO:0005794; GO:0005802; GO:0005829; GO:0006890; GO:0007030; GO:0007053; GO:0007110; GO:0007111; GO:0007112; GO:0010314; GO:0031267; GO:0031410; GO:0031985; GO:0032154; GO:0032266; GO:0036089; GO:0043001; GO:0046718; GO:0048194; GO:0051225; GO:0070273; GO:0070300; GO:0090307; GO:0140312; GO:0140450,"actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; protein targeting to Golgi apparatus [GO:0140450]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053]; symbiont entry into host cell [GO:0046718]",cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],cargo adaptor activity [GO:0140312]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; small GTPase binding [GO:0031267],GO:0000910; GO:0005794; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0072659,cytokinesis; Golgi apparatus; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane
OG_03933,0.2867062064734312,OG_03933,FUN_016049-T1,Peve_00011814,Pocillopora_meandrina_HIv1___RNAseq.g21636.t1,three_way,52.112,,,,,,,,,,,,,,,,,
OG_01974,0.2866879412697263,OG_01974,FUN_008079-T1,Peve_00041217,Pocillopora_meandrina_HIv1___RNAseq.g30082.t1,three_way,88.34400000000001,FUN_008079-T1,Q9Z2Q4,,,,,69.2,1253.0,0.0,1754.2,sp|Q9Z2Q4|METH_RAT Methionine synthase OS=Rattus norvegicus OX=10116 GN=Mtr PE=1 SV=1,,,,,,
OG_02332,0.2866442322647901,OG_02332,FUN_008927-T1,Peve_00036396,Pocillopora_meandrina_HIv1___RNAseq.g4036.t1,three_way,85.159,FUN_008927-T1,Q6P268,PDCL3_DANRE,,Phosducin-like protein 3 (Viral IAP-associated factor 1 homolog),Danio rerio (Zebrafish) (Brachydanio rerio),52.8,248.0,1.9999999999999999e-63,243.8,sp|Q6P268|PDCL3_DANRE Phosducin-like protein 3 OS=Danio rerio OX=7955 GN=pdcl3 PE=2 SV=1,GO:0001525; GO:0005737; GO:0005783; GO:0006457; GO:0006915; GO:0010628; GO:0043184; GO:0044183; GO:0048471,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184],GO:0005783; GO:0006457; GO:0012501; GO:0043226; GO:0044183,endoplasmic reticulum; protein folding; programmed cell death; organelle; protein folding chaperone
OG_03635,0.2866328297843912,OG_03635,FUN_014855-T1,Peve_00038800,Pocillopora_meandrina_HIv1___RNAseq.g22371.t1,three_way,96.05733333333332,FUN_014855-T1,Q6P2Q9,PRP8_HUMAN,,Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220),Homo sapiens (Human),92.1,2321.0,0.0,4492.2,sp|Q6P2Q9|PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens OX=9606 GN=PRPF8 PE=1 SV=2,GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157,"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_02982,0.2865861012142935,OG_02982,FUN_012152-T1,Peve_00035458,Pocillopora_meandrina_HIv1___TS.g16648.t1,three_way,75.35416666666667,FUN_012152-T1,Q8NEN0,,,,,32.3,885.0,5.2000000000000004e-117,423.7,sp|Q8NEN0|ARMC2_HUMAN Armadillo repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=ARMC2 PE=1 SV=4,,,,,,
OG_04504,0.2865212879475566,OG_04504,FUN_022016-T1,Peve_00042666,Pocillopora_meandrina_HIv1___RNAseq.g3182.t2,three_way,75.399,FUN_022016-T1,P07228,,,,,38.2,808.0,2.6e-144,514.2,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_03801,0.2864785072040064,OG_03801,FUN_015184-T1,Peve_00023889,Pocillopora_meandrina_HIv1___RNAseq.g22343.t1,three_way,40.410833333333336,FUN_015184-T1,P34331,PLK1_CAEEL,,Serine/threonine-protein kinase plk-1 (EC 2.7.11.21) (Polo-like kinase 1),Caenorhabditis elegans,29.1,292.0,1.2e-19,100.1,sp|P34331|PLK1_CAEEL Serine/threonine-protein kinase plk-1 OS=Caenorhabditis elegans OX=6239 GN=plk-1 PE=1 SV=4,GO:0000776; GO:0000793; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007052; GO:0007077; GO:0007098; GO:0007147; GO:0030496; GO:0040038; GO:0045132; GO:0051233; GO:0051726; GO:0106310; GO:0110039,centrosome cycle [GO:0007098]; female meiosis II [GO:0007147]; meiotic chromosome segregation [GO:0045132]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic spindle organization [GO:0007052]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of nematode male tail tip morphogenesis [GO:0110039]; regulation of cell cycle [GO:0051726],centrosome [GO:0005813]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005634; GO:0005694; GO:0005815; GO:0007010; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0061024; GO:0140013; GO:0140096,"cytokinesis; catalytic activity; nucleus; chromosome; microtubule organizing center; cytoskeleton organization; chromosome segregation; transferase activity; reproductive process; organelle; membrane organization; meiotic nuclear division; catalytic activity, acting on a protein"
OG_07285,0.2864426135940192,OG_07285,FUN_033611-T1,Peve_00007851,Pocillopora_meandrina_HIv1___TS.g24988.t1b,three_way,76.69316666666667,FUN_033611-T1,Q80TP3,UBR5_MOUSE,,"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog)",Mus musculus (Mouse),42.4,2918.0,0.0,1864.0,sp|Q80TP3|UBR5_MOUSE E3 ubiquitin-protein ligase UBR5 OS=Mus musculus OX=10090 GN=Ubr5 PE=1 SV=2,GO:0003723; GO:0005634; GO:0005737; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0031647; GO:0032700; GO:0032991; GO:0033696; GO:0043130; GO:0045879; GO:0048471; GO:0050847; GO:0061630; GO:0071596; GO:0071629; GO:0071630; GO:0140861; GO:0141198,cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of gene expression [GO:0010628]; progesterone receptor signaling pathway [GO:0050847]; protein branched polyubiquitination [GO:0141198]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; DNA repair; chromatin organization; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_01757,0.2864103010891979,OG_01757,FUN_007100-T1,Peve_00033790,Pocillopora_meandrina_HIv1___RNAseq.g19049.t1b,three_way,84.0445,FUN_007100-T1,O95714,HERC2_HUMAN,,E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2),Homo sapiens (Human),53.6,4960.0,0.0,4944.0,sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283],centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; plasma membrane; DNA repair; intracellular protein transport; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08775,0.2863849234653778,OG_08775,FUN_038060-T1,Peve_00000948,Pocillopora_meandrina_HIv1___RNAseq.g795.t1,three_way,78.47183333333334,FUN_038060-T1,Q70CQ4,UBP31_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31),Homo sapiens (Human),42.1,537.0,7.000000000000003e-110,399.4,sp|Q70CQ4|UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens OX=9606 GN=USP31 PE=1 SV=2,GO:0004843; GO:0005634; GO:0006508; GO:0016579,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_04067,0.2863001183319076,OG_04067,FUN_016388-T1,Peve_00033767,Pocillopora_meandrina_HIv1___RNAseq.g9766.t1,three_way,44.09583333333333,,,,,,,,,,,,,,,,,
OG_01343,0.2862740878742785,OG_01343,FUN_005244-T1,Peve_00003366,Pocillopora_meandrina_HIv1___RNAseq.g8140.t2,three_way,77.56250000000001,FUN_005244-T1,Q8TDJ6,,,,,34.9,3319.0,0.0,1533.5,sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2,,,,,,
OG_08459,0.2862697334049177,OG_08459,FUN_037228-T1,Peve_00044304,Pocillopora_meandrina_HIv1___TS.g13535.t1,three_way,54.508833333333335,,,,,,,,,,,,,,,,,
OG_07349,0.286242238147792,OG_07349,FUN_033756-T1,Peve_00004915,Pocillopora_meandrina_HIv1___RNAseq.g28747.t1,three_way,85.5945,FUN_033756-T1,Q13136,LIPA1_HUMAN,,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),Homo sapiens (Human),45.4,1218.0,1.3e-187,658.7,sp|Q13136|LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1,GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077,cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; spine apparatus [GO:0097444],,GO:0005829; GO:0007010; GO:0007155; GO:0034330; GO:0043226,cytosol; cytoskeleton organization; cell adhesion; cell junction organization; organelle
OG_08912,0.2862135367081938,OG_08912,FUN_038346-T1,Peve_00000091,Pocillopora_meandrina_HIv1___RNAseq.g1103.t2,three_way,68.69033333333334,FUN_038346-T1,Q9JJW6,ALRF2_MOUSE,,Aly/REF export factor 2 (Alyref) (RNA and export factor-binding protein 2),Mus musculus (Mouse),62.2,164.0,9.5e-45,181.8,sp|Q9JJW6|ALRF2_MOUSE Aly/REF export factor 2 OS=Mus musculus OX=10090 GN=Alyref2 PE=1 SV=1,GO:0003697; GO:0003723; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0051028,mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380],cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681],RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003723; GO:0016071,DNA binding; RNA binding; mRNA metabolic process
OG_04737,0.2859447390039367,OG_04737,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_05330,0.2859445575766041,OG_05330,FUN_024034-T1,Peve_00020334,Pocillopora_meandrina_HIv1___RNAseq.g19276.t1,three_way,96.28633333333332,FUN_024034-T1,P30676,,,,,85.9,354.0,2e-176,619.8,sp|P30676|GNAI_PATPE Guanine nucleotide-binding protein G(i) subunit alpha OS=Patiria pectinifera OX=7594 PE=1 SV=3,,,,,,
OG_02390,0.285933437359101,OG_02390,FUN_009014-T1,Peve_00021062,Pocillopora_meandrina_HIv1___RNAseq.g14291.t1,three_way,68.24033333333333,FUN_009014-T1,Q3U0M1,TPPC9_MOUSE,,Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein),Mus musculus (Mouse),31.7,1140.0,3e-141,504.6,sp|Q3U0M1|TPPC9_MOUSE Trafficking protein particle complex subunit 9 OS=Mus musculus OX=10090 GN=Trappc9 PE=1 SV=2,GO:0005737; GO:0005783; GO:0006888; GO:0006901; GO:0021987; GO:0030182; GO:0099022; GO:1990071,cerebral cortex development [GO:0021987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neuron differentiation [GO:0030182]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; TRAPPII protein complex [GO:1990071],,GO:0005783; GO:0016192; GO:0030154; GO:0043226; GO:0048856,endoplasmic reticulum; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development
OG_06141,0.2859149558766732,OG_06141,FUN_027963-T1,Peve_00031347,Pocillopora_meandrina_HIv1___RNAseq.g14047.t1,three_way,67.17033333333333,FUN_027963-T1,P16333,NCK1_HUMAN,,SH2/SH3 adapter protein NCK1 (Cytoplasmic protein NCK1) (NCK adapter protein 1) (Nck-1) (SH2/SH3 adapter protein NCK-alpha),Homo sapiens (Human),41.3,380.0,7e-76,285.8,sp|P16333|NCK1_HUMAN SH2/SH3 adapter protein NCK1 OS=Homo sapiens OX=9606 GN=NCK1 PE=1 SV=1,GO:0000122; GO:0000164; GO:0004860; GO:0005102; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007172; GO:0008093; GO:0010976; GO:0012506; GO:0016477; GO:0019904; GO:0030032; GO:0030159; GO:0030334; GO:0030674; GO:0030838; GO:0030971; GO:0034976; GO:0035591; GO:0036491; GO:0036493; GO:0042102; GO:0042110; GO:0045296; GO:0045944; GO:0046627; GO:0046875; GO:0048013; GO:0050860; GO:0071074; GO:0140311; GO:0140374; GO:0140693; GO:1902237; GO:1903676; GO:1903679; GO:1903898,"actin filament organization [GO:0007015]; antiviral innate immune response [GO:0140374]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036491]; response to endoplasmic reticulum stress [GO:0034976]; signal complex assembly [GO:0007172]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]",cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506],cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; molecular condensate scaffold activity [GO:0140693]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein sequestering activity [GO:0140311]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159],GO:0002376; GO:0005634; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0006355; GO:0043226; GO:0048870; GO:0060090; GO:0065003; GO:0098542; GO:0098772; GO:0140313,immune system process; nucleus; endoplasmic reticulum; cytosol; ribosome; plasma membrane; regulation of DNA-templated transcription; organelle; cell motility; molecular adaptor activity; protein-containing complex assembly; defense response to other organism; molecular function regulator activity; molecular sequestering activity
OG_08393,0.2859148483114187,OG_08393,FUN_037005-T1,Peve_00032342,Pocillopora_meandrina_HIv1___RNAseq.g26694.t1,three_way,58.15716666666667,FUN_037005-T1,Q9NZM4,BICRA_HUMAN,,BRD4-interacting chromatin-remodeling complex-associated protein (Glioma tumor suppressor candidate region gene 1 protein),Homo sapiens (Human),50.0,118.0,1.2e-22,110.5,sp|Q9NZM4|BICRA_HUMAN BRD4-interacting chromatin-remodeling complex-associated protein OS=Homo sapiens OX=9606 GN=BICRA PE=1 SV=2,GO:0000785; GO:0005634; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0045893; GO:0140288; GO:0140537; GO:1902459,chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],transcription regulator activator activity [GO:0140537],GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0098772,nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_01556,0.2858710900215808,OG_01556,FUN_006436-T1,Peve_00024930,Pocillopora_meandrina_HIv1___RNAseq.g20293.t1,three_way,69.03933333333335,FUN_006436-T1,Q8BW70,,,,,34.7,1038.0,8.4e-156,552.7,sp|Q8BW70|UBP38_MOUSE Ubiquitin carboxyl-terminal hydrolase 38 OS=Mus musculus OX=10090 GN=Usp38 PE=1 SV=2,,,,,,
OG_04742,0.2857596187458006,OG_04742,FUN_022619-T1,Peve_00012271,Pocillopora_meandrina_HIv1___TS.g21800.t2,three_way,49.095333333333336,FUN_022619-T1,A8QMS7,,,,,33.0,282.0,6.9e-33,142.5,sp|A8QMS7|MYD88_TAKRU Myeloid differentiation primary response protein MyD88 OS=Takifugu rubripes OX=31033 GN=myd88 PE=2 SV=1,,,,,,
OG_10114,0.2857188820224951,OG_10114,FUN_043484-T1,Peve_00021709,Pocillopora_meandrina_HIv1___RNAseq.g7934.t1,three_way,54.963,FUN_043484-T1,Q8R2H1,,,,,25.2,357.0,1.1e-17,92.4,sp|Q8R2H1|IKBL1_RAT NF-kappa-B inhibitor-like protein 1 OS=Rattus norvegicus OX=10116 GN=Nfkbil1 PE=2 SV=2,,,,,,
OG_05054,0.2856646100919518,OG_05054,FUN_023250-T1,Peve_00019253,Pocillopora_meandrina_HIv1___RNAseq.g17400.t1,three_way,95.03433333333334,FUN_023250-T1,Q9GR88,,,,,85.8,431.0,4.2e-216,751.9,sp|Q9GR88|ERF1_POLMI Eukaryotic peptide chain release factor subunit 1 OS=Polyandrocarpa misakiensis OX=7723 GN=ERF1 PE=2 SV=1,,,,,,
OG_09814,0.285634718760542,OG_09814,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),49.4,1473.0,0.0,1337.0,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09814,0.285634718760542,OG_09814,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),30.0,247.0,2.5e-08,63.9,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09462,0.2856121519213455,OG_09462,FUN_041481-T1,Peve_00015167,Pocillopora_meandrina_HIv1___RNAseq.g15673.t1,three_way,81.04583333333333,FUN_041481-T1,Q6NVN0,SOX2_XENTR,,Transcription factor Sox-2 (SRY (sex determining region Y)-box 2),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),45.8,271.0,2.8e-42,174.1,sp|Q6NVN0|SOX2_XENTR Transcription factor Sox-2 OS=Xenopus tropicalis OX=8364 GN=sox2 PE=2 SV=1,GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0007399; GO:0008283; GO:0021522; GO:0021538; GO:0021982; GO:0031101; GO:0043565; GO:0045893; GO:0045944; GO:0048592; GO:0060119; GO:0071599; GO:1905040; GO:1905812,cell population proliferation [GO:0008283]; epithalamus development [GO:0021538]; eye morphogenesis [GO:0048592]; fin regeneration [GO:0031101]; inner ear receptor cell development [GO:0060119]; nervous system development [GO:0007399]; otic placode development [GO:1905040]; otic vesicle development [GO:0071599]; pineal gland development [GO:0021982]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of motor neuron axon guidance [GO:1905812]; spinal cord motor neuron differentiation [GO:0021522],cytoplasm [GO:0005737]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09893,0.2856088323690735,OG_09893,FUN_042972-T1,Peve_00039022,Pocillopora_meandrina_HIv1___RNAseq.g7104.t1,three_way,74.01466666666667,FUN_042972-T1,A5PMR2,UBP33_DANRE,,Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33),Danio rerio (Zebrafish) (Brachydanio rerio),44.1,884.0,6.5e-205,715.7,sp|A5PMR2|UBP33_DANRE Ubiquitin carboxyl-terminal hydrolase 33 OS=Danio rerio OX=7955 GN=usp33 PE=2 SV=1,GO:0004197; GO:0004843; GO:0005813; GO:0006508; GO:0006897; GO:0007399; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0048471; GO:0051298; GO:0070536; GO:0071108,axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],centrosome [GO:0005813]; perinuclear region of cytoplasm [GO:0048471],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0016192; GO:0016787; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; microtubule organizing center; vesicle-mediated transport; hydrolase activity; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_06984,0.2854927816775973,OG_06984,FUN_032123-T1,Peve_00040721,Pocillopora_meandrina_HIv1___RNAseq.g5374.t1,three_way,85.32833333333333,FUN_032123-T1,Q8K4B0,MTA1_MOUSE,,Metastasis-associated protein MTA1,Mus musculus (Mouse),52.5,571.0,1e-152,542.3,sp|Q8K4B0|MTA1_MOUSE Metastasis-associated protein MTA1 OS=Mus musculus OX=10090 GN=Mta1 PE=1 SV=1,GO:0000978; GO:0003682; GO:0003713; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005874; GO:0006302; GO:0006338; GO:0008270; GO:0010212; GO:0016581; GO:0032922; GO:0042659; GO:0043153; GO:0043161; GO:0045475; GO:0045814; GO:0045892; GO:0045893; GO:1902499; GO:2000736,"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]",cytoplasm [GO:0005737]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581],chromatin binding [GO:0003682]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005635; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0030163; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nuclear envelope; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; protein catabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_05789,0.2854499275018172,OG_05789,FUN_025767-T1,Peve_00021328,Pocillopora_meandrina_HIv1___RNAseq.g10372.t1,three_way,75.75,FUN_025767-T1,P31508,,,,,64.9,37.0,9.2e-06,52.4,sp|P31508|ESCA_APIME Escargot/snail protein homolog (Fragment) OS=Apis mellifera OX=7460 PE=3 SV=1,,,,,,
OG_01760,0.2852882982692644,OG_01760,FUN_007115-T1,Peve_00017834,Pocillopora_meandrina_HIv1___TS.g28404.t1,three_way,70.838,FUN_007115-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),30.5,1384.0,1.1000000000000001e-164,582.8,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_02474,0.2852366763016946,OG_02474,FUN_009677-T1,Peve_00024097,Pocillopora_meandrina_HIv1___RNAseq.g24567.t1,three_way,78.88666666666667,FUN_009677-T1,Q54LV8,,,,,59.6,94.0,9.6e-25,114.0,sp|Q54LV8|RL34_DICDI Large ribosomal subunit protein eL34 OS=Dictyostelium discoideum OX=44689 GN=rpl34 PE=3 SV=1,,,,,,
OG_08653,0.2852241466509641,OG_08653,FUN_037849-T1,Peve_00002752,Pocillopora_meandrina_HIv1___RNAseq.g1438.t1,three_way,68.4055,,,,,,,,,,,,,,,,,
OG_02630,0.2852189026134595,OG_02630,FUN_010783-T1,Peve_00004471,Pocillopora_meandrina_HIv1___RNAseq.g21210.t1,three_way,72.516,FUN_010783-T1,Q8IXJ9,,,,,32.9,429.0,7.2e-42,173.7,sp|Q8IXJ9|ASXL1_HUMAN Polycomb group protein ASXL1 OS=Homo sapiens OX=9606 GN=ASXL1 PE=1 SV=4,,,,,,
OG_07598,0.2851872406684233,OG_07598,FUN_034312-T1,Peve_00011305,Pocillopora_meandrina_HIv1___RNAseq.g28493.t1,three_way,91.465,FUN_034312-T1,Q9VSF3,UBC2M_DROME,,Nedd8-conjugating enzyme UbcE2M (EC 2.3.2.34) (Nedd8 carrier protein),Drosophila melanogaster (Fruit fly),74.9,179.0,1.4e-77,290.4,sp|Q9VSF3|UBC2M_DROME Nedd8-conjugating enzyme UbcE2M OS=Drosophila melanogaster OX=7227 GN=UbcE2M PE=1 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0036211; GO:0045116; GO:0045879; GO:0061059; GO:0061654,negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein modification process [GO:0036211]; protein neddylation [GO:0045116],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03566,0.2851541221271726,OG_03566,FUN_014715-T1,Peve_00023482,Pocillopora_meandrina_HIv1___RNAseq.g22525.t1,three_way,70.94933333333333,FUN_014715-T1,Q5RA75,,,,,35.2,1159.0,4.4e-158,560.5,sp|Q5RA75|F135A_PONAB Protein FAM135A OS=Pongo abelii OX=9601 GN=FAM135A PE=2 SV=1,,,,,,
OG_02508,0.285082666896573,OG_02508,FUN_010020-T1,Peve_00036457,Pocillopora_meandrina_HIv1___RNAseq.g24255.t1,three_way,74.96866666666666,FUN_010020-T1,Q7ZWN6,Z703A_XENLA,,Zinc finger protein 703-A,Xenopus laevis (African clawed frog),29.2,517.0,1.9e-22,108.6,sp|Q7ZWN6|Z703A_XENLA Zinc finger protein 703-A OS=Xenopus laevis OX=8355 GN=znf703-a PE=2 SV=2,GO:0005634; GO:0005737; GO:0008270; GO:0016363; GO:0017015; GO:0030335; GO:0034111; GO:0034333; GO:0045892; GO:0051726; GO:0060828,adherens junction assembly [GO:0034333]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],zinc ion binding [GO:0008270],GO:0005634; GO:0006355; GO:0034330; GO:0043226,nucleus; regulation of DNA-templated transcription; cell junction organization; organelle
OG_05121,0.2850129085082138,OG_05121,FUN_023383-T1,Peve_00015212,Pocillopora_meandrina_HIv1___TS.g17098.t2,three_way,73.90266666666666,FUN_023383-T1,Q26534,,,,,53.8,314.0,1.4e-95,351.7,sp|Q26534|CATL_SCHMA Cathepsin L OS=Schistosoma mansoni OX=6183 GN=CL1 PE=2 SV=1,,,,,,
OG_00550,0.2849358898109592,OG_00550,FUN_001591-T1,Peve_00023228,Pocillopora_meandrina_HIv1___RNAseq.g1993.t1,three_way,76.23216666666666,FUN_001591-T1,Q9H0F5,,,,,47.2,125.0,2.9000000000000002e-30,134.4,sp|Q9H0F5|RNF38_HUMAN E3 ubiquitin-protein ligase RNF38 OS=Homo sapiens OX=9606 GN=RNF38 PE=1 SV=4,,,,,,
OG_09361,0.2846949380982539,OG_09361,FUN_040473-T1,Peve_00004019,Pocillopora_meandrina_HIv1___TS.g256.t1,three_way,67.65716666666667,FUN_040473-T1,Q68ED7,CRTC1_MOUSE,,CREB-regulated transcription coactivator 1 (Mucoepidermoid carcinoma translocated protein 1 homolog) (Transducer of regulated cAMP response element-binding protein 1) (TORC-1) (Transducer of CREB protein 1),Mus musculus (Mouse),36.4,132.0,1.2e-08,62.4,sp|Q68ED7|CRTC1_MOUSE CREB-regulated transcription coactivator 1 OS=Mus musculus OX=10090 GN=Crtc1 PE=1 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007613; GO:0008140; GO:0016604; GO:0032793; GO:0043153; GO:0045944; GO:0048511; GO:0051289; GO:0097009; GO:1902631,energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886],cAMP response element binding protein binding [GO:0008140],GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0050877; GO:0065003,nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; nervous system process; protein-containing complex assembly
OG_01685,0.2846771309442981,OG_01685,FUN_006917-T1,Peve_00044394,Pocillopora_meandrina_HIv1___RNAseq.g19806.t1,three_way,80.5865,FUN_006917-T1,E2RQ08,RPN1_CANLF,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Ribophorin I) (RPN-I) (Ribophorin-1),Canis lupus familiaris (Dog) (Canis familiaris),50.0,580.0,2.0000000000000005e-165,583.9,sp|E2RQ08|RPN1_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 OS=Canis lupus familiaris OX=9615 GN=RPN1 PE=1 SV=1,GO:0005791; GO:0005829; GO:0006486; GO:0008250; GO:0018279; GO:0160226; GO:0160227,protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279],cytosol [GO:0005829]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226]; oligosaccharyltransferase complex B [GO:0160227]; rough endoplasmic reticulum [GO:0005791],,GO:0005783; GO:0005829; GO:0006486; GO:0009101; GO:0043226; GO:1901135,endoplasmic reticulum; cytosol; protein glycosylation; glycoprotein biosynthetic process; organelle; carbohydrate derivative metabolic process
OG_07261,0.2846732830669965,OG_07261,FUN_033038-T1,Peve_00017501,Pocillopora_meandrina_HIv1___RNAseq.g24448.t1,three_way,84.66233333333334,FUN_033038-T1,Q5ZM55,,,,,46.0,624.0,7.899999999999999e-83,309.7,sp|Q5ZM55|FEM1B_CHICK Protein fem-1 homolog B OS=Gallus gallus OX=9031 GN=FEM1B PE=2 SV=1,,,,,,
OG_09716,0.2846473706121172,OG_09716,FUN_041962-T1,Peve_00043495,Pocillopora_meandrina_HIv1___RNAseq.g15154.t1,three_way,93.26933333333334,FUN_041962-T1,P20340,RAB6A_HUMAN,,Ras-related protein Rab-6A (Rab-6) (EC 3.6.5.2),Homo sapiens (Human),85.4,205.0,1.1e-94,347.4,sp|P20340|RAB6A_HUMAN Ras-related protein Rab-6A OS=Homo sapiens OX=9606 GN=RAB6A PE=1 SV=3,GO:0000139; GO:0002080; GO:0003924; GO:0005525; GO:0005654; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006890; GO:0006891; GO:0012505; GO:0016020; GO:0018125; GO:0019882; GO:0019904; GO:0030667; GO:0031175; GO:0031410; GO:0031489; GO:0032588; GO:0034067; GO:0034498; GO:0036064; GO:0042147; GO:0070062; GO:0070381; GO:0072385; GO:1903292,"antigen processing and presentation [GO:0019882]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; minus-end-directed organelle transport along microtubule [GO:0072385]; neuron projection development [GO:0031175]; peptidyl-cysteine methylation [GO:0018125]; protein localization to Golgi apparatus [GO:0034067]; protein localization to Golgi membrane [GO:1903292]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",acrosomal membrane [GO:0002080]; ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904],GO:0002376; GO:0003824; GO:0003924; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0031410; GO:0043226,immune system process; catalytic activity; GTPase activity; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_07569,0.2846441036200551,OG_07569,FUN_034231-T1,Peve_00000637,Pocillopora_meandrina_HIv1___RNAseq.g28439.t1,three_way,80.96333333333334,FUN_034231-T1,Q8VI63,,,,,46.2,212.0,1.0999999999999999e-47,191.4,sp|Q8VI63|MOB2_MOUSE MOB kinase activator 2 OS=Mus musculus OX=10090 GN=Mob2 PE=1 SV=1,,,,,,
OG_03414,0.2846436843827926,OG_03414,FUN_014462-T1,Peve_00023416,Pocillopora_meandrina_HIv1___RNAseq.g22646.t2,three_way,80.2825,FUN_014462-T1,Q9C086,IN80B_HUMAN,,INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog) (hIes2) (PAP-1-associated protein 1) (PAPA-1) (Zinc finger HIT domain-containing protein 4),Homo sapiens (Human),52.8,195.0,3.8e-12,73.9,sp|Q9C086|IN80B_HUMAN INO80 complex subunit B OS=Homo sapiens OX=9606 GN=INO80B PE=1 SV=2,GO:0000723; GO:0005654; GO:0005730; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0008270; GO:0016604; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],Ino80 complex [GO:0031011]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],zinc ion binding [GO:0008270],GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226,nucleoplasm; nucleolus; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle
OG_02822,0.2845749008692166,OG_02822,FUN_011810-T1,Peve_00020919,Pocillopora_meandrina_HIv1___RNAseq.g23237.t1,three_way,64.20366666666666,,,,,,,,,,,,,,,,,
OG_09805,0.2845441081307115,OG_09805,FUN_042623-T1,Peve_00016196,Pocillopora_meandrina_HIv1___RNAseq.g11512.t1,three_way,79.597,FUN_042623-T1,Q5F3Z7,,,,,46.0,448.0,2.6e-95,350.5,sp|Q5F3Z7|CTSL2_CHICK CTD small phosphatase-like protein 2 OS=Gallus gallus OX=9031 GN=CTDSPL2 PE=2 SV=2,,,,,,
OG_00372,0.2845289843321942,OG_00372,FUN_001213-T1,Peve_00033813,Pocillopora_meandrina_HIv1___RNAseq.g29512.t1,three_way,79.601,FUN_001213-T1,P20072,,,,,62.2,312.0,2.1999999999999997e-105,384.4,sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2,,,,,,
OG_05906,0.2844231025186746,OG_05906,FUN_026093-T1,Peve_00036299,Pocillopora_meandrina_HIv1___RNAseq.g10574.t1a,three_way,64.66183333333333,FUN_026093-T1,Q9Y6M1,IF2B2_HUMAN,,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),Homo sapiens (Human),30.0,474.0,8.6e-34,146.4,sp|Q9Y6M1|IF2B2_HUMAN Insulin-like growth factor 2 mRNA-binding protein 2 OS=Homo sapiens OX=9606 GN=IGF2BP2 PE=1 SV=2,GO:0000932; GO:0001817; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007399; GO:0009653; GO:0010494; GO:0017148; GO:0043489; GO:0045182; GO:0048027; GO:0051028; GO:0070934; GO:0097009; GO:0106106; GO:1990247,anatomical structure morphogenesis [GO:0009653]; cold-induced thermogenesis [GO:0106106]; CRD-mediated mRNA stabilization [GO:0070934]; energy homeostasis [GO:0097009]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; RNA stabilization [GO:0043489],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182],GO:0003723; GO:0005634; GO:0005829; GO:0005856; GO:0043226; GO:0045182; GO:0048856; GO:0060090,RNA binding; nucleus; cytosol; cytoskeleton; organelle; translation regulator activity; anatomical structure development; molecular adaptor activity
OG_09021,0.2842715973941062,OG_09021,FUN_038610-T1,Peve_00002803,Pocillopora_meandrina_HIv1___RNAseq.g988.t1,three_way,58.11266666666667,FUN_038610-T1,Q60437,BAIP2_CRIGR,,BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2) (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53),Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),31.7,221.0,2.2e-23,111.7,sp|Q60437|BAIP2_CRIGR BAR/IMD domain-containing adapter protein 2 OS=Cricetulus griseus OX=10029 GN=BAIAP2 PE=1 SV=1,GO:0001726; GO:0005654; GO:0005829; GO:0005856; GO:0007009; GO:0008093; GO:0008360; GO:0016020; GO:0030175; GO:0030838; GO:0032956; GO:0051017; GO:0051764; GO:0070064,actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin filament polymerization [GO:0030838]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ruffle [GO:0001726],cytoskeletal anchor activity [GO:0008093]; proline-rich region binding [GO:0070064],GO:0005654; GO:0005829; GO:0005856; GO:0043226; GO:0060090; GO:0061024,nucleoplasm; cytosol; cytoskeleton; organelle; molecular adaptor activity; membrane organization
OG_03055,0.2842713534005844,OG_03055,FUN_012302-T1,Peve_00038607,Pocillopora_meandrina_HIv1___RNAseq.g23764.t1,three_way,58.20183333333334,FUN_012302-T1,Q640M1,,,,,32.3,764.0,3.5e-72,274.6,sp|Q640M1|UT14A_MOUSE U3 small nucleolar RNA-associated protein 14 homolog A OS=Mus musculus OX=10090 GN=Utp14a PE=1 SV=1,,,,,,
OG_06624,0.2840945430553649,OG_06624,FUN_030046-T1,Peve_00008452,Pocillopora_meandrina_HIv1___RNAseq.g17345.t1,three_way,89.0,FUN_030046-T1,Q1JPX3,,,,,66.2,497.0,2.4e-196,686.4,sp|Q1JPX3|SYFA_DANRE Phenylalanine--tRNA ligase alpha subunit OS=Danio rerio OX=7955 GN=farsa PE=2 SV=2,,,,,,
OG_05043,0.2840070287174004,OG_05043,FUN_023227-T1,Peve_00029804,Pocillopora_meandrina_HIv1___RNAseq.g717.t1,three_way,76.54016666666666,FUN_023227-T1,Q8NB25,F184A_HUMAN,,Protein FAM184A,Homo sapiens (Human),26.8,1100.0,2.1e-22,109.8,sp|Q8NB25|F184A_HUMAN Protein FAM184A OS=Homo sapiens OX=9606 GN=FAM184A PE=1 SV=3,GO:0000932; GO:0005615; GO:0005829; GO:0034451; GO:0036064; GO:0043231,,centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; P-body [GO:0000932],,GO:0005615; GO:0005815; GO:0005829; GO:0043226,extracellular space; microtubule organizing center; cytosol; organelle
OG_09336,0.2839924858723224,OG_09336,FUN_040299-T1,Peve_00038649,Pocillopora_meandrina_HIv1___TS.g20792.t1,three_way,42.627833333333335,FUN_040299-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),24.5,4769.0,0.0,1096.6,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_04972,0.283927434440023,OG_04972,FUN_023079-T1,Peve_00038939,Pocillopora_meandrina_HIv1___RNAseq.g1654.t1,three_way,68.149,FUN_023079-T1,Q09326,MGAT2_RAT,,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)",Rattus norvegicus (Rat),42.2,417.0,1.4e-95,351.7,"sp|Q09326|MGAT2_RAT Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Rattus norvegicus OX=10116 GN=Mgat2 PE=1 SV=1",GO:0000139; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0015934; GO:0018279; GO:0030145; GO:0030246; GO:0042803; GO:0098556,oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; large ribosomal subunit [GO:0015934],"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0005975; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_09034,0.2839161651453454,OG_09034,FUN_038634-T1,Peve_00013495,Pocillopora_meandrina_HIv1___RNAseq.g26493.t1,three_way,76.94633333333333,FUN_038634-T1,Q99PT9,KIF19_MOUSE,,Kinesin-like protein KIF19,Mus musculus (Mouse),46.3,864.0,9.200000000000002e-180,632.5,sp|Q99PT9|KIF19_MOUSE Kinesin-like protein KIF19 OS=Mus musculus OX=10090 GN=Kif19 PE=1 SV=2,GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0060404; GO:0070462,axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462],axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; plus-end-directed microtubule motor activity [GO:0008574],GO:0003774; GO:0003824; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_06635,0.2838886155031161,OG_06635,FUN_030183-T1,Peve_00004642,Pocillopora_meandrina_HIv1___RNAseq.g17361.t1,three_way,86.83633333333333,FUN_030183-T1,Q4ZIN3,MBRL_HUMAN,,Membralin (Transmembrane protein 259),Homo sapiens (Human),57.5,454.0,1.4999999999999998e-127,458.0,sp|Q4ZIN3|MBRL_HUMAN Membralin OS=Homo sapiens OX=9606 GN=TMEM259 PE=1 SV=1,GO:0005783; GO:0005789; GO:0034976; GO:1904294,positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],,GO:0005783; GO:0043226,endoplasmic reticulum; organelle
OG_02358,0.2838396470593947,OG_02358,FUN_008961-T1,Peve_00006948,Pocillopora_meandrina_HIv1___RNAseq.g4042.t1,three_way,60.446,,,,,,,,,,,,,,,,,
OG_01240,0.2837741561419681,OG_01240,FUN_004926-T1,Peve_00034769,Pocillopora_meandrina_HIv1___RNAseq.g8365.t1,three_way,75.525,,,,,,,,,,,,,,,,,
OG_01639,0.2837680709044804,OG_01639,FUN_006776-T1,Peve_00012349,Pocillopora_meandrina_HIv1___RNAseq.g20024.t1,three_way,61.361666666666665,FUN_006776-T1,Q5F489,,,,,35.5,262.0,1.3000000000000001e-30,136.3,sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1,,,,,,
OG_01639,0.2837680709044804,OG_01639,FUN_006776-T1,Peve_00012349,Pocillopora_meandrina_HIv1___RNAseq.g20024.t1,three_way,61.361666666666665,FUN_006776-T1,Q5F489,,,,,54.2,72.0,2.9e-14,82.0,sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1,,,,,,
OG_05882,0.2837528481867898,OG_05882,FUN_026035-T1,Peve_00022186,Pocillopora_meandrina_HIv1___TS.g13968.t3,three_way,87.66533333333334,FUN_026035-T1,Q5ZKI4,,,,,58.3,604.0,6.5000000000000004e-186,652.1,sp|Q5ZKI4|CCD93_CHICK Coiled-coil domain-containing protein 93 OS=Gallus gallus OX=9031 GN=CCDC93 PE=2 SV=1,,,,,,
OG_06022,0.2837376649695202,OG_06022,FUN_026564-T1,Peve_00043274,Pocillopora_meandrina_HIv1___RNAseq.g4519.t1,three_way,45.92583333333333,FUN_026564-T1,Q9DD78,,,,,32.7,107.0,3.3e-12,75.1,sp|Q9DD78|TLR21_CHICK Toll-like receptor 2 type-1 OS=Gallus gallus OX=9031 GN=TLR2-1 PE=2 SV=1,,,,,,
